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Abbreviations Commonly Used in This Thesis.
bp base pair
CIAP calf intestinal alkaline phosphatase
cMGF chicken myelomonocytic growth factor
Con A concanavalin A
DEAE diethylaminoethyl
EDF eosinophil differentiation factor
EDTA ethylenediamine tetraacetic acid
G-, GM-, M-CSF granulocyte-, granulocyte-macrophage
Hepes
macrophage-colony stimulating factor 






LTR long terminal repeat
MCGF mast cell growth factor
MES 2-N-morpholino-ethanesulphonic acid
PFU plaque forming units
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Interleukin-3 (IL-3) is a multilineage haemopoietic growth 
regulator, normally expressed by activated T lymphocytes 
(Garland, 1984; Nicola and Vadas, 1984; Hapel e_t al_., 1985a;
Iscove and Roitsch, 1985; Rennick et a^L., 1985). However, the 
murine myelomonocytic leukaemia cell line WEHI-3B (Warner, Moore 
and Metcalf, 1969; Metcalf and Nicola, 1982) produces IL-3 
constitutively (Metcalf, Moore and Warner, 1969; Ralph, Moore and 
Nilsson, 1976; Lee, Hapel and Ihle, 1982) and does not appear to 
produce significant levels of the other lymphokines normally 
secreted by T lymphocytes after stimulation (Dr. A. Hapel, 
unpublished data). It has been proposed that the genetic change 
leading to the constitutive expression of IL-3 may have been a 
key event in the development of this leukaemia (Dexter and Allen, 
1983; Schrader and Crapper, 1983; Garland, 1984; Iscove and 
Roitsch, 1985). The aim of this thesis was to characterize the 
change that led to the altered expression of IL-3 in the 
leukaemia cell line WEHI-3B.
Initially a survey of DNA from various mouse strains and
cell lines, using the Southern blot technique and an IL-3 cDNA
(Fung et_ 1984) as probe, revealed a single copy of the IL-3
haploid
gene in the mouse^genome displaying restriction site polymorphism 
(Campbell e_t al_., 1985). The Southern blot of the WEHI-3B cell
line DNA suggested the presence of the normal gene together with 
a rearranged one.
To investigate the nature of this rearrangement, genomic X 
clones carrying the IL-3 genes were isolated from a WEHI-3B X
( V)
library. Restriction mapping, blotting and partial sequencing 
revealed that in the rearranged gene there was a 5.0 kb insertion 
present 215 bp upstream of the IL-3 promoter (Ymer et al., 1985). 
This insertion was identified as an intracisternal A-particle 
(IAP) genome, one of a family of endogenous retrovira1-1ike 
elements reiterated approximately 1,000-fold per mouse haploid 
genome (Lueders and Kuff, 1977 and 1980; Ono e_t al., 1980). IAP 
genomes can act as mobile elements, and have influenced the 
expression of other mouse genes. For example, the cellular 
oncogene c-mos has been shown to be activated by IAP insertion 
(Canaani et al., 1983; Horowitz e_t al., 1984) whereas insertional 
inactivation of a K-chain gene by an IAP genome has also been 
reported (Kuff et a_l., 1983; Hawley, Shulman and Hozumi, 1984).
Expression studies were carried out involving the 
transfection of A clones into BALB/c NIH 3T3 cells and monkey 
COS-1 cells. Clones carrying the rearranged IL-3 gene produced 
high levels of IL-3 whereas those containing the normal gene 
produced no significant levels. These results confirm that the 
IAP genome insertion upstream of the IL-3 gene is responsible for 
altered IL-3 expression. This may be due to one of several 
mechanisms. The proximity of the long terminal repeat (LTR) to 
the IL-3 gene could provide an enhancer. Alternatively, the IAP 
genome may have insertionally inactivated a cis-acting regulatory 
sequence or moved it upstream away from the IL-3 gene. It is 
thus possible that WEHI-3B arose initially from a neutrophil- 
macrophage progenitor cell and the activation of the IL-3 gene 
may have been an important transitional step in the production of
this leukaemia.
(Vi)
The IAP element present in the rearranged IL-3 gene (IAP- 
IL3) was completely sequenced providing the first sequence of an 
IAP element which had recently transposed (Ymer e_t al., 1986).
Sequence comparisons enabled some clarification of its structure 
and evolutionary relationship with other retroviruses. IAP-IL3 
was found to be 5095 bp in length, with identical LTRs of 337 bp. 
The LTRs show many of the conserved sequence elements identified 
in other retroviruses. Comparison with other available sequence 
of IAP genomes (Burt, Reith and Brammar, 1984; Ono et^  a_l., 1985;
Lueders and Mietz, 1986) indicates that IAP-IL3 is a deleted type 
I element. It carries a deletion covering the 3' end of the 
putative IAP gag gene and extending into the 5' end of the 
putative IAP pol gene. Comparison between the pol region of IAP- 
IL3 and other retroviruses suggests that IAP-IL3 is most closely 
related to type B and type D retroviruses.
IAP-IL3 has extensive sequence homology with an IgE-binding 
factor cDNA (Martens et al., 1985) and evidence presented here 
indicates that it was derived from a member of the mouse IAP 
sequence family (Ymer and Young, 1986). This raises the 
interesting possibility that some members of the highly 
reiterated mouse IAP sequence family may evolve to encode 
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The haemopoietic growth factor interleukin-3.
1. Introduction
The haemopoietic system maintains balanced levels of the 
various blood cell types and responds to physiological challenge, 
such as hypoxia, bleeding or infection, by transiently altering 
the output of cells of a given lineage. All blood cells are 
believed to originate from a small population of multipotential 
stem cells that is formed during early embryonic life and 
thereafter maintains haemopoiesis by extensive self-regeneration. 
Thus, haemopoietic progenitor cells proliferate actively as they 
undergo an ordered sequence of committment and differentiation 
steps (Till and McCulloch, 1980). Two mechanisms normally act in 
concert to keep the population size of haemopoietic cells within 
physiological limits. First, differentiation eventually leads to 
terminal cells that have either lost the capacity to divide 
(erythrocytes, platelets, granulocytes) or which enter a 
quiescent state (macrophages, lymphocytes). Second, the 
survival, growth and differentiation of haemopoietic precursor 
cells are dependent upon the presence of specific growth factors, 
which act at various points of the different lineages (Schrader 
et al., 1983; Iscove, 1984; Nicola and Vadas, 1984; Metcalf,
1986). Derangements of this complex process of blood cell 
formation do occur and result in diseases ranging from anaemia to 
leukaemia.
2. Nomenclature of haemopoietic factors.
As yet there is no uniform nomenclature for growth factors 
involved in haemopoiesis. They were initially known as 
"lymphokines" (Dumonde e_t al., 1969) or "monokines" depending on
1
the secreting cell type. They were also defined on the basis of 
their biological activity in particular assays. For example, the 
term "colony-stimulating factor" or CSF has been used to describe 
factors which promote the formation of colonies of differentiated 
cells from committed progenitor cells _in vitro. Four different 
CSFs have been distinguished by Metcalf (1981): Granulocyte,
Granulocyte-Macrophage, Macrophage and Multicolony CSFs (G-CSF,
GM-CSF, M-CSF and Multi-CSF).
A more systematic term "interleukin" has been proposed to 
name those factors that act as communication signals between 
different populations of leukocytes (Aarden e_t a_l., 1979). The
names interleukin-1 (IL—1) and interleukin-2 (IL-2) were 
introduced to define two factors which were distinguished by 
their biological and biochemical characteristics. IL-1 was 
defined as a macrophage-derived factor which facilitates the 
production of other lymphokines by helper T cells (Gery and 
Handschumacher, 1974; Larsson, Iscove and Coutinho, 1980; Smith, 
Gilbride and Favata, 1980; Smith e_t cLL., 1980). IL-2 was defined 
as a factor which mediates the differentiation and amplification 
of cytotoxic T cells (Di Sabato, Chen and Erickson, 1975; Morgan, 
Ruscetti and Gallo, 1976; Gillis and Smith, 1977; Watson e_t al., 
1979; Smith, 1980).
Other interleukins have subsequently been described, such as 
IL-3, the subject of this thesis and which is discussed in more 
detail belcw. Recently a lymphokine known as B cell growth 
factor or B cell stimulatory factor 1 has been designated as IL-4 
(Mom a e_t a_l., 1986; Smith e_t aJN , 1986; Yokota e_t al_., 1 986 ). It 
is involved in the co-stimulation of anti-IgM-activated B cells,
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i n d u c t i o n  o f  l a  a n t i g e n  on r e s t i n g  B c e l l s  a n d  s t i m u l a t i o n  o f  I g E  
a n d  I g G l  p r o d u c t i o n ,  a s  w e l l  a s  p o s s e s s i n g  T c e l l  a n d  m a s t  c e l l  
g r o w t h  f a c t o r  a c t i v i t i e s  d i s t i n c t  f r o m I L - 2  a n d  I L - 3  ( Ho wa r d  e t  
a l . ,  1982 ;  V i t e t t a  e t  a l . ,  1985 ;  C o f f m a n  a n d  C a r t y ,  1986 ;  Lee e t  
a l „  1986;  Noma et: a l . ,  1 9 8 6 ) .  A n o t h e r  f a c t o r  known a l s o  a s  
e o s i n o p h i l  d i f f e r e n t i a t i o n  f a c t o r  (EDF) o r  B c e l l  g r o w t h  f a c t o r  
I I  h a s  a l s o  b e e n  r e f e r r e d  t o  a s  I L - 4  ( O ' G a r r a  e_t a _ l . , 1 9 86 ;  
S a n d e r s o n  e t  a l . ,  1986)  b u t  K i n a s h i  e_t a l *  ( 1986)  h a v e  p r o p o s e d  
t o  c a l l  i t  I L - 5 .  T h i s  f a c t o r  h a s  m i t o g e n i c  a n d  d i f f e r e n t i a t i n g  
a c t i v i t y  on p r e - a c t i v a t e d  B c e l l s  ( O ' G a r r a  e_t al_. ,  1 9 8 6 ) .
The f i n d i n g  t h a t  f a c t o r s  s u c h  a s  I L - 1  a l s o  h a v e  e f f e c t s  on 
n o n - l y m p h o i d  t i s s u e  ( r e v i e w e d  by  O p p e n h e i m e t  a_l. ,  1986)  h a s  l e d
t o  a mor e  g e n e r a l i z e d  d e f i n i t i o n  o f  i n t e r l e u k i n s .  I t  h a s  b e e n  
s u g g e s t e d  t h a t  t h e  o n l y  r e l a t i o n s h i p  t o  l e u k o c y t e s  n e c e s s a r y  f o r  
a s u b s t a n c e  t o  c a r r y  a n  i n t e r l e u k i n  d e s i g n a t i o n  s h o u l d  be t h a t  i t  
i s  p r o d u c e d  by  l e u k o c y t e s  ( n o t  n e c e s s a r i l y  e x c l u s i v e l y )  a n d  t h a t  
i t  f u n c t i o n s  d u r i n g  i n f l a m m a t o r y  r e s p o n s e s  ( S m i t h  e t  a l . , 1 9 8 6 ) .
The i s o l a t i o n  a n d  e x p r e s s i o n  o f  cDNA c l o n e s  f o r  s u c h  f a c t o r s  
s h o u l d  a l l o w  v e r i f i c a t i o n  o f  t h e i r  b i o l o g i c a l  a c t i v i t i e s  u s i n g  
" r e c o m b i n a n t "  p r o t e i n s  a n d  a i d  i n  c l a r i f i c a t i o n  o f  t h e  
n o m e n c l a t u r e .
3 .  I L - 3  a nd  t h e  m u r i n e  l e u k a e m i a  c e l l  l i n e  WEHI-3B.
I h l e ,  P e p e r s a c k  a n d  R e b a r  ( 1 9 8 1 )  p a r t i a l l y  p u r i f i e d  w h a t  
t h e y  b e l i e v e d  t o  be  a n  u n i q u e  l y m p h o k i n e  n a me d  i n t e r l e u k i n - 3  ( I L -  
3) ,  p r e s e n t  i n  t h e  c o n d i t i o n e d  me d i um o f  Con A - s t i m u l a t e d  T 
l y m p h o c y t e s ,  w h i c h  c o u l d  i n d u c e  t h e  e x p r e s s i o n  o f  2 0 - a -  
h y d r o x y s t e r o i d  d e h y d r o g e n a s e  ( 2 0 - a - S DH)  i n  c u l t u r e s  o f  p r e - T  
c e l l s  f r o m T c e l l - d e f i c i e n t  m i c e .  S u b s e q u e n t  wo r k  h a s  s h o wn  t h a t
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I L - 3  i s  p r o d u c e d  by a n t i g e n -  o r  m i t o g e n - s t i m u l a t e d  m u r i n e  T 
l y m p h o c y t e s  a n d  a l s o  by  a n u m b e r  o f  Con A o r  a n t i g e n - s t i m u l a t e d  T 
c e l l  l y m p h o ma  a n d  h y b r i d o m a  c e l l  l i n e s  ( C l a r k - L e w i s  a n d  S c h r a d e r ,  
1981 ;  I h l e ,  P e p e r s a c k  a n d  R e b a r ,  1981 ;  Yung e_t £^L., 19 8 1 ;  I s c o v e  
e t  a 1 . ,  19 8 2 ) .
A n o t h e r  s o u r c e  o f  I L - 3  i s  t h e  m y e l o m o n o c y t i c  l e u k a e m i a  c e l l  
l i n e  WEHI-3B D” . T h i s  c e l l  l i n e  w a s  o r i g i n a l l y  d e r i v e d  f r o m  a 
l e u k a e m i a  i n d u c e d  i n  a BALB/c mous e  by  t h e  i n j e c t i o n  o f  m i n e r a l  
o i l  ( W a r n e r ,  Moore  a n d  M e t c a l f ,  1 9 6 9 ) .  A v a r i a n t  o f  t h e  
c o n t i n u o u s  c e l l  l i n e  e s t a b l i s h e d  (WEHI-3B;  R a l p h ,  Moore  a n d  
N i l s s o n ,  1976)  wa s  f o u n d  t o  be h y p e r d i p l o i d  i n  k a r y o t y p e ,  
m a c r o p h a g e - l i k e  m o r p h o l o g i c a l l y ,  f o r m e d  c o l o n i e s  _in_ v i t r o  a n d  was  
u n r e s p o n s i v e  t o  t h e  i n d u c t i o n  o f  d i f f e r e n t i a t i o n  (D~ s u b l i n e ;  
M e t c a l f ,  Moore  a n d  W a r n e r ,  1 9 69 ;  M e t c a l f  a n d  N i c o l a ,  1982)
Le e ,  H a p e l  a n d  I h l e ,  ( 1 9 8 2 )  s u r v e y e d  a n u m b e r  o f  c e l l  l i n e s  
i n  o r d e r  t o  o b t a i n  a g o o d  s o u r c e  o f  I L - 3  f o r  p u r i f i c a t i o n  
s t u d i e s .  The y  f o u n d  t h a t  WEHI-3B p r o d u c e d  h i g h  l e v e l s  o f  I L - 3  
c o n s t i t u t i v e l y ,  a n d  t h a t  Con A o r  p h o r b o l  m y r i s t i c  a c e t a t e  
( c o m m o n l y  u s e d  t o  a c t i v a t e  T c e l l s )  made l i t t l e  d i f f e r e n c e  t o  t h e  
l e v e l s  o f  I L - 3  p r o d u c e d .  L e e ,  H a p e l  a n d  I h l e  ( 1982)  d i s p u t e d  t h e  
m y e l o i d  o r i g i n  o f  WEHI-3B s i n c e  t h e y  o b s e r v e d  t h e  e x p r e s s i o n  o f  
T h y - 1  a n t i g e n  w h i c h  i s  n o r m a l l y  a s s o c i a t e d  w i t h  t h e  T c e l l  
l i n e a g e .  H ow e v e r  i t  h a s  b e e n  s h own  t h a t  t h i s  a n t i g e n  i s  
e x p r e s s e d  by  p r o g e n i t o r s  o f  n e u t r o p h i l s ,  m a c r o p h a g e s  a n d  m a s t  
c e l l s  ( S c h r a d e r ,  B a t t y e  a n d  S c o l l a y ,  1982)  a n d  by e s t a b l i s h e d  
m y e l o i d  c e l l  l i n e s  e x p r e s s i n g  m a r k e r s  t y p i c a l  o f  g r a n u l o c y t e  o r  
m a c r o p h a g e  l i n e a g e s  ( D e x t e r  e_t a l . ,  1980 ;  I s c o v e ,  1 9 8 4 ) .  Thus  
t h e  WEHI-3B c e l l  l i n e  i s  t h e  o n l y  k n o w n  m y e l o i d  s o u r c e  o f  I L - 3 .
I n  a d d i t i o n ,  t h e s e  c e l l s  d o  n o t  a p p e a r  t o  p r o d u c e  s i g n i f i c a n t
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l e v e l s  o f  a n y  o f  t h e  o t h e r  l y m p h o k i n e s  n o r m a l l y  s e c r e t e d  by T 
l y m p h o c y t e s  a f t e r  s t i m u l a t i o n  ( f o r  e x a m p l e  I L - 2 ,  Y - i n t e r f e r o n  a n d  
GM-CSF; D r .  A. H a p e l ,  u n p u b l i s h e d  d a t a ) .
4 .  S t u d i e s  u s i n g  p u r i f i e d  I L - 3 .
C o n d i t i o n e d  m e d i a  f r o m  WEHI-33 c e l l s  a n d  s t i m u l a t e d  T 
l y m p h o c y t e s  h a v e  b e e n  s h o wn  t o  c o n t a i n  a v a r i e t y  o f  b i o l o g i c a l  
a c t i v i t i e s  w h i c h  i n c l u d e  f a c t o r s  i n v o l v e d  i n  t h e  p r o l i f e r a t i o n  
a n d  d i f f e r e n t i a t i o n  o f  v a r i o u s  c e l l s  i n  t h e  h a e m o p o i e t i c  s y s t e m .  
T h e s e  i n c l u d e  t h o s e  o f  P c e l l - s t i m u l a t i n g  f a c t o r  ( C l a r k - L e w i s  a n d  
S c h r a d e r ,  1 9 8 1 ) ,  h i s t a m i n e - p r o d u c i n g  c e l l - s t i m u l a t i n g  f a c t o r  (Dy 
e t  a l . ,  1 9 8 1 ) ,  m u l t i c o l o n y  s t i m u l a t i n g  f a c t o r  ( M u l t i - C S F ?
M e t c a l f ,  1 9 8 1 ) ,  m a s t  c e l l  g r o w t h  f a c t o r  (Yung e t  a l . ,  1 9 8 1 ) ,  
b u r s t - p r o m o t i n g  a c t i v i t y  ( I s c o v e  e t  a l . ,  1982)  a n d  h a e m o p o i e t i c  
c e l l  g r o w t h  f a c t o r  ( B a z i l l  e_t a l . ,  1 9 8 3 ) .  The q u e s t i o n  o f  
w h e t h e r  a s i n g l e  m o l e c u l e  o r  a n u m b e r  o f  c l o s e l y  r e l a t e d  
m o l e c u l e s  a r e  r e s p o n s i b l e  f o r  t h i s  s p e c t r u m  o f  b i o l o g i c a l  
a c t i v i t i e s  was  i n i t i a l l y  i n v e s t i g a t e d  by p u r i f i c a t i o n  o f  t h e  
f a c t o r s  i n v o l v e d .
The m o s t  e x t e n s i v e  i n i t i a l  c h a r a c t e r i z a t i o n  o f  I L - 3  was  
c a r r i e d  o u t  by I h l e  e t  a l .  ( 1 9 8 2 a  a nd  1 9 8 3 ) .  T h e s e  a u t h o r s  
p u r i f i e d  I L - 3  t o  a p p a r e n t  h o m o g e n e i t y  f r o m  W E H I - 3 B - c o n d i t i o n e d  
m e d i u m .  The a b i l i t y  o f  WEHI-3B c e l l s  t o  g row i n  l a r g e  v o l u m e s  i n  
o n l y  1-2% f o e t a l  c a l f  s e r u m  was  a d v a n t a g e o u s  s i n c e  i t  m i n i m i z e d  
t h e  e x t r a n e o u s  p r o t e i n  c o n t e n t .  Y i e l d s  o f  5-10% o f  i n i t i a l  
a c t i v i t y  a n d  2 - 1 0  pg o f  p u r i f i e d  p r o t e i n  w e r e  o b t a i n e d  f r o m  150 
l i t r e s  o f  me d iu m.  The c o n c e n t r a t i o n  o f  I L - 3  r e q u i r e d  f o r  50% 
m a x i m a l  r e s p o n s e  wa s  a p p r o x i m a t e l y  1 0 “ ^  m , w h i c h  i s  w i t h i n  t h e  
r a n g e  f o u n d  f o r  o t h e r  g r o w t h  f a c t o r s  s u c h  a s  I L - 2  (Robb ,  K u t n y
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and Chowdhry, 1983), erythropoietin (Miyake, Kung and Goldwasser, 
1977) and other CSFs (Burgess, Camakaris and Metcalf, 1977; 
Stanley and Heard, 1977; Nicola et al., 1983). The purified IL- 
3 was glycosylated and gave an apparent molecular weight of 28 
kilodaltons on SDS-polyacrylam ide gels. The NH2~terminal 
sequence was shown to be Asp-Thr-His-Arg-Leu-Thr-Arg-Thr-Leu. 
Comparison with known protein sequences indicated that this was 
unique. Other workers have also purified IL-3 (to various 
degrees) from WEHI-3B conditioned medium (Iscove et. al., 1982;
Bazill e_t 1^^ ., 1983; Clark-Lewis, Kent and Schrader, 1984; Urdal 
et al., 1 9 84 ).
It was demonstrated that purified IL-3 produced typical 
dose-response curves for the following assays; 20-a-SDH 
induction; mast cell growth factor; P cell-stimulating factor; 
histamine-producing cell-stimulating factor; and CSF activities 
(Ihle £t. al., 19 83 ). Iscove e_t al. (1 982) reported that the 
erythroid burst-promoting activity and granulocyte-macrophage and 
megakaryocyte colony-stimulating activities in WEHI-3B 
conditioned medium all copurified through a number of procedures. 
Schrader e_t al_. ( 1983; Clark-Lewis, Kent and Schrader, 1984)), 
using purified P cell-stimulating factor, found this factor to be 
active on a wide range of haemopoietic stem cells and progenitor 
cells. From these studies, a single polypeptide is implicated. 
Since WEHI-3B was used extensively in the studies discussed in 
this thesis, and because IL-3 is a more systematic name, this 
term will be used in preference to the above alternatives 
throughout this work.
The highly purified IL-3 isolated from WEHI-3B conditioned
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T O Cmedium has also been [ JI ]-labe 1led, without any apparent loss 
of activity, for receptor studies by Palaszynski and Ihle (1984; 
Ihle et al., 1985). From this work it was found that there are 
1,500-5,000 specific high affinity (K^ approximately IO--*-*- M) IL- 
3 receptors per cell on IL-3-dependent cell lines derived from 
long-term bone marrow cultures (discussed below). Lower receptor 
numbers have been observed on normal bone marrow cells (50-1,000 
per cell). In autoradiographs all granulocyte, monocyte and 
eosinophil cells were labelled, with receptor numbers decreasing 
with increasing maturation and with eosinophils exhibiting twice 
the labelling of neutrophils. No labelling of lymphoid or 
nucleated erythroid cells was observed (Metcalf and Nicola, 
unpublished data cited by Metcalf, 1986). Other studies 
involving covalent crosslinking of iodinated IL-3 to its 
receptor, as well as anti-IL-3 antisera immunoprecipitation of 
iodinated IL-3 surface receptor, reveal that the specific murine 
IL-3 receptor is a polypeptide which has an estimated molecular 
weight of 65-70 kilodaltons (May and Ihle, 1986), although 55 
kilodaltons has also been reported (Metcalf, 1986).
5. Biological roles of IL-3.
The induction of expression of 20-ct-SDH (assumed to be a 
specific T-cell lineage marker; Weinstein, 1977) by IL-3 led to 
the proposal that this factor had a direct effect on early T cell 
differentiation (Ihle, Pepersack and Rebar, 1981; Ihle e_t al., 
1983). However, it has been shown that 20-ct-SDH is also 
expressed by myeloid and stromal cell lines (Garland and Dexter, 
1982; Schaffar-Deshayes et al., 1983) and in many different 
haemopoietic lineages including macrophages. It can also be 
induced by a variety of stimuli including M-CSF and GM-CSF (Hapel
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et a 1., 1985b). There is as yet no unequivocal evidence for
direct effects of IL-3 on cells committed to the T or B 
lymphocyte lineages.
It seems that IL-3 is the most broadly acting member of the 
family of haemopoietic growth factors identified to date and 
could be considered a multi-lineage haemopoietic factor (Iscove 
and Roitsch, 1985). It supports the proliferation (self-renewal) 
and differentiation of multipotential stem cells (Nicola and 
Johnson, 1982; Schrader and Clark-Lewis, 1982; Garland et al., 
1983) and stimulates colony formation from early erythroid, 
eosinophil, megakaryocyte and mast progenitor cells (Burgess et 
al., 1980; Clark-Lewis and Schrader, 1981; Yung e_t al., 1981; 
Iscove et al., 1982). IL-3 can induce the differentiation and 
maturation of neutrophils, granulocytes, macrophages, eosinophils 
and mast cells (Greenberger et al., 1983; Prystowsky e_t al.,
1984; Iscove and Roitsch, 1985). However, the final maturation 
of erythroid and megakaryocyte cells requires additional factors 
(Iscove, 1978; Williams et al., 1981 and 1982).
6. IL-3-dependent cell lines.
Various continuous cell lines have been established from 
long term bone marrow cultures using WEHI-3B-conditioned medium 
as a growth supplement (Dexter, e_t al., 1980; Greenberger, 1980). 
These cell lines are dependent upon the conditioned medium for 
their growth and proliferation, however they do not differentiate 
nor are they leukaemic, and they are considered to be myeloid 
precursors. It has been found that partially purified IL-3 
supports the growth of these "factor-dependent" cell lines, which 
respond in a dose dependent manner (Hapel et a_1., 1982; Ihle st
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al., 1982b). The factor-dependent cell lines FDC-P1 and 32D cl- 
23 (Dexter ejt al., 1980; Greenberger et_ al., 1983) are routinely 
used in biological IL-3 assays although they can also respond to 
human IL-2 and murine GM-CSF respectively (Hapel, Warren and 
Hume, 1984; Warren, Hargreaves and Hapel, 1985).
Molecular studies of interleukin-3.
1. Introduction
Purification of factors like IL-3 using conventional 
biochemical methods is difficult due to the minute quantities of 
material available and their very high biological activities. 
Even after extensive purification there is the problem that part 
of the biological activities observed might be attributable to 
other contaminating factors. This has led to the application of 
recombinant DMA techniques, allowing studies of IL-3 gene 
structure and regulation of expression as well as yielding 
"recombinant" growth factor for further biological studies.
2. Cloning of cDNA for murine IL-3.
The cloning of cDNA coding for murine IL-3, using the cell 
line WEHI-3B as a source of mRtMA, was first reported by this 
laboratory (Fung e_t al., 1984). The assay for IL-3 mRNA used 
involved translation of size fractionated mRNA in Xenopus laevis 
oocytes, followed by the measurement of IL-3 activity in the 
oocyte incubation medium using the IL-3-dependent cell line 32D 
cl-23 (Greenberger e_t al., 1983; Hapel, Warren and Hume, 1984). 
The purified IL-3 mRNA was used as template to synthesize cDNA 
(Land e_t al., 1981), which was inserted into the vector pAT153 
(Twigg and Sherratt, 1980) by G-C tailing (Michelson and Orkin,
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1982) .
The cDNA library was initially screened using the "hybrid- 
release-translation" method (Parnes e_t al., 1981). This resulted 
in the isolation of a cDNA clone with a short insert of 139 bp.
A deoxyribonucleotide primer complementary to the 5’ end of the 
cDNA insert was synthesized and used to screen a second library 
enriched for cDNA fragments larger than 500 bp. In this way a 
longer cDNA clone (pILM3) was obtained which contained the 
complete IL-3 coding sequence. Details of the screening 
procedure used are presented in the results section of Chapter 2 
of this thesis.
A short time after the paper by Fung e_t a_l. ( 1984) was 
published a report appeared describing the isolation of a cDNA 
clone for a murine mast cell growth factor (MCGF; Yokota e_t al., 
1984). Except for one nucleotide, the DNA sequence was identical 
to that of the IL-3 cDNA. It is therefore clear that MCGF cDNA 
actually encodes IL-3, which is known to have MCGF activity. The 
MCGF cDNA clone was obtained after screening a library 
constructed from mRNA isolated from a T cell line of C57BL/6J 
origin known to produce MCGF after Con A stimulation (Nabel et_ 
al., 1981). MCGF activity was assayed using a factor-dependent 
mast cell line. A feature of this study was the use of the pcD 
cloning vector (Okayama and Berg, 1983), which allows expression 
of cDNA inserts following transfection into monkey COS-7 cells. 
Thus, the fact that clones containing the complete MCGF coding 
sequence had been obtained was verified by direct expression of 
the clones to yield MCGF activity.
The sequence of clone pILM3 showed a single open
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reading frame and, assuming that the first ATG from the 5' end 
serves as the initiation codon, specifies a polypeptide of 166 
amino acids with a predicted 27 amino acid hydrophobic leader 
sequence at the NF^-terminus and 4 potential N-glycosylation 
sites. It should be noted however that a clone starting at 
nucleotide 41 can still express high levels of IL-3 activity 
(Yokota £t. a_l., 1984) indicating that alternative start sites are
possible. Two different NF^-term inal amino acids have been 
reported for mature IL-3 (Ihle e_t al., 1983; Clark-Lewis, Kent 
and Schrader, 19 84 ; Conlan e_t a_l., 19 85).
3. Cloning of the gene for murine IL-3.
The availability of cDNA clones for IL-3 has enabled the 
isolation of the murine IL-3 gene, by Miyatake et^  aJL ( 1985b) and 
also in this laboratory (Campbell e_t a_l. 1985). The IL-3 gene 
exists as a single copy per haploid genome, as seen by Southern 
hybridization (Southern, 1975 and 1979) using the IL-3 cDNA as 
probe. Campbell et al. (1985) cloned BALB/c liver chromosomal 
DMA, digested to completion with the restriction endonuclease 
EcoRI, into the vector AgtWES.AB (Leder, Tiemeier and Enquist, 
1977). The digested chromosomal DNA was first enriched for IL-3 
gene fragments by size fractionation on an agarose gel (discussed 
in more detail in the results of Chapter 2 in this thesis). 
Miyatake et al. ( 1985b) isolated the IL-3 gene from a A Charon 4A 
library prepared from BALB/c sperm DNA, using the MCGF cDNA as a 
probe. Four bases present in the sequence of Campbell e_t al.
( 1985) are absent from the sequence of Miyatake e_t a^ . (1985b). 
There are no other differences.
Analysis of the nucleotide sequence of the IL-3 gene has
11
revealed several features. The gene contains 4 introns 
interrupting the coding sequence between codons. The sequence of 
the exons is in exact agreement with the sequence of the IL-3 
cDNA isolated from WEHI-3B, establishing that the unprocessed 
primary structure of IL-3 is identical in WEHI-3B and BALB/c. 
Sequences important for RNA transcription were also identified, 
such as the TATA box (Breathnach and Chambon, 1981; Nevins, 1983) 
present 31 nucleotides from the start of transcription and 
several potential CAT boxes (Breathnach and Chambon, 1981) 
located upstream. These are separated by a G-C rich region that 
maybe a candidate for an enhancer (Khoury and Gruss, 1983;
Gidoni, Dynan and Tjian, 1984; McKnight £t al., 1984). Also 
present in the 3’ region were the polyadenylation signal AATAAA 
(Proudfoot and Brownlee, 1976; Nevins, 1983) and, 11 bp 
downstream (Miyatake e_t a_l., 1985b) a site for the
endonucleolytic cleavage of the precursor mRNA to yield the 3' 
poly (A)+ attachment site (Higgs et^  al., 1983; Montell e_t al., 
1983 ) .
The largest intron (number 2) contains a tandem repeating 
sequence made up of approximately 12 copies of a 14-15 bp 
sequence. This sequence exhibits some homology with the 
following; a human genomic repetitive DNA sequence isolated by 
hybridization with the human BK papovavirus enhancer (Rosenthal, 
et al., 1983); a repeat within a human myoglobin gene intron 
(Weller e_t aJ^ ., 1984); the highly conserved 21 bp repeat sequence
in the U3 region of the long terminal repeats (LTRs) of the human 
T-cell leukaemia viruses, HTLVI and HTLVII (Seiki e_t ad., 1983; 
Shimotohno e^ t al., 1984; Sodroski £t al_., 1984). It has been
suggested that these latter repeats may play a role in conferring
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l y m p h o i d  c e l l  s p e c i f i c i t y  on t h e s e  r e t r o v i r u s e s  ( S h i m o t o h n o  e_t 
a l . ,  1984 ;  S o d r o s k i  e_t al_.,  1 9 8 4 ) .  A n o t h e r  t a n d e m  r e p e t i t i v e
e l e m e n t  i s  p r e s e n t  i n  t h e  I L - 3  g e n e  b e t w e e n  t h e  t r a n s l a t i o n  
t e r m i n a t i o n  c o d o n  a n d  t h e  p o l y a d e n y l a t i o n  s i g n a l  ( C a m p b e l l  e_t 
a l . ,  1 9 8 5 ) .  T h i s  e l e m e n t  a p p e a r s  t o  be  b a s e d  o n  a 5'  TATT 3'  
r e p e a t  u n i t ,  a n d  r e s e m b l e s  s i m i l a r l y  l o c a t e d  r e p e a t s  i n  t h e  I L - 2  
g e n e  ( D e g r a v e  e t^  a l _ . , 1 9 8 3  ; F u j i t a  e j t  a _ l . , 1 9 8 3 ;  H o l b r o o k  ejt  a _ l . , 
1 98 4)  a n d  m e m b e r s  o f  t h e  human a - i n t e r f e r o n  g e n e  f a m i l y  ( G o e d d e l  
e t  a 1 . ,  19 8 1 ) .
4 .  E x p r e s s i o n  o f  I L - 3  f r o m  r e c o m b i n a n t  DMA c o n s t r u c t s .
E x p r e s s i o n  s t u d i e s  h a v e  b e e n  c a r r i e d  o u t  by  Dr.  A. H a p e l  i n  
c o l l a b o r a t i o n  w i t h  t h i s  l a b o r a t o r y .  An I L - 3  cDMA was  r e c l o n e d  
i n t o  t h e  v e c t o r  pSV2£ie_o ( S o u t h e r n  a n d  B e r g ,  1 9 8 2 ) ,  a n d  monkey  
COS-1 c e l l s  t r a n s f e c t e d  w i t h  t h e  r e s u l t i n g  c o n s t r u c t  ( H a p e l  e_t 
a l . ,  1 9 8 5 a ) .  The  c h r o m a t o g r a p h i c  p r o p e r t i e s  o f  t h e  t r a n s i e n t l y  
e x p r e s s e d  I L - 3  on D E A E - S e p h a c e 1 a n d  p h e n y l - S e p h a r o s e  w e r e  t h e  
s a m e  a s  t h o s e  o f  I L - 3  p r o d u c e d  b y  W E H I - 3 B ,  a n d  t h e  e x p r e s s e d  I L - 3  
wa s  p u r i f i e d  1 0 , 0 0 0 - f o l d  i n  t h i s  way.  The e x p r e s s e d  m a t e r i a l  
e x h i b i t e d  g r o w t h  f a c t o r  a c t i v i t y  f o r  I L - 3  d e p e n d e n t  c e l l  l i n e s  
a n d  t h e  b r o a d  r a n g e  o f  b i o l o g i c a l  a c t i v i t i e s  p r e v i o u s l y  
a t t r i b u t e d  t o  I L - 3  on  t h e  b a s i s  o f  s t u d i e s  w i t h  h i g h l y  p u r i f i e d  
m a t e r i a l  f r o m  WEHI-3B c o n d i t i o n e d  med ium ( I h l e  e_t a l . , 1982a  a n d  
1983)  o r  w i t h  a n t i b o d i e s  t o  s u c h  m a t e r i a l  ( B o w l i n ,  S c o t t  and  
I h l e ,  1 9 8 4 ) .  H a p e l  et.  a l . ( 1 98 5 a )  a l s o  o b s e r v e d  low b u t  
d e t e c t a b l e  l e v e l s  o f  M-CSF a c t i v i t y  i n  COS-1 c e l l  medium 
t r a n s f e c t e d  w i t h  pSV^n e o  c o n t a i n i n g  no i n s e r t .  I t  w a s  s u g g e s t e d  
t h a t  t h i s  may h a v e  b e e n  r e s p o n s i b l e  f o r  t h e  i n c r e a s e d  p e r c e n t a g e  
o f  m a c r o p h a g e  c o l o n i e s  i n  b o n e  m a r r o w  c u l t u r e s  s t i m u l a t e d  by  t h e
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e x p r e s s e d  I L - 3  r e l a t i v e  t o  p u r i f i e d  I L - 3 .  R e n n i c k  ej: aJL. ( 1985)  
a l s o  c a r r i e d  o u t  e x p r e s s i o n  s t u d i e s  u s i n g  a f u l l  l e n g t h  I L - 3  cDNA 
c l o n e d  d i r e c t l y  i n  an  e u k a r y o t i c  e x p r e s s i o n  v e c t o r ,  pcD.  A p a r t  
f r o m  t h e  a b s e n c e  o f  T c e l l  g r o w t h  f a c t o r  a c t i v i t y  a n d  B c e l l  
g r o w t h  o r  d i f f e r e n t i a t i o n  f a c t o r  a c t i v i t y ,  a c t i v i t i e s  w e r e  a s  
m e n t i o n e d  a b o v e .
To o b t a i n  l a r g e r  q u a n t i t i e s  o f  p u r e  I L - 3  ( f r e e  o f  
c o n t a m i n a t i n g  g r o w t h  f a c t o r s )  t h e  I L - 3  cDNA was  e x p r e s s e d  i n  E. 
c o l i . I n i t i a l  w o r k  f r o m  t h i s  l a b o r a t o r y  ( M-c .  Fung a n d  Dr .  I .  
Young,  u n p u b l i s h e d  r e s u l t s )  i n v o l v e d  e x p e r i m e n t s  e x p r e s s i n g  t h e  
I L - 3  cDNA u n d e r  t h e  c o n t r o l  o f  t h e  s t r o n g  t a c  p r o m o t e r  i n  pDR540 
( R u s s e l l  a n d  B e n n e t t ,  1 9 8 2 ) .  B i o l o g i c a l l y  a c t i v e  I L - 3  was  
p r o d u c e d ,  i n d i c a t i n g  t h a t  g l y c o s y l a t i o n  wa s  n o t  e s s e n t i a l  f o r  
a c t i v i t y ,  b u t  p r o t e o l y t i c  d e g r a d a t i o n  a p p e a r e d  t o  be  a m a j o r  
p r o b l e m  a f f e c t i n g  y i e l d s .  E x p r e s s i o n  was  i m p r o v e d  by t h e  u s e  o f  
h o s t  s t r a i n s  d e f i c i e n t  i n  t h e  I o n  p r o t e a s e  ( G o t t e s m a n  e_t a 1 . ,
1981)  b u t  t h e  l e v e l s  o f  I L - 3  o b t a i n e d  w e r e  s t i l l  r e l a t i v e l y  l o w .  
More p r o m i s i n g  r e s u l t s  w e r e  o b t a i n e d  u s i n g  f u s i o n  c o n s t r u c t s  
w h e r e  t h e  c o d i n g  s e q u e n c e  f o r  I L - 3  wa s  f u s e d  t o  t h e  p r o m o t e r ,  
r i b o s o m e  b i n d i n g  s i t e  a n d  a s h o r t  p o r t i o n  o f  t h e  NH2” t e r m i n a l  
c o d i n g  s e q u e n c e  o f  t h e  E. c o l i  $ - g a l a c t o s i d a s e  g e n e .  The 
e x p r e s s i o n  e x p e r i m e n t s  h a v e  now b e e n  c o n s i d e r a b l y  e x t e n d e d  i n  
c o l l a b o r a t i o n  w i t h  B i o t e c h n o l o g y  A u s t r a l i a  P t y .  L t d .  a n d  
e x p r e s s i o n  h a s  i n c r e a s e d  t o  t h e  p o i n t  w h e r e  a new b a nd  
c o r r e s p o n d i n g  t o  t h e  I L - 3  p r o t e i n  c a n  be  s e e n  i n  c e l l  e x t r a c t s  
e x a m i n e d  by  SDS g e l  e l e c t r o p h o r e s i s .  R e c o m b i n a n t  I L - 3  c a n  now be 
p u r i f i e d  f r o m  t h e  b a c t e r i a l  c e l l s  a n d  p r e p a r e d  i n  m i l l i g r a m  
q u a n t i t i e s .  The I L - 3  e x p r e s s e d  i n  E. c o l i  h a s  a l l  o f  t h e  
b i o l o g i c a l  a c t i v i t i e s  f o u n d  f o r  I L - 3  e x p r e s s e d  i n  monkey  COS-1
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cells.
The expression of IL-3 cDNA in E. coli under the control of 
a pL-T4 regulatory sequence was achieved by Kindler e_t al.
( 1986), who then used the recombinant protein for i_n vivo 
studies. When detectable blood levels of IL-3 were maintained in 
normal mice, the number of haemopoietic progenitors increased at 
least 2-fold within 3 days. Kindler et a_l. (1986) also observed 
exogenous IL-3 effects in irradiated mice which have a depressed 
number of haemopoietic progenitors. Treatment with IL-3 resulted 
in the elevation to almost normal numbers of progenitor cells, 
with most haemopoietic development taking place in the spleen and 
to a small extent in the liver. This was accompanied by reduced 
progenitor numbers in the bone marrow, indicating mobilization of 
cells. Also using recombinant protein, Metcalf e_t a_l. ( 1986) 
injected IL-3 into normal adult mice and found a 10-fold increase 
in blood eosinophils and elevated levels of maturing 
granulocytes, eosinophils, nucleated erythroid cells and 
megakaryocytes, and up to 100-fold increase in mast cells 
compared to the control mice. Although progenitor cell 
frequencies in the spleen rose 6 to 18-fold, the bone marrow 
remained unchanged (Metcalf et al., 1986).
The powerful effect of recombinant IL-3 on haemopoiesis 
indicates the importance of obtaining a cDNA for a human 
equivalent to mouse IL-3. Based on the above results, it could 
be expected that a human recombinant IL-3 would be valuable for 
treating various forms of bone marrow deficiencies, for instance, 
those resulting from cancer chemotherapy or lethal irradiation 
required for bone marrow transplantation.
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5.  I L - 3  o f  o t h e r  s p e c i e s .
T h e  w o r k  d i s c u s s e d  s o  f a r  f o r  I L - 3  h a s  b e e n  c a r r i e d  o u t  i n  
m u r i n e  s y s t e m s ,  w h i l e  a t  t h e  c o m m e n c e m e n t  o f  t h i s  t h e s i s  a human 
c o u n t e r p a r t  h a d  n o t  y e t  b e e n  c h a r a c t e r i z e d .  S o u t h e r n  a n a l y s i s  
u s i n g  t h e  m u r i n e  I L - 3  cDNA a s  p r o b e  f a i l e d  t o  d e t e c t  h o m o l o g o u s  
s e q u e n c e s  i n  m o s t  m a m m a l i a n  DMA u n d e r  l ow s t r i n g e n c y  c o n d i t i o n s .  
The i s o l a t i o n  a n d  a n a l y s i s  o f  t h e  r a t  I L - 3  g e n e  i n  t h i s  
l a b o r a t o r y  ( C o h e n ,  H a p e l  a n d  Young,  1986)  r e v e a l e d  t h a t  t h e  e x o n -  
i n t r o n  b o u n d a r i e s  w e r e  c o n s e r v e d  b e t w e e n  t h e  r a t  a n d  mouse  b u t  
o n l y  t h e  5'  f l a n k i n g  r e g i o n  s h o w e d  h i g h  h o m o l o g y  (90%).  The 
o v e r a l l  a m i n o  a c i d  h o m o l o g y  wa s  59% w h i c h  r e d u c e s  t o  54% a f t e r  
r e m o v a l  o f  t h e  p u t a t i v e  s i g n a l  p e p t i d e ,  t h e  m o s t  c o n s e r v e d  p a r t  
o f  t h e  p r o t e i n .  T h i s  t o g e t h e r  w i t h  t h e  f a c t  t h a t  t h e r e  was  
l i t t l e  c r o s s - r e a c t i v i t y  o f  t h e  r e s p e c t i v e  I L - 3  p r o t e i n s  on r a t  
a n d  m o u s e  b o n e  m a r r o w  c e l l s  s u g g e s t  t h a t  t h e  r a t  I L - 3  a n d  i t s  
r e c e p t o r  h a v e  e v o l v e d  s i g n i f i c a n t l y  a w a y  f r o m  t h e  m u r i n e  s y s t e m .
R e c e n t l y  h o w e v e r ,  Yang e t  al_. ( 1986)  r e p o r t e d  t h e  i s o l a t i o n  
o f  t h e  human I L - 3  g e n e .  An a s s a y  s y s t e m  r o u t i n e l y  u s e d  by t h e s e  
w o r k e r s  f o r  human GM-CSF i n v o l v e d  t h e  _in v i t r o  p r o l i f e r a t i o n  o f  
p r i m a r y  m y e l o i d  l e u k a e m i c  b l a s t  c e l l s  ( G r i f f i n  e t  a l . , 1 9 8 4) .
The a c t i v i t y  o f  a n o v e l  h a e m o p o i e t i c  f a c t o r  was  d e t e c t e d  i n  t h e  
c o n d i t i o n e d  med i um o f  a g i b b o n  T c e l l  l i n e  w h i c h  was  more  
e f f e c t i v e  t h a n  human  r e c o m b i n a n t  GM-CSF i n  s u p p o r t i n g  t h e  
p r o l i f e r a t i o n  o f  t h e  l e u k a e m i c  b l a s t  c e l l s ,  e v e n  a f t e r  
p r e i n c u b a t i o n  w i t h  a n t i - G M - C S F  a n t i s e r u m .  A cDNA c l o n e  f o r  t h i s  
n o v e l  f a c t o r  was  i s o l a t e d  u s i n g  e x p r e s s i o n  i n  monkey  COS-1 c e l l s .  
T h i s  c l o n e  w a s  f o u n d  t o  e n c o d e  a p r o t e i n  w i t h  29% a m i n o  a c i d  a n d  
45% n u c l e o t i d e  s e q u e n c e  h o m o l o g y  t o  m u r i n e  I L - 3 ,  w i t h  t h e  h i g h e s t  
h o m o l o g y  i n  t h e  5'  r e g i o n  o r  s i g n a l  p e p t i d e .  P r e l i m i n a r y
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e x p r e s s i o n  s t u d i e s  s h o w e d  t h a t  t h i s  f a c t o r  a l s o  s u p p o r t e d  t h e  
g r o w t h  o f  e r y t h r o i d  a s  w e l l  a s  m y e l o i d  p r o g e n i t o r s ,  t h e r e b y  
d i s p l a y i n g  I L - 3 - l i k e  a c t i v i t i e s .  The cDNA w a s  u s e d  t o  i s o l a t e  
t h e  human  g e n e  f r o m  a X g e n o m i c  l i b r a r y  a n d  t h i s  was  f o u n d  t o  
h a v e  99.5% h o m o l o g y  w i t h  t h e  g i b b o n  d e r i v e d  p r o b e .  T h a t  t h e  
h uma n  g e n e  h a s  v e r y  s i m i l a r  e x o n - i n t r o n  s t r u c t u r e  t o  t h e  m u r i n e  
I L - 3  g e n e  p r o v i d e s  f u r t h e r  e v i d e n c e  t h a t  t h i s  f a c t o r  i s  p r i m a t e  
I L - 3 .
6 .  H a e m o p o i e t i c  r e g u l a t o r s  r e l a t e d  t o  I L - 3 .
A n u m b e r  o f  g l y c o p r o t e i n  g r o w t h  f a c t o r s  a c t i v e  on c u l t u r e d  
mouse  h a e m o p o i e t i c  c e l l s  h a v e  b e e n  d e s c r i b e d  w h i c h  a r e  
b i o c h e m i c a l l y  d i s t i n c t  f r o m  I L - 3 .  Mos t  o f  t h e s e  a c t  i n d i v i d u a l l y  
on c e l l s  i n  o n l y  o ne  o r  t w o  o f  t h e  v a r i o u s  h a e m o p o i e t i c  l i n e a g e s  
( I s c o v e ,  1984 ;  N i c o l a  a n d  V a d a s ,  1984;  M e t c a l f ,  1 9 8 6 ) .  E x a m p l e s  
i n c l u d e  e r y t h r o p o i e t i n  ( M i y a k e ,  Kung a n d  G o l d w a s s e r ,  1 9 7 7 ) ,  GM- 
CSF ( B u r g e s s  e_t a l . ,  1981)  a nd  M-CSF o r  CSF-1 ( T e r t i a n  e_t a l . ,
1 9 8 1 )  . GM-CSF i s  t h e  m o s t  c l o s e l y  r e l a t e d  t o  I L - 3  i n  t e r m s  o f  i t s  
b i o l o g i c a l  a c t i v i t y  a n d  b o t h  a r e  p r o d u c e d  by a n t i g e n -  o r  m i t o g e n -  
s t i m u l a t e d  T l y m p h o c y t e s ,  T h y b r i d o m a s  a n d  T l y m p h o m a s  ( B u r g e s s
e t  a l . ,  1981)  b u t  no GM-CSF i s  p r o d u c e d  by t h e  WEHI-3B c e l l  l i n e  
(Dr .  A. H a p e l ,  u n p u b l i s h e d  d a t a ) .  A l t h o u g h  GM-CSF c a n  a l s o  
s u p p o r t  t h e  g r o w t h  o f  m a c r o p h a g e - g r a n u l o c y t e  p r e c u r s o r s ,  i t  
d i f f e r s  f r o m  I L - 3  i n  n o t  s u p p o r t i n g  m a s t  c e l l  g r o w t h  ( C l a r k - L e w i s  
a n d  S c h r a d e r ,  1 9 8 1 ) ,  o r  m e g a k a r y o c y t e  c o l o n i e s  ( I s c o v e  e_t a l . ,
1 9 8 2 )  . GM-CSF i s  r e a d i l y  s e p a r a t e d  f r o m  I L - 3  b e c a u s e  i t  i s  m o r e  
s t r o n g l y  r e t a r d e d  on DEAE c o l u m n s  ( B u r g e s s ,  C a m a k a r i s  and  
M e t c a l f ,  1977 ;  C l a r k - L e w i s  a n d  S c h r a d e r ,  1981 ;  I h l e  e_t a l . ,
1983)  .
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The  cDMA c l o n e s  a n d  t h e  r e s p e c t i v e  g e n e s  f o r  a n u m b e r  o f  
l y m p h o k i n e s  a n d  h a e m o p o i e t i c  g r o w t h  f a c t o r s  h a v e  now b e e n  
i s o l a t e d  f r o m  human a n d  m u r i n e  s o u r c e s  ( T a b l e  1 . 1 ) .  I n  a l l  c a s e s  
e x a m i n e d  s o  f a r  t h e r e  i s  o n l y  a s i n g l e  g e n e  c o d i n g  f o r  e a c h  
f a c t o r  p e r  h a p l o i d  g e n o m e .  The s e q u e n c e  o f  t h e  g e n e s  f o r  t h e  
l y m p h o k i n e s  I L - 2 ,  I L - 3  a n d  Y - i n t e r f e r o n ,  w h i c h  a r e  p r o d u c e d  by 
a c t i v a t e d  T l y m p h o c y t e s ,  show o n l y  l i m i t e d  h o m o l o g i e s  ( D e g r a v e  e t  
a 1 . ,  1 9 8 3 ;  F u j i t a  e_t a _ l . , 1 9 8 3  ; C a m p b e l l  e t  a 1 . ,  1 9 8 5 ;  S t a n l e y  e_t 
a l . ,  1 9 8 5 ) .  S i m i l a r  r e s u l t s  w e r e  f o u n d  w i t h  t h e  c o m p a r i s o n  o f  
t h e  a m i n o  a c i d  s e q u e n c e s .  Th u s  t h e  g e n e s  f o r  t h e s e  l y m p h o k i n e s  
a p p e a r  t o  be  u n i q u e  a n d  n o t  t o  b e l o n g  t o  a r e l a t e d  f a m i l y .  More  
w o r k  i s  r e q u i r e d  t o  u n d e r s t a n d  t h e  r e g u l a t i o n  o f  l y m p h o k i n e  g e n e  
e x p r e s s i o n  i n  T l y m p h o c y t e s .  H o w e v e r ,  r e c e n t l y  F u j i t a  et_ a l . 
( 1 9 86 )  h a v e  f o u n d  u n i q u e  DMA s e q u e n c e s  w i t h i n  t h e  5 ’ f l a n k i n g  
r e g i o n  t h a t  a r e  r e s p o n s i b l e  f o r  t h e  c e l l  t y p e  a n d  i n d u c t i o n -  
s p e c i f i c  e x p r e s s i o n  o f  t h e  I L - 2  g e n e .  S t u d i e s  by Chan e t  a l . 
( 1 98 6)  a l s o  i n d i c a t e  t h i s  f o r  GM-CSF.
I t  a p p e a r s  t h a t  m o s t  m u r i n e  c e l l s  o f  t h e  g r a n u l o c y t e -  
m a c r o p h a g e  l i n e a g e  s i m u l t a n e o u s l y  e x p r e s s  r e c e p t o r s  f o r  t h r e e  o r  
f o u r  CSFs ,  a n  a p p a r e n t l y  r e d u n d a n t  s i t u a t i o n .  R e c e n t  b i n d i n g  
s t u d i e s  o f  b o n e  m a r r o w  c e l l s  i n v o l v i n g  i o d i n a t e d  g r o w t h  f a c t o r  
h a v e  i n d i c a t e d  c r o s s - i n f l u e n c e s  b e t w e e n  d i f f e r e n t  CSF r e c e p t o r s  
( W a l k e r  e t  a l . ,  1 9 8 5 ) .  T h e r e  i s  no d i r e c t  c o m p e t i t i o n  f o r  
r e c e p t o r  b i n d i n g  b e t w e e n  t h e  CSFs ,  b u t  b i n d i n g  o f  I L - 3  t o  i t s  
r e c e p t o r s  l e a d s  t o  d o w n - m o d u l a t i o n  o f  r e c e p t o r s  f o r  a l l  o t h e r  
CSFs;  b i n d i n g  o f  GM-CSF t o  i t s  r e c e p t o r s  d o e s  n o t  i n f l u e n c e  I L - 3  
r e c e p t o r  b i n d i n g  b u t  d o w n - m o d u l a t e s  r e c e p t o r s  f o r  G-CSF a n d  M- 
CSF; h i g h  c o n c e n t r a t i o n s  o f  M-CSF d o w n - m o d u l a t e  GM-CSF r e c e p t o r s  
a nd  h i g h  c o n c e n t r a t i o n s  o f  G-CSF d o w n - m o d u l a t e  r e c e p t o r s  f o r  M-
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Table 1.1: Isolation of human or mouse cDNA/genes of various 
haemopoietic factors and lymphokines (IL-3 has 
already been discussed).
Factor Isolated References
IL-2 Human and mouse 
cDNA and genes
Degrave et al. (1983) 
Devos et al. (1983)
Fujita et al. ( 1983 ) 
Taniguchi et al. (1983) 
Fuse et al. ( 1984 ) 
Yokota et al. (1985)
IL-4 Human and mouse 
cDNA
Lee et al. (1986) 
Noma et al. ( 1986 ) 
Yokota et al. (1986)
IL-5/EDF Mouse cDNA Kinashi et al. (1986)
Y-Inter feron Human and mouse 
cDNA, human 
gene
Devos et al. ( 1982)
Gray and Goeddel (1982) 
and (1983)
Gray et al. (1982)
Taya et al. (1983)
GM-CSF Human and mouse 
cDNA and genes
Gough et al. (1984) 
Cantrell et al. (1985) 
Lee et al. (1985) 
Miyatake et al. (1985a) 
Stanely el al. (1985) 
Wong et al. ( 1985 )
G-CSF Human cDNA 
and gene
Nagata et al. (1986a, t
M-CSF Human cDNA Kawasaki et al. (1985)
Erythropoietin Human cDNA 
and gene
Lee-Huang (1984) 
Jacobs et al. (1985) 
Lin et al. (1985)
CSF. The m o l e c u l a r  w e i g h t  o f  t h e  GM-CSF r e c e p t o r  i s  
a p p r o x i m a t e l y  51 k i l o d a l t o n s  ( W a l k e r  a n d  B u r g e s s ,  1 9 8 5 ) ,  w h i c h  i s  
s i m i l a r  t o  t h a t  r e p o r t e d  f o r  I L - 3  ( M e t c a l f ,  1 9 8 6 ) ,  w h i l e  G-CSF 
a n d  M-CSF r e c e p t o r s  a r e  a b o u t  150 a n d  165 k i l o d a l t o n s  
r e s p e c t i v e l y .  The o n l y  l y m p h o k i n e  r e c e p t o r  g e n e s  o r  cDNAs c l o n e d  
t o  d a t e  a r e  t h o s e  f o r  mo u s e  a n d  human I L - 2  (Cosman e t  a l . ,  1984;  
L e o n a r d  e t  a l . ,  1984 a n d  1 985 ;  M i k a i d o  e t  a l . ,  1984 ;  I s h i d a  e t  
a_l. ,  1 9 85 ;  S h i m u z u  e_t a l . ,  1 9 8 5 ) .  T h e r e  i s  e v i d e n c e  h o w e v e r  t h a t  
t h e  c - fms  p r o t o - o n c o g e n e  p r o d u c t  i s  c l o s e l y  r e l a t e d  t o  t h e  M-CSF 
r e c e p t o r  ( S h e r r  e t  a l . ,  1 9 8 5 ) .
P o s s i b l e  r o l e  o f  h a e m o p o i e t i c  g r o w t h  f a c t o r s  i n  t u m o r i g e n i c i t y .
1.  I n t r o d u c t i o n
I L - 3  h a s  c h a r a c t e r i s t i c s  t y p i c a l  o f  a v a r i e t y  o f  g r o w t h  
f a c t o r s  s h o w n  t o  r e g u l a t e  m a m m a l i a n  c e l l  a n d  t i s s u e  d e v e l o p m e n t  
i n  v i t r o . G r o w t h  f a c t o r s  may be  d e f i n e d  a s  p o l y p e p t i d e s  t h a t  
s t i m u l a t e  c e l l  p r o l i f e r a t i o n  a n d  d i f f e r e n t i a t i o n  t h r o u g h  b i n d i n g  
t o  s p e c i f i c  c e l l  s u r f a c e  r e c e p t o r s .  T h e r e  a r e  a l s o  f a c t o r s  t h a t  
a r e  n e g a t i v e  r e g u l a t o r s  o f  g r o w t h  w h i c h  h a v e  n o t  b e e n  a s  
e x t e n s i v e l y  s t u d i e d  ( r e c e n t l y  r e v i e w e d  by Wang a n d  Hsu,  1 9 8 6 ) .
Much o f  t h e  i m p e t u s  f o r  t h e  s t u d y  o f  g r o w t h  f a c t o r s  h a s  come 
f r om t h e i r  p r e s u m e d  i n v o l v e m e n t  i n  c a n c e r .  E v i d e n c e  d a t e s  t o  
e a r l y  w o r k  s h o w i n g  a d e c r e a s e d  s e r u m  r e q u i r e m e n t  f o r  g r o w t h  o f  
t r a n s f o r m e d  c e l l s  ( B u r k ,  19 6 6 ;  T e m i n ,  1966 a nd  1967 ;  H o l l e y  a nd  
K i e r n a n ,  19 68 ;  D u l ' o e c c o ,  1 9 7 0 ;  J a i n c h i l l  a n d  T o d a r o ,  1 9 7 0 ;  S m i t h  
a nd  S c h e r ,  1 9 7 1 ) .  W i t h  t h e  a d v e n t  o f  s e r u m - f r e e  c u l t u r e  
t e c h n i q u e s  a n d  t h e  a v a i l a b i l i t y  o f  p u r i f i e d  g r o w t h  f a c t o r s ,  t h e  
a l t e r e d  s e r u m  r e q u i r e m e n t  i n  t r a n s f o r m e d  c e l l s  c o u l d  be 
t r a n s l a t e d  i n t o  d i m i n i s h e d  r e q u i r e m e n t  f o r  s p e c i f i c  g r o w t h
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f a c t o r s  ( B a r n e s  a n d  S a t o ,  1980 ;  K a p l a n ,  A n d e r s o n  a n d  O z a n n e ,
1 9 8 2 )  . More  c o n v i n c i n g  e v i d e n c e  h a s  come f r o m t h e  w o r k  l i n k i n g  
some  t r a n s f o r m i n g  r e t r o v i r a l  g e n e s  ( o n c o g e n e s  o r  v - o n c ) t o  
c e l l u l a r  g e n e s  c o d i n g  f o r  g r o w t h  f a c t o r s  o r  t h e i r  r e c e p t o r s  
( p r o t o - o n c o g e n e s  o r  c - o n c ; r e v i e w e d  by H e l d i n  a nd  W e s t e r m a r k ,  
1 9 84 ;  H u n t e r ,  19 8 5 ;  G o u s t i n  e t  a l . ,  1 9 8 6 ) .  F o r  e x a m p l e ,  t h e  v -  
s i s  g e n e  o f  t h e  s i m i a n  s a r c o m a  v i r u s  i s  r e l a t e d  t o  p l a t e l e t -  
d e r i v e d  g r o w t h  f a c t o r  ( D o o l i t t l e  ej: a l . ,  1983 ;  W a t e r f i e l d  e t  a l . ,
1 9 8 3 )  , a n d  t h e  v - fms  o n c o g e n e  i s  r e l a t e d  t o  t h e  M-CSF r e c e p t o r
( S h e r r  e_t a l . ,  1 9 8 5 ) .  T h i s ,  t o g e t h e r  w i t h  t h e i r  c e l l  s t a g e -  
s p e c i f i c  e x p r e s s i o n  d u r i n g  d e v e l o p m e n t  ( M u l l e r  et.  a l . , 19 8 2 ;
K e l l y  e_t a l . ,  1 983 ;  Gonda  a n d  M e t c a l f ,  1984 ;  G r e e n b e r g  a n d  Z i f f ,  
1984 ;  K r u i j e r  £t_ a l . ,  1 9 8 4 ;  T h o m p s on  e_t a l . ,  1986)  l e n d s  w e i g h t  
t o  t h e  v i e w  t h a t  some  p r o t o - o n c o g e n e  p r o d u c t s  a r e  i n v o l v e d  i n  t h e  
g r o w t h  f a c t o r - r e c e p t o r - r e s p o n s e  p a t h w a y  l e a d i n g  t o  c e l l  
p r o l i f e r a t i o n  a n d  d i f f e r e n t i a t i o n .  A l t e r a t i o n s  r e s u l t i n g  i n  
c o n s t i t u t i v e  e x p r e s s i o n ,  a t  an  a p p r o p r i a t e  s t a g e ,  o f  a n y  o f  t h e  
c o n t r o l l i n g  e l e m e n t s  a l o n g  t h i s  p a t h w a y  may r e p r e s e n t  s t e p s  i n  
t u m o u r  d e v e l o p m e n t ,  l e a d i n g  t o  t h e  u n c o u p l i n g  o f  d i f f e r e n t i a t i o n  
f r o m  g r o w t h  a n d  c o n s e q u e n t l y  u n c o n t r o l l e d  p r o l i f e r a t i o n .
A s e l f - s t i m u l a t o r y  o r  " a u t o c r i n e "  m e c h a n i s m  h a s  b e e n  
p r o p o s e d  t o  e x p l a i n  t h e  g r o w t h  f a c t o r  i n d e p e n d e n c e  o f  t u m o u r  
c e l l s .  T h e r e  a r e  n o r m a l  p h y s i o l o g i c a l  e x a m p l e s  o f  c e l l s  a b l e  t o  
r e s p o n d  t o  a g r o w t h  f a c t o r  w h i c h  t h e y  p r o d u c e .  T - h e l p e r  c e l l s  
b o t h  p r o d u c e  a n d  r e s p o n d  t o  I L - 2  ( M e u e r  e t  a l . , 1984 ;  Moses  e_t
a l . ,  1984)  a n d  a r t e r i a l  s m o o t h  m u s c l e  c e l l s  f r o m  v e r y  y o u n g  r a t s  
o r  r a t s  w i t h  a r t e r i a l  w a l l  t r a u m a  r e l e a s e  a n d  r e s p o n d  t o  
p l a t e l e t - d e r i v e d  g r o w t h  f a c t o r - l i k e  p e p t i d e s  ( S e i f e r t ,  S c h w a r t z  
a n d  B o w e n - P o p e ,  19 8 4 ;  W a l k e r ,  B o w e n - P o p e  a n d  R e i d y ,  1 9 8 4 ) .  I n
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r e l a t i o n  t o  t u m o u r  c e l l s ,  t h e  " a u t o c r i n e  h y p o t h e s i s "  s t a t e s  t h a t  
p r o t o - o n c o g e n e s  c o n f e r  g r o w t h  f a c t o r  a u t o n o m y  on c e l l s  n o t  o n l y  
by c o d i n g  d i r e c t l y  f o r  p e p t i d e  g r o w t h  f a c t o r s  o r  t h e i r  r e c e p t o r s  
b u t  a l s o  by  a m p l i f y i n g  t h e  m i t o g e n i c  s i g n a l s  o f  a g r o w t h  f a c t o r  
a t  i t s  r e c e p t o r  ( S p o r n  a n d  T o d a r o ,  1980 ;  S p o r n  a n d  R o b e r t s ,
1 9 8 5 ) .  T h i s  m o d e l  h a s  b e e n  e x p a n d e d  t o  i n c l u d e  t h e  c o n c e p t  t h a t  
m a l i g n a n t  t r a n s f o r m a t i o n  may a l s o  r e s u l t  f r om f a i l u r e  t o  e x p r e s s  
o r  r e s p o n d  t o  s p e c i f i c  n e g a t i v e  r e g u l a t o r s  o f  c e l l  g r o w t h  ( S p o r n  
a n d  R o b e r t s ,  1 9 8 5 ) .
2.  G r o w t h  f a c t o r  g e n e  e x p r e s s i o n  by  h a e m o p o i e t i c  c e l l s .
( a )  P o s s i b l e  i n v o l v m e n t  o f  a u t o c r i n e  m e c h a n i s m s .
Much a t t e n t i o n  h a s  b e e n  f o c u s e d  on t h e  p o s s i b i l i t y  o f  
a u t o c r i n e  m e c h a n i s m s  i n v o l v e d  i n  h a e m o p o i e t i c  d i s o r d e r s  s u c h  a s  
l e u k a e m i a s .  M e t c a l f  ( 1 9 8 5  a n d  1986)  p o i n t s  o u t  t h a t  p r i m a r y  
l e u k a e m i a s  a r e  d e p e n d e n t  on e x o g e n o u s  g r o w t h  f a c t o r  in. v i t r o  a n d  
a l t h o u g h  t h e s e  a n d  p a s s a g e d  l e u k a e m i a  c e l l s  h a ve  b e e n  s h o w n  t o  
p r o d u c e  h a e m o p o i e t i c  f a c t o r s  an  a u t o c r i n e  m e c h a n i s m  may n o t  be  a 
common c a u s e  o f  l e u k a e m i a .  M e t c a l f  a r g u e s  t h a t  w h e t h e r  o r  n o t  
t h e  f i r s t  l e u k a e m i a  c e l l  p r o d u c e s  f a c t o r  i s  l i k e l y  t o  be 
i r r e l e v a n t  i f  i t  i s  b a t h e d  i n  f l u i d  c o n t a i n i n g  g r o w t h  f a c t o r ( s )  
p r o d u c e d  by  t h e  v a r i o u s  t i s s u e  s o u r c e s .  D e s p i t e  t h i s ,  t h e  
a c q u i s i t i o n  o f  t h e  c a p a c i t y  t o  s y n t h e s i z e  g r o w t h  f a c t o r s  h a s  b e e n  
o b s e r v e d  i n  some h a e m o p o i e t i c  c e l l  l i n e s .
The g i b b o n  l y m p h o s a r c o m a  c e l l  l i n e  MLA-144 ( K a w a k a m i  e t  a l . , 
1972)  p r o d u c e s  I L - 2  c o n s t i t u t i v e l y  a n d  e x p r e s s e s  I L - 2  r e c e p t o r s  
( S m i t h ,  1 9 8 3 ) .  H o w e v e r ,  u p on  m i t o g e n  s t i m u l a t i o n ,  t h e  s y n t h e s i s  
a n d  s e c r e t i o n  o f  I L - 2  i n c r e a s e s  3 0 -  t o  5 0 - f o l d  o v e r  t h e
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c o n s t i t u t i v e  l e v e l  ( R a b i n  e t  a_l. ,  1981;  L i n  a n d  Robb,  1 9 8 5 ) .
S o u t h e r n  a n a l y s i s  a n d  s u b s e q u e n t  i s o l a t i o n  o f  I L - 2  cDNA c l o n e s  
f r o m  MLA-144 r e v e a l e d  t h a t  i n  t h e  3' u n t r a n s l a t e d  r e g i o n  o f  one  
c l o n e  was  s e q u e n c e  h o m o l o g o u s  t o  t h e  t y p e  C g i b b o n  l e u k a e m i a  
v i r u s  (GLV) l o n g  t e r m i n a l  r e p e a t  (Chen e_t a l . ,  1 9 8 5 ) .  T h i s  
r e t r o v i r u s  h a s  b e e n  o b s e r v e d  a s s o c i a t e d  w i t h  s e v e r a l  t y p e s  o f  
h a e m o p o i e t i c  t u m o u r s  ( S n y d e r  e t  a l . ,  1 9 7 3 ) .  B o t h  h y b r i d - r e l e a s e -  
t r a n s l a t i o n  a n d  SI  n u c l e a s e  a n a l y s i s  o f  t h e  I L - 2  mRNA f r o m  
n o n i n d u c e d  MLA-144 c e l l s  p r o v i d e d  e v i d e n c e  t h a t  i n  t h e s e  c e l l s  
I L - 2  t r a n s c r i p t s  c ame  f r o m  t h e  r e a r r a n g e d  a n d  n o t  t h e  n o r m a l  I L - 2  
g e n e .  T h i s  s t r o n g l y  s u g g e s t s  a r o l e  f o r  t h e  3'  v i r a l  i n s e r t i o n  
i n  t h e  c o n s t i t u t i v e  a c t i v a t i o n  o f  t h e  I L - 2  g e n e  i n  t h e  MLA-144 
c e l l  l i n e .  F u r t h e r  S o u t h e r n  a n a l y s i s  h a s  r e v e a l e d  t h e  p r e s e n c e  
o f  GLV s e q u e n c e s  i n  t h e  5'  f l a n k i n g  r e g i o n  o f  t h e  I L - 2  g e n e ,  
s u g g e s t i n g  t w o  i n t e g r a t i o n  e v e n t s  may h a v e  o c c u r r e d  a d j a c e n t  t o  
t h i s  g e n e  (Chen e t  a_l. , 198 5) .
D u p r e z ,  L e n o i r  a n d  D a u t r y - V a r s a t  ( 19 8 5 )  h a v e  s h o w n  d i r e c t l y  
t h e  a u t o c r i n e  p r o d u c t i o n  o f  I L - 2  b y  a T l y m p h o m a  c e l l  l i n e  ( IARC 
301)  w h i c h  e x p r e s s e s  r e c e p t o r s  f o r  t h i s  l y m p h o k i n e  
c o n s t i t u t i v e l y .  When t h e s e  c e l l s  a r e  g r o w n  a t  l ow c e l l  
d e n s i t i e s ,  g r o w t h  i s  p o o r  o r  n o n e x i s t e n t  a n d  e x o g e n o u s  I L - 2  i s  
r e q u i r e d ,  w h i l e  a t  h i g h  c e l l  d e n s i t i e s  e x o g e n o u s  I L - 2  i m p r o v e s  
c e l l  g r o w t h .  A n t i b o d i e s  t o  e i t h e r  I L - 2  o r  i t s  r e c e p t o r  w e r e  
f o u n d  t o  i n h i b i t  t h e  g r o w t h  o f  t h i s  c e l l  l i n e  i n  t h e  a b s e n c e  o f  
e x o g e n o u s  I L - 2 ,  c l e a r l y  d e m o n s t r a t i n g  t h a t  IARC 301 c e l l s  a r e  
d e p e n d e n t  on t h e  I L - 2  t h e y  p r o d u c e  t h e m s e l v e s ,  a n d  t h u s  d i s p l a y  
a u t o c r i n e  s t i m u l a t i o n .  T h e s e  r e s u l t s  w e r e  r e p r o d u c i b l e  w i t h  
c l o n a l l y  p r o p a g a t e d  IARC 301 c e l l s ,  r u l i n g  o u t  t h e  p o s s i b i l i t y  
t h a t  d i f f e r e n t  c e l l s  a r e  e i t h e r  p r o d u c i n g  I L - 2  o r  r e s p o n d i n g  t o
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i t .
A n o t h e r  e x a m p l e  i n v o l v e s  t h e  o n s e t  o f  p r o d u c t i o n  o f  a 3 c e l l  
g r o w t h  f a c t o r  a c t i v i t y  by E p s t e i n - B a r r  V i r u s  (EBV) t r a n s f o r m e d  B 
l y m p h o c y t e s ,  w h i c h  c a n  p r o l i f e r a t e  i n  t h e  a b s e n c e  o f  e x o g e n o u s  
f a c t o r  ( N i l s s o n  a nd  K l e i n ,  1982 ;  G o rd o n  e t  a l . ,  1 9 8 4 ) .  I t  h a s  
b e e n  s u g g e s t e d  t h a t  t h i s  may r e p r e s e n t  a c r i t i c a l  s t e p  i n  t h e  
m a l i g n a n t  e v o l u t i o n  o f  human l y m p h o m a s  h a r b o u r i n g  t h e  EBV g e n o m e ,  
f o r  e x a m p l e ,  B u r k i t t ' s  l y m p h o m a  ( Go r d o n  e t  a l . ,  1 9 8 4 ) .  T h u s  I L - 2  
a n d  p o s s i b l y  B c e l l  g r o w t h  f a c t o r ,  c a n  s t i m u l a t e  t h e  g r o w t h  o f  
some t u m o u r  c e l l  l i n e s  by a n  a u t o c r i n e  m e c h a n i s m .
Mo de l  s t u d i e s  h a v e  b e e n  u n d e r t a k e n  i n  o r d e r  t o  r e c r e a t e  t h e  
a u t o c r i n e  s t e p  t o w a r d s  t u m o r i g e n i c i t y .  I n i t i a l l y  S c h r a d e r  a n d  
C r a p p e r  ( 1 9 8 3 )  u s e d  DMA f r o m  WEHI-3B c e l l s  t o  t r a n s f o r m  an 
i m m o r t a l i z e d  b u t  I L - 3 - d e p e n d e n t  n o n - t u m o r i g e n i c  
m e g a k a r y o c y t e / m a s t  c e l l  p o p u l a t i o n .  C e l l  l i n e s  w e r e  o b t a i n e d  
t h a t  no l o n g e r  r e q u i r e d  I L - 3  f o r  t h e i r  s u r v i v a l ,  a n d  p r o d u c e d  
t h i s  f a c t o r ,  a s  w e l l  a s  f o r m i n g  t u m o u r s  i n  s y n g e n e i c  m i c e .
More  r e c e n t  s t u d i e s  h a v e  i n v o l v e d  t h e  i n t r o d u c t i o n  o f  
h a e m o p o i e t i c  f a c t o r s ,  u s i n g  r e t r o v i r a l  v e c t o r s ,  i n t o  t h e  
i m m o r t a l i z e d  b u t  n o n - t u m o r i g e n i c  m y e l o i d  c e l l  l i n e  FDC-P1 ( D e x t e r  
e t  a l . ,  1 9 8 0 ) .  T h i s  c e l l  l i n e  r e q u i r e s  e i t h e r  GM-CSF o r  I L - 3  f o r  
i t s  s u r v i v a l ,  h o w e v e r ,  i t  i s  b l o c k e d  i n  d i f f e r e n t i a t i o n .  Lang  et. 
a l . ( 1 9 8 5 )  c l o n e d  t h e  m u r i n e  GM-CSF cDNA i n  t h e  M o l o n e y  m u r i n e  
l e u k a e m i a  v i r u s  ( M o - ML V ) - b a s ed  s h u t t l e  v e c t o r  pZ I PN eo S V (X )1 
( C e p k o ,  R o b e r t s  a n d  M u l l i g a n ,  1 9 8 4 ) .  H e l p e r - f r e e  GM-CSF cDNA 
c o n t a i n i n g  v i r u s  (GMV) w a s  u s e d  t o  i n f e c t  FDC-P1 c e l l s  a n d  G4 18 -  
r e s i s t a n t  a u t o n o m o u s l y  p r o l i f e r a t i n g  c e l l s  w e r e  o b t a i n e d  a n d  
e s t a b l i s h e d  a s  c l o n a l  c e l l  l i n e s .  A l l  t h e s e  c e l l  l i n e s  p r o d u c e d
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GM-CSF, as indicated by bioassay of the culture media and by 
Northern analysis of mRNA. [125j]GM-CSF binding studies showed 
that most of the cell lines retained GM-CSF receptor levels 
similar to those of the parental FDC-P1 cells. When GMV/FDC-P1 
cells were injected into syngeneic mice, progressively growing 
leukaemias developed, whereas uninfected FDC-P1 cells were non- 
tumorigenic. These tumours were reisolated and the cells found 
to be factor-independent and to possess the distinctive karyotype 
of the original FDC-P1 parental cells. Surprisingly, Lang et. al. 
(1985) were unable to demonstrate that anti-GM-CSF antiserum 
could block the autocrine growth of the GMV/FDC-P1 cells. This 
led these investigators to conclude that GM-CSF must be able to 
interact with its receptor intracellularly. Similar retroviral 
expression work involving IL-3 will be discussed in Chapter 5 in 
relation to the results of this thesis.
(b) Factor-independence obtained through non-autocrine 
mechanisms.
It has been shown in recent studies that factor independence 
does not necessarily mean that the cell produces its own growth 
factor. In regard to haemopoetic cells, Cook e_t al. ( 1985) and 
Pierce et_ a_l. ( 1985) in similar studies investigated the effects 
of Abelson murine leukaemia virus (Ab-MuLV) transformation on IL- 
3 dependence. This retrovirus carries the v-abl oncogene. Cook 
et al. (1985) used Ab-MuLV to transform FDC-P1 cells. Factor 
independent cells were derived which expressed the viral genome 
and were tumorigenic in syngeneic mice. However the results of 
Northern analysis and bioassay of the culture supernatants 
indicated that these cells did not produce IL-3 or GM-CSF, 
factors normally required to support the parent FDC-P1 cells.
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The receptor numbers for these factors remained unaltered.
Pierce et a_l. (1985) transformed normal IL-3 dependent mast cells 
with Ab-MuLV and obtained similar results. These transformed 
mast cells continued to proliferate in the presence of specific 
anti-IL-3 antisera, previously shown to inhibit the growth of IL- 
3-dependent cells (Pierce et. al., 1985).
In other studies, Rapp et_ a_l. ( 1985) have found that 
transformation of IL-2- or IL-3-dependent cell lines (CTB6 and 
FDC-P1, respectively) with the v-myc oncogene led to an 
abrogation of factor dependence. In both cases the resulting 
transformants were tumorigenic in T cell deficient mice. No 
growth factor activity was detected in their culture media 
and receptor levels for IL-2 or IL-3 remained unaltered. These 
results implicate a non-autocrine mechanism.
Wheeler e_t a_l. ( 1986) introduced v-fms into SV40- 
immörtalized, M-CSF-dependent macrophages, rendering them 
independent of M-CSF for their survival and tumorigenic in T cell 
deficient mice. These cells did not produce M-CSF as indicated 
by bioassay of culture medium and Northern analysis of mRNA.
These workers have suggested that the v-fms product may be an 
unregulated kinase that provides growth stimulatory signals in 
the absence of ligand resulting in factor independence by a non­
autocrine mechanism. Rearrangements of the c-fms proto-oncogene 
have also been reported. The c-f ms (Groffen et_ a_l., 1983;
Roussel et al., 1983) and GM-CSF (Huebner et al., 1985; Le Beau 
e_t al., 1986) loci are adjacent on the distal long arm of human 
chromosome 5. Deletions involving this region of the chromosome 
have been detected in the 5q- syndrome, a pleiotrophic disorder
25
(Sokal et al., 1975; Kerkhofs £t_ al., 1982) leaving patients
predisposed to myeloid leukaemia (Sokal et a_l., 1975) or
polycythemia vera (an increase in bone marrow-derived cells, 
especially erythroblasts and erythrocytes; Wisniewski and 
Hirschhorn, 1983).
(c) Concerted action of oncogenes in transformation.
The autocrine hypothesis offers some explanation as to the 
role of growth factors in the development of tumorigenicity. If 
the only lesion associated with tumour cells was the 
inappropriate production of their growth regulator, this would 
not be enough to explain how the normal differentiation programme 
(which would lead to cell death) appears to be blocked. 
Furthermore, experimental transformation, for example, of normal 
fibroblasts with an activated v-myc oncogene, is not sufficient 
to cause formation of transformed colonies. Full transformation 
seems to require a second cooperating oncogene from the ras 
family of oncogenes (Land, Parada and Weinberg, 1983a and b). 
Similar results have been obtained in studies using other 
transforming genes (Newbold and Overell, 1983; Ruley, 1983; 
Bechade, Calothy and Pessac, 1985). Thus there is evidence that 
conversion of a normal cell to a malignant one is a multi-step 
process and an autocrine production of a growth factor may 
represent only one step which confers a proliferative advantage 
to a cell.
Aims of this thesis.
Little is currently known concerning the mechanisms 
controlling the expression of haemopoietic growth regulators such 
as IL-3. These mechanisms surely play a key role in maintaining
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a normal balance of the various blood cell types. In light of 
the discussion of haemopoietic growth factors and their link with 
tumorigenesis, the myelomonocytic leukaemia cell line WEHI-3B is 
of great interest. This is an example of a cell type that 
normally responds to but does not produce IL-3, producing this 
factor in a deregulated manner. It has been proposed that the 
genetic change leading to the constitutive expression of IL-3 may 
have been a key event in the development of this leukaemia 
(Dexter and Allen, 1983; Schrader and Crapper, 1983; Garland, 
1984; Iscove and Roitsch, 1985). The aim of this thesis was to 
study in detail the change that led to altered expression of IL-3 
by the WEHI-3B cell line, hopefully shedding light on the 
evolution of this leukaemia and furthering the understanding of 
the normal regulation of IL-3 expression.
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Chapter 2
Examination of the IL-3 genes present in various mouse strains 
and cell lines by Southern hybridization.
Introduction
The work presented in this Chapter describes the use of 
synthetic oligodeoxyribonucleotide probes to isolate a cDNA clone 
encoding murine IL-3 and its subsequent use to examine the IL-3 
genes in various mouse strains and cell lines by Southern 
hybridization. The relevant hybridization methods are described 
below.
1. Synthetic oligodeoxyribonucleotides as probes.
Synthetic oligodeoxyribonucleotides are convenient probes 
for the isolation of specific cloned DMA sequences. When some of 
the amino acid sequence of a gene product is known, it is 
possible to predict the nucleotide sequence of the corresponding 
region of the gene and then synthesize an
oligodeoxyribonucleotide that can be used to identify clones 
containing the desired sequences. Similarly, an 
oligodeoxyribonucleotide probe can be prepared if a portion of 
the DNA sequence of a desired gene or cDNA is known. 
Oligodeoxyribonucleotides have a 5'0H after synthesis (reviewed 
by Itakura, Rossi and Wallace, 1984) and can be labelled by 
transferring [y-^P] from ATP using T4 polynucleotide kinase 
(Maxam and Gilbert, 1977; Richardson, 1981).
One of the first successful studies using an 
oligodeoxyri'oonucleotide as a probe was in the isolation of the 
Saccharomyces cerevisiae iso-l-cytochrome c gene (Montgomery et 
a 1., 1978; Szostak et_ a_l., 1979 ). This was an unusual case in 
that the sequence of the iso-l-cytochrome c gene could be 
predicted precisely because of the availability of amino acid 
sequences of a number of frame-shift mutants (Stewart and
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Sherman, 1974). Previously it had been shown that high ionic 
strength solutions enhance duplex stability (Lipsett, Heppel and 
Bradley, 1961; Astell and Smith, 1971 and 1972) therefore 
hybridization and washing were carried out in 4 x SSC (1 x SSC 
consists of 0.15 M MaCl and 0.015 M sodium citrate). 
Hybridization times of only 30 min were used, indicating that 
oligodeoxyribonucleotides form duplexes rapidly (Montgomery £t 
al., 197 8 ).
In a series of model studies Wallace e_t al. ( 1979 and 1981a) 
have examined the hybridization properties of synthetic 
oligodeoxyribonucleotides by Southern analysis (Southern, 1975 
and 1979). Efficient hybridization of oligodeoxyribonucleotides 
11, 14 or 17 bp in length (11-, 14- or 17-mers) to complementary 
0X174 sequence was observed. Stability increased with duplex 
length, as indicated by the temperature at which half the 
duplexes dissociated, or (34, 41 and 54°C respectively).
Hybridization of these oligodeoxyribonucleotides to a sequence 
containing a single mismatch produced significantly lower 
values for each (for example 43°C for the 17-mer). The 
location of a mismatch also affects hybrid duplex stability 
(Gillam, Waterman and Smith, 1975; Smith, 1983) a terminally 
located mismatch being least destabilizing. Wallace et al. 
(1981a) found that these have a of about 5°C lower than 
perfectly matched duplexes. Observations of the hybridization 
properties of a large number of oligodeoxyribonucleotides 
provided an empirical formula for estimating the of perfectly 
matched duplexes (Suggs e t al., 1981a). In 6 x SSC (or its 
equivalent) the is calculated by summing 2°C for each A-T bp 
and 4°C for each G-C bp. Thus by careful selection of
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h y b r i d i z a t i o n  a n d  w a s h i n g  t e m p e r a t u r e  ( a p p r o x i m a t e l y  5 - 1 5 ° C  b e l o w  
T^)  p e r f e c t l y  m a t c h e d  d u p l e x e s  c a n  be  d i s c r i m i n a t e d  f r o m  t h o s e  
w i t h  m i s m a t c h e s .  T h i s  a g r e e s  w i t h  t h e  f i n d i n g s  f r o m  e a r l i e r  
s t u d i e s  u s i n g  t h e r m a l  c h r o m a t o g r a p h y  i n v o l v i n g  o l i g o n u c l e o t i d e -  
c e l l u l o s e s  ( r e v i e w e d  by  S m i t h ,  1 9 8 3 ) .
Due t o  t h e  r e d u n d a n c y  o f  t h e  g e n e t i c  c o d e  i t  i s  u s u a l l y  n o t  
p o s s i b l e  t o  p r e d i c t  an  u n i q u e  n u c l e o t i d e  s e q u e n c e  f r o m  t h e  known 
a m i n o  a c i d  s e q u e n c e .  One a p p r o a c h  h a s  b e e n  t o  s y n t h e s i z e  a 
m i x t u r e  o f  o l i g o d e o x y r i b o n u c l e o t i d e s  c o n t a i n i n g  a l l  p o s s i b l e  
c o d i n g  s e q u e n c e s .  I n  S o u t h e r n  b l o t s  o f  DNA i s o l a t e d  f r o m  
g e n o m i c  c l o n e s ,  W a l l a c e  e t  a_l. ( 1 9 8 1 a )  s u c c e s s f u l l y  u s e d  a 
m i x t u r e  o f  8 d i f f e r e n t  1 3 - m e r s  t o  i d e n t i f y  s p e c i f i c  ß - g l o b i n  g e ne  
f r a g m e n t s .  Th u s  i t  i s  p o s s i b l e  t o  d e t e c t  h y b r i d i z a t i o n  o f  an  
o l i g o d e o x y r i b o n u c l e o t i d e  f o r m i n g  a p e r f e c t l y  m a t c h e d  d u p l e x  i n  
t h e  p r e s e n c e  o f  7 n o n - c o m p l e m e n t a r y  o l i g o d e o x y r i b o n u c l e o t i d e s .  
M i x e d  s e q u e n c e  o l i g o d e o x y r i b o n u c l e o t i d e  p r o b e s  h a v e  b e e n  u s e d  
s u c c e s s f u l l y  f o r  t h e  i s o l a t i o n  o f  many c l o n e d  s e q u e n c e s  ( f o r  
e x a m p l e  S u g g s  e t  a_l. ,  1 9 81 b)  b u t  t o  c o v e r  a l l  c o d o n  p o s s i b i l i t i e s
i t  h a s  b e e n  n e c e s s a r y  t o  s y n t h e s i z e  up t o  384 d i f f e r e n t  
o l i g o d e o x y r i b o n u c l e o t i d e s  ( W h i t e h e a d  e_t a l . ,  1 9 8 3 ) .  The n u m b e r  
o f  p o s s i b i l i t i e s  c a n  be  m i n i m i z e d  by  c h o o s i n g  a p a r t  o f  t h e  
s e q u e n c e  r i c h  i n  a m i n o  a c i d s  s p e c i f i e d  by a s i n g l e  c o d o n  ( f o r  
e x a m p l e  m e t h i o n i n e  o r  t r y p t o p h a n )  o r  by  t w o  c o d o n s  ( f o r  e x a m p l e  
h i s t i d i n e  o r  t y r o s i n e ) .  A n o t h e r  a p p r o a c h  i s  t o  s y n t h e s i z e  one  
l o n g  u n i q u e  s e q u e n c e  o l i g o d e o x y r i b o n u c l e o t i d e  ( A n d e r s o n  a n d  
K i n g s t o n ,  19 8 3 ;  J a y e  e t  a l . ,  1983 ;  U l l r i c h  e t  a l . ,  1 9 8 4 ;  r e v i e w e d  
by L a t h e ,  1 9 8 5 ) .  H e r e  t h e  i n c r e a s e d  p r o b e  l e n g t h  i s  u s e d  t o  
c o n f e r  s p e c i f i c i t y ,  s e l e c t i n g  a p a r t  o f  t h e  p r o t e i n  s e q u e n c e  r i c h  
i n  s i n g l e  o r  t w o  c o d o n  a m i n o  a c i d s  a n d  c o n s i d e r i n g  c o d o n
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preferences. More recent innovations have been to use modified 
deoxyribonucleotide residues to enhance the stability of A-T base 
pairs (Huynh-Dinh ejt al., 1985) or deoxyinosine at ambiguous
positions in degenerate codons (Ohtsuka e_t al., 1985).
The concentration of [ ^ P  ]-labelled oligodeoxyribonucleotide 
probe which has been used varies from approximately 1 ng/ml 
(Wallace £jt £l_., 1981a) to 17 ng/ml (Montgomery e_t al., 1978) of
each oligodeoxyribonucleotide species, at specific activities of 
about 5.0-7.0 x 10^ cpm/ug (Suggs e_t al., 1981a). These levels 
are adequate for screening libraries by colony or plaque 
hybridization and to analyze subsequent clones by Southern 
analysis. However, oligodeoxyribonucleotide probes are not as 
satisfactory as polydeoxyri'oonucleotide probes for the detection 
of single copy eukaryote genes on Southern blots of total genomic 
DMA, as labelling is limited to only one [^Pj per 
oligodeoxyribonucelotide molecule. Despite this, 
oligodeoxyribonucleotides have been used to detect point 
mutations in human alleles responsible for certain genetic 
disorders (for example Sickle-cell anaemia) by direct 
hybridization to dried agarose gels containing digested genomic 
DMA fragments (Conner e_t al., 1983). It has been found that 
oligodeoxyribonucleotides hybridize more effectively to DMA 
fragments in agarose gels than to the same fragments transferred 
to nitrocellulose (Meinkoth and Wahl, 1984). However a high 
degree of non-specific hybridization to high molecular weight DMA 
was observed (Conner et_ al_., 1983). A recent method improving
the specific activity used terminal deoxynucleotidyl transferase 
to add several labelled dAMP residues to the 3* end of 
oligodeoxyribonucleotides (Collins and Hunsaker, 1985).
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The complexity of the target genome must also be considered 
when designing oligodeoxyribonucleotide probe. Statistically, 
the minimum length (N) required for a sequence to be unique 
within a genome has been calculated from the relationship:
4n = 2 x number of bp in the target genome (Thomas, 1966; 
McConaughy and McCarthy, 1967; Astell and Smith,
1972 ) .
In the case of the mammalian genome of 3 x 10^ bp, N = 17.
2. Polydeoxyribonucleotides as probes.
(a) Hybridization.
Longer probes, such as cDNA probes, are more satisfactory 
than oligodeoxyribonucleotides for the detection of single copy 
eukaryote genes by Southern hybridization, having greater 
specificity, stability and higher radioactivity on a molar basis. 
They also allow the detection of related sequences, with lower 
homologies, by varying the hybridization conditions. For probes 
larger than 150 bp the Tm (temperature of the mid-point of the 
thermal denaturation transition; Marmur, Rownd and Schildkraut, 
1963) of a DMA duplex decreases by 1°C with every 1% of base 
pairs that are mismatched (Bonner et al., 1973).
Theoretical predictions of hybridization kinetics for such 
probes (reviewed by Meinkoth and Wahl, 1984; Anderson and Young, 
1985) are made difficult because the exact concentration and 
availability of immobilized nucleic acid is unknown. For 
polydeoxyribonucleotide duplexes larger than 200 bp, the duplex 
stability is independent of length (Steiner and Beers, 1961;
McConaughy and McCarthy, 1967; Michelson and Monny, 1967; Astell
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and Smith, 1972) however there are other factors which can 
influence the hybridization of long probes. At 0°C hybridization 
proceeds extremely slowly but as the temperature is raised the 
rate increases dramatically, reaching a broad maximum about 20- 
25°C below Tm for DNA-DNA annealing (Marmur and Doty, 1961).
This relationship applies to the formation of both well-matched 
and poorly matched hybrids, although the curve is displaced 
towards lower temperature for mismatched duplexes (Bonner e_t al., 
1973). Ideally hybridizations should be done at a temperature 
that is 20-25°C below Tm.
Ionic strength of the solution also has profound effects on 
hybridization of long probes. An increase in Tm of 15-25°C 
occurs with an order of magnitude (for example 0.1 M to 1.0 M) 
increase in ionic strength (Inman and Baldwin, 1962; Marmur,
Rownd and Schildkraut, 1963; Oliver, Wartell and Ratcliff, 1977; 
Hillen, Goodman and Wells, 1981). Hybridization rates also 
increase with increasing ionic strength of the solution. This 
effect is most dramatic at low salt concentrations (less than 0.1 
M Na + ) where a 2-fold increase in concentration increases the 
hybridization rate 5 to 10-fold. Above 0.1 M Na + the rate 
dependence is less, but still marked up to about 1.5 M Na + 
(Wetmur and Davidson, 1968; Britten, Graham and Neufeld, 1974).
Dextran sulphate has been used to increase the rate of 
hybridization (Wahl, Stern and Stark, 1979). Nucleic acids are 
excluded from the volume of a solution occupied by the polymer 
and hence their effective concentration is increased. This 
effect is most marked for polydeoxyribonucleotides longer than 
approximately 250 bp, not being observed with
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o l i g o d e o x y r i b o n u c l e o t i d e  14 bp i n  l e n g t h ,  a n d  i s  t h o u g h t  t o  be 
d ue  t o  f o r m a t i o n  o f  c o n c a t e m e r s  v i a  a n n e a l i n g  o f  o v e r l a p p i n g  
s e q u e n c e s  ( M e i n k o t h  a n d  W a h l ,  1 9 8 4 ) .  A l t h o u g h  d e x t r a n  s u l p h a t e  
i s  u s e f u l  i n  c i r c u m s t a n c e s  w h e r e  t h e  r a t e  o f  h y b r i d i z a t i o n  i s  t h e  
l i m i t i n g  f a c t o r  i n  d e t e c t i n g  s e q u e n c e  o f  i n t e r e s t ,  i t  i s  
u n n e c e s s a r y  f o r  m o s t  p u r p o s e s .  I t  i s  a l s o  d i f f i c u l t  t o  h a n d l e  
b e c a u s e  o f  i t s  v i s c o s i t y  a n d  c a n  l e a d  t o  h i g h  b a c k g r o u n d s  
( M a n i a t i s ,  F r i t s c h  a n d  S a m b r o o k ,  1 982 ;  A n d e r s o n  a n d  Young ,  1 9 8 5 ) .  
R e c e n t l y ,  p o l y e t h y l e n e  g l y c o l  h a s  b e e n  u s e d  a s  an  a l t e r n a t i v e  
( A m a s i n o ,  1 9 8 6) .
The s t a b i l i t y  o f  a p r o b e  h y b r i d i z i n g  t o  b o u n d  DNA i s  a l s o  
a f f e c t e d  by  t h e  p r e s e n c e  o f  f o r m a m i d e .  The r a t e  o f  h y b r i d i z a t i o n  
r e a c t i o n s  i n  80% f o r m a m i d e  i s  a p p r o x i m a t e l y  3 - 4  t i m e s  s l o w e r  t h a n  
i n  a q u e o u s  s o l u t i o n  ( C a s e y  a n d  D a v i d s o n ,  1977)  w h i l e  e a c h  1% 
i n c r e a s e  i n  t h e  c o n c e n t r a t i o n  o f  f o r m a m i d e  d e c r e a s e s  t h e  T m o f  a 
DNA d u p l e x  by 0 . 72°C ( Mc Co n au g h y ,  L a i r d  a n d  M c C a r t h y ,  1 9 6 9 ) .
Th us  t h e  u s e  o f  f o r m a m i d e  e n a b l e s  h y b r i d i z a t i o n  t o  be c a r r i e d  o u t  
a t  l o w e r  t e m p e r a t u r e s .
From t h e  d i s c u s s i o n  a b o v e  i t  c a n  be  s e e n  t h a t  s t r i n g e n c y  c a n  
be a l t e r e d  by a d j u s t i n g  t h e  s a l t  a n d / o r  f o r m a m i d e  c o n c e n t r a t i o n  
a n d / o r  by c h a n g i n g  t h e  t e m p e r a t u r e .  I t  i s  o f t e n  c o n v e n i e n t  t o  
p e r f o r m  t h e  h y b r i d i z a t i o n  a t  l ow s t r i n g e n c y  a n d  w a s h  a t  
i n c r e a s i n g  s t r i n g e n c i e s ,  a n a l y z i n g  t h e  r e s u l t s  a f t e r  e a c h  w a s h ,  
e n a b l i n g  t h e  d e t e c t i o n  o f  s e q u e n c e s  s h a r i n g  l e s s  t h a n  100% 
h o m o l o g y  w i t h  t h e  p r o b e .
( b )  S y n t h e s i s  o f  cDNA p r o b e s  u s i n g  r a nd o m  p r i m i n g .
A n u m b e r  o f  m e t h o d s  h a v e  b e e n  u s e d  t o  r a d i o a c t i v e l y  l a b e l  
cDNA p r o b e s .  T h e s e  i n c l u d e  n i c k - t r a n s l a t i o n  o r  cDNA s y n t h e s i s
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from a primed bacteriophage M13 template which label the entire 
plasmid or phage genome containing a desired insert (Rigby e_t 
al., 1977; Hu and Messing, 1982; Ricca, Taylor and Kalinyak,
1982). The signal to background hybridization is often 
suboptimal under these conditions, especially when the insert is 
small compared to the size of the vector. This is particularly 
important when detecting rare sequences, such as single copy 
genes in the DNA of higher eukaryotes. Radioactively labelling 
only the insert, rather than the entire vector, considerably 
increases the signal to background hybridization of the resultant 
probe.
A method frequently used in this thesis involves primed 
synthesis using random oligodeoxyribonucleotides. It has been 
shown that oligodeoxyribonucleotides can serve as primers for 
copying single-stranded templates by a variety of DNA polymerases 
(Keir, 1962; Taylor, Illmensee and Summers, 1976; Rabbitts ejt 
a 1., 1977 ; Noye s et a^ l., 1979; Hudson e t a 1., 1981; Sood,
Pereira and Weissman, 1981). These primers were originally 
prepared by deoxyribonuclease (DNase) I digestion of calf thymus 
DNA (Taylor, Illmensee and Summers, 1976). The diversity of 
these oligodeoxyribonucleotides is so large as to ensure that 
some will be complementary to sequences in the template nucleic 
acid. As different oligodeoxyribonucleotides bind to different 
sequences in the template, in theory all parts of the template 
are represented in the resulting probe at approximately equal 
frequency.
For preparation of probes, Feinberg and Vogelstein (1983) 
isolated DNA fragments which were denatured, annealed to the
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random 6-mers and a complementary DMA strand synthesized using 
one [ ]-labe lied dMTP (either dATP or dCTP) and E. coli DMA
polymerase (Pol) I Klenow (large) fragment (Jacobsen, Klenow and 
Overgaard-Hansen, 1974). Probes produced from a 1200 bp 
restriction fragment template had an average size of 800 bases, 
specific activities obtained were 0.7-3.7 x 10^cpm/ug and up to 
90% label incorporation was achieved, depending upon the amounts 
of DNA template and triphosphate precursors used. Such a probe 
functioned efficiently for a Southern hybridization experiment, 
where 24-48 h exposure was adequate to visualize bands 
corresponding to a single copy gene in complex DMA.
3. Southern blotting,
(a) Using nitrocellulose.
Southern's technique (Southern, 1979 and 1975) for blotting 
electrophoretically fractionated DMA from an agarose gel onto 
nitrocellulose by capillary transfer established that transfers 
were faithful replicas of the high-resolution gel patterns. 
Capillary transfer techniques require the following steps: 
electrophoresis, fragmentation (optional), denaturation, 
neutralization, noncovalent binding onto nitrocellulose and 
detection of specific immobilized sequences by hybridization.
For genomic blots it is recommended to use approximately 10 yg of 
chromosomal DMA digested by the desired restriction 
endonuclease(s) (Maniatis, Fritsch and Sambrook, 1982).
Fragmentation of DMA to average single-strand lengths of 
approximately 1,000 bp enables the efficient transfer and 
retention of DMA molecules regardless of their original size or 
conformation (for example supercoil and linear; Meinkoth and
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W a h l ,  1 9 8 4 ) .  U l t r a v i o l e t  (UV) l i g h t  ( L i s ,  P r e s t i d g e  a n d  H o g n e s s ,  
1978)  o r  HCl f r a g m e n t a t i o n  ( W ah l ,  S t e r n  a n d  S t a r k ,  1979)  
t r e a t m e n t s  h a v e  b e e n  u s e d .  D e n a t u r a t i o n  o f  s m a l l  DMA f r a g m e n t s  
( a b o u t  l e s s  t h a n  200 bp)  w i t h  g l y o x a l  a n d  d i m e t h y l  s u l p h o x i d e  h a s  
b e e n  r e p o r t e d  t o  p r o m o t e  t h e i r  r e t e n t i o n  on n i t r o c e l l u l o s e  
( T h o m a s ,  1 9 8 0 ) .  A c c o r d i n g  t o  M a n i a t i s ,  F r i t s c h  a n d  S a m b r o o k  
( 1 9 8 2 )  a n d  M e i n k o t h  a n d  Wahl  ( 1 9 8 4 ) ,  f r a g m e n t e d  DMA t r a n s f e r s  
v e r y  r a p i d l y ,  o n l y  1 - 2  h b e i n g  r e q u i r e d  t o  t r a n s f e r  g r e a t e r  t h a n  
90% o f  t h e  DMA f r o m  a 1.5 c m - t h i c k  g e l .  The n u c l e i c  a c i d  i s  t h e n  
f i x e d  t o  n i t r o c e l l u l o s e  b y  b a k i n g  i n  a v a c u u m  o v e n  u s u a l l y  f o r  2 
h a t  8 0 ° C .
The m e c h a n i s m  o f  n u c l e i c  a c i d  b i n d i n g  t o  n i t r o c e l l u l o s e  i s  
u n k n o w n  b u t  h a s  b e e n  a s s u m e d  t o  be n o n c o v a l e n t .  T h i s  a s s u m p t i o n  
h a s  l e d  t o  t h e  b e l i e f  t h a t  i m m o b i l i z e d  n u c l e i c  a c i d s  m i g h t  be 
e l u t e d  f r o m  t h e  n i t r o c e l l u l o s e  d u r i n g  s t r i n g e n t  w a s h i n g  
p r o c e d u r e s  a n d  p r o v i d e d  o ne  i n c e n t i v e  f o r  d e v e l o p m e n t  o f  
a l t e r n a t i v e  s u p p o r t s  ( s e e  b e l o w ) .  H o w e v e r ,  i n  n u m e r o u s  
i n d e p e n d e n t  e x p e r i m e n t s  w i t h  DNA b o u n d  t o  n i t r o c e l l u l o s e ,  i t  h a s  
b e e n  p o s s i b l e  t o  r e m o v e  t h e  m a j o r i t y  o f  t h e  h y b r i d i z e d  p r o b e  
m o l e c u l e s  w i t h o u t  e l u t i n g  s i g n i f i c a n t  q u a n t i t i e s  o f  t h e  b o u n d  
n u c l e i c  a c i d s  ( M e i n k o t h  a n d  W a h l ,  1 9 8 4 ) .
( b )  A l t e r n a t i v e s  t o  u s i n g  n i t r o c e l l u l o s e .
Due t o  t h e  r e l a t i v e l y  l ow c o s t ,  c o n v e n i e n c e  o f  u s e ,  a n d  
r e u s a b i l i t y ,  n i t r o c e l l u o s e  i s  t h e  s u p p o r t  o f  c h o i c e  f o r  m o s t  
h y b r i d i z a t i o n a p p l i c a t i o n s .  H o w e v e r  DMA f r a g m e n t s  s m a l l e r  t h a n  
a b o u t  2 0 0 - 3 0 0  bp b i n d  p o o r l y  t o  n i t r o c e l l u l o s e  a n d  p r o l o n g e d  
h y b r i d i z a t i o n  c a n  make  t h e s e  f i l t e r s  v e r y  b r i t t l e .  O t h e r  
m a t e r i a l s  h a v e  b e e n  d e v e l o p e d  t o  o v e r c o m e  some o f  t h e s e
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d i s a d v a n t a g e s  s u c h  a s  d i a z o t i z e d  p a p e r  ( A l w i n e ,  Kemp a n d  S t a r k ,  
1 9 7 7 ;  A l w i n e  e_t a l . ,  1979)  a n d  n y l o n  ( Ca n no n ,  H e i n h o r s t  a n d  
W e s s b a c h ,  1 9 8 5 ;  Reed  a n d  Mann,  19 8 5 ;  T a y l o r ,  1 9 8 5 ) .  The n y l o n  
s u p p o r t s  h a v e  b e e n  e x t e n s i v e l y  d e v e l o p e d  a s  t h e y  r e m a i n  p l i a b l e  
a n d  e a s y  t o  h a n d l e  a f t e r  b a k i n g  a n d  n u m e r o u s  h y b r i d i z a t i o n s .  
A n o t h e r  a l t e r n a t i v e  i s  t o  h y b r i d i z e  r a d i o a c t i v e  p r o b e s  d i r e c t l y  
w i t h  DMA i n  d r i e d  a g a r o s e  g e l s  ( S h i n n i c k  e_t a l . ,  1975 ;  P u r r e l l o  
a n d  B a l a z s ,  19 8 3 ;  T s a o ,  B r u n k  a n d  P e a r l m a n ,  1 9 8 3 ) .  DMA f r a g m e n t s  
1 - 5 0  kb l o n g  a r e  q u a n t i t a t i v e l y  r e t a i n e d  i n  t h e  d r y  g e l ,  b u t  
t h e r e  i s  some  l o s s  o f  s m a l l  f r a g m e n t s  ( s m a l l e r  t h a n  300 bp)  
d u r i n g  d r y i n g  a n d / o r  h y b r i d i z a t i o n  a n d  e x t e n s i v e  h y b r i d z a t i o n  i n  
f o r m a m i d e  c a n  a l s o  s o l u b i l i z e  t h e  g e l  ( M e i n k o t h  a n d  W a h l ,  1 9 84) .
Some o f  t h e  t e c h n i q u e s  d i s c u s s e d  a b o v e  a r e  u s e d  t h r o u g h o u t  
t h i s  t h e s i s ,  i n i t i a l l y  ( t h i s  C h a p t e r )  f o r  t h e  i s o l a t i o n  o f  an  I L -  
3 cDMA a n d  s u b s e q u e n t l y  i n  t h e  u t i l i z a t i o n  o f  t h i s  cDMA a s  a 
p r o b e  i n  v a r i o u s  S o u t h e r n  a n a l y s i s  e x p e r i m e n t s .
M a t e r i a l s
Med i a
1 .  A n t i b i o t i c s ;
( a )  P e n i c i l l i n  ( C o m m o n w e a l t h  S e r u m  L a b o r a t o r i e s )  was  
d i s s o l v e d  i n  s t e r i l e  w a t e r  a t  10^ u n i t s / m l  a n d  u s e d  a t  
100 u n i t s / m l  (1 u n i t  = 600 ng p e n i c i l l i n ) .
(b)  S t r e p t o m y c i n  ( G l a x o )  was  d i s s o l v e d  i n  w a t e r  a t  100 
mg/ml  a n d  u s e d  a t  100 j i g / m l .
( c )  T e t r a c y c l i n e  ( B o e h r i n g e r  M a n n h e i m )  was  d i s s o l v e d  i n  50%
( v / v ) e t h a n o l  a t  1 2 . 5  mg/ml  a n d  u s e d  a t  15 y g / m l .
2.  B med i um;  3.7% ( w / v )  b r a i n - h e a r t  i n f u s i o n  ( O x o i d ) .
3 .  B a g a r  p l a t e s ;  B medium p l u s  1.5% ( w / v )  a g a r  ( D i f c o ) .
38
4. D u l b e c c o ' s  m o d i f i e d  E a g l e s  med ium o r  DMEM ( G i b c o  
L a b o r a t o r i e s )  wa s  p r e p a r e d  a nd  s u p p l e m e n t e d  i n  a s i m i l a r  
m a n n e r  t o  RPM I- 1 6 4 0  b e l o w .
5. F o e t a l  c a l f  s e r u m  was  o b t a i n e d  f r o m  F l ow L a b o r a t o r i e s .
6. RP MI - 1 6 40  ( G i b c o  L a b o r a t o r i e s )  med i um ( 1 0 3 . 9  g) was  
d i s s o l v e d  i n  10 1 o f  r e a g e n t  g r a d e  w a t e r  ( p r e p a r e d  u s i n g  a 
M i l l i - Q  4 b o w l  p y r o g e n - f r e e  s y s t e m ,  Mo. ZD20 115 94 ) .  Added 
w e r e  20 mM MaHCC^, 10 mM H e p e s  ( F l o w  L a b o r a t o r i e s ) ,  7 . 5  yM 
m o n o t h i o g l y c e r o l  a n d  2 mM g l u t a m a t e .  The s o l u t i o n  was  
f i l t e r e d  t h r o u g h  0 .22  ym M i l l i p o r e  f i l t e r  a n d  s t e r i l i t y  
c h e c k e d  by  i n c u b a t i o n .
Mouse s t r a i n s
A l l  mouse  s t r a i n s ,  A / J ,  AKR, A.TL ( D a v i d  a n d  S h r e f f l e r ,
1 9 7 2 ) ,  BALB/c,  CBA, C 5 7 B 1 / 6 J ,  C 5 7 B 1 / 1 0 J ,  DBA/2J a n d  Mew Z e a l a n d  
B l a c k ,  w e r e  o b t a i n e d  f r o m  t h e  A n i m a l  B r e e d i n g  E s t a b l i s h m e n t  o f  
t h e  J o h n  C u r t i n  S c h o o l  o f  M e d i c a l  R e s e a r c h .
M u r i n e  c e l l  l i n e s
FMP1.6 wa s  o r i g i n a l l y  o b t a i n e d  f r o m  Dr.  S.  H a s t h o r p e  o f  t h e  
C a n c e r  I n s t i t u t e ,  P e t e r  M cC a l l u m H o s p i t a l ,  M e l b o u r n e .  EL-4 a nd  
P815 w e r e  o b t a i n e d  f r o m  Dr .  K. L a f f e r t y  o f  t h e  J o h n  C u r t i n  S c h o o l  
o f  M e d i c a l  R e s e a r c h ,  C a n b e r r a .  T h e s e  c e l l  l i n e s ,  t o g e t h e r  w i t h  
WEHI-3B D“ , F D C - P 1 ,  3 2D c l - 2 3  a n d  P388Dj_ w e r e  a l l  g r o w n  a n d  
p r o v i d e d  by  Dr .  A. H a p e l ,  a l s o  o f  t h e  J o h n  C u r t i n  S c h o o l  o f  
M e d i c a l  R e s e a r c h ,  C a n b e r r a .
R e a g e n t s
1. [ y - 3 2 p ] A T P  ( A d e n o s i n e  5 ' - [  y - ^ P  ] t r i p h o s p h a t e  ,
t r i e t h y l a m m o n i u m  s a l t )  g r e a t e r  t h a n  5 , 0 0 0  C i / m m o l ,  was  
o b t a i n e d  f r o m  A m e r s h a m .
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2. A g a r o s e ,  e l e c t r o p h o r e s i s  g r a d e ,  was o b t a i n e d  f r om S i gma  
( T y p e  I I ) .
3. [ a - 3 2 p ] d A T P  ( D e o x y a d e n o s  i n e  S ' - f a - ^ P ]  t r i p h o s p h a t e ,
t r i e t h y l a m m o n i u m  s a l t )  a p p r o x i m a t e l y  3 , 0 0 0  C i / m m o l ,  was  
o b t a i n e d  f r om Amersham.
4. L o w - m e l t i n g - t e m p e r a t u r e  a g a r o s e ,  e l e c t r o p h o r e s i s  g r a d e ,  was  
o b t a i n e d  f rom S i gma  (Type V I I ) .
5. S a r k o s y l  (N - l a u r o y l s a r c o s i n e ),  was  o b t a i n e d  f r om S i gm a  (L 
5 1 2 5 ) .
S o l u t i o n s
1. 6 x B r o m o p h e n o l  b l u e  d ye  m i x :  40% ( w / v )  s u c r o s e ,  0.1% ( w / v )  
b r o m o p h e n o l  b l u e ,  50 mM EDTA, pH 8 . 0 .
2. D e i o n i z e d  f o r m a m i d e :  J u s t  p r i o r  t o  u s e ,  2.5 g A m b e r l i t e  MB 1 
( Ajax  C h e m i c a l s )  was  g e n t l y  s t i r r e d  i n  50 ml f o r m a m i d e  f o r  1 
h a t  room t e m p e r a t u r e ,  a f t e r  w h i c h  t h e  s o l u t i o n  was  f i l t e r e d  
t h r o u g h  Whatman No. 1 f i l t e r  p a p e r .
3. D e n h a r d t ' s  s o l u t i o n :  0.02% ( w / v )  e a c h  o f  F i c o l l  400
( P h a r m a c i a ,  No. 1 7 - 0 4 0 0 - 0 1 ) ,  p o l y v i n y l p y r r o l i d o n e  ( S i g m a ,
No. PVP 360)  a n d  b o v i n e  s e r u m  a l b u m i n  ( f r a c t i o n  V, f r om 
A r m o u r - P h a r m a c e u t i c a l  Co. L t d . ) .
4. 10 mM d e o x y r i b o n u c l e o t i d e  t r i p h o s p h a t e  (dNTP) s t o c k s :  dATP, 
dCTP, dGTP a nd  dTTP w e r e  o b t a i n e d  f rom B o e h r i n g e r  Mannhe i m.  
S o l i d  dNTPs w e r e  d i s s o l v e d  i n  TE b u f f e r ,  pH 7.5 ( s e e  b e l o w ) ,  
t o  g i v e  t h e  d e s i r e d  c o n c e n t r a t i o n  and  s t o r e d  a t  - 2 0 ° C .
5.  L a m b d a  (X) DNA: W i l d  t y p e  X DNA w a s  p r e p a r e d  i n  t h i s  
l a b o r a t o r y  u s i n g  Method  7 (b) d e s c r i b e d  i n  C h a p t e r  3. The 
DNA was  d i s s o l v e d  i n  TE b u f f e r ,  pH 7 .5 .  B e f o r e  u s e  i t  was  
h e a t e d  f o r  5 min  a t  65°C,  t o  d e n a t u r e  t h e  c o h e s i v e  e n d s  o f  
t h e  m o l e c u l e ,  t h e n  r a p i d l y  c h i l l e d  t o  0°C.
40
6. P h e n o l :  As n e e d e d ,  p h e n o l  (BDH C h e m i c a l s )  was  r e m o v e d  f r o m
t h e  f r e e z e r ,  w e i g h e d  i n t o  a b e a k e r  a n d  m e l t e d  a t  65°C.  8 -
h y d r o x y q u i n o l i n e  was  a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  0.1% 
( w / w ) .  The m e l t e d  p h e n o l  was  t h e n  e x t r a c t e d  o n c e  w i t h  an 
e q u a l  v o l u m e  o f  1.0 M T r i s - H C l ,  pH 8 . 0 ,  f o l l o w e d  by  r e p e a t e d  
e x t r a c t i o n  w i t h  0.1 M T r i s - H C l ,  pH 8 . 0 ,  p l u s  0.2% ( v / v )  2 -  
m e r c a p t o e t h a n o l , u n t i l  t h e  pH o f  t h e  a q u e o u s  p h a s e  was  
g r e a t e r  t h a n  7 . 6 .  The p h e n o l  wa s  s t o r e d  u n d e r  t h i s  b u f f e r  
i n  a d a r k  b o t t l e  f o r  up t o  o n e  m o n t h  a t  4°C.  ( M a n i a t i s ,  
F r i t s c h  a n d  S a m b r o o k ,  1 9 8 2 ) .
7. 2% s i l a n e  s o l u t i o n :  2% ( v / v )  d i m e t h y l d i c h l o r o s i l a n e  ( A j a x  
C h e m i c a l s )  i n  t r i c h l o r o e t h a n e .
8. S o n i c a t e d  s a l m o n  s p e r m  DNA: The DNA ( S i g m a ,  No. D 1626)  was  
d i s s o l v e d  i n  TE b u f f e r ,  pH 7 . 5 ,  t o  a c o n c e n t r a t i o n  o f  4 
m g / m l .  T h i s  s o l u t i o n  wa s  s o n i c a t e d  u s i n g  a s o n i c  p e n  
( T e c h n i c  I n t e r n a t i o n a l )  w i t h  5 t o  8 b u r s t s  o f  5 s e c  a t  
m a x i m u m  p o w e r .  I t  w a s  d i s p e n s e d  i n  1 ml  l o t s  a n d  s t o r e d  a t  
- 2 0 ° C .
9.  SSC:  0 . 1 5  M N a C l ,  0 . 0 1 5  M s o d i u m  c i t r a t e ,  pH 7 . 0 .
10.  T r i s - a c e t a t e  b u f f e r :  0 .04  M T r i s - a c e t a t e , 0 . 0 0 1  M EDTA, pH
8 . 0 .
1 1 .  TE b u f f e r :  10 mM T r i s - H C l ,  pH 7 . 5 ,  0 . 1  mM EDTA.
A l l  o t h e r  c h e m i c a l s  u s e d  w e r e  o f  t h e  h i g h e s t  p u r i t y
c o m m e r c i a l l y  a v a i l a b l e .
V e c t o r s  a n d  b a c t e r i a l  h o s t  s t r a i n s
1 .  pAT153 ( Twi gg  a n d  S h e r r a t t ,  1 9 8 0 ) .
2. E. c o l i  HB101 ( B o y e r  a n d  R o u l l a n d - D u s s o i x ,  1 9 6 9 ;  B o l i v a r  a nd
B ac k ma n ,  1 9 7 9 ) :  F “ , hsdS2Q ( r g ,  nig),  r e c A 1 3 , a r a - 1 4 , p r o A 2 , 
l a c Y l , g a l K 2 , r p s L 2 0  (Smr ), x y l - 5 , m t l - 1 , s u p E 4 4 , X“ .
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Me t h o d s
1. I s o l a t i o n  o f  h i g h - m o l e c u l a r - w e i g h t  DNA f r o m  m a m m a l i a n  c e l l s .
Some o f  t h e  DMA p r e p a r a t i o n s  u s e d  w e r e  k i n d l y  p r o v i d e d  by 
Mr. M - c .  Fung a n d  Ms R. J o h n s o n .  The m e t h o d  e m p l o y e d  h e r e  was  
m o d i f i e d  f r o m  G r o s s - B e l l a r d ,  O u d e t  a n d  Chambon ( 1 9 7 3 ) .
( a )  From w h o l e  t i s s u e .
The f o l l o w i n g  p r o c e d u r e  i s  f o r  5 g o f  t i s s u e .  S t e r i l e  
i n s t r u m e n t s  a n d  m a t e r i a l s  w e r e  u s e d .  The f r e s h l y  k i l l e d  a n i m a l  
was  s w a b b e d  w i t h  70% ( v / v )  e t h a n o l  b e f o r e  d i s s e c t i o n .  The t i s s u e  
o f  i n t e r e s t  w a s  r e m o v e d  a n d  p l a c e d  i n  a p e t r i  d i s h  a n d  w e i g h e d .  
I n t o  a n o t h e r  c l e a n  p e t r i  d i s h  6 ml  o f  r e s u s p e n s i o n  b u f f e r  (100  mM 
EDTA, 30 mM T r i s - H C l ,  pH 8 .0)  wa s  a l i q u o t e d  a n d  t h e n  t h e  d i s h  
t i l t e d  by r e s t i n g  i t  on i t s  l i d .  The t i s s u e  w a s  f o r c e d  t h r o u g h  a 
f i n e  w i r e  s i e v e  (70 m e s h ,  B r i t i s h  s t a n d a r d )  u s i n g  a g l a s s  r o d  
w i t h  a f l a t t e n e d  e n d ,  w h i l e  h o l d i n g  t h e  s i e v e  i n  t h e  r e s u s p e n s i o n  
b u f f e r .  The r e s u l t i n g  c e l l  s u s p e n s i o n  wa s  f o r c e d  t h r o u g h  a 25 
g a u g e  n e e d l e  i n t o  a s t e r i l e  125 ml  f l a s k  u s i n g  a 10 ml  s y r i n g e .  
The v o l u m e  o f  t h e  c e l l  s u s p e n s i o n  was  c h e c k e d  u s i n g  a p i p e t t e  a nd  
a d j u s t e d  t o  8 ml  w i t h  a d d i t i o n a l  r e s u s p e n s i o n  b u f f e r ,  w h i c h  was  
f i r s t l y  u s e d  t o  w a s h  t h e  s i e v e  a n d  p e t r i  d i s h  a n d  s u b s e q u e n t l y  
p a s s e d  t h r o u g h  t h e  25 g a u g e  n e e d l e  i n t o  t h e  s ame  f l a s k .  To t h e  
c e l l  s u s p e n s i o n ,  8 ml  o f  l y s i s  b u f f e r  ( 1 0 0  mM EDTA, 30 mM T r i s -  
HCl ,  pH 8 . 0 ,  2% w / v  S a r k o s y l )  was  a d d e d .  L y s i s  wa s  c a r r i e d  o u t  
f o r  4 h a t  room t e m p e r a t u r e  w i t h  g e n t l e  a g i t a t i o n  ( a p p r o x i m a t e l y  
100  r p m ).
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( b )  From c u l t u r e d  c e l l s .
DNA p r e p a r a t i o n s  f r o m  c u l t u r e d  c e l l s  w e r e  u s u a l l y  made f r om
o
10° c e l l s ,  w h i c h  w e r e  p e l l e t e d  i n  a s t e r i l e  50 ml  p o l y p r o p y l e n e  
d i s p o s a b l e  t u b e  ( C o r n i n g )  by  c e n t r i f u g a t i o n  a t  1700 r pm,  f o r  5 
m i n  a t  r o o m  t e m p e r a t u r e .  1 .5  ml  o f  l y s i s  b u f f e r  w a s  a d d e d  t o  t h e  
p e l l e t  a n d  t h e  s u s p e n s i o n  s t o r e d  a t  - 2 0 ° C .  S t o r a g e  i n  l y s i s  
b u f f e r  h e l p s  t o  a v o i d  t h e  p r o b l e m  o f  t h e  c e l l s  c l u m p i n g  d u r i n g  
r e s u s p e n s i o n .
When r e q u i r e d ,  t h e  c e l l s  w e r e  t h a w e d  a n d  p r o t e i n a s e  K 
( E b e l i n g  e t  a l . ,  1974 ;  o b t a i n e d  f r o m  B o e h r i n g e r  M an n h e i m )  a nd  
S a r k o s y l  w e r e  a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  0 . 1  m g / m l  a n d  1% 
( w / v )  r e s p e c t i v e l y .  The v o l u m e  w a s  made up t o  8 .0  ml  w i t h  
r e s u s p e n s i o n  b u f f e r  a n d  t h e  s u s p e n s i o n  p l a c e d  i n  a s t e r i l e  125 ml 
f l a s k .  L y s i s  o f  t h e  c e l l s  wa s  c a r r i e d  o u t  f o r  5 t o  8 h a t  37°C 
w i t h  g e n t l e  a g i t a t i o n  o f  a p p r o x i m a t e l y  100 r pm.
( c )  U l t r a c e n t r i f u g a t i o n  a n d  DMA p u r i f i c a t i o n .
8 g o f  C s C l  w a s  a d d e d  p e r  8 ml  l y s a t e  f r o m  e i t h e r  t i s s u e s  o r  
c u l t u r e d  c e l l s  a n d  m i x e d  g e n t l y  u n t i l  a l l  t h e  s a l t  wa s  d i s s o l v e d .  
T h i s  s o l u t i o n  w a s  t r a n s f e r r e d  t o  a 50 T i  p o l y a l l o m e r  c e n t r i f u g e  
t u b e  ( Beckman  No. 3 2 6 8 1 4 ) ,  0.4 ml o f  10 m g / m l  e t h i d i u m  b r o m i d e  
was  a d d e d  a n d  m i x e d  i n  t h o r o u g h l y .  The t u b e s  w e r e  c e n t r i f u g e d  i n  
a 50 T i  B ec kma n  r o t o r  a t  4 1 , 0 0 0  r p m ,  f o r  36 h a t  16°C.  The DNA 
b a n d  w a s  w i t h d r a w n  u s i n g  a 5 ml  s y r i n g e  a n d  a n  18 g a u g e  n e e d l e .
To a v o i d  s h e a r i n g  o f  t h e  DNA, t h e  n e e d l e  w a s  r e m o v e d  f r o m  t h e  
s y r i n g e  b e f o r e  t r a n s f e r r i n g  t h e  s o l u t i o n  t o  a s i l i c o n i z e d  
q u i c k f i t  t u b e .  The e t h i d i u m  b r o m i d e  wa s  r e m o v e d  by  e x t r a c t i n g  
t h e  DNA s o l u t i o n  5 t i m e s  w i t h  2 v o l u m e s  o f  C s C l - s a t u r a t e d  
i s o p r o p a n o l .  The DNA w a s  t h e n  d i a l y z e d  a t  4°C a g a i n s t  a 5 0 0 - f o l d
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volume of TE buffer, pH 7.5, the buffer being changed three times 
aftera minimum of 6 h dialysis.
For quantitating the amount of DMA, optical density (OD) 
readings of diluted aliquots were taken at wavelengths 260 nm and 
280 nm. The reading at 2 6 0 nm allows the calculation of the 
concentration from the relationship that an OD of 1.0 corresponds 
to a concentration of 50 yg/ml of double-stranded DMA. The ratio 
between the readings at 260 nm and 280 nm (0°26o/OD280  ^ provides 
an estimate of the purity of the nucleic acid. Pure preparations 
of DMA have a ratio of 1.8, however if there is contamination 
with protein the 0^2 6 O ^ 1^  8 0 will be significantly less than this 
value (Maniatis, Fritsch and Sambrook, 1982). Generally 1 mg of 
DMA was obtained from 10® cultured cells, and 160 yg DMA per g of 
tissue .
2. Digestion of DMA with restriction endonucleases.
Restriction endonucleases were purchased from Mew England 
Biolabs or Boehringer Mannheim. The restriction enymes were used 
at the temperature recommended by the manufacturers in either 
medium salt buffer (50 mM MaCl, 10 mM Tris-HCl, pH 7.5, 10 mM 
MgCl2, 6 mM 2-mercaptoethanol) or high salt buffer (100 mM MaCl, 
50 mM Tris-HCl, pH 7.5, 10 mM MgC^/ 6 mM 2-mercaptoethanol) 
according to their MaCl requirement. Usually a 2-fold excess of 
enzyme was used in incubations of 1 to 3 h. The volume of 
restriction enzyme added was always kept below l/10th of the 
total reaction volume to avoid inhibitory effects of the glycerol 
present in the enzyme storage buffers. Reactions were stopped by 
the addition of either 0.2 M EDTA to a final concentration of 20 
mM or the addition of l/6th of the final volume of 6 x
44
b r o m o p h e n o l  b l u e  d y e  m i x .
3. A n a l y t i c a l  a g a r o s e  g e l  e l e c t r o p h o r e s i s .
DMA was  f r a c t i o n a t e d  by e l e c t r o p h o r e s i s  t h r o u g h  a g a r o s e  g e l s  
p r e p a r e d  i n  T r i s - a c e t a t e  b u f f e r ,  pH 8 . 0 ,  i n  a h o r i z o n t a l  s l a b  g e l  
a p p a r a t u s .  The c o n c e n t r a t i o n  o f  a g a r o s e  u s e d  v a r i e d  a c c o r d i n g  t o  
t h e  s i z e  o f  t h e  DMA f r a g m e n t s  o f  i n t e r e s t .  E i t h e r  0.5 o r  1.0 cm 
w i d e  w e l l s  w e r e  u s e d  a c c o r d i n g  t o  s a m p l e  s i z e  (30 y 1 o r  60 y 1) .
E l e c t r o p h o r e s i s  wa s  c a r r i e d  o u t  a t  room t e m p e r a t u r e  u n t i l  
t h e  b r o m o p h e n o l  b l u e  d y e  h a d  m i g r a t e d  t o  t h e  e n d  o f  t h e  g e l .
T h i s  g e n e r a l l y  w a s  o v e r n i g h t  a t  25 mA o r  2 t o  3 h a t  100 mA. DNA 
was  s t a i n e d  e i t h e r  d u r i n g  e l e c t r o p h o r e s i s  w i t h  0.5 y g / m l  e t h i d i u m  
b r o m i d e  i n  t h e  g e l  a n d  r u n n i n g  b u f f e r  o r  a f t e r  e l e c t r o p h o r e s i s  by 
s o a k i n g  t h e  g e l  i n  300 ml  w a t e r  c o n t a i n i n g  0.5 yig/ml  e t h i d i u m  
b r o m i d e  f o r  30 m i n .  I n  e i t h e r  c a s e  t h e  g e l  w a s  d e s t a i n e d  b r i e f l y  
i n  w a t e r  a n d  t h e  DNA v i s u a l i z e d  w i t h  u l t r a - v i o l e t  (UV) l i g h t  
u s i n g  a 254 nm t r a n s i H u m i n a t o r  ( U l t r a - v i o l e t  P r o d u c t s ,  San 
G a b r i e l ,  USA). The g e l s  w e r e  p h o t o g r a p h e d  u n d e r  UV i l l u m i n a t i o n  
u s i n g  a P o l a r o i d  c a m e r a  ( m o d e l  545)  a n d  f i l m  ( h i g h  s p e e d  t y p e  
57)  .
4. 0 1 i g o d e o x y r i b o n u c l e o t i d e  s y n t h e s i s .
The s y n t h e t i c  p r i m e r s  u s e d  i n  t h i s  t h e s i s  w e r e  p r e p a r e d  by 
Dr .  I .  Young a n d  Mr.  G. Mayo.  A l l  g l a s s w a r e  wa s  s i l i c o n i z e d  
u s i n g  2% s i l a n e  s o l u t i o n  a n d  a l l  p l a s t i c  a p p a r a t u s  was  
s t e r i l i z e d .
0 1 i g o d e o x y r i b o n u c l e o t i d e s  w e r e  s y n t h e s i z e d  by  t h e  p h o s p h i t e  
p h o s p h o t r i e s t e r  r o u t e  ( T a n a k a  a n d  L e t s i n g e r ,  1 982 ;  M c B r i d e  and
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Caruthers, 1983). After cleavage from the silica supports the 
oligodeoxyribonucleotides were purified by High Pressure Liquid 
Chromatography (HPLC) using a Whatman Partisil-10SAX ion exchange 
column. The column was packed and equilibrated in buffer A (1 mM 
KPO4, pH 6.3, 60% v/v formamide). Samples were loaded and eluted 
using a linear gradient from 100% buffer A, to 30% buffer A, 70% 
buffer B (0.3 M KPO^, pH 6.3, 60% v/v formamide), at a flow rate
of 1 ml/min for 45 min. The elution was monitored by measuring 
the absorbance at 270 nm. Peak fractions were pooled, diluted 1 
in 2 in buffer A, reloaded on the column, and eluted using a 
steep linear gradient from 80% buffer A, 20% buffer B to 30% 
buffer A, 70% buffer B for 10-12 min. The peak fraction was 
collected and desalted using a Sephadex G-25 (Pharmacia) column. 
1.5 ml fractions were collected and absorbance at 270 nm was 
measured. The peak fractions were combined and dried by rotary 
evaporation. The sample was finally resuspended in TE buffer, pH 
7.5.
5. Isolation of DNA fragments from agarose gels using DEAE-
cellulose membranes (Schleicher and Schuell NA-45).
This was used according to the manufacturer's instructions 
which were based on the original work of Winberg and Hammarskjöld 
( 19 80) and Dretzen e t al. (1981).
Samples of digested DNA (60 pi) were loaded directly into 1 
cm wide wells in an agarose gel of the appropriate concentration 
containing 0.5 pg/ml ethidium bromide. These were 
electrophoresed into the gel at 100 mA, the gel was covered with 
Tris-acetate buffer, pH 8.0, also containing 0.5 pg/ml ethidium 
bromide, and electrophoresis continued for a further 2 h. DEAE
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m e m b r a n e s  w e r e  w a s h e d  f o r  10 m i n  i n  10 mM EDTA, pH 7 . 6 ,  5 m i n  i n  
0.5 M NaOH, f o l l o w e d  by  s e v e r a l  r a p i d  w a s h e s  i n  d i s t i l l e d  w a t e r .
A s t r i p  o f  m e m b r a n e  w a s  p l a c e d  i n  a c u t  ma d e  j u s t  a h e a d  o f  t h e  
b a n d  o f  i n t e r e s t  a n d  e l e c t r o p h o r e s i s  c o n t i n u e d  f o r  a p p r o x i m a t e l y  
5 mi n  u n t i l  b i n d i n g  wa s  c o m p l e t e .  T h i s  was  j u d g e d  by e t h i d i u m  
b r o m i d e  f l u o r e s c e n c e  u s i n g  a h a n d  h e l d  UV m o n i t o r  (300 nm; 
o b t a i n e d  f r o m  C l e m c o  U l t r a - v i o l e t  P r o d u c t s ) .  R e s i d u a l  a g a r o s e  
w a s  r e m o v e d  by  w a s h i n g  5 o r  6 t i m e s  i n  a g l a s s  s c i n t i l l a t i o n  v i a l  
c o n t a i n i n g  NET b u f f e r  ( 0 . 1 5  M Na Cl ,  0.1 mM EDTA, 20 mM T r i s - H C l ,  
pH 8 . 0 ) .  F o r  t h e  e l u t i o n  o f  d o u b l e - s t r a n d e d  DNA, DEAE m e m b r a n e s  
w e r e  s u b m e r g e d  i n  h i g h  s a l t  NET b u f f e r  (1 .0  M Na Cl ,  0.1 mM EDTA, 
20 mM T r i s - H C l ,  pH 8 . 0 )  i n  a s i l i c o n i z e d  10 ml  t u b e .  U s u a l l y  80 
Ul  o f  h i g h  s a l t  NET b u f f e r  was  u s e d  p e r  1.0 x 0 .5  cm m e m b r a n e .
T h e  t u b e  w a s  s h a k e n  f o r  35 m i n  a t  6 5 ° C  a n d  t h e  b u f f e r  t r a n s f e r r e d  
t o  a n o t h e r  s t e r i l e  s i l i c o n i z e d  10 ml  t u b e .  The m e m b r a n e s  w e r e  
w a s h e d  ( a s  a b o v e )  w i t h  a f u r t h e r  a l i q u o t  o f  h i g h  s a l t  NET b u f f e r  
( 1 / 4  t h e  o r i g i n a l  v o l u m e  u s e d )  w h i c h  wa s  t h e n  p o o l e d  w i t h  t h e  
f i r s t  s a m p l e .  The e t h i d i u m  b r o m i d e  wa s  r e m o v e d  by  e x t r a c t i o n  
t w i c e  w i t h  3 v o l u m e s  o f  w a t e r - s a t u r a t e d  n - b u t a n o l .  The  DNA was  
p r e c i p i t a t e d  by t h e  a d d i t i o n  o f  2 v o l u m e s  o f  a b s o l u t e  e t h a n o l ,  
m i x i n g  w e l l  a n d  s t o r i n g  i n  a d r y - i c e / e t h a n o l  b a t h  f o r  3 h.  The 
s a m p l e  w a s  c e n t r i f u g e d  a t  2 0 , 0 0 0  r pm  f o r  30 m i n  i n  a S o r v a l l  SS 34  
r o t o r  a t  4°C.  The p e l l e t  wa s  w a s h e d  w i t h  c o l d  ( - 2 0 ° C )  a b s o l u t e  
e t h a n o l ,  d r i e d  u n d e r  v a c u u m  a n d  t h e n  d i s s o l v e d  i n  500 p i  TE 
b u f f e r ,  pH 7 . 5 .  S o d i u m  a c e t a t e ,  pH 5 . 5 ,  wa s  a d d e d  t o  a f i n a l  
c o n c e n t r a t i o n  o f  0.3 M a n d  r e - p r e c i p i t a t e d  a s  a b o v e  t o  r e m o v e  
r e s i d u a l  NaCl .  The f i n a l  DNA c o n c e n t r a t i o n  was  d e t e r m i n e d  by 
a g a r o s e  g e l  e l e c t r o p h o r e s i s  a n d  c o m p a r i s o n  w i t h  DNA s t a n d a r d s  o f  
known c o n c e n t r a t i o n  by  e t h i d i u m  b r o m i d e  f l u o r e s c e n c e  u n d e r  UV 
i l l u m i n a t i o n .
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6. Preparation of [ 32P]-labe lied probes.
(a) Measurement of radioactivity in nucleic acids.
1 yl samples of reaction mixtures were taken after thorough 
mixing and added to 29 yl 0.2 M EDTA. 10 y 1 of this was added to 
10 ml 50% (v/v) ethanol in a polyethylene scintillation vial. 
Another 10 yl was added to 100 yl of 500 yg/ml calf thymus 
carrier DNA (Sigma, D 1501) in a 5 ml tube. 5 ml ice cold, 10% 
(w/v) trichloroacetic acid (TCA) was added and the tube mixed and 
placed in ice for 15 min. The precipitate was collected by 
negative pressure filtration through a Whatman GF/C glass-fibre 
disc (2.5 cm diameter). The filter was washed 6 times with 5 ml 
of ice cold 10% (w/v) TCA and twice with 100% ethanol, dried by 
suction and placed in a scintillation vial containing 10 ml 50% 
(v/v) ethanol. Nucleic acids greater than 20 nucleotides in 
length are quantitatively precipitated by this procedure 
(Maniatis, Fritsch and Sambrook, 1982). The first vial measures 
the total radioactivity in the sample; the second, containing the 
filter, measures the radioactivity incorporated into nucleic 
acids, allowing the calculation of the efficiency of 
incorporation of radioiabelled nucleotide.
(b) 5'-labelling of synthetic oligodeoxyribonucleotides.
This method is based on Maxam and Gilbert (1977), Goodman 
and MacDonald (1979) and Maniatis, Fritsch and Sambrook (1982).
A typical reaction was carried out in 50 yl containing 14.4 
pmoles of oligodeoxyribonucleotide 5‘OH groups, 14.4 pmoles (72 
yCi) [y -32 P ] ATP, 70 mM Tris-HCl, pH 7.6, 10 mM MgCl2, 5 mM
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dithiothreitol and 5 units of T4 polynucleotide kinase 
(Pharmacia). This enzyme is in vast excess as one unit of 
activity is defined as that which catalyses the incorporation of 
1 nmole of [22P]-phosphate per h into an acid precipitable 
fraction (Richardson, 1981). The reaction was incubated at 37°C 
for 1 h, then heated for 10 min at 65°C. The probe was separated 
from low-molecular-weight material by chromatography on a 5 ml 
Sephadex G-50 fine (Pharmacia) column in buffer containing 10 mM 
Tris-HCl, pH 7.5, 1 mM EDTA and 100 mM MaCl.
Incorporation, determined by comparing the radioactivity of 
aliquots taken before and after separation on the column, was 
approximately 70 to 80% and the estimated specific activity about
p2.0 x 10 cpm/yg. Concentration of the 5' end-labelled 
oligodeoxyribonucleotides used in hybridizations was 
approximately 20 ng/ml.
(c) Synthesis of [22P]-labelled fragments using random 
priming.
This method is based on that of Taylor, Illmensee and 
Summers, (1976) and Feinberg and Vogelstein (1983).
Probes were prepared by primed synthesis using an isolated 
DMA fragment as template and synthetic decamer of random 
sequences as primer. A typical reaction in 20 y1 contained: 100 
ng of template DMA and 1 yg of primer which had been heated 
together for 3 min at 100°C and snap chilled to 0°C; 50 mM 
potassium phosphate buffer, pH 6.8, 10 mM magnesium acetate, 10 
mM dithiothre itol, 5 00 yM dCTP, 5 00 yM dGTP, 5 00 yM dTTP, 60 
pmoles dATP, 15 pmoles [a-22P]dATP (45 yCi) and 3 units of _E. 
coli DMA polymerase I large fragment (obtained from Boehringer
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M a n n h e i m ) .  The r e a c t i o n  wa s  a l l o w e d  t o  p r o c e e d  f o r  2 h a t  37°C.  
I n c o r p o r a t i o n  i n t o  a c i d  p r e c i p i t a b l e  m a t e r i a l  [ M e t h o d  6 ( a ) ] ,  was  
a b o u t  70% w i t h  a s p e c i f i c  a c t i v i t y  o f  a p p r o x i m a t e l y  8 x 10® 
cpm/pig DMA s y n t h e s i z e d .  T h i s  c o u l d  be  a l t e r e d  a s  r e q u i r e d  by 
c h a n g i n g  t h e  r a t i o  o f  l a b e l l e d  t o  u n l a b e l l e d  dATP u s e d  i n  t h e  
r e a c t i o n .  The DMA p r o b e  wa s  s e p a r a t e d  f r o m  l o w - m o l e c u l a r - w e i g h t  
m a t e r i a l  by c h r o m a t o g r a p h y  on a 5 ml S e p h a d e x  G-50 f i n e  c o l u m n  i n  
b u f f e r  c o n t a i n i n g  10 mM T r i s - H C l ,  pH 7 . 5 ,  1 mM EDTA a n d  100  mM 
MaCl.  The p r o b e  wa s  d e n a t u r e d  b e f o r e  u s e  by h e a t i n g  f o r  5 mi n  a t  
100°C a n d  s n a p - c h i l l i n g  i n  i c e - w a t e r .
7 .  M u c l e i c  a c i d  h y b r i d i z a t i o n .
(a)  P r e p a r a t i o n  o f  n i t r o c e l l u l o s e  f i l t e r s  f o r  c o l o n y  
h y b r i d i z a t i o n .
T h i s  i s  a m o d i f i c a t i o n  o f  t h e  m e t h o d s  o f  G r u n s t e i n  a n d  
H o g n e s s  ( 1 9 7 5 ) ,  G r u n s t e i n  a n d  W a l l i s  ( 1 9 7 9 )  a n d  Mae da ,  G r o s s  a n d  
P e s t k a  ( 1 9 8 1 ) .
C o l o n i e s  t o  be  s c r e e n e d  f o r  r e c o m b i n a n t  p l a s m i d  w e r e  p i c k e d  
u s i n g  s t e r i l e  t o o t h p i c k s  a n d  s p o t t e d  i n t o  a g r i d  p a t t e r n  
( i m p r e s s e d  w i t h  a r e p l i c a t o r )  o n t o  B a g a r  c o n t a i n i n g  t h e  
a p p r o p r i a t e  a n t i b i o t i c s .  The r e p l i c a t o r  wa s  s t e r i l i z e d  by r i n s i n g  
i t  o n c e  i n  a p e t r i  d i s h  c o n t a i n i n g  w a t e r ,  t w i c e  i n  a b s o l u t e  
e t h a n o l  a n d  t h e n  i g n i t i n g  t h e  r e s i d u a l  e t h a n o l  i n  a b u n s e n  f l a m e .  
The p l a t e s  w e r e  i n c u b a t e d  o v e r n i g h t  a t  37°C a n d  k e p t  a s  m a s t e r  
p l a t e s .  An u n a u t o c l a v e d  n i t r o c e l l u l o s e  d i s c  (85 mm d i a m e t e r ,  
S c h l e i c h e r  a n d  S c h u e l l  BA85) l a b e l l e d  w i t h  b l u e  b a l l - p o i n t  f o r  
o r i e n t a t i o n ,  was  l o w e r e d  o n t o  a s e c o n d  B a g a r  p l a t e  ( c o n t a i n i n g  
a n t i b i o t i c s )  u s i n g  t w o  p a i r s  o f  s t e r i l e  b l u n t - e n d  f o r c e p s .  The
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f i l t e r  was  a l l o w e d  t o  w e t  c o m p l e t e l y  e n s u r i n g  t h a t  no b u b b l e s  
w e r e  t r a p p e d .  The r e p l i c a t o r  wa s  p l a c e d  o v e r  t h e  c o l o n i e s  on t h e  
m a s t e r  p l a t e ,  p r e s s e d  g e n t l y ,  t h e n  u s e d  t o  i n o c u l a t e  t h e  s e c o n d  
p l a t e  w i t h  a n i t r o c e l l u l o s e  f i l t e r .  The m a s t e r  p l a t e s  w e r e  
s t o r e d  a t  4°C w r a p p e d  i n  P a r a f i l m  ( A m e r i c a n  Can Co. )  a n d  t h e  
n i t r o c e l l u l o s e  c o v e r e d  p l a t e s  i n c u b a t e d  o v e r n i g h t  a t  37°C.
Two s h e e t s  o f  Wh at man  3MM w e r e  l a y e d  on t h e  b o t t o m  o f  e a c h  
o f  f o u r  t r a y s .  The Wha t man  3MM o f  o n e  d i s h  was  s a t u r a t e d  w i t h  
0.5 M NaOH, w i t h  t h e  e x c e s s  f l u i d  r e m o v e d  u s i n g  a p a s t e u r  
p i p e t t e .  The n i t r o c e l l u l o s e  d i s c  w i t h  t h e  c o l o n i e s  w a s  l a y e d  on 
t h e  Whatman 3MM, u s i n g  f o r c e p s ,  w i t h  t h e  c o l o n i e s  f a c i n g  u p w a r d s .  
The f i l t e r  w a s  l e f t  t h e r e  f o r  10 mi n  t o  l y s e  t h e  c e l l s .  The 
f i l t e r  wa s  t r a n s f e r r e d  t o  t h e  n e x t  t r a y ,  w h e r e  t h e  W ha t man  3MM 
p a p e r  h ad  b e e n  s a t u r a t e d  w i t h  1 M T r i s - H C l ,  pH 7 . 4 ,  a n d  l e f t  f o r  
10 m i n ,  t o  n e u t r a l i z e  t h e  a l k a l i .  T h i s  was  r e p e a t e d  i n  t h e  t h i r d  
t r a y .  I n  t h e  f i n a l  t r a y  t h e  Wh a t man  3MM h a d  b e e n  s a t u r a t e d  w i t h  
2 x SSC,  a n d  t h e  f i l t e r  was  l e f t  a f u r t h e r  10 m i n .  F i n a l l y  t h e  
f i l t e r  wa s  a i r  d r i e d ,  p l a c e d  b e t w e e n  t w o  p i e c e s  o f  c l e a n  Whatman  
3MM p a p e r  a n d  b a k e d  f o r  2 h a t  3 0 ° C  i n  a v a c u u m  o v e n .  At  t h i s  
p o i n t  t h e  n i t r o c e l l u l o s e  c o u l d  be  s t o r e d  a t  room t e m p e r a t u r e  
u n d e r  v a c u u m .
(b) S o u t h e r n  b l o t t i n g .
The t r a n s f e r  o f  DMA f r o m  a g a r o s e  g e l s  t o  n i t r o c e l l u l o s e  was  
p e r f o r m e d  by a p r o c e d u r e  b a s e d  on t h e  m e t h o d s  o f  S o u t h e r n  ( 1 9 7 5 ) ,  
( 19 79 )  a n d  M a n i a t i s ,  F r i t s c h  a n d  S a m b r o o k  ( 1 9 8 2 ) .
D i g e s t s  o f  DNA w e r e  c a r r i e d  o u t  i n  50 y l  v o l u m e s  a f t e r  w h i c h  
10 y l  o f  6 x b r o m o p h e n o l  b l u e  d y e  m i x  w a s  a d d e d .  S a m p l e s ,  
t o g e t h e r  w i t h  a p p r o p r i a t e  DNA s i z e  m a r k e r s ,  w e r e  l o a d e d  d i r e c t l y
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into 1 cm wide wells of a agarose gel. These were 
e lec trophoresed into the gel at 100 mA for 10 min, the gel 
covered with Tris-acetate buffer, pH 8.0, and electrophoresis 
continued overnight at 25 mA. After staining with ethidium 
bromide and photography, the gel was trimmed and the marker lanes 
removed. The gel was soaked in 500 ml denaturation solution (0.5 
M NaOH, 1.5 M NaCl) with gentle agitation at 50 rpm for 1 h at 
room temperature. Next the gel was rinsed with water, then 
soaked in neutralization solution (1 M Tris-HCl, pH 8.0, 1.5 M
NaCl) for 1 h at room temperature with gentle agitation.
Blotting was carried out as illustrated in Figure 2.1. Three 
sheets of Whatman 3MM paper saturated with 20 x SSC were placed 
on a clean horizontal glass plate above a metal tray containing 
20 x SSC, so that the 3MM paper dipped into the solution. After 
the neutralization step, the gel was placed onto the saturated 
3MM paper and smoothed down by a gloved hand to remove bubbles 
trapped between gel and paper. Strips of Parafilm or Saranwrap 
(DOW Chemicals) were placed along each edge of the gel, flush 
with the edge to ensure that the nitrocellulose filter would not 
be in direct contact with the 3MM paper. A piece of 
nitrocellulose (Schleicher and Schuell BA85) was cut to the same 
dimensions as the gel. This was firstly wet with distilled 
water, then 20 x SSC and subsequently layed on top of the gel, 
again ensuring not to trap bubbles. Three sheets of 3MM paper 
cut to the same size as the gel were saturated with water, then 
20 x SSC and placed on top of the nitrocellulose filter. Finally 
a stack of dry paper towels, a glass plate and a weight (0.5 to 
1.0 kg) were placed on top.
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8Figure 2.1; Cross-section of a Southern transfer apparatus.
(1) tray filled with 20 x SSC, (2) glass plate (supported by two 
sides of tray), (3) wick of three sheets of Whatman 3MM paper 
soaked with 20 x SSC, (4) Parafilm or Saranwrap around all sides 
of gel, (5) gel, (6) nitrocellulose soaked in water then 20 x 
SSC, (7) three sheets of Whatman 3MM paper similarly treated, (8) 
10 cm stack of dry paper towels, (9) glass plate, (10) weight of 
0.5 to 1 kg.
The DNA fragments were allowed to transfer overnight and 
after blotting the nitrocellulose filter was briefly washed in 2 
x SSC to remove excess salt, air-dried for 30 min then baked in a 
vacuum oven for 2 h at 8CPc between two sheets of Whatman 3MM 
paper. Filters can at this point be stored under vacuum at room 
temperature.
(c) Hybridization conditions.
In all colony hybridization experiments [^P] end-labelled 
oligodeoxyribonucleotides were used. Prior to hybridization the 
stored nitrocellulose filter discs were moistened with 6 x SSC. 
The filters were then separated from the Whatman 3MM paper, and 
sealed in a thick plastic ( 250 pm) bag (up to 10 filters per bag) 
with one small opening. Prehybridization fluid (10 ml, 
prewarmed) consisting of 6 x SSC, 5 x Denhardt's solution 
(Denhardt, 1966), 250 yg/ml of sonicated, heat-denatured salmon 
sperm DMA, 50 mM sodium phosphate, pH 7.0, was added to the bag. 
Before sealing the bag care was taken to remove any air bubbles. 
This bag was then sealed in a thinner (40 pm) polythene bag. 
Prehybridization was for 2 h at a temperature 5 to 10°C below the 
apparent dissociation temperature (T^ ). For a perfect match 
formed in 6 x SSC, this is estimated by summing 2°C for each A-T 
and 4°C for each G-C bp. This generally applies for primers less 
than 20 nucleotides long (Suggs e_t al_., 1981a).
The prehybridization fluid was removed from the bag and 
replaced by 5 ml prewarmed hybridization solution (6 x SSC, 5 x 
Denhardt's solution, 250 yg/ml of sonicated, heat denatured 
salmon sperm DMA, 20 mM sodium phosphate, pH 7.0, 20 ng/ml end- 
labelled probe). Hybridization was at the same temperature for
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18 t o  20 h.
A l l  p r o b e s  u s e d  i n  t h e  S o u t h e r n  h y b r i d i z a t i o n  e x p e r i m e n t s  
w e r e  p r e p a r e d  by r a n d o m  p r i m e r  s y n t h e s i s  [ M e t h o d  6 ( c ) ]  a n d  
h o m o l o g o u s  t o  t h e  s e q u e n c e s  t o  be d e t e c t e d ,  t h u s  m o d e r a t e l y  
s t r i n g e n t  c o n d i t i o n s  w e r e  e m p l o y e d .  P r e h y b r i d i z a t i o n  (2 h) o f  
S o u t h e r n  b l o t s  wa s  a t  65°C i n  6 x SSC,  5 x D e n h a r d t ' s  s o l u t i o n ,
250 y g / m l  s o n i c a t e d ,  d e n a t u r e d  s a l m o n  s p e r m  DMA a n d  0.5% ( w / v )
SDS i n  t w o  s e a l e d  p l a s t i c  b a g s  ( a s  a b o v e ) .  G e n e r a l l y  100 y l  o f  
h y b r i d i z a t i o n  f l u i d  w a s  u s e d  p e r  cm^ o f  f i l t e r .  T h i s  wa s  
r e p l a c e d  by a n  e q u a l  v o l u m e  o f  h y b r i d i z a t i o n  f l u i d ,  i d e n t i c a l  t o  
t h e  p r e h y b r i d i z a t i o n  s o l u t i o n  e x c e p t  f o r  t h e  a d d i t i o n  o f  10 mM 
EDTA a n d  5 n g / m l  o f  a d e n a t u r e d  d o u b l e - s t r a n d e d  p r o b e  s y n t h e s i z e d  
by  t h e  r a n d o m  p r i m e r  m e t h o d .  H y b r i d i z a t i o n  w a s  f o r  18 t o  20 h a t  
65°C .
( d )  W a s h i n g  c o n d i t i o n s  a n d  a u t o r a d i o g r a p h y .
C o l o n y  h y b r i d i z a t i o n  f i l t e r s  w e r e  w a s h e d  f i r s t l y  a t  room 
t e m p e r a t u r e  i n  500  m l  o f  6 x SSC f o r  20 m i n ,  f o l l o w e d  b y  a w a s h  
a t  t h e  h y b r i d i z a t i o n  t e m p e r a t u r e  i n  a l a r g e  v o l u m e ,  d e p e n d i n g  on 
t h e  n u m b e r  o f  f i l t e r s ,  o f  6 x SSC f o r  1 h w i t h  g e n t l e  a g i t a t i o n .  
F o r  S o u t h e r n s ,  t h e  w a s h i n g  p r o c e d u r e  wa s  s i m i l a r  e x c e p t  t h a t  2 x 
SSC a n d  65°C w a s  u s e d .  The b a c k g r o u n d  o f  t h e  f i l t e r s  w a s  c h e c k e d  
w i t h  a h a n d  m o n i t o r  ( M i n i - i n s t r u m e n t  L t d . ,  m o d e l  5 - 1 0 ) .  The 
w a s h i n g  w a s  c o n t i n u e d  u n t i l  t h e  b a c k g r o u n d  wa s  b e l o w  10 c o u n t s  
p e r  s e c .  E x c e s s  f l u i d  w a s  b l o t t e d  o f f  t h e  f i l t e r s  by  p l a c i n g  
t h e m  on Wha t man  3MM p a p e r .  The f i l t e r s  w e r e  t h e n  p l a c e d  i n  a n  
a u t o r a d i o g r a p h y  c a s s e t t e  f i t t e d  w i t h  a D u p o n t  L i g h t n i n g  P l u s  
i n t e n s i f y i n g  s c r e e n ,  c o v e r e d  w i t h  S a r a n w r a p  a n d  e x p o s e d  t o  X - r a y  
f i l m  ( F u j i  RX o r  Kodak XAR-5) a t  - 7 0 ° C .  The X - r a y  f i l m  was
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d e v e l o p e d  i n  a Kodak X-OMAT p r o c e s s o r .
R e s u l t s
1. Use o f  s y n t h e t i c  o l i g o d e o x y r i ' o o n u c l e o t i d e s  t o  i s o l a t e  a cDNA 
c l o n e  e n c o d i n g  m u r i n e  I L - 3 .
(a )  B a c k g r o u n d  i n f o r m a t i o n  on cDNA l i b r a r y  c o n s t r u c t i o n  a n d  
i n i t i a l  s c r e e n i n g .
As o u t l i n e d  i n  t h e  f i r s t  c h a p t e r  o f  t h i s  t h e s i s ,  t h e
s t a r t i n g  p o i n t  f o r  t h e  m o l e c u l a r  s t u d i e s  o f  I L - 3  w a s  t h e
f o r
i s o l a t i o n  i n  t h i s  l a b o r a t o r y  o f  a cDNA c l o n e  c o d i n g ^ m u r i n e  I L - 3 .
A cDNA l i b r a r y  w a s  c o n s t r u c t e d  by Mr.  M - c .  Fung  u s i n g  mRNA 
i s o l a t e d  f r o m  t h e  l e u k a e m i a  c e l l  l i n e  WEHI-3B w h i c h  p r o d u c e s  I L - 3  
c o n s t i t u t i v e l y .  The mRNA w a s  e n r i c h e d  by s i z e  f r a c t i o n a t i o n  on a 
s u c r o s e  g r a d i e n t  a n d  a s s a y e d  by t r a n s l a t i o n  i n  Xe no p us  l a e v i s  
o o c y t e s .  D o u b l e - s t r a n d e d  cDNA wa s  s y n t h e s i z e d  (L an d  e t  a l . ,
1981)  a n d  i n s e r t e d  i n t o  t h e  P s t i  r e s t r i c t i o n  s i t e  o f  t h e  v e c t o r  
pAT153 ( T w i g g  a n d  S h e r r a t t ,  1980)  by  G-C t a i l i n g  ( M i c h e l s o n  a n d  
O r k i n ,  1 9 8 2 ) .  The cDNA l i b r a r y  w a s  t r a n s f o r m e d  i n t o  t h e  E. c o l i  
s t r a i n  HB101 ( B o y e r  a n d  R o u l l a n d - D u s s o i x ,  1969 ;  B o l i v a r  a nd  
B a c k m a n ,  1979)  a n d  t h e  r e s u l t i n g  t r a n s f o r m a n t s  s e l e c t e d  by 
t e t r a c y l i n e  r e s i s t a n c e .  The c l o n e s  w e r e  g r o w n  i n  p o o l s  o f  10 a n d  
s c r e e n e d  by Mr.  M - c .  Fung u s i n g  t h e  h y b r i d - r e l e a s e - t r a n s l a t i o n  
m e t h o d  o f  P a r n e s  et.  al^. ( 1 9 8 1 ) .  T h i s  i n v o l v e d  t h e  p r e p a r a t i o n  o f  
DNA f r o m  t h e s e  p o o l e d  c l o n e s  a n d  c o n v e r s i o n  o f  t h e  p l a s m i d s  t o  a 
l i n e a r  f o r m  w i t h  BamHI r e s t r i c t i o n  e n d o n u c l e a s e .  C o n t a m i n a t i n g  
RNA w a s  d e s t r o y e d  by  a l k a l i n e  h y d r o l y s i s ,  t h e  DNA h y b r i d i z e d  w i t h  
WEHI-3B mRNA a n d  t h e  b o u n d  mRNA e l u t e d  a n d  t h e n  t r a n s l a t e d  i n  
o o c y t e s .
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One positive pool of 10 clones was detected. Individual 
clones from this group were rescreened in the same manner, and a 
single positive clone (pILMl) was obtained. The cDNA insert in 
this clone was very short (139 bp). Therefore, to obtain a 
longer cDNA clone, a second cDNA library was constructed. My own 
participation in this project consisted of the screening of a 
size fractionated cDNA library (described below) using a 
synthetic oligodeoxyribonucleotide probe.
(b) Further screening using an oligodeoxyribonucleotide 
probe.
An oligodeoxyribonucleotide primer of 21 bases (21-mer; 5'
TTGAAGCTTGGAGTCCCAGGT 3') corresponding to nucleotides 92-112 of 
the pILMl cDNA insert was synthesized. The single clones 
constituting a second library, prepared from cDNA fragments 
larger than 500 bp, were plated in a grid pattern on tetracycline 
B agar using sterile toothpicks and transferred to a 
nitrocellulose filter [Method 7 (a)]. Included on a separate 
filter was a negative control of HB101 colonies, grown on B agar. 
On each of the test filters there was a negative control, HB101 
containing pAT153, and a positive control, HB101 containing 
pILMl. Based on the rule of 2°C for each A-T bp and 4°C for each 
G-C bp, the T^ of the 21-mer was approximately estimated to be 
64°C. The temperature chosen for hybridization was 55°C, 9°C 
less than T^ . The 21-mer was end-labelled using [y-^PlATP and T4 
polynucleotide kinase [Method 6 (b)], to a specific activity of 
approximately 2.0 x 10®cpm/yg. The nitrocellulose filters were 
hybridized and washed as outlined in Methods 7 (c) and (d). 
Filters were exposed to Fuji RX X-ray film, with an intensifying 
screen at -70°C for 24 and 48 h. Two positives (pILM2 and pILM3)
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were identified and the autoradiographs are shown in Figure 2.2.
To establish that both pILM2 and pILM 3 were authentic 
positives and stable transformants, 33 single colonies of each 
type were replated in a grid pattern and the resulting 
nitrocellulose filter probed with [22P]-labelled 21-mer. All 
clones hybridized to this probe.
pILM3 was shown by DNA sequencing to carry an insert of 629 
bp excluding the G-C tails (Fung ejt al., 1984) whereas the pILM2 
cDNA insert was identical to that of pILMl (Dr. H. Campbell, 
unpublished results). The structure of pILM3 and complete cDNA 
sequence are shown in Figures 2.3 and 2.4, respectively. This 
cDNA insert contained the IL-3 coding region but was missing a 
portion of the 3' untranslated region (Fung e_t al., 1984). A
primer, P2 (5' ATAAATTGATAAGACAT 3'), was synthesized which is 
complementary to a portion of the 3' region of the IL-3 cDNA 
sequence in pILM3 (Figure 2.4). This was end-labelled and used 
to screen the first and second cDNA libraries for clones with 
this region. The T^ was estimated at 40°C, and hybridization 
carried out at 30°C. No further clones were detected, although 
there was hybridization to the positive control, pILM3.
Once the IL-3 cDNA clone carrying the complete coding 
sequence was isolated, work was commenced relating to the main 
theme of this thesis; the study of IL-3 gene structure. Initial 
work involved Southern hybridization using the [22P]-labelled IL- 
3 cDNA as probe.
2. Isolation of an IL-3 cDNA fragment.
Digestion with Hindlll and Ncol restriction endonucleases
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Figure 2.2: Autoradiograph of two filters from the colony
screening of the second cDNA library.
A [ P ]-end-labelied 21-mer was used to screen this library for 
IL-3 cDNA. Two positive clones, pILM2 (2) and pILM3 (3), and the 
positive control, pILMl (1), are indicated.





Nco I ^ p f  
G-C tail
Figure 2.3; Structure of pILM3.
The double-stranded cDNA was inserted into the vector pAT153 by 
G-C tailing, transformed into E. coli HB101 and transformants 
selected for by tetracycline resistance. Indicated also are the 
Hindi!I and Ncol sites used for isolating the 467 bp fragment 
involved in later hybridization experiments.
M V L A S S T T S  I H T M L L L L L M L F  
AACCCCTTGGAGGACCAGAACGAGACAATGGTTCTTGCCAGCTCTACCACCAGCATCCACACCATGCTGCTCCTGCTCCTGATGCTCTTC
10 20 30 40 50 60 70 80 90
H L
r l
G L Q A S I S G R D T H R L T R T L N C S S I V K E I I
CACCTGGGACTCCAAGCTTCAATCAGTGGCCGGGATACCCACCGTTTAACCAGAACGTTGAATTGCAGCTCTATTGTCAAGGAGATTATA
100 H 120 130 140 150 160 170 180
G K L P E P E L K T D D E G P S L R N K S F R R V N L S K F
GGG AAGCTC C C AG AAC CTG AACTC AAAACTG ATGATG AAGGACCCTCTCTGAGG AATAAG AGCTTTCGG AGAGTAAACCTGTCC AAATTC
190 200 210 220 230 240 250 260 270
V E S Q G E V D P E D R Y V I K S N L Q K L N C c L P T S A
GTGGAAAGCCAAGGAGAAGTGGATCCTGAGGACAGATACGTTATCAAGTCCAATCTTCAGAAACTTAACTGTTGCCTGCCTACATCTGCG
280 290 B 300 310 320 330 340 350 360
N D S A L P G V F I R D L D D F R K K L R F Y M V H L N D L
AATGACTCTGCGCTGCCAGGGGTCTTCATTCGAGATCTGGATGACTTTCGGAAGAAACTGAGATTCTACATGGTCCACCTTAACGATCTG
370 380 390 400 410 420 430 440 450
E T V L T S R P P Q P A S G S V S P N R G T V E c
GAGACAGTGCTAACCTCTAGACCACCTCAGCCCGCATCTGGCTCCGTCTCTCCTAACCGTGGAACCGTGGAATGTTAAAACAGCAGGCAG 
460 470 480 490 500 510 520 530 540
AGCACCTAAAGTCTGAATGTTCCTCATGGCCCATGGTCAAAAGGATTTTACATTCCTTTATGCCATCAAATGTCTTATCAATTTATCTA
550 560 570' 580 590 600 610 620
F i g u r e  2 . 4 : N u c l e o t i d e  s e q u e n c e  o f  t h e  cDNA i n s e r t  o f  pILM3
(Fung  e t  a j . . ,  1984  ).
A l s o  shown a r e  the  p r e d i c t e d  ami no  a c i d  s e q u e n c e  o f  murine  IL-3  
and r e l e v a n t  r e s t r i c t i o n  s i t e s :  B, BamHI; H, Hind i I I ; N, Nco l .
The 2 1- mer  s u c c e s s f u l l y  u s e d  in  s c r e e n i n g  t h e  s e c o n d  cDNA l i b r a r y  
i s  i n d i c a t e d  a s  PI  and t h e  p r i m e r  u s e d  i n  s c r e e n i n g  f o r  c l o n e s  
c o n t a i n i n g  t h e  3' r e g i o n  a s  P2.
wa s  u s e d  t o  p r e p a r e  a f r a g m e n t  f r o m  p l a s m i d  pILM3 ( F i g u r e s  2.3 
a n d  2 .4)  t h a t  c o v e r s  m o s t  o f  t h e  c o d i n g  r e g i o n  o f  t h e  I L - 3  cDNA 
s e q u e n c e .  T h i s  f r a g m e n t  w a s  u s e d  e x t e n s i v e l y  a s  a t e m p l a t e  f o r  
t h e  p r e p a r a t i o n  o f  [ ] - l a b e l l e d  I L - 3  cDMA p r o b e s  i n  t h i s  w o rk .
A p p r o x i m a t e l y  25 yg  o f  pILM3 p l a s m i d  DMA wa s  i n i t i a l l y  
d i g e s t e d  w i t h  H i n d 1 1 1  i n  m e d i u m  s a l t  b u f f e r  a t  3~Pc. The  s a l t  
c o n c e n t r a t i o n  was  t h e n  a d j u s t e d  t o  h i g h  s a l t  c o n d i t i o n s  ( M e t h o d  
2) a n d  Mcol  d i g e s t i o n  c a r r i e d  o u t .  The s a m p l e s  w e r e  l o a d e d  o n t o  
a 1% a g a r o s e  g e l  a n d  t h e  4 6 7  b p  f r a g m e n t  o f  i n t e r e s t  w a s  i s o l a t e d  
u s i n g  D E A E - c e l l u l o s e  m e m b r a n e  ( M e t h o d  5) .  A p p r o x i m a t e l y  1.4 y g  
o f  f r a g m e n t  w a s  i s o l a t e d  i n  t h i s  way (38% r e c o v e r y ) .
3 .  E x a m i n a t i o n  o f  t h e  I L - 3  g e n e  o f  v a r i o u s  s t r a i n s  o f  m i c e .
S o u t h e r n  a n a l y s i s  wa s  c a r r i e d  o u t  u s i n g  c h r o m o s o m a l  DMA 
i s o l a t e d  f r o m  t h e  b r a i n  a n d  l i v e r  o f  v a r i o u s  mouse  s t r a i n s .  
G e n e r a l l y ,  15 y g  DMA w a s  d i g e s t e d  t o  c o m p l e t i o n  w i t h  a s p e c i f i c  
r e s t r i c t i o n  e n d o n u c l e a s e  f o r  3 h a t  37°C.  F o r  g e n o m i c  S o u t h e r n s ,  
2 yg w i l d  t y p e  A DMA d i g e s t e d  w i t h  r e s t r i c t i o n  e n d o n u c l e a s e  
H i n d i I I  was  u s e d  a s  a s i z e  m a r k e r .  S a m p l e s  w e r e  r u n  o v e r n i g h t  on 
a 1% a g a r o s e  g e l ,  t r a n s f e r r e d  t o  a n i t r o c e l l u l o s e  f i l t e r  a nd  
h y b r i d i z e d  t o  [ ] - l a b e l l e d  I L - 3  cDMA p r o b e  u n d e r  m o d e r a t e l y
s t r i n g e n t  c o n d i t i o n s .
To a s s e s s  t h e  n u m b e r  o f  c o p i e s  o f  t h e  I L - 3  g e n e  p r e s e n t  i n  
t h e  m u r i n e  g e n o m e ,  c h r o m o s o m a l  DMA was  d i g e s t e d  w i t h  t h e  
r e s t r i c t i o n  e n d o n u c l e a s e  E c o R I , w h i c h  d o e s  n o t  c u t  t h e  I L - 3  cDMA 
s e q u e n c e  ( F ung  e_t a l . ,  1984 ;  Y o k o t a  e t  a l . ,  1 9 8 4 ) .  A l s o  i n c l u d e d  
on i n i t i a l  S o u t h e r n  b l o t s  wa s  pILM3 ( a p p r o x i m a t e l y  4300 bp i n  
l e n g t h )  l i n e a r i z e d  w i t h  E c o RI .  The a m o u n t  o f  p l a s m i d  DMA l o a d e d  
o n t o  t h e  a g a r o s e  g e l  w a s  e s t i m a t e d  a s  e q u i v a l e n t  t o  a s i n g l e  c op y
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of the IL-3 gene in the mouse genome. This was calculated as 
follows:
15 x 10 g (chromosomal DMA digested)
3.0 x 109 bp/haploid genome x 660 g/mol bp
_  1 o= 7.6 x 10 ■LO moles of genome present
For a single copy gene, 7.6 x IO”-*-9 moles of pILM3 should be 
loaded.
7.6 x 10"18 moles x 4300 bp/pILM3 x 660 g/mol bp =  22 pg
Thus approximately 22 pg of pILM3 was used to represent one gene 
copy. The probe was prepared by random primer synthesis [Method 
6 (c)] using the 467 bp Hindlll-Mcol fragment, isolated as above 
from pILM3, as template.
As shown in Figure 2.5, a single hybridizing fragment was 
observed. This was of appropriate intensity for a single-copy 
gene. The size of this genomic EcoRI fragment varied from about 
8.5 kb for BALB/c, C57B1/6J and C57B1/10J, 10 kb for A.TL and
CBA, to 16 kb for Mew Zealand Black. Mot shown in Figure 2.5 are 
the mouse strains AKR, A/J and DBA/2J. A/J and DBA/2J gave a 
similar result to BALB/c, whereas AKR had a single hybridizing 
EcoRI band of approximately 10 kb. Experiments using DMA from 
brain tissue of these mouse strains gave identical results to 
those obtained using liver DMA. These results suggest that the 
differences in size of the EcoRI hybridizing bands are due to 
restriction site changes occurring between strains.
Chromosomal DMA from BALB/c and Mew Zealand Black mice
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Figure 2.5: Southern hybridization of EcoRI-digested genomic 
DMA from various mouse strains.
The probe used was derived from the 467 bp Hindi!I-Ncol fragment 
of a murine IL-3 cDNA clone. The approximate sizes of the 
largest (16 kb) and the smallest (8.5 kb) bands observed are 
indicated, (a) C57B1/6J, (b) C57B1/10J, (c) BALB/c, (d) CBA, (e) 
New Zealand Black, (f) A.TL.
a b c d e f
digested with the restriction endonucleases BamHI and Hindlll
gave identical Southern analysis results, as shown in Figure 2.6. 
Digestion with BamHI revealed two hybridizing bands of about 2.7 
kb and 10 kb. With HindlII, a single band of about 6.4 kb was 
observed in both cases. These results are consistent with the 
presence of a single copy of the IL-3 gene in the haploid genome. 
The presence of two bands in the case of Ba_mHI is due to the 
presence of a BamHI site known to lie between the H i ndl 11 and 
Nco I sites in the cDNA (Figure 2.4; Fung et al., 19 84 ; Yokota e_t 
al., 1984) which delimit the probe fragment used. A single band 
is obtained with Hindi!I digestion, despite the presence of a 
Hindlll site in the cDNA, since this site was used in excision of 
the HinduI-NcoI template fragment allowing only DNA to one side 
of this site to hybridize with the probe. Thus the gene 
arrangement in New Zealand Black and BALB/c mice appears to be 
the same with respect to the sequences hybridizing to this probe.
Further Southern analysis was carried out using chromosomal 
DNA digested with various restriction endonucleases to determine 
the presence of introns in the IL-3 gene. Recognition sites of 
the enzymes chosen, BstEII, PstI, Pvul, Sail and XmnI, were all 
known not to be present in the cDNA sequence (Fung e_t a_l., 1984;
Yokota et al., 1984). BALB/c chromosomal DNA was used and an 
EcoRI digest was also included as a control. It was demonstrated 
that PstI and PvuII cut the IL-3 gene, as indicated by the 
presence of more than one hybridizing band and thus there are 
intervening sequences present in the IL-3 gene.
The information obtained from the Southern analysis 
contributed to the isolation and sequencing of the IL-3 gene by 
this laboratory (Campbell et al., 1985). Genomic DNA from BALB/c
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Figure 2.6: Southern hybridization of genomic DNA from BALB/c
and New Zealand Black mice with murine IL-3 cDNA 
probe following digestion with various restriction 
endonucleases.
Approximate sizes are indicated in kb. (a) BALB/c, EcoRI; (b)
New Zealand Black, EcoRI; (c) BALB/c, BamHI; (d) New Zealand
Black, BamHI; (e) BALB/c, Hindlll; (f) New Zealand Black,
Hindlll.
a b o d e  f
liver was digested to completion with EcoRI, size fractionated on
agarose gels and a fraction enriched for fragments carrying the 
IL-3 gene was cloned into the vector XgtWES.XB (Leder, Tiemeier 
and Enquist, 1977). The IL-3 gene was also isolated and 
nucleotide sequence determined by Miyatake e_t al. ( 1985b). The 
gene was shown to be located close to the 3' end of the 8.5 kb 
EcoRI fragment detected in the Southern analysis.
4. Examination of the IL-3 gene of various mouse cell lines.
Southern analysis was carried out on EcoRI digested 
chromosomal DNA isolated from the various cell lines described in 
Table 2.1. The probe was prepared using the Hindlll-Ncol cDNA 
fragment as template for random primer synthesis. The results 
are shown in Figure 2.7, where these digests are compared to 
EcoRI digested BALB/c liver DNA, the standard mouse DNA used in 
this study.
The cell lines FDC-P1 and 32D cl-23 are dependent on IL-3 
for growth and appear to be immortalized bone marrow progenitors 
which are blocked in differentiation. The cell lines P388D]_ and 
P815 are factor-independent myeloid cells. FMP1.6 is also a 
factor-independent cell line derived from the dependent cell line 
FMP1.1 (Hasthorpe, 1980). EL-4 is a T cell lymphoma line which 
produces IL-3 when stimulated by phorbol myristate acetate and 
thus displays similar regulation of IL-3 expression to normal T 
lymphocytes. Southern analysis of these cell lines revealed a 
single hybridizing EcoRI band of similar size to that found in 
genomic DNA from 3ALB/c mice. WEHI-3B, which produces IL-3 
constitutively, is a macrophage-like leukaemia cell line, a cell 
type that normally would not express IL-3. Southern analysis
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Table 2.1: Murine cell lines used in Southern analysis.
Cell line Strain of Cell/tumour IL-3
origin type Production
1FDC-P1 DBA/2J Early myeloid 
precursor
-






4P815 BALB/c Mastocytoma -




6FMP1.6 DBA/2J Mast cell­
like -
7WEHI-3B D" BALB/c Myelomonocytic
leukaemia
Constitutive
References: ■'•Dexter et al. ( 1980).
2Greenberger e_t al_. ( 1983).
"3 Dawe and Potter, (1957); Koren, Handwerger and 
Wunderlich (1975).
4Dunn and Potter, (1957).
^Farrar e_t a_l. (1980); Ihle e_t a_l. ( 1982b).
^Hasthorpe, (1980).
^Metcalf, Moore and Warner, ( 1969); Warner, Moore and 
Metcalf, (1969); Ralph, Moore and Nilsson, (1976); 
Lee, Hapel and Ihle, (1982); Metcalf and Nicola 
(1982).
All the above cell lines were grown by Dr. A. Hapel. The cell 
lines P388Di, P815, EL-4 and FMP1.6 were grown in DMEM 
supplemented with 10% foetal calf serum, glutamine and the 
antibiotics penicillin and streptomycin. The cell lines WEHI-3B, 
FDC-P1 and 32D cl-23 were grown in RPMI-1640 medium supplemented 
with the above ingredients. For FDC-P1 and 32D cl-23, the medium 
also included 10% WEHI-3B conditioned medium (Warren, Hargreaves 
and Hapel, 1985), a source of IL-3. All cells were grown at 37°C 
in a 5% CO2 incubator (GallenKamp, FSE Scientific).
Figure 2.7: Southern hybridization of genomic DNA from
different cell lines with murine IL-3 cDNA probe 
following digestion with EcoRI restriction 
endonuclease.
Approximate sizes are indicated in kb. (a) WEHI-3B, (b) FMP1.6, 
(c) EL-4, (d) P388D1, (e) P815, (f) 32D cl-23, (g) FDC-P1, (h) 
BALB/c liver.
a b c d e f g h
8.5
showed that as well as the usual 8.5 kb EcoRI band, there is an
additional 3.8 kb band of approximately equal intensity, 
suggesting that WEHI-3B may carry one normal and one rearranged 
IL-3 gene.
Further Southern analysis of WEHI-3B chromosomal DNA was 
carried out after digestion with BamHI and Hindlll restriction 
endonucleases. Since WEHI-3B cells were originally derived from 
BALB/c mice, genomic blots using BALB/c DNA were done in 
parallel. The HindiII digest revealed a single hybridizing band 
of the size observed in BALB/c mice (6.4 kb). Since the Hindlll 
site is located near the 5' end of the IL-3 gene cDNA (Figures 
2.3 and 2.4), this suggests that at least at the 3' end the 
normal and rearranged genes are similar. This was also verified 
by the EcoRI/Hindlll double digest where a single band of about 
3.0 kb was seen in both BALB/c and WEHI-3B DNA.
As shown in Figure 2.6, BALB/c DNA digested with BamHI gives 
rise to two hybridizable bands, of about 2.7 and 10 kb, on the 
Southern blot using the IL-3 cDNA probe. In the WEHI-3B DNA 
blots these two bands are present plus an extra band of about 3.5 
kb. This together with the above suggested that there has been 
some change in the 5' region of the gene, resulting in the 
different cutting patterns observed. A more detailed study of 
the rearranged gene in WEHI-3B is presented in Chapter 3.
Discuss ion
The hybrid-release-translation technique of Parnes e_t al. 
(1981) was successfully used by Mr. M -c. Fung to identify a 
short cDNA clone encoding a portion of IL-3. This technique is a
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tedious one when compared with the secondary screening of the 
clones, carried out using a single synthetic
oligodeoxyribonucleotide whose sequence was based on that of the 
short IL-3 clone. This approach allowed the isolation of a 
longer IL-3 cDMA clone (pILM3) which carried the complete coding 
sequence for IL-3 and was a very useful probe for subsequent 
experiments described in this thesis.
A survey of various mouse strains was carried out using 
Southern analysis and a fragment derived from the isolated IL-3 
cDNA clone pILM3 as probe. The results presented here suggest 
there is only a single gene for IL-3 in the haploid mouse genome. 
A number of different mouse strains possess a single hybridizing 
genomic EcoRI fragment seen in Southern hybridization, and this 
fragment varies somewhat in size between different mouse strains, 
in agreement with a simple model in which all strains have a 
single IL-3 gene flanked by EcoRI sites whose position varies 
between some strains. Using other restriction enzymes, the 
single gene model was further supported by an examination of the 
BALB/c and Mew Zealand Black strains, which have a large 
difference in the size of the EcoRI fragments, using other 
restriction enzymes.
Preliminary Southern analysis using DMA digested with 
various restriction endonucleases revealed the presence of 
introns in the IL-3 gene. This was subsequently confirmed from 
the DMA sequence of the IL-3 gene (Campbell e_t al., 1985; 
Miyatake e_t al., 1985b) which was shown to consist of 5 exons 
interrupted by 4 introns.
Of particular interest were the results obtained with the
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l e u k a e m i a  c e l l  l i n e  WEHI-3B w h i c h  was  d e r i v e d  f r o m  t h e  BALB/c 
mouse  s t r a i n ,  a n d  p r o d u c e s  I L - 3  c o n s t i t u t i v e l y  a t  r e l a t i v e l y  h i g h  
l e v e l s .  A n a l y s i s  o f  g e n o m i c  DMA f r o m  t h i s  c e l l  l i n e  by  S o u t h e r n  
h y b r i d i z a t i o n  u s i n g  t h e  I L - 3  cDMA p r o b e  i n d i c a t e d  a n  a d d i t i o n a l  
h y b r i d i z i n g  EcoRI  b a n d  o f  a p p r o x i m a t e l y  3.8 kb ,  w i t h  a s i m i l a r  
i n t e n s i t y  t o  t h e  e x p e c t e d  8.5  kb b a n d .  F u r t h e r  S o u t h e r n  a n a l y s i s  
s u g g e s t e d  t h a t  t h e r e  i s  a c h a n g e  i n  o ne  o f  t h e  I L - 3  g e n e  a l l e l e s  
o f  t h i s  c e l l  l i n e  i n  t h e  5'  r e g i o n  o f  t h e  g e n e .  The p o s s i b i l i t y  
t h a t  t h e r e  i s  a c o n n e c t i o n  b e t w e e n  t h e  s t r u c t u r a l  a l t e r a t i o n  i n  
t h e  v i c i n i t y  o f  t h e  I L - 3  g e n e  a n d  c o n s t i t u t i v e  I L - 3  p r o d u c t i o n  i n  
t h i s  c e l l  l i n e  wa s  f u r t h e r  i n v e s t i g a t e d  a n d  t h i s  w o r k  i s  
d e s c r i b e d  i n  C h a p t e r  3. A l l  o t h e r  c e l l  l i n e s  s u r v e y e d  s h o w e d  no 
a l t e r a t i o n  i n  t h e  h y b r i d i z a b l e  E c o RI  b a n d  r e l a t i v e  t o  t h e  BALB/c 
s t a n d a r d .
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Chapter 3
Isolation and characterization of the rearranged interleukin-3 
gene from the leukaemia cell line WEHI-3B.
Introduction
(a) Approach
An essential step in the analysis of the change observed in 
or near the IL-3 gene of WEH I-3 B cells was to isolate this 
rearranged gene and its normal counterpart. As the nature of the 
change was not known, a complete genomic library consisting of 
overlapping fragments was used. The alternative of using a 
partial library prepared from a source enriched for the gene 
sequences of interest (Tilghman e_t al., 1977; Tonegawa et_ al., 
1977) had been used successfully in this laboratory (Campbell et 
al., 1985) for the isolation of an EcoRI restriction fragment 
carrying the murine IL-3 gene but was not suitable in the present 
case .
Bacteriophage X and cosmid DMA cloning vectors have been 
used for genomic library construction. Cosmids allow the cloning 
of large DMA fragments (up to 50 kb) however such fragments are 
not often required and cosmids are generally more difficult to 
use than X vectors. The availability of a wide variety of 
tailored Xvectors (Blattner et_ al_., 1977; Leder, Tiemeir and
Enquist, 1977; Murray, Brammar amd Murray, 1977; Karn et al., 
1980; Loenen and Brammar, 1980; Frischauf e_t al., 1983), combined 
with the development of the _in vitro packaging (Hohn and Murray, 
1977; Sternberg, Tiemeir and Enquist, 1977) and plaque 
hybridization (Benton and Davis, 1977) techniques has provided an 
efficient method for the construction and screening of complete 
genomic libraries.
(b) Bacteriophage X vectors.
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The b a c t e r i o p h a g e  X c h r o m o s o m e  i s  a l i n e a r  d o u b l e - s t r a n d e d  
DNA m o l e c u l e  o f  48 . 5  k b ,  w i t h  12 bp o f  s i n g l e - s t r a n d e d  
c o m p l e m e n t a r y  c o h e s i v e  e n d s  ( S a n g e r  e t  a l . ,  1 9 8 2 ) .  V e c t o r  
c o n s t r u c t i o n  h a s  t a k e n  a d v a n t a g e  o f  t h e  f a c t  t h a t  t h e  c e n t r a l  
r e g i o n  ( a b o u t  40%) o f  t h e  m o l e c u l e  i s  n o n - e s s e n t i a l  f o r  l y t i c  
p r o p a g a t i o n  o f  t h e  v i r u s ,  a n d  t h a t  p h a g e  DMA o f  78 t o  105% o f  
w i l d - t y p e  g enome  l e n g t h  i s  v i a b l e  ( W e i l  et. a l . ,  19 7 2 ;  B r a m m a r ,  
1 9 8 2 ) .  T h e r e  a r e  g e n e r a l l y  t w o  t y p e s  o f  X v e c t o r s ,  i n s e r t i o n  o r  
r e p l a c e m e n t ,  w h i c h  d i f f e r  i n  t h e i r  a b i l i t y  t o  c a r r y  s m a l l  o r  
l a r g e  f r a g m e n t s  o f  f o r e i g n  DMA.
I n s e r t i o n  v e c t o r s  h a v e  a s i n g l e  t a r g e t  s i t e  a t  w h i c h  DMA i s  
i n s e r t e d .  T h e s e  v e c t o r s  c o m m o n l y  l a c k  a b o u t  20% o f  t h e  w i l d  t y p e  
g e n o m e  ( M u r r a y ,  1 9 8 3 ) ,  a l l o w i n g  c l o n i n g  o f  s m a l l  DMA f r a g m e n t s  (0 
t o  12 kb;  de  Wet  e_t a l . ,  1 9 8 0 ) .  T h e s e  w i l l  n o t  be  d i s c u s s e d  
f u r t h e r  a s  t h e  l a r g e  n u m b e r  o f  r e c o m b i n a n t  c l o n e s  r e q u i r e d  t o  
o b t a i n  a r a r e  s e q u e n c e  o f  i n t e r e s t  m a k e s  t h e m  u n s u i t a b l e  f o r  
c o n s t r u c t i n g  e u k a r y o t i c  g e n o m i c  l i b r a r i e s .
R e p l a c e m e n t  o r  s u b s t i t u t i o n  v e c t o r s  p o s s e s s  r e s t r i c t i o n  
c l o n i n g  s i t e s  f l a n k i n g  a r e g i o n  t h a t  c a r r i e s  n o n - e s s e n t i a l  g e n e s  
a n d  c a n  be  r e m o v e d  a n d  r e p l a c e d  by f o r e i g n  DMA. C l e a v a g e  w i t h  an  
a p p r o p r i a t e  e n z y m e  g e n e r a t e s  t h r e e  f r a g m e n t s ;  t h e  r i g h t  a n d  l e f t  
a r m s  c o n t a i n i n g  g e n e s  e s s e n t i a l  f o r  l y t i c  p r o p a g a t i o n  a n d  t h e  
d i s p e n s i b l e  " s t u f f e r "  f r a g m e n t .  By c o n f i n i n g  t h e  e s s e n t i a l  g e n e s  
t o  s m a l l  r e g i o n s  o n  t h e  a r m s ,  up  t o  23 kb  o f  f o r e i g n  DMA 
( F r i s c h a u f  et.  a l . ,  1983)  c a n  be  c l o n e d  i n t o  s u c h  v e c t o r s .
Many o f  t h e s e  v e c t o r s  a l l o w  t h e  d i s c r i m i n a t i o n  o f  p a r e n t a l  
a n d  r e c o m b i n a n t  p h a g e  by  a p h e n o t y p i c  c h a n g e  a s s o c i a t e d  w i t h  t h e  
l o s s  o f  g e n e s  c a r r i e d  on  t h e  s t u f f e r  f r a g m e n t .  S y s t e m s  u s i n g  t h e
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lacZ gene, coding for ß-galactosidase, are common. This enzyme
can hydrolyse 5-bromo-4-chloro-3-indolyl-3-D-galactoside (X-gal) 
provided in the plating medium producing a non-diffusable blue 
dye. If vectors carrying this gene in their stuffer fragment are 
grown in lacZ~ hosts, in the presence of X-gal, parental phage 
will produce blue plaques while the recombinant phage will form 
clear plaques. One such vector is Charon 16A (Blattner e_t al., 
1977; Williams and Blattner, 1979). Alternatively a lac promoter 
on the stuffer fragment may be detected in lacZ+ hosts since 
phage replication produces sufficient copies of the lac operator 
to titrate the host lac repressor and thus activate the 
chromosomal lacZ gene in absence of an inducer (Blattner e_t al., 
1977; Williams and Blattner, 1979). Another variation relies on 
suppression of an amber mutation in the host lacZ gene by a 
suppressor gene within the stuffer (for example MM781; Murray, 
Brammar and Murray, 1977). In this case the medium must include 
an inducer such as isopropyl-ß-D-thiogalactopyranoside (IPTG). 
Complementation of other deficient host cell functions have also 
been used, for example biotin (Charon 4, 4A, 10 and 11; Williams 
and Blattner, 1979).
The vector AgtWES.T5-622 (Davison, Brunei and Menchez, 1979) 
provides the advantage of a selectable screening system. The 
stuffer fragment of this vector consists of two fragments of 
bacteriophage T5 DMA carrying the A3 gene. In the presence of 
this gene A, like T5, will not grow in E. coli hosts carrying the 
Collb plasmid. Another, widely used selectable system makes use 
of the fact that growth of wild-type X is restricted in P2 
lysogens. Lambda strains lacking the genes gam and red, involved 
in homologous recombination and DMA replication, are able to grow
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in P2 lysogens (Zissler, Signer and Schaefer, 1971a and b), 
albeit with reduced plaque size. These poorly understood 
phenotypes (Smith, 1983) are referred to as Spi+ (Sensitive to £2 
interference) and Spi”. The growth of Spi” phage can be enhanced 
by the inclusion on the \ arms of Chi sequences, which are 
substrates for host recA-mediated recombination (Lam e_t al.,
1974; Henderson and Weil, 1975; Stahl, 1979). Spi"" strains, 
being reliant on the host recombination system, will not grow in 
recA" hosts (Brammar, 1982). Thus if the gam and red genes are 
located on the stuffer fragment, recombinants (Spi”) only will 
grow on recA+ P2 lysogenic hosts, while the parental type phage 
(Spi+) can grow on recA~ hosts. Both will grow on recA+ hosts.
When replacement vectors are being used, the arms are 
normally separated from the stuffer by NaCl, sucrose gradient or 
agarose gel fractionation to prevent competition between the 
foreign DNA and stuffer during ligation. The vectors EMBL3 and 4 
(Frischauf ejt a_l., 1983) have been designed with an extra
safeguard. The stuffer fragment is flanked by a polylinker 
providing three restriction sites in inverse orientation: arm- 
SaII-BamHI-EcoRI-stuffer-EcoRI-BamHI-Sall-arm. Digestion with 
both BamHI and EcoRI produces arms with BamHI cohesive ends and 
stuffer with EcoRI cohesive ends. The short (10 bp) BamHI-EcoRI 
adaptor fragments are left in solution during ethanol or 
isopropanol precipitation of the preparation. These vectors also 
utilize the Spi phenotypic selection.
(c) Preparation of genomic DNA.
DNA used for the preparation of genomic libraries must be of 
high-molecular-weight to allow for the production of random large
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fragments suitable for insertion into a cloning vector. A truly 
random library can only be generated from DMA that has been 
fractionated in a sequence independent manner, for example, by 
controlled mechanical shearing. However it is more convenient to 
fractionate DMA by partial digestion with a restriction 
endonuclease (Maniatis ejt al., 1978) as cohesive ends 
complementary to a vector preparation can be obtained. If the 
enzyme used digests frequently compared to the desired fragment 
size, partial digestion will produce a set of overlapping 
fragments sufficiently random for most purposes. It cannot be 
guaranteed however that all regions of the genome will be 
represented in the desired size range, since large regions 
without cleavage sites may exist and not all sites may be cleaved 
with equal efficiency.
The commonly used restriction endonucleases Sau3A and Mbol 
both produce cohesive ends compatible with BamHI cohesive ends. 
They recognize a 4 bp sequence, which will occur on average once 
every 4^  (256) base pairs in random sequence DMA. BamHI 
recognizes a 6 bp sequence occurring once in 4 (4096 bp) and is
therefore unsuitable for preparation of overlapping fragments for 
library construction. In order to prevent the rearrangement of 
genomic DMA during the cloning procedure, insert DMA preparations 
are usually dephosphorylated (for example by calf alkaline 
intestinal phosphatase) to prevent self ligation, or size 
fractionated so that two fragments ligated together into one 
vector would be too large to be viable. Generally high- 
molecular-weight DMA is partially digested with either Sau3A or 
Mbol to produce fragments in the desired size range, 
dephosphorylated and then is ligated into BamHI digested vector.
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(d) In vitro packaging.
Once the genomic DMA fragments have been ligated to the X 
vector arms, the recombinant DMA must be introduced into 
bacterial cells in order to propagate phage. This has been 
accomplished by directly transfecting competent cells (Mandel and 
Higa, 1970) however this is very inefficient. An alternative is 
to package the recombinant DMA into bacteriophage particles in 
vitro and use these to infect appropriate bacterial hosts (Becker 
and Gold, 1975; Hohn and Murray, 1977; Sternberg, Tiemeir and 
Enquist, 1977).
In vitro packaging uses extracts prepared from bacteria 
infected with Xmutants deficient in certain genes required for 
lytic growth and assembly of phage particles. The E gene product 
is a major head component required for assembly of the earliest 
identifiable precursor, and mutants in this gene accumulate all 
components of the viral capsid. Mutants in the D gene 
accumulate empty "preheads", as the D protein is involved in the 
coupled process of insertion of XDMA into the head precursor and 
subsequent maturation of the head. Mutants of the A gene also 
accumulate empty heads, as the A protein is involved in the 
insertion of XDNA into the phage head and cleavage of the 
concatenated, precursor DMA at the cohesive ends. Complementary 
extracts have been prepared from cells infected with A” or E , or 
with D~ or E~ strains.
Each of the above strains also carries additional mutations. 
A temperature sensitive £l_ mutation allows induction of lytic 
phage growth, as the product of this gene is a repressor protein 
necessary for the maintenance of lysogeny. A mutation in the S_
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gene prevents lysis and causes the accumulation of capsid
components after induction of the lysogen. Other mutants in the
host and phage genes minimize the risk of packaging endogenous \
DMA present in the extracts (b2-region deletion, effectively
removing the A attachment site) or of generalized recombination
between endogenous \ DMA and added recombinant genomes (redB in X
and recA in the E. coli host). There are various protocols
available for the preparation of extracts (Hohn and Murray, 1977;
Sternberg, Tiemeir and Enquist, 1977; Maniatis, Fritsch and
7 qSambrook, 1982), producing efficiencies of 10 to 10° plaque 
forming units per yg of intact XDMA.
(e) Library size.
Assuming complete randomness of cloned sequence, the size of 
library (M) necessary to provide a desired probability (P, 
usually 0.99) of including a particular DMA sequence can be 
determined statistically (Clarke and Carbon, 1976):
M = ln (1-P)
In (1-f)
where f is the fractional proportion of the genome in a single 
recombinant, that is, insert size/size of haploid genome.
Although cloning is not completely random and insert size varies 
somewhat, this provides an approximation sufficient for most 
purposes. Thus if a library of 20 kb inserts is prepared from a 
eukaryotic genome (3 x 10^ bp), to have a 99% chance of obtaining 
a single desired sequence, about 7 x 10^ clones should be 
screened.
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(f) Screening a library.
The plaque hybridization method of Benton and Davis (1977) 
allows the screening of many recombinants at one time, in 
contrast to previous methods (Jones and Murray, 1975; Kramer, 
Cameron and Davis, 1976). Mitrocellulose filters can be laid 
over plating medium containing plaques, absorbing moisture from 
the agarose together with phage particles and DMA. Thus a 
replica of the plaque layout can be obtained, and duplicate lifts 
can also be made. The DMA on the filter is then denatured and 
neutralized prior to fixation by baking. These filters can be 




The murine cell line MIH 3T3 and COS-1 monkey cells were 
provided by Dr. A. Hapel of the John Curtin School of Medical 
Research.
Media
1. Chloramphenicol (Sigma), was added to liquid media as a 
solid to give a final concentration of 200 ug/ml.
2. 5 x 56 mineral-salts medium (Stroobant, Young and Gibson, 
197 2 ); 76 mM (MH4)2S04, 4 mM MgS04, 196 mM MaH2P04, 389 mM 
K2HP04, pH 7.5.
3. 2 x Hepes buffered phosphate saline; 0.28 M MaCl, 1.5 M 
Ma2HP04, 50 mM Hepes pH 7.1.
4. H medium; 0.8% (w/v) MaCl, 1% (w/v) tryptone (Difco), pH
7.5.
5. Luria (L) medium; 1% (w/v) MaCl, 1% (w/v) tryptone, 0.5%
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( w / v )  y e a s t  e x t r a c t  ( D i f c o ) ,  pH 7 . 5 .
6. L u r i a - M a g n e s i u m  (LM) m e d i u m :  10 mM MgS04 , 10 mM NaCl ,
1% ( w / v )  t r y p t o n e ,  0.5% ( w / v )  y e a s t  e x t r a c t ,  pH 7 .5 .
7. 2 M M a g n e s i u m  (Mg2 + ) :  1 M MgCl2 , 1 M MgS04 .
8. SOB m e d i u m :  2.5 mM KC1, 10 mM NaCl ,  2% ( w / v )  t r y p t o n e ,  0.5% 
( w / v )  y e a s t  e x t r a c t ,  pH 7 . 0 .
9.  SOB + Mg2 + : SOB me d i um,  0 . 0 2  M Mg2 + .
10 .  SOC: SOB me d i um,  0 . 0 2  M Mg2 + , 0 . 2  M g l u c o s e .
11.  S o l i d  m e d i a :  F o r  p l a t e s  1.5% ( w / v )  a g a r  ( D i f c o )  o r  a g a r o s e  
( S i g m a ,  T yp e  I )  w a s  a d d e d  t o  l i q u i d  m e d i a  p r i o r  t o  
a u t o c l a v i n g .  F o r  t o p  a g a r / a g a r o s e  0.7% ( w / v )  was  a d d e d
s i m i l a r l y .
12.  S u p p l e m e n t e d  m i n i m a l  m e d i u m :  1 x 5 6  m i n e r a l - s a l t s  m e d i u m ,
0.0002% ( w / v )  v i t a m i n  Bl  ( BDH C h e m i c a l s ) ,  0.03 M g l u c o s e ,  
0 .001% ( w / v )  F e S 0 4 , 0 . 0 0 2 %  ( w / v )  C a ( N 0 3 )2 .
13 .  2 x YT: 1% ( w / v )  y e a s t  e x t r a c t ,  1.6% ( w / v )  t r y p t o n e ,  1%
( w / v )  N a C l .
R e a g e n t s
1. Ammonium p e r s u l p h a t e ,  was  o b t a i n e d  f r o m  A j a x  C h e m i c a l s .
2. B o v i n e  s e r u m  a l b u m i n ,  wa s  o b t a i n e d  f r o m  B o e h r i n g e r  
Mannhe im ( m o l e c u l a r  b i o l o g y  g r a d e ,  No.  7 1 1 4 5 4 ) .
3. PEG 6000 ( P o l y e t h y l e n e  g l y c o l  6 0 0 0 ) ,  was  o b t a i n e d  f r o m  K o c h -  
L i g h t  L t d .
4.  MATS ( M e t h a c r y l i c  a c i d  3 - t r i m e t h o x y - s i l y l p r o p y l  e s t e r )  w a s  
o b t a i n e d  f r o m  T o k y o  K a s e i .
5. TEMED (N,N,N'  , N ' - T e t r a m e t h y l e t h y l e n e d i a m i n e ) , was  o b t a i n e d  
f r o m  EGA-Chemi e .
-3
6. [ 5 ' -  H j T h y m i d i n e ,  a p p r o x i m a t e l y  5 - 2 0  C i / m m o l ,  wa s  o b t a i n e d  
f r om Amer sham.
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7. Urea (ultra pure), was obtained from BRL.
Solutions
1. 40% (w/v) acrylamide solution: 38% (w/v) acrylamide (BDH
Chemicals) and 2% (w/v) N, N'-methylbisacrylamide (BDH 
Chemicals) were dissolved in water and then deionized with 
40 g/1 Amberlite MB 1 for 1 h. The solution was filtered 
through Whatman Mo. 1 filter paper, and stored at 4°C in the 
dark.
2. ATP (Adenosine 5' triphosphate), was obtained from Sigma.
The solid was dissolved in TE buffer, pH 7.5 to a 
concentration of 10 mM. This was stored at -20°C.
3. CIAP (calf intestinal alkaline phosphatase), was obtained 
from Sigma (Mo. P5521). This enzyme was supplied as a 
suspension in ammonium sulphate. An aliquot of CIA? in an 
Eppendorf tube was centrifuged 5 min at 4°C. The 
supernatant was removed and the pellet was resuspended in 
sterile distilled water to a concentration of approximately 
2 units/yl prior to use. The enzyme is stable for at least 
one month in this form when stored at 4°C (Maniatis, Fritsch 
and Sambrook, 1982).
4. 10 mM ddMTP (2', 3'-Dideoxynucleotide-5'-triphosphate) 
stocks: ddATP, ddCTP, ddGTP and ddTTP were obtained from 
Boehringer Mannheim. Solid ddNTPs were dissolved in
TE buffer, pH 7.5 to give the desired concentration and 
stored at -20°C.
5. DNase free RNase: Bovine pancreatic RNase (RNase A, obtained 
from Sigma, Type I-AS), was dissolved at a concentration of 
10 mg/ml in 10 mM Tris-HCl, pH 7.5 and 15 mM MaCl. This
s o l u t i o n  wa s  h e a t e d  f o r  15 mi n  a t  100°C,  c o o l e d  s l o w l y  t o  
room t e m p e r a t u r e  a n d  t h e n  a l i q u o t e d  a n d  s t o r e d  a t  - 2 0 ° C .
6. F o r m a m i d e  g e l  d ye  m i x :  0 .15  g o f  b o t h  x y l e n e  c y a n o l  a nd  
b r o m o p h e n o l  b l u e  a n d  4 ml o f  0.5 mM EDTA pH 8 . 0 ,  made up t o  
100 ml  w i t h  d e i o n i z e d  f o r m a m i d e .  The d ye  mi x  was  s t o r e d  i n  
t h e  d a r k  a t  room t e m p e r a t u r e .
7.  IPTG ( I s o p r o p y l - 6 - D - t h i o g a l a c t o p y r a n o s i d e ) ,  w a s  o b t a i n e d  
f r o m  S i g m a .  4 mg was  d i s s o l v e d  i n  1 ml s t e r i l e  d i s t i l l e d  
w a t e r  a n d  s t o r e d  a t  - 2 0 ° C .
8.  SM s o l u t i o n :  0 .01% ( w / v )  g e l a t i n  ( D i f c o ) ,  0 . 0 0 8  M MgS04 , 0 . 1  
M N a C l ,  0 . 0 5  M T r i s - H C l ,  pH 7 . 5 .
9.  20 x S S P E :  3 . 0  M N a C l ,  0 . 2  M NaH2 P04 , 0 . 0 2  M EDTA, pH 7 . 4 .
10.  STET: 8% ( w / v )  s u c r o s e ,  0.5% ( v / v )  T r i t o n  X - 1 0 0 ,  50 mM EDTA, 
10 mM T r i s - H C l ,  pH 8 . 0 .
1 1 .  10 x T3E b u f f e r :  0 . 8 9  M T r i z m a - b a s e ,  0 . 8 9  M b o r i c  a c i d ,  0 . 0 2  
M EDTA, pH 8 . 3 .
12 .  , 10 x ( H i g h  T r i s )  TBE:  1 . 3 4  M T r i z m a - b a s e ,  0 . 4 5  M b o r i c  a c i d ,
0 . 0 3  M EDTA, pH 8 . 8 .
13.  T r a n s f o r m a t i o n  b u f f e r :  10 mM MES ( f r o m  C a l b i o c h e m - B e h r i n g ) ,
100  mM R b C l ,  45 mM M n C l 2 , 10 mM C a C l 2 , 3 mM h e x a m i n e  c o b a l t  
c h l o r i d e .  The pH wa s  a p p r o x i m a t e l y  6 .15 a n d  t h e  s o l u t i o n  
s t o r e d  a t  4°C.
14.  X - g a l  ( 5 - b r o m o - 4 - c h l o r o - 3 - i n d o l y l - 8 “ D - g a l a c t o p y r a n o s i d e ), 
w a s  o b t a i n e d  f r o m  S i g m a .  20 mg w a s  d i s s o l v e d  i n  1 ml  
d i m e t h y l f o r m a m i d e  a n d  s t o r e d  a t  - 2 0 ° C .
A l l  o t h e r  c h e m i c a l s  u s e d  w e r e  o f  t h e  h i g h e s t  p u r i t y  
c o m m e r c i a l l y  a v a i l a b l e .
V e c t o r s  a n d  b a c t e r i a l  h o s t  s t r a i n s .
1 .  B a c t e r i o p h a g e  v e c t o r  AEMBL 3A ( F r i s c h a u f  e t  a l . ,  1 9 8 3 ) .
75
2. pBR322 (Bolivar et al., 1977 ).
3. E_. coli strain ED8654 (Murray, Brammar and Murray, 1977): 
supE, supF, hsdR (r£,m£), metB , trpR.
4. E. coli strain JM101 (Messing, 1983):
Alacpro, supE, thi, F' traD36, proAB, lacI^Z AM15.
5. M13mp8 (Messing and Vieira, 1982).
6. E. coli strain MM530 (Lehrach and Frischauf, 1982; Frischauf 
et al., 1983):
hsdR (r£, mJ), supF, F+, recA.
Me thods.
1. Phenol extraction and precipitation of DMA.
After an enzymic reaction involving DMA was completed (in an 
Eppendorf tube), the volume was adjusted to 40 0 pi with TE 
buffer, pH 7.5. An equal volume of equilibrated phenol (solution 
no. ,6, Chapter 2) was added, the sample vortexed for 5 s, 
centrifuged for 5 min at room temperature and the aqueous phase 
transferred to a fresh Eppendorf tube. The sample was then 
extracted twice with 2 volumes of water-saturated diethyl ether 
by vortexing for 5 s, centrifuging for 30 s and the ether removed 
by suction. Residual ether was evaporated by heating the samples 
for 5 min at 65°C.
The DMA was precipitated by adding 3 M sodium acetate, pH 
5.5, to an end concentration of 0.3 M, followed by 2 volumes of 
cold (-20°C) absolute ethanol. The sample was placed in a dry- 
ice/ethanol bath for 1 h and then centrifuged for 15 min at 4°C. 
The resulting pellet was washed with cold absolute ethanol and 
dried under vacuum at room temperature. The pellet was finally
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d i s s o l v e d  i n  TE b u f f e r ,  pH 7 . 5 .
2. I s o l a t i o n  o f  DNA f r a g m e n t s  f r o m  l o w - m e l t i n g - t e m p e r a t u r e
a g a r o s e .
D i g e s t s  w e r e  c a r r i e d  o u t  i n  50 y 1 a f t e r  w h i c h  10 y l  o f  6 x 
b r o m o p h e n o l  d y e  mi x  w a s  a d d e d .  S a m p l e s  w e r e  l o a d e d  i n t o  1 cm 
w i d e  w e l l s  o f  a  l o w - m e l t i n g - t e m p e r a t u r e  a g a r o s e  g e l  ( W i e s l a n d e r ,  
1 9 7 9 ) .  E l e c t r o p h o r e s i s  was  c a r r i e d  o u t  a t  4°C i n  T r i s - a c e t a t e  
b u f f e r ,  pH 8.0 a n d  0.5  y g / m l  e t h i d i u m  b r o m i d e ,  a t  35 mA 
o v e r n i g h t .  The  DNA b a n d s  w e r e  v i s u a l i z e d  u s i n g  a 300 nm LJV 
t r a n s i l i u m i n a t o r  a n d  t h e  b a n d  o f  i n t e r e s t  c u t  f r o m  t h e  g e l  w i t h  a 
c l e a n  s c a l p e l  b l a d e  a n d  p l a c e d  i n t o  a n  E p p e n d o r f  t u b e .  An 
a p p r o x i m a t e l y  e q u a l  v o l u m e  o f  TE b u f f e r ,  pH 7 . 5 ,  w a s  a d d e d  t o  t h e  
g e l  f r a g m e n t ,  w h i c h  w a s  m e l t e d  f o r  5 mi n  a t  65°C w i t h  o c c a s i o n a l  
s h a k i n g .  At  r oom t e m p e r a t u r e ,  t h e  s o l u t i o n  wa s  p h e n o l  e x t r a c t e d  
(3 t i m e s )  a n d  p r e c i p i t a t e d  a s  a b o v e  ( Me t ho d  1 ) .
3. ‘ C o n v e r s i o n  o f  3'  p r o t r u d i n g  e n d s  o f  DNA f r a g m e n t s  t o  b l u n t
e n d s .
The r e a c t i o n  m i x t u r e  c o n t a i n e d  up t o  5 y g o f  DNA f r a g m e n t s  
w i t h  p r o t r u d i n g  e n d s ,  67 mM T r i s - H C l ,  pH 8 . 0 ,  6.7 mM M g C ^ f  1 niM 
d i t h i o t h r e i t o l ,  0 .5  mM o f  e a c h  dNTP a n d  9 u n i t s  o f  T4 DNA 
p o l y m e r a s e  (New E n g l a n d  B i o l a b s )  i n  a f i n a l  v o l u m e  o f  30 y l  a n d  
was  i n c u b a t e d  f o r  2 h a t  15°C.  The t u b e  was  p l a c e d  i n  i c e ,  t h e  
r e a c t i o n  wa s  s t o p p e d  by a d d i n g  100 y l  e q u i l i b r a t e d  p h e n o l  and  
v o r t e x i n g  f o r  10 s .  The  v o l u m e  o f  t h e  a q u e o u s  p h a s e  wa s  a d j u s t e d  
t o  400 y l  w i t h  TE b u f f e r ,  pH 7 . 5 ,  p h e n o l  e x t r a c t e d  a n d  
p r e c i p i t a t e d  a s  i n  M e t h o d  1 a b o v e .
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4. Dephosphorylation of enzyme-digested plasmid or M13 DMA
vectors.
The phosphate from the 5' termini was removed to prevent 
self ligation of DMA molecules. This procedure was used for 5 ug 
of vector completely digested with a specific restriction 
endonuclease, and DMA subsequently phenol extracted and 
precipitated as in Method 1 above.
Dephosphorylation of linearized vectors was carried out in 
100 yl containing 50 mM Tris-HCl, pH 9.0, 1 mM MgC^/ and 1 unit 
of calf intestinal alkaline phosphatase (CIAP). To 
dephosphorylate protruding 5' termini, the reaction mixture was 
incubated for 30 min at 37°C, another 1 unit of CIAP added and 
the reaction mixture incubated for a further 30 min. To 
dephosphorylate linearized vectors with blunt ends or recessed 5' 
termini, the reaction mixture was incubated for 15 min at S'Pc, 
then 15 min at 56°C, another 1 unit of CIAP added and the 
incubation repeated at both temperatures. After incubation, the 
sample was phenol extracted and precipitated as above.
5. Ligation of DMA fragments with plasmid or M13 DMA vectors.
DMA fragments were ligated to the vector DMA usually in a 
molar ratio of 3:1 in 50 mM Tris-HCl, pH 7.5, 10 mM MgC^/ 50 
pg/ml bovine serum albumin, 1 mM ATP, 1 mM dithiothreitol, and 6 
units of T4 DMA ligase (Weiss et. al., 1968; obtained from Mew 
England Biolabs). Reaction mixtures were incubated for 12 h at 
15°C for ligation of cohesive ends or 24 h for ligation of blunt 
ends. After incubation, the ligated DMA in the reaction mixture 
was used directly for transformation or transfection without any 
further purification.
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6. Construction and screening of a WEHI-3B bacteriophage X
library.
(a) Preparation of host cells.
E. coli strain ED8654 was used for plating the WEHI-3B 
library. These cells were grown on L agar overnight at 37°C.
One colony was used to inoculate 10 ml of L medium supplemented 
with 0.2% (w/v) maltose in a sterile 125 ml flask. Maltose was 
included to induce the maltose operon, which contains the lamb 
gene coding for the X receptor (Maniatis, Fritsch and Sambrook, 
1982). The cells were grown overnight at 37°C, shaking at 200 
rpm.
The resulting culture was transferred to a sterile 
tube and centrifuged 10 min in a bench top centrifuge. The 
supernatant was discarded and the pelleted cells resuspended in 1 
ml öf L medium. A further 6.5 ml of L medium was added, plus 75 
Vi 1 of 1 M MgSC^. The resuspended cells were transferred into a 
sterile glass screw-capped tube and stored at 4°C. It was found 
that the highest plating efficiencies were achieved if the cells 
were used within 2 days of preparation.
(b) Titration of bacteriophage X stocks.
Host cells prepared as in Method 6 (a) were diluted 1 in 4 
using 0.01 M MgSO^. 100 yl of these cells was placed in a 
sterile 5 ml plastic tube. The Xphage stock was serially 
diluted in SM solution and 100 pi 1 of each dilution added to the 
cells. These were mixed and incubated for 20 min at 37°C to 
allow the bacteriophage particles to adsorb to the cells. 3 ml
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of molten (55°C) L top agar was added to the phage-cell mix, the 
tube quickly inverted and the contents immediately poured onto a 
90 mm diameter petri dish containing 30 ml of set L bottom agar. 
The plate was swirled gently to ensure an even distribution of 
bacteria and top agar. The plates were left for 10 min at room 
temperature in a biohazard hood to allow the L top agar to 
harden, and the lids to dry. Plates were then inverted and 
incubated for 10 to 12 h at 37°C. The resulting plaques were 
counted and the concentration of the phage in the stock expressed 
as plaque forming units (PFU)/ml.
(c) Construction of a WEHI-3B bacteriophage X library.
The WEHI-3B bacteriophage \ library used in this thesis was 
constructed by Dr. I. Young and Mr. W. Tucker. The in vitro 
packaging mixes were prepared by Dr. A. George.
Digests of genomic DMA were carried out using three 2-fold 
dilutions of the restriction endonuclease Mbol, for 1 h at 37°C. 
The highest concentration of Mbol used was 0.3 units/ug of DMA. 
Samples of the digests were electrophoresed on a 0.5% (w/v) 
agarose gel to determine which enzyme concentration gave the 
highest proportion of fragments in the 14 to 20 kb fragment size 
range. The optimal digests were electrophoresed overnight in a 
0.7% low-melting-temperature agarose gel in Tris-acetate buffer, 
pH 8.0, containing 0.5 jjg/ml ethidium bromide. Fragments in the 
size range 14 to 20 kb were excised from the gel, phenol 
extracted and ethanol precipitated (Methods 1 and 2). The final 
approximate concentration was determined by agarose gel 
electrophoresis and comparison with DMA standards of known 
concentration by ethidium bromide fluorescence under UV
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illumination.
DMA of the vector AEMBL 3A was prepared as in Method 7 (b) 
below. 100 y g was digested with EcoRI in high salt buffer for 2 
h at 3~Pc, the salt concentration adjusted with MaCl to 150 mM, 
and the vector further digested with BamHI for 2 h at 37°C. This 
resects the stuffer fragment (13.7 kb) and leaves the X arms with 
3amHI ends, which are compatible with the Mbol ends of the insert 
DMA. The digested vector DMA was phenol extracted, precipitated 
and dissolved in TE buffer, pH 7.5. As an extra safeguard 
against obtaining religated arms and stuffer fragment, the DMA 
was electrophoresed overnight at 4°C in a 0.7% low-melting- 
temperature agarose gel in Tris-acetate buffer, pH 8.0 containing 
0.5 iig/ml ethidium bromide. The bands containing the two arms 
(9.2 kb and 19.4 kb) were cut out, phenol extracted, ethanol 
precipitated and dissolved in TE buffer, pH 7.5.
Small-scale ligations were performed to determine the best 
ratio of DMA fragments to vector. Each ligation reaction 
contained 0.5 yg of vector and approximately 100, 200 or 400 ng
of fragments. 130 units of T4 DMA ligase was added and the 
reaction was incubated for 1 h at room temperature, then 
overnight at 15°C.
The ligation reactions were placed on ice. The packaging 
mixes, sonic extract (SE) and freeze-thaw lysate (FTL) [prepared 
using Eh coli strains BHB2688 and BHB2690 (Hohn, 1979) by 
standard protocols of Maniatis, Fritsch and Sambrook, (1982)] 
were collected from -70°C storage and also placed on ice. The SE 
was thawed first and 15 yl aliquots placed in precooled Eppendorf 
tubes. The FTL was then thawed and 10 yl added to the first
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p r e c o o l e d  t u b e ,  t h e n  i m m e d i a t e l y  o ne  s a m p l e  o f  l i g a t e d  DMA was  
a d d e d .  T h i s  was  m i x e d  w e l l  a n d  t h e  t u b e  r e t u r n e d  t o  i c e .  T h i s  
w a s  r e p e a t e d  f o r  e a c h  s a m p l e .  The  p o s i t i v e  c o n t r o l  w a s  500  ng o f  
u n d i g e s t e d  v e c t o r ,  AEMBL 3A. A l l  s a m p l e s  w e r e  c e n t r i f u g e d  1 s 
a n d  t h e n  l e f t  a t  r o o m  t e m p e r a t u r e  f o r  1 h t o  a l l o w  a s s e m b l y  o f  
t h e  p h a g e  p a r t i c l e s .  To e a c h  t u b e  500 yl  o f  SM s o l u t i o n  a nd  1 
d r o p  o f  c h l o r o f o r m  w e r e  t h e n  a d d e d  a n d  t h e  t u b e  m i x e d  g e n t l y .
The t u b e s  w e r e  c e n t r i f u g e d  b r i e f l y  a n d  t h e  s o l u t i o n  t i t r a t e d .
F o r  p a c k a g e d  l i g a t i o n s ,  1 0 “  ^ a n d  1 0 ”  ^ d i l u t i o n s ,  a n d  f o r  t h e  
v e c t o r  c o n t r o l  1 0 “  ^ a n d  1 0 “  ^ d i l u t i o n s  w e r e  u s e d .  T h e s e  w e r e  
p l a t e d  o u t  a s  i n  M e t h o d  6 ( b ) .  3 x io"*7 PFU/yg  DMA wa s  r e g u l a r l y
o b t a i n e d  f o r  t h e  n o n - c o n c a t e r m e r i c  AEMBL 3A c o n t r o l  a n d  10^ PFU 
( t o t a l )  f o r  a l i g a t i o n  r e a c t i o n .
Th e  l i g a t i o n  w a s  s c a l e d  up  10 t o  20 t i m e s  i n  o r d e r  t o
c
p r e p a r e  a c o m p l e t e  l i b r a r y  ( i n  e x c e s s  o f  10 PFU).  L a r g e r  s c a l e  
p a c k a g i n g  r e a c t i o n s  w e r e  d o n e  i n  i n d i v i d u a l  l o t s  u s i n g  30 u l  SE, 
20 ]i 1 FTL a n d  20 y l  l i g a t i o n  mi x  p e r  E p p e n d o r f  t u b e ,  i n c l u d i n g  an  
u n d i g e s t e d  v e c t o r  c o n t r o l .  T h e s e  w e r e  i n c u b a t e d  f o r  1 h a t  room 
t e m p e r a t u r e ,  a f t e r  w h i c h  1 ml  o f  SM s o l u t i o n  a n d  1 d r o p  o f  
c h l o r o f o r m  w e r e  a d d e d .
The l i b r a r y  w a s  c o n c e n t r a t e d  by  c o m b i n i n g  t h e  p h a g e  
s o l u t i o n s  i n  a s t e r i l e  SW41 T i  t u b e  (Be ck ma n  No. 3 3 1 3 7 2 ) ,  l e a v i n g  
t h e  c h l o r o f o r m  b e h i n d .  T h i s  was  c e n t r i f u g e d  a t  2 5 , 0 0 0  r pm,  f o r  2 
h i n  a B e c k m a n  SW41 T i  r o t o r .  Th e  s u p e r n a t a n t  w a s  p o u r e d  o f f  a n d  
t h e  t u b e  d r a i n e d .  1 ml  o f  SM s o l u t i o n  wa s  a d d e d  t o  t h e  p e l l e t ,  
w h i c h  w a s  m i x e d  a n d  l e f t  a t  4°C f o r  a t  l e a s t  2 h t o  a i d  
r e s u s p e n s i o n  o f  p h a g e .  T h i s  was  m i x e d  a g a i n  a n d  t i t r a t e d .
The l i b r a r y  w a s  v e r i f i e d  t o  c o n s i s t  o f  g r e a t e r  t h a n  99%
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r e c o m b i n a n t s  by  t i t r a t i n g  on  s t r a i n s  NM530 ( w h i c h  a l l o w s  
p r o p a g a t i o n  o f  p a r e n t  p h a g e  v e c t o r )  a n d  ED8654 ( w h i c h  a l l o w s  t h e  
g r o w t h  o f  b o t h  p a r e n t a l  v e c t o r  a n d  r e c o m b i n a n t s ) .
(d )  P l a t i n g  t h e  X l i b r a r y .
The p l a t e s  u s e d  h e r e  w e r e  20 x 30 cm P y r e x  ' p a t i s s e r i e '  
d i s h e s ,  w i t h  s p e c i a l l y  c o n s t r u c t e d  s t a i n l e s s  s t e e l  l i d s .  T h e s e  
w e r e  a u t o c l a v e d  a n d  d r i e d  ( a p p r o x i m a t e l y  60°C) .  F o u r  o f  t h e s e  
d i s h e s  w e r e  u s e d  a t  o n e  t i m e ,  e a c h  p l a t e d  w i t h  a p p r o x i m a t e l y  2 x 
105 PFU.
L b o t t o m  a g a r  w a s  p r e p a r e d  a n d  a u t o c l a v e d  i n  300  ml  l o t s  a n d  
k e p t  m o l t e n  a t  55°C u n t i l  n e e d e d .  The P y r e x  d i s h e s  w e r e  p l a c e d  
on  l e v e l l i n g  t r a y s  i n  a b i o h a z a r d  h o o d  a n d  a d j u s t e d  w i t h  a s p i r i t  
l e v e l .  3 0 0  ml  L b o t t o m  a g a r  w a s  p o u r e d  i n t o  e a c h  d i s h  a n d  
a l l o w e d  t o  h a r d e n  f o r  30 m i n  w i t h  t h e  l i d s  s l i g h t l y  o p e n .  T h e s e  
p l a t e s  c o u l d  b e  s t o r e d  a t  4°C i n  p l a s t i c  b a g s ,  h o w e v e r  t h e y  had  
t o  be  p r e w a r m e d  a t  37°C a n d  t h e  l i d s  f r e e d  o f  c o n d e n s a t i o n  b e f o r e  
u s e .  L t o p  a g a r o s e  wa s  u s e d  f o r  p l a t i n g  s i n c e  a g a r  p e e l s  o f f  
more  e a s i l y  d u r i n g  n i t r o c e l l u l o s e  l i f t i n g  a n d  c o n t r i b u t e s  t o  
h i g h e r  b a c k g r o u n d  d u r i n g  h y b r i d i z a t i o n .  S t e r i l e  30 ml  l o t s  o f  
0.7% ( w / v )  L t o p  a g a r o s e  w e r e  p r e p a r e d  a n d  s t o r e d  a t  4°C i n  SS34 
t u b e s .  B e f o r e  u s e  t h e s e  w e r e  a u t o c l a v e d  b r i e f l y  a n d  k e p t  m o l t e n  
a t  5 5 ° C .
The X l i b r a r y  p h a g e  s t o c k  was  d i l u t e d  w i t h  SM s o l u t i o n  t o  
g i v e  2 x 10^ P F U / m l .  To e a c h  o f  4 s t e r i l e  5 ml  p l a s t i c  t u b e s ,
2 5 0  l i l  ED 8 6 5 4 c e l l s ,  7 5 0  u l  0 .01M M g S 0 4 a n d  1 ml  p h a g e  w e r e  
a d d e d ,  m i x e d  a n d  i n c u b a t e d  f o r  20 mi n  a t  37°C.  A f t e r  i n c u b a t i o n  
t h e  p h a g e - c e l l  mi x  wa s  a d d e d  t o  t h e  m o l t e n  L t o p  a g a r o s e  w h i c h  
w a s  m i x e d  q u i c k l y  by  i n v e r s i o n  a n d  p o u r e d  o n t o  t h e  L b o t t o m  a g a r .
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The top agarose was allowed to harden for 15 min and the lids 
dried. The dishes were incubated in a 37°C incubator overnight 
but were not inverted.
Titration of the library stock was normally done in the 
morning using freshly prepared host cells. That same evening, 
after obtaining the results of the titration, the library was 
plated out. This minimized problems with day to day variation in 
titration results.
(e) Plaque lifts using nitrocellulose.
The method used (Maniatis, Fritsch and Sambrook, 1982) was 
adapted from that of Benton and Davis (1977).
The plates were incubated until the plaques were just 
beginning to make contact with one another (approximately 12 h). 
After incubation, the Pyrex dishes were chilled for 1 h at 4°C. 
Two sheets of nitrocellulose (19 x 14 cm) were used per dish and 
duplicate lifts were made to distinguish between true and false 
positives after hybridization. Thus in total, 16 sheets of
cnitrocellulose were required for 4 dishes, screening 8 x 10 
phage.
Each sheet of nitrocellulose was labelled with a blue ball­
point pen and laid onto the agarose surface one at a time using 
two clean pairs of blunt forceps, placing the mid section of the 
filter down first. Two filters each covered half of the dish, 
with an overlap of approximately 1 cm in the centre. Once 
completely wet, the filters were orientated by marking them and 
the plates in 5 positions asymmetrically using India Ink in a 1 
ml syringe fitted with an 18 gauge needle. After 1 min, the
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filters were removed and placed, DMA side up, in a tray 
containing 250 ml of denaturing solution (1.5 M MaCl, 0.5 M MaOH) 
for 60 sec. The filters were then transferred into 250 ml of 
neutralizing solution (0.5 M Tris-HCl, pH 8.0, 1.5 M MaCl) for 5
min. The filters were briefly rinsed in 250 ml of 2 x SSPE and 
air dried. After every 4 filters the solutions were changed.
The filters were placed between clean pieces of Whatman 3MM paper 
and baked in a vacuum oven for 2 h at 80°C. At this point the 
nitrocellulose filters were stored under vacuum at room 
temperature.
(f) Hybridization.
The nitrocellulose filters between Whatman 3MM were placed 
onto the surface of a tray of 6 x SSC until they became 
thoroughly wetted from beneath, after which the nitrocellulose 
filters were peeled away and completely submerged. All 16 
filters were stacked into a flat-bottomed plastic box containing 
400 ml of prewash solution consisting of 50 mM Tris-HCl, pH 8.0,
1 M MaCl, 1 mM EDTA, pH 8.0 and 0.1% (w/v) SDS. The box was 
sealed tightly with its lid and the filters washed for 1 to 2 h 
at 42°C with gentle agitation (100 rpm). This prewash was 
designed to remove from the filters any absorbed medium, 
fragments of agarose or loose bacterial debris (Maniatis, Fritsch 
and Sambrook, 1982).
The prewash solution was poured off and replaced by 400 ml 
of prehybridization solution consisting of 50% (v/v) deionized 
formamide, 5 x Denhardt's solution, 6 x SSC, 100 yg/ml heat- 
denatured, sonicated, salmon sperm DMA, 50 mM sodium phosphate 
buffer, pH 6.8, 1 mM sodium pyrophosphate and 0.1 mM ATP.
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Prehybridization was for 2 to 4 h at 42°C. The use of 
hybridization solutions containing 50% formamide allowed 
incubation at 42°C, presenting less of an evaporation problem 
than the use of 65°C for solutions without formamide present.
2 2All [ ] -labelled probes used in library screening were 
prepared from double-stranded cloned DNA inserts using the random 
primer Method 6 (c) of Chapter 2. For library screening, the 
probe synthesis was scaled up and the probe used at a 
concentration of about 10® cpm/ml (specific activity 
approximately 4.0 x 10® cpm/^g DNA synthesized). The 
unincorporated label was not separated from the probe but instead 
the reaction mixture added directly to the prehybridization 
solution after denaturation (5 min, 100°C followed by snap- 
chilling in ice-water). Since unincorporated label was added 
with the probe, ATP and pyrophosphate were included in the 
hybridization solution (Ullrich et al_., 1984). Hybridization was
for 24 h at 42°C, to allow for the fact that hybridization is 
approximately two times slower in 50% formamide (Casey and 
Davidson, 1977; Maniatis, Fritsch and Sambrook, 1982). After 
hybridizaton, the solution containing the probe was transferred 
into a plastic container and stored at 4°C until further use.
(g) Washing of filters and autoradiography.
After hybridization, the filters were firstly washed in 1 1 
of 2 x SSC for 20 min at room temperature and then in two changes 
of 2 1 of 2 x SSC for 1 h at 65°C. The filters were placed on 
Whatman 3MM paper to remove excess fluid then placed between two 
layers of Saranwrap. They were then exposed to X ray film (Kodak 
XAR-5) for 24 h at -70°C in autoradiography cassettes fitted with
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intensifying screens (Dupont Lightning Plus). The films were 
orientated with 1 y 1 dots of India ink containing [a-^P]dATP j_n 
the cassettes.
(h) Purification of recombinant phage containing sequences 
hybridizing to the probe.
When a positive signal was identified on an autoradiograph, 
the films, filters and subsequently the plates, were aligned 
using the orientation marks. A sterile scalpel blade was used to 
remove an area of top agarose of approximately 1 cm^ covering the 
region where the positive signal was identified and the agarose 
placed in an Eppendorf tube containing 1 ml of SM solution and a 
drop of chloroform. This was mixed and left to stand at room 
temperature for 2 h to allow the phage to diffuse out of the 
agarose and the phage stock stored at 4°C. This phage stock was 
titrated and subsequently rescreened at a lower plaque density 
(about 500 per plate) using petri dishes and nitrocellulose discs 
(which were used Chapter 2 for colony hybridization). The 
original probe solution was reused. Plating and screening were 
continued until the plaques were pure, that is, when all plaques 
on a petri dish hybridized to the probe.
(i) Preparation of a plate lysate stock.
Approximately 10^ PFU were plated out using ED8654 as host. 
This gave confluent lysis on a 90 mm diameter petri dish after 
overnight incubation at 37°C. 5 ml of SM solution was added to
the plate and the top agarose scraped off using a bent and sealed 
pasteur pipette. The agarose and SM solution were placed in a 
sterile centrifuge tube (Sorvall SS34) and the plate rinsed with
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a f u r t h e r  1 ml  SM s o l u t i o n .  C h l o r o f o r m  t o  a f i n a l  c o n c e n t r a t i o n
o f  2% w a s  a d d e d  a n d  t h e  t u b e  s h a k e n ,  l e f t  a t  r o o m  t e m p e r a t u r e  f o r  
15 min  a n d  c e n t r i f u g e d  a t  1 0 , 0 0 0  rpm f o r  30 mi n  a t  4°C.  The 
s u p e r n a t a n t  was  t r a n s f e r r e d  i n t o  a s t e r i l e  s c r e w - c a p p e d  g l a s s  
t u b e ,  c h l o r o f o r m  a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  1% a n d  t h e  
t u b e  s t o r e d  a t  4°C.  The p h a g e  s t o c k  was  t h e n  t i t r a t e d .  T h i s  
p r o c e d u r e  g e n e r a l l y  y i e l d e d  a p h a g e  s t o c k  o f  a p p r o x i m a t e l y  1 0 ^  
PFU/ml
7 .  I s o l a t i o n  o f  b a c t e r i o p h a g e  A DNA.
( a )  R a p i d  s m a l l - s c a l e  p r e p a r a t i o n .
T h i s  m e t h o d  wa s  m o d i f i e d  f r o m  t h a t  o f  M a n i a t i s ,  F r i t s c h  a n d  
S a m b r o o k  ( 198 2 ) a n d  w a s  u s e d  i n  t h e  r a p i d  i s o l a t i o n  o f  DMA f r o m  
p u r e  s t o c k s  o f  A p h a g e .
A p p r o x i m a t e l y  1CP PFU w e r e  p l a t e d  a s  i n  M e t h o d  6 (b)  b u t  
u s i n g  LM t o p  a n d  b o t t o m  a g a r o s e .  A g a r  w a s  n o t  u s e d  s i n c e  m o s t  
b a t c h e s  o f  a g a r  c o n t a i n  p o t e n t  i n h i b i t o r s  o f  r e s t r i c t i o n  
e n d o n u c l e a s e s .  W i t h  t h i s  c o n c e n t r a t i o n  o f  p h a g e  p a r t i c l e s  
c o n f l u e n t  l y s i s  wa s  a c h i e v e d  a f t e r  o v e r n i g h t  i n c u b a t i o n  a t  37°C.
To e a c h  p l a t e ,  5 ml  o f  SM s o l u t i o n  w a s  a d d e d  d i r e c t l y  o n t o  
t h e  a g a r o s e  s u r f a c e  a n d  t h e  b a c t e r i o p h a g e  a l l o w e d  t o  d i f f u s e  i n t o  
t h e  l i q u i d ,  h o l d i n g  t h e  p l a t e s  f o r  2 h a t  r o o m  t e m p e r a t u r e  w i t h  
c o n s t a n t ,  g e n t l e  s h a k i n g  (50 r p m ) .  The SM s o l u t i o n  w a s  t h e n  
h a r v e s t e d  w i t h  a p a s t e u r  p i p e t t e  a n d  p l a c e d  i n  an  SS34 t u b e .  The 
b a c t e r i a l  d e b r i s  wa s  r e m o v e d  by c e n t r i f u g a t i o n  a t  1 0 , 0 0 0  r p m ,  f o r  
30 mi n  a t  4^C.  The s u p e r n a t a n t  was  r e c o v e r e d  c a r e f u l l y  a n d  RNase 
A a n d  DNase I  ( S i g m a )  w e r e  a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  1 
y g / m l  a n d  t h e  m i x t u r e  i n c u b a t e d  30 min  a t  37°C.  To e a c h  t u b e ,  an
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e q u a l  v o l u m e  o f  a s o l u t i o n  c o n t a i n i n g  20% ( w / v )  PEG a n d  2 M MaCl  
i n  SM wa s  a d d e d  a n d  t h e  t u b e s  h e l d  f o r  1 h a t  0°C.  The 
p r e c i p i t a t e d  p h a g e  w e r e  h a r v e s t e d  by  c e n t r i f u g a t i o n  a t  1 0 , 0 00  rpm 
f o r  30 mi n  a t  4°C.  The s u p e r n a t a n t  was  d i s c a r d e d  a n d  t h e  t u b e  
d r a i n e d  o n t o  a c l e a n  p i e c e  o f  t i s s u e .  E a c h  p e l l e t  was  
r e s u s p e n d e d  i n  0.5 ml SM s o l u t i o n  by  v o r t e x i n g  a n d  w a r m i n g  t o  
37°C.  The t u b e s  w e r e  t h e n  c e n t r i f u g e d  1 mi n  i n  a b e n c h  t o p  
c e n t r i f u g e  t o  b r i n g  t h e  l i q u i d  down o f f  t h e  t u b e  w a l l s .  The 
p h a g e  s o l u t i o n  w a s  t r a n s f e r r e d  t o  a s t e r i l e  E p p e n d o r f  t u b e  a n d  
c e n t r i f u g e d  2 m i n  t o  r e m o v e  d e b r i s .  The s u p e r n a t a n t  was  r e m o v e d  
c a r e f u l l y  a n d  t r a n s f e r r e d  t o  a f r e s h  E p p e n d o r f  t u b e .  P r o t e i n a s e  
X ( 5 0  y g / m l ) ,  0.1% ( w / v )  SDS a n d  5 mM EDTA, pH 8 . 0 ,  w e r e  a d d e d  
a n d  t h e  m i x t u r e  i n c u b a t e d  f o r  60 m i n  a t  6 5 ° C .  Th e  m i x t u r e  w a s  
t h e n  e x t r a c t e d  o n c e  w i t h  a n  e q u a l  v o l u m e  o f  e q u i l i b r a t e d  p h e n o l ,  
t h e n  e q u i l i b r a t e d  p h e n o l / c h l o r o f o r m / i s o a m y l a l c o h o l  ( 2 5 : 2 4 : 1 )  mix  
a n d  f i n a l l y  w i t h  c h l o r o f o r m / i s o a m y l a l c o h o l  ( 2 4 : 1 ) .  D u r i n g  t h e  
e x t r a c t i o n ,  t h e  p h a s e s  w e r e  m i x e d  g e n t l y ,  s o  a s  t o  n o t  s h e a r  t h e  
X DMA, a n d  t h e n  c e n t r i f u g e d  f o r  5 mi n  a t  room t e m p e r a t u r e .  A f t e r  
e a c h  e x t r a c t i o n ,  t h e  a q u e o u s  p h a s e  wa s  t r a n s f e r r e d  t o  a f r e s h  
t u b e .  F i n a l l y  t h e  a q u e o u s  p h a s e  was  e x t r a c t e d  t w i c e  w i t h  two  
v o l u m e s  o f  w a t e r - s a t u r a t e d  d i e t h y l  e t h e r ,  t h e  r e s i d u a l  e t h e r  was  
r e m o v e d  by  e v a p o r a t i o n  f o r  5 m i n  a t  65°C a n d  t h e  DMA p r e c i p i t a t e d  
a s  d e s c r i b e d  i n  M e t h o d  1.
S i n c e  t h e  q u a n t i t y  o f  RMA p r e s e n t  a t  t h i s  s t a g e  w a s  s t i l l  
h i g h ,  t h e  s a m p l e s  w e r e  i n c u b a t e d  w i t h  1 y g / m l  RNase A a s e c o n d  
t i m e  f o r  30 m i n  a t  3 7 ° C .  The  s a m p l e  w a s  a g a i n  p h e n o l  e x t r a c t e d  
a n d  p r e c i p i t a t e d .  The DMA p e l l e t  was  d i s s o l v e d  i n  50 y 1 TE 
b u f f e r ,  pH 7 . 5 .  The c o n c e n t r a t i o n  o f  DNA w a s  d e t e r m i n e d  by 
e l e c t r o p h o r e s i n g  a 2 y l  s a m p l e  i n  a 1% a g a r o s e  g e l .  The  g e l  was
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subsequently stained with ethidium bromide and the fluorescence 
under ÜV light of the DMA band compared with DMA standards. 
Generally, the yield was approximately 4 jjg for each plate.
This method allowed the quick characterization of X clones, 
even though digestion of the phage DMA with restriction 
endonucleases was not always complete.
(b) Large-scale preparation.
This method was adapted from Maniatis, Fritsch and Sambrook 
( 1982 ) .
It is important in this method to optimize the initial ratio 
of cells to bacteriophage to give maximum production of phage. A 
pilot experiment was therefore carried out to determine the best 
multiplicity of infection (MOI) or number of phage per number of 
cells, for the specific host cell and bacteriophage. The pilot 
experiment was carried out on l/100th scale of the final 
experiment and the MOI used were in the range of 0.01 to 0.2.
The stock of ED8654 cells prepared as in Method 6 (a) was at 
a concentration of about 1.0 x 10^cells/ml. A 50 yl undiluted 
aliquot or 5 x lo"^  cells was mixed with enough phage to give the 
desired MOI and incubated 20 min at 37°C. This was then added to 
10 ml of L medium containing 0.2% maltose and 10 mM MgSO^ in a 
sterile 125 ml flask, which was then incubated at 37°C, with 
shaking at 200 rpm. 100 y1 aliquots were taken every hour and 
the OD^qq values measured. These results were graphed and the 
optimum MOI selected, that being the one where complete lysis was 
achieved at the end of 5 h incubation.
When the MOI had been selected, the scale was increased 100-
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f o l d .  To t w o  t u b e s  e a c h  c o n t a i n i n g  2.5 ml o f  u n d i l u t e d  c e l l s ,  an  
a p p r o p r i a t e  a m o u n t  o f  p h a g e  wa s  a d d e d  t o  g i v e  t h e  d e s i r e d  MOI. 
T h e s e  w e r e  i n c u b a t e d  20 m i n  a t  37°C,  w i t h  p e r i o d i c  s h a k i n g .  The 
c o n t e n t s  o f  e a c h  t u b e  wa s  a d d e d  t o  s e p a r a t e  p r e w a r m e d  b a f f l e d  2 
1 f l a s k s  c o n t a i n i n g  5 00 ml  o f  L m e d i u m  p l u s  0.2% m a l t o s e  a n d  10 
mM MgSO^. E a c h  f l a s k  was  t h e n  i n c u b a t e d  a t  37°C w i t h  s h a k i n g .  
A f t e r  2 h o f  i n c u b a t i o n ,  a l i q u o t s  w e r e  t a k e n  p e r i o d i c a l l y  a n d  t h e  
ODgoo d e t e r m i n e d .  Once  c o m p l e t e  l y s i s  h a d  o c c u r r e d ,  10 ml o f  
c h l o r o f o r m  w a s  a d d e d  a n d  t h e  i n c u b a t i o n  c o n t i n u e d  a f u r t h e r  45 
m i n  a t  37°C.  The l y s a t e  wa s  t h e n  s t o r e d  a t  4°C o v e r n i g h t .  A 
s a m p l e  o f  0 . 1  m l  w a s  r e m o v e d ,  t h e  d e b r i s  s p u n  d o w n  i n  a n  
E p p e n d o r f  t u b e  a n d  t h e  r e s u l t i n g  s u p e r n a t a n t  t i t r a t e d  f o r  t h e  
c o n c e n t r a t i o n  o f  p h a g e .  The e x p e c t e d  y i e l d  w a s  a b o u t  10-LJ PFU 
t o t a l  w h i c h  c o r r e s p o n d s  t o  a f i n a l  y i e l d  o f  a b o u t  500  t o  800  yg  
DMA.
The s t o r e d  f l a s k s  w e r e  w a r m e d  t o  room t e m p e r a t u r e ,  a n d  DNase 
I a n d  RNase  A a d d e d ,  b o t h  t o  a f i n a l  c o n c e n t r a t i o n  o f  1 y g / m l .  
T h e s e  w e r e  i n c u b a t e d  f o r  30 mi n  a t  room t e m p e r a t u r e  w i t h  
o c c a s i o n a l  s h a k i n g .  S o l i d  NaCl  t o  a f i n a l  c o n c e n t r a t i o n  o f  1 M 
w a s  d i s s o l v e d  i n  e a c h  f l a s k  a n d  t h e  m i x t u r e  h e l d  f o r  30 m i n  a t  
0°C.  T h e s e  p r e p a r a t i o n s  w e r e  t h e n  c e n t r i f u g e d  i n  a S o r v a l l  GS3 
r o t o r  a t  5 , 0 0 0  rpm f o r  15 m i n ,  a t  4°C.  The s u p e r n a t a n t s  w e r e  
r e c o v e r e d  a n d  c e n t r i f u g e d  a g a i n  t o  r e m o v e  d e b r i s .  The  r e s u l t i n g  
s u p e r n a t a n t s  w e r e  p o o l e d  i n t o  a f r e s h  s t e r i l e  2 1 f l a s k  
c o n t a i n i n g  a m a g n e t i c  s t i r r e r .  To p r e c i p i t a t e  t h e  p h a g e ,  s o l i d  
PEG wa s  a d d e d  t o  a f i n a l  c o n c e n t r a t i o n  o f  10% ( w / v )  a n d  d i s s o l v e d  
by  s t i r r i n g  a t  room t e m p e r a t u r e ,  t h e n  t h e  m i x t u r e  wa s  h e l d  f o r  1 
h a t  0°C i n  a i c e - w a t e r  b a t h .  To r e c o v e r  t h e  p r e c i p i t a t e d  p h a g e ,  
t h e  s o l u t i o n  w a s  c e n t r i f u g e d  i n  a GS3 r o t o r  a t  5 , 0 0 0  r pm  f o r  15
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min, at 4°C. The supernatant was discarded and the phage pellet 
resuspended in firstly 8 ml SM solution, then another 8 ml was 
used to rinse the GS3 bottles. The pooled phage stocks were 
transferred to sterile screw-capped glass tubes for storage. At 
this point samples were taken and titrated to determine the 
recovery of phage.
The phage stocks were transferred to a SS34 tube on a 
weighing balance. To achieve a final density of 1.45 g/ml, CsCl 
was added as follows:
41.5
Weight of phage solution x ____ = g CsCl
58.5
The CsCl was dissolved and the solution placed in a clear 
cellulose nitrate ultracentrifuge tube (Beckman No. 344059). The 
tubes were filled to within 3 mm of the top, with a solution of 
1.45 g/ml density containing CsCl in SM solution. The sample was 
centrifuged in an SW41 Ti rotor at 35,000 rpm, for 40 h at 4°C.
A bluish-white band containing the phage particles was 
removed from the gradient using a 2.5 ml syringe fitted with an 
18-gauge needle. The harvested phage were placed in another 
clear cellulose nitrate tube, topped up with the 1.45 g/ml 
density CsCl solution and centrifuged again for 40 h at 35,000 
rpm and 4°C.
The single band was harvested and placed in a dialysis bag. 
To remove the CsCl, this was dialyzed against 1,000 volumes of 50 
mM Tris-HCl, pH 8.0, 10 mM NaCl, 10 mM MgCl2, twice for 1 h at 
room temperature. The solution was transferred to an SS34 tube 
and a sample titrated for the viable phage concentration. To the
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tube was added 20 mM EDTA, 0.5% (w/v) SDS and 50 yg/ml proteinase 
K (final concentrations). This was mixed and incubated for 1 h 
at 65°C. An equal volume of equilibrated phenol was added, mixed 
well and centrifuged at 5,000 rpm for 5 min at room temperature. 
The aqueous phase was transferred to a Sorvall SE12 tube, where 
an equal volume of equilibrated phenol/chloroform/isoamylalcohol 
mix (25:24:1) was added, the tube mixed and centrifuged at 4,000 
rpm for 5 min at room temperature. The aqueous phase was 
transferred to a dialysis bag and dialysed three times against
1.000 volumes of TE buffer, pH 7.5 at 4°C for 24 h. The DMA 
concentration was determined by measuring the OD2 5 Q. Before 
removing samples to determine the DNA concentration X DMA was 
heated for 5 min at 65°C then rapidly chilled in ice-water to 
denature the cohesive ends, reduce viscosity and ensure 
representative sampling.
8 . Southern hybridization (modifications).
The method used for the Southern analysis of recombinant 
phage DNA was essentially the same as that illustrated in Figure
2.1 (Chapter 2), with modifications recommended by Meinkoth and 
Wahl (1984).
After electrophoresis, staining and photography the gel was 
soaked in 0.25 M HC1 for 7 min, with gentle agitation (100 rpm) 
at room temperature. The gel was rinsed with distilled water to 
remove excess acid, then soaked in two 500 ml changes of 
denaturation solution (1.5 M NaCl, 0.5 M NaOH) for 5 min. This 
was followed by neutralization in 500 ml of 1.5 M NaCl, 0.5 M 
Tris-HCl, pH 8.0, twice for 20 min. The blotting procedure was 
similar to that in Figure 2.1, however there was no reservoir of
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20 x SSC. The gel was placed on 4 sheets of Whatman 3MM paper, 
cut to about 4 cm larger than the gel, soaked in 20 x SSC. 
Nitrocellulose and 3 sheets of 3MM paper (both soaked in 20 x 
SSC) were placed on top of the gel, followed by a 3 cm stack of 
dry paper towels and a light weight to keep the towels 
compressed. The gel was surrounded by Parafilm strips. The 
transfer was allowed to proceed for 2 h, after which the 
nitrocellulose was rinsed in 6 x SSC, air dried and baked in a 
vacuum oven at 80°C for 2 h. The filter was stored in the usual 
manner.
Hybridization conditions were the same as those described 
for screening the A library, except that there was no prewash and 
only 200 ml of hybridization solution was used. After 
prehybridization, the solution was replaced with fresh solution 
and the denatured probe added.
* To allow hybridization of different probes to the same 
Southern blot, it was necessary to elute already hybridized probe 
from the nitrocellulose. To achieve this, the filter was washed 
twice in 500 ml of distilled water for 20 min at 65^C with gentle 
agitation (50 rpm) and then air dried and stored under vacuum at 
room temperature until needed.
9. High efficiency transformation of E. coli cells.
however dimethylformamide was used instead of dimethylsulphoxide
This method is based on that of Hanahan (1983)^Thiswas used
for transformation of E. coli cells with either plasmids or M13 
vectors.
(a) Preparation of competent cells.
20 ml of SOB + Mg^+ was inoculated with the E. coli strain
Q A
to be transformed and grown in a 125 ml sterile side-arm flask 
(200 rpm, 37°C). The cells were harvested at approximately 4 x 
107 cells/ml (Xlett 100 for the strains used in this thesis). The 
flask was then transferred to ice for 10 min, the culture poured 
into a precooled sterile SS34 tube and centrifuged for 10 min at 
3,000 rpm, 4°C. The cells were resuspended in 6.7 ml (1/3 
original volume) of cold transformation buffer by gentle 
vortexing and placed on ice for 10 min. The cells were pelleted 
as before and resuspended in 1.6 ml transformation buffer. 56 yl 
of di me thy 1 forma m ide was added, the tube swirled gently to mix 
and left on ice for 5 min. After this, 56 y 1 2.25 M 
dithiothre itol was added and the cells held on ice for a further 
10 min. Finally, another 56 yl of dimethylformam ide was added 
and the cells were left on ice for 5 min.
210 y1 aliquots of cells were placed into pre-cooled sterile 
5 ml plastic tubes. To this, DMA (in less than 10 yl) was added, 
the tubes swirled gently and left on ice for 1 h. Next the cells 
were heat shocked at 42°C for 90 sec, after which the tubes were 
returned immediately to ice.
(b) Transformation using plasmids.
To each tube, 800 yl of SOC (at room temperature) was added 
and the mixtures incubated for 1 h at 37 0^, with shaking at 200 
rpm. This period allows the bacteria to recover and to begin to 
express the antibiotic resistance gene used for selection. A 
further 2 ml SOC was added to each tube and the cells pelleted in 
a bench top centrifuge for 5 min at room temperature. The final 
cell pellet was resuspended in 50 yl SOB + Mg^+ and plated onto 
one or more plates containing L medium and appropriate antibiotic
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for selection. These were inverted and incubated overnight at
37°C.
(c) Transfection using Ml3 bacteriophage.
The host used with the M13 vectors was E. coli strain JM101. 
In order to distinguish between recombinant plaques and those of 
the parent vector, a complementation assay was used. Both the 
M13 vector and JM101 cells carry defective but complementary 
portions of the ß-ga lactos idase gene. In the presence of inducer 
(IPTG) M13 infected cells produce functional ß-galactosidase 
which is readily identified by including a lactose analogue, X- 
gal, in the plating medium. This compound is hydrolysed by ß- 
galactosidase to produce bromo-chloroindole which gives M13 
plaques a blue color. In recombinant phage foreign DNA inserted 
at the cloning sites within the ß-galactosidase gene prevents 
complementation and colorless M13 plaques result.
After heat shock, the cells were placed in ice and 2 ml SOC 
added. The cells were then pelleted by centrifugation in a bench 
top centrifuge for 5 min and the final cell pellet was 
resuspended in 50 yl SOB + Mcp+ and added to 3 ml of molten H top 
agar (at 42°C) containing 0.2 mg/ml X-gal and 0.16 mg/ml IPTG. 
This was mixed and poured onto a dry supplemented minimal agar 
plate and swirled to ensure even distribution of cells and H top 
agar. The plates were left at room temperature for 10 min to 
allow the top agar to harden, then inverted and incubated 
overnight at 37°C.
10. Plasmid DNA isolation.
The method employed here, for both small and large-scale
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preparations, was the rapid boiling method of Holmes and Quigley 
(1981) .
(a) Rapid small-scale preparation.
Up to 24 different plasmids could be conveniently isolated 
at one time, which made it useful for screening purposes.
2 ml aliquots of L medium containing the appropriate 
antibiotic were placed into 24 sterile 5 ml plastic tubes and 
inoculated from colonies using toothpicks. These tubes were 
incubated overnight at 37°C, with shaking at 200 rpm.
1.5 ml of each culture was poured into Eppendorf tubes and 
cells pelleted by centrifugation for 1 min at room temperature. 
The supernatant was removed by aspiration, leaving the bacterial 
pellet as dry as possible. The cell pellets were resuspended, 
using toothpicks, in 350 yl STET solution which consists of 8% 
(w/v) sucrose, 0.5% (v/v) Triton X-100, 5 0 mM EDTA, pH 8.0 and 10 
mM Tris-HCl, pH 8.0. To this, 25 yl of a freshly prepared 
solution of lysozyme (10 mg/ml in 10 mM Tris-HCl, pH 8.0; 
obtained from Sigma) was added, the solutions mixed by vortexing 
for 5 sec and then the tubes placed in a boiling water bath for 
40 sec. The tubes were centrifuged immediately for 10 min at 
room temperature. The resulting pellet was removed with a tooth 
pick and discarded. To the supernatant 42 y 1 3 M sodium acetate, 
pH 5.5, and 420 yl of isopropanol were added and mixed by 
vortexing. The tubes were stored in a dry-ice/ethanol bath for 1 
h, centrifuged for 15 min at ftc and the resulting pellet washed 
with diethyl ether. The pellet was dried under vacuum at room 
temperature and finally dissolved in 50 yl TE buffer, pH 7.5.
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RNA was removed by adding 50 yg/ml DNase free RNase, 
incubating for 30 min at 37°C, then phenol extracting and 
precipitating as in Method 1. The final plasmid pellet was 
dissolved in 50 yl of TE buffer, pH 7.5. These preparations were 
generally sufficiently pure to be digested completely with 
restriction endonucleases or to be used in ligation reactions.
(b) Large-scale preparation.
A single colony of cells carrying the plasmid was used to 
inoculate 10 ml of L medium containing the appropriate 
antibiotic. This was grown overnight at 37°C, with shaking at 
200 rpm.
1 litre of supplemented minimal medium also containing 0.5% 
(w/v) casamino acids (Difco), in a baffled 2 1 flask, was 
inoculated with the overnight culture. This was shaken (200 rpm) 
at 37°C until the culture had reached mid logarithmic phase of 
growth (Klett reading 150). 0.2 g of chloramphenicol (Clewell,
1972) was added and the culture shaken for another 16 h at 37°C. 
The cells were collected by centrifugation in a Sorvall GS3 rotor 
at 5,000 rpm for 10 min at 0°C and resuspended in 70 ml of STET 
buffer. 5 ml of lysozyme (10 mg/ml in 10 mM Tris-HCl, pH 8.0) 
was added and mixed in well. The sample was then aliquoted into 
24 SS34 centrifuge tubes (approximately 3 ml per tube) and the 
tubes heated at 100°C for 2 min then centrifuged at 20,000 rpm, 
for 30 min at 0°C. The clear supernatants were collected with a 
10 ml pipette, pooled and extracted twice with an equal volume of 
equilibrated phenol:chloroform:isoamylalcohol (25:24:1), removing 
the aqueous phase to a fresh tube. An equal volume of 
isopropanol was added and mixed in well. The mixture was kept in
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a d r y - i c e / e t h a n o l  b a t h  f o r  15 min  a n d  c e n t r i f u g e d  i n  an  SS34 
r o t o r  a t  1 5 , 0 0 0  r p m ,  f o r  10 mi n  a t  0°C.  The p e l l e t  wa s  w a s h e d  
w i t h  d i e t h y l  e t h e r  a n d  d r i e d  u n d e r  v a c u u m .  The f i n a l  p e l l e t  was  
r e s u s p e n d e d  i n  16 ml  o f  TE b u f f e r ,  pH 7 . 5 .  16 g o f  C s C l  was  a d d e d  
a n d  m i x e d  i n  g e n t l y  u n t i l  a l l  o f  t h e  s a l t  wa s  d i s s o l v e d .  0.8 ml 
o f  e t h i d i u m  b r o m i d e  (10 m g / m l )  was  a d d e d  a n d  m i x e d  i n  w e l l .  The 
s o l u t i o n  w a s  d i v i d e d  i n t o  t wo  50 T i  p o l y a l l o m e r  t u b e s  a n d  
c e n t r i f u g e d  i n  a 50 T i  r o t o r  a t  4 3 , 0 0 0  rpm f o r  46 h a t  16°C.  The 
l o w e r  b a n d  o f  p l a s m i d  DMA w a s  w i t h d r a w n  u s i n g  a 5 ml s y r i n g e  
f i t t e d  w i t h  a n  18 g a u g e  n e e d l e .  The DMA s o l u t i o n  wa s  e x t r a c t e d  5 
t i m e s  w i t h  2 v o l u m e s  o f  C s C l - s a t u r a t e d  i s o p r o p a n o l .  The 
p r e p a r a t i o n  wa s  t h e n  d i a l y z e d  a t  4°C a g a i n s t  t h r e e  c h a n g e s  o f  500 
v o l u m e s  o f  TE b u f f e r ,  pH 7 . 5 ,  o v e r  48 h.
11.  DMA s e q u e n c i n g  by  t h e  c h a i n  t e r m i n a t i o n  m e t h o d  ( S a n g e r ,
N i c k l e n  a n d  C o u l s o n ,  1 9 7 7  ; S a n g e r  e_t a l . ,  19 82 ) .
( a )  P r e p a r a t i o n  o f  M13 t e m p l a t e s .
U s u a l l y  24 t e m p l a t e s  w e r e  p r e p a r e d  a t  o ne  t i m e .  One d r o p  
o f  o v e r n i g h t  c u l t u r e  o f  E.  c o l  i  s t r a i n  J M 1 0 1  w a s  a d d e d  t o  50 ml  
o f  2 x YT m e d i u m .  S i n g l e  p l a q u e s ,  r e s u l t i n g  f r o m  a t r a n s f e c t i o n  
a s  i n  M e t h o d  9 ( c ) ,  o f  t h e  r e c o m b i n a n t  M13 p h a g e  w e r e  p i c k e d  w i t h  
s t e r i l e  t o o t h p i c k s  a n d  t r a n s f e r r e d  t o  2 ml o f  t h e  d i l u t e d  JM101 
c u l t u r e  i n  5 ml  p l a s t i c  t u b e s .  The t u b e s  w e r e  s h a k e n  a t  200 r p m,  
f o r  14 h a t  37°C.  The  c e l l s  w e r e  p e l l e t e d  f r o m  1.5 ml o f  e a c h  
c u l t u r e  i n  a n  E p p e n d o r f  c e n t r i f u g e  f o r  5 mi n  a t  room t e m p e r a t u r e .  
Two 600 y l  a l i q u o t s  o f  e a c h  s u p e r n a t a n t  w e r e  c a r e f u l l y  
t r a n s f e r r e d  i n t o  f r e s h  E p p e n d o r f  t u b e s .  300 y l  o f  2.5 M MaCl,
20% ( w / v )  PEG w a s  a d d e d  t o  e a c h ,  m i x e d  i n  w e l l  a n d  t h e  t u b e s  h e l d  
a t  room t e m p e r a t u r e  f o r  15 m i n .  T h e s e  w e r e  t h e n  c e n t r i f u g e d  i n
99
an E p p e n d o r f  c e n t r i f u g e  f o r  5 mi n .  The s u p e r n a t a n t  was  c a r e f u l l y  
r e m o v e d  by a s p i r a t i o n  a n d  t h e  t u b e  wa s  r e c e n t r i f u g e d  b r i e f l y  a n d  
t h e  s u p e r n a t a n t  a g a i n  r e m o v e d ,  l e a v i n g  t h e  p e l l e t  a s  d r y  a s  
p o s s i b l e .  The p e l l e t  was  r e s u s p e n d e d  i n  100 y l  TE b u f f e r ,  pH 
7 . 5 ,  a n d  e x t r a c t e d  o n c e  w i t h  50 y l  o f  e q u i l i b r a t e d  p h e n o l .  The  
a q u e o u s  p h a s e  wa s  t h e n  e x t r a c t e d  t w i c e  w i t h  1 ml  o f  w a t e r -  
s a t u r a t e d  d i e t h y l  e t h e r .  10 y l  o f  3 M s o d i u m  a c e t a t e ,  pH 5 . 5 ,  
a n d  2 5 0  y l  o f  c o l d  a b s o l u t e  e t h a n o l  w e r e  a d d e d  a n d  m i x e d  i n  w e l l .  
Th e  m i x t u r e  w a s  k e p t  i n  a d r y - i c e  e t h a n o l  b a t h  f o r  1 h a n d  
c e n t r i f u g e d  i n  a n  E p p e n d o r f  c e n t r i f u g e  f o r  15 mi n  a t  4°C.  The 
p e l l e t  w a s  w a s h e d  w i t h  c o l d  a b s o l u t e  e t h a n o l ,  d r i e d  u n d e r  v a c u u m 
a n d  f i n a l l y  r e s u s p e n d e d  i n  50 y l  o f  TE b u f f e r ,  pH 7 .5 .
(b)  P r e p a r a t i o n  o f  5% a c r y l a m i d e  s e q u e n c i n g  g e l s .
The a c r y l a m i d e  g e l s  w e r e  c o v a l e n t l y  b o n d e d  t o  o ne  o f  t h e  
g l a s s  b a c k i n g  p l a t e s  t o  f a c i l i t a t e  s u b s e q u e n t  d r y i n g  o f  t h e  g e l .
5 ml  o f  S i l a n e  m i x t u r e  ( 5 0  y l  HATS,  10 m l  e t h a n o l  a n d  3 30 y l  10% 
a c e t i c  a c i d )  wa s  s p r e a d  e v e n l y  on t h e  c l e a n  g l a s s  b a c k  p l a t e  
u s i n g  a K i m w i p e  t i s s u e  a n d  a l l o w e d  t o  d r y  f o r  3 m i n  i n  a 
f u m e h o o d .  The p l a t e  w a s  t h e n  w a s h e d  w i t h  e t h a n o l ,  d r i e d  a n d  
p o l i s h e d  w i t h  a f r e s h  K i m w i p e .  5 ml  o f  s i l i c o n i z i n g  s o l u t i o n  (5% 
o f  d i m e  t h y I d i c h l o r o s i l a n e  i n  t r i c h l o r o e t h a n e ) was  s p r e a d  e v e n l y  
o n  t h e  n o t c h e d  g l a s s  p l a t e ,  d r i e d  f o r  3 m i n  a n d  t h e n  r i n s e d  w i t h  
e t h a n o l .  The t w o  p l a t e s  w e r e  t h e n  t a p e d  t i g h t l y  t o g e t h e r  a l o n g  
s i d e s  a n d  b o t t o m ,  s e p a r a t e d  by 0.3 mm ' P l a s t i c a r d '  s p a c e r s  down 
on e a c h  s i d e .  5% a c r y l a m i d e  g e l s  w e r e  t h e  m o s t  c o m m o n l y  u s e d  a n d  
60 ml  o f  u r e a - a c r y l a m i d e  w a s  p r e p a r e d  f o r  e a c h  3 6 . 5  cm x 20 cm 
g e l .  To 2 8 . 8  g o f  u r e a ,  7 . 5  ml  40% a c r y l a m i d e  s t o c k ,  6 ml  10 x 
T3E a n d  e n o u g h  d i s t i l l e d  w a t e r  t o  b r i n g  t h e  v o l u m e  t o  a b o u t  50 ml
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w e r e  a d d e d  a n d  t h e  u r e a  d i s s o l v e d  a t  3 7 ° C .  Th e  s o l u t i o n  w a s  ma d e  
u p  t o  60 ml  w i t h  d i s t i l l e d  w a t e r ,  120  p i  o f  TEMED w a s  a d d e d  a n d  
t h e  s o l u t i o n  f i l t e r e d  ( S c h l e i c h e r  a n d  S c h u e l l ,  BA85,  0 . 45  pm) 
i n t o  a 2 5 0  ml  f l a s k ,  p l a c e d  u n d e r  v a c u u m  f o r  10 m i n  a n d  h e l d  f o r  
a b o u t  2 mi n  i n  i c e .  400 y l  o f  10% ( w / v )  f r e s h l y  p r e p a r e d  
a mmoni um p e r s u l p h a t e  s o l u t i o n  was  a d d e d  t o  t h e  a c r y l a m i d e - u r e a  
s o l u t i o n  a n d  m i x e d  i n  w e l l  b u t  a v o i d i n g  b u b b l e  f o r m a t i o n .  The 
m i x t u r e  was  i m m e d i a t e l y  p o u r e d  i n t o  t h e  c a v i t y  b e t w e e n  t h e  t wo  
g l a s s  p l a t e s  w h i l e  h o l d i n g  t h e  g e l  p l a t e s  a t  a l ow a n g l e .  
I m m e d i a t e l y  a f t e r  p o u r i n g  wa s  c o m p l e t e d  a 24 o r  32 w e l l  f o r m e r  o f  
P l a s t i c a r d  wa s  i n s e r t e d  i n t o  t h e  t o p  o f  t h e  g e l  a n d  c o v e r e d  w i t h  
S a r a n w r a p  t o  e x c l u d e  a i r .  Th e  g e l  w a s  a l l o w e d  t o  s e t  f o r  1 h a t  
r oom t e m p e r a t u r e .  G e l s  c o u l d  be  p r e p a r e d  a d a y  b e f o r e  u s e .
( c )  The  s e q u e n c i n g  r e a c t i o n .
8 pil o f  M13 t e m p l a t e  a n d  1 y 1 s e q u e n c i n g  p r i m e r  (5 n g )  i n  
a n n e a l i n g  b u f f e r  ( 1 0  mM T r i s - H C l ,  pH 8 . 0 ,  10 mM M g C ^ )  w e r e  m i x e d  
w e l l  a n d  s e a l e d  i n  a c a p i l l a r y  t u b e .  The u n i v e r s a l  p r i m e r  
d e s c r i b e d  by D u c k w o r t h  e t  a l .  ( 1 9 8 1 )  (5 '  GTAAAACGACGGCCAGT 3 ’ ) 
was  u s e d  i n  t h e  s e q u e n c i n g  r e a c t i o n  u n l e s s  o t h e r w i s e  s p e c i f i e d .  
Th e  c a p i l l a r y  w a s  p l a c e d  i n  a b o u t  5 0 0  ml  o f  b o i l i n g  w a t e r  f o r  3 
mi n  t h e n  a l l o w e d  t o  c o o l  s l o w l y  t o  r oom t e m p e r a t u r e  i n  t h e  w a t e r .
The s e a l e d  g l a s s  c a p i l l a r y  c o n t a i n i n g  t h e  a n n e a l e d  p r i m e r -  
t e m p l a t e  w a s  r i n s e d  w i t h  d i s t i l l e d  w a t e r ,  d r i e d  w i t h  t i s s u e  a n d  
c u t  o p e n  w i t h  a d i a m o n d  p e n .  A b o u t  2 . 5  u n i t s  o r  0 . 5  y l  o f  E.  
c o l i  DMA p o l y m e r a s e  I  l a r g e  ( Kl e n o w)  f r a g m e n t  wa s  a d d e d  t o  t h e  
c a p i l l a r y  t h e  s a m p l e  m i x e d  a n d  e x p e l l e d  i n t o  an  E p p e n d o r f  t u b e .
2 y l  a l i q u o t s  o f  t h i s  m i x t u r e  w e r e  p l a c e d  i n t o  t h e  b o t t o m  o f  4 
c a p - l e s s  E p p e n d o r f  t u b e s  p l a c e d  i n  a r a c k  i n c l i n e d  a t  4 5° .
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The 2 x termination mixes were prepared as shown in Table 
3.1. These are comprised of equal volumes of
dideoxytriphosphates (ddNTPs) and dNTPs. The concentrations of 
ddMTPs used was determined by assay in previous sequencing 
reactions. These were included in the dN* (dA*. dC*, dG*, dT*) 
mixes shown in Table 3.2 and used in sequencing reactions. 2 yl 
of each dN* mix was placed inside the rim of one of cap-less 
Eppendorfs containing a template mix.
The reactions were started by brief centrifugation to mix 
the drops, the tubes returned to the rack and placed in a 37°C 
water bath for 15 min. The rack of tubes was then removed and 
inclined at an angle of 45°. A 2 pi drop of chase solution (0.5 
mM dNTPs) was added to each tube inside the rim. Drops were 
mixed together by brief centrifugation and incubated for a 
further 15 min at 37°C. 4 yl of formamide dye mix was added to
each tube as above. The drops were mixed by centrifugation and 
the tubes placed in a boiling water bath for 5 min to denature 
and concentrate the samples prior to loading on an acrylamide 
sequencing gel.
(d) Electrophoresis of samples.
About 2.5 yl of each reaction mixture was loaded onto a 5% 
acrylamide gel. Electrophoresis usually was carried out in 1 x 
TBE, pH 8.3, initially at 40 Watts constant power and then at 30 
Watts once the temperature of the gel reached 55°C. For gels 
which were electrophoresed for longer than 3 h, 1 x (high Tris) 
TBE, pH 8.8, was used, and the running buffer replaced every 1.5 
h.
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Table 3.1: Composition of 2 x termination mixes used for DMA 
sequencing.
2 x dTTP 
mix (yl)
2 x dCTP 
mix (yl)
2 x dGTP 
mix (y1)
2 x dATP 
mix (yl)
dTTP ( 1 mM) 15 300 300 212
dCTP { 1 mM) 300 15 300 212
dGTP ( 1 mM) 300 300 15 212
2 x dNTP buffer 75 75 75 54
ddTTP (0.4 mM) 690 - - -
ddCTP (0.05 mM) - 690 - -
ddGTP (0.1 mM) - - 690 -
ddATP (0.025 mM) - - - 690
tota 1 1,380 1,380 1,380 1,380
These were stored at -20°C. 2 x dNTP buffer contains 0.1 M Tris-
HC1, pH 8.0, 2 mM EDTA. The optimum concentrations of ddNTP were 
determined by test sequencing.
Tabl e  3.2: The c o m p o s i t i o n  o f dN* mi xes f o r  DNA s e q u e n c i n g .
dA* mix dC* mix dG* mix dT* mix
( y l ) ( y l ) ( y l ) ( y l )
2 x dATP mix 7 . 0 - - -
2 x dCTP mix - 7. 0 - -
2 x dGTP mix - - 7. 0 -
2 x dTTP mix - - - 7. 0
[ a - 32P ]dATP 
(10 y C i / y l )
1.4 2.8 1. 4 1.4
dATP (5 yM) 
s t e r i l i z e d
1.4 1.4 1.4 1.4
d i s t i l l e d  E^O 4. 2 2.8 4 . 2 4. 2
t o t a l 14. 0 14.0 14.0 14.0
These  dN* mi xes  were  p r e p a r e d  j u s t  p r i o r  t o  u se .  U s u a l l y  6 
t e m p l a t e s  were  s e q u e n c e d  a t  one t i me  and e l e c t r o p h o r e s e d  i n  a 5% 
a c r y l a m i d e  g e l  w i t h  24 w e l l s .  2 yl  was  r e q u i r e d  f o r  e a c h  
t e m p l a t e ,  t h u s  14 y l  o f  dN* mi x  was  p r e p a r e d  a l l o w i n g  f o r  2 y l  
e x t r a .
Electrophoresis was usually stopped 10 min after the 
bromophenol blue dye reached the bottom of the gel (approximately 
1.5 h). The two glass plates were separated leaving the 
acrylamide gel bonded to the back plate. The urea was eluted 
from the gel in 10% acetic acid for 30 min with occasional 
shaking. The gel was then completely dried in a drying cupboard 
(approximately 1 h, 60°C) and cooled to room temperature. 
'Scotchgard' (3M Co.) was sprayed evenly on top of the gel to 
prevent the film sticking to the gel. This was left for 5 min to 
allow the Scotchgard to dry completely.
An X-ray film (Fuji, RX) was placed directly on top of the 
dried gel and covered by a glass plate to ensure good contact.
The film was exposed overnight and developed in a Kodak X-OMAT 
autoprocessor.
(e) Computer analysis of data.
Assembly and analysis of DNA sequencing data was performed 
using the computer programs of Staden (1980, 1982b). DNA
sequence data were entered directly from autoradiograms into the 
computer using a digitizer (Staden, 1984). The Genbank database 
was searched using the program of Wilbur and Lipman (1983) kindly 
provided in VAX/VMS format by J. Maizel.
(f) Double stranded sequencing by the chain termination 
method (Wallace e_t al., 1981b).
500 ng of linear double-stranded DNA and 5 ng of primer in 
10 \il of 10 mM Tris-HCl, pH 8.5, 10 mM MgCl2 were sealed in a 
capillary tube. The tube was heated for 3 min at 100°C then 
snap-chilled in a dry-ice/ethanol bath.
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The N* m i x e s  w e r e  p r e p a r e d  a s  i n  T a b l e  3 .2 .  2 y 1 o f  e a c h  N*
mi x  (dA*,  dG*,  dC*,  dT*)  was  a d d e d  t o  t h e  b o t t o m  o f  a d i f f e r e n t  
s t e r i l i z e d  c a p l e s s  E p p e n d o r f  t u b e  p l a c e d  i n  a r a c k  i n c l i n e d  a t  an  
a n g l e  o f  4 5 ° .  The c a p i l l a r y  t u b e  was  t h a w e d  u n d e r  r u n n i n g  
d i s t i l l e d  w a t e r  a n d  d r i e d ,  t h e n  c u t  o p e n  a n d  p u t  i n t o  a c o l d  
E p p e n d o r f  t u b e  i n  a n  i c e  b a t h .  1 y 1 100 mM T r i s - H C l ,  pH 8 . 5 ,  100 
mM MgCl 2 a n d  0.5 y l  ( 2 . 5  u n i t s )  Kl enow f r a g m e n t  o f  E. c o l i  DNA 
p o l y m e r a s e  I  w e r e  a d d e d  t o  t h e  c a p i l l a r y  t u b e .  The a n n e a l e d  DNA 
a n d  Kl enow w e r e  m i x e d  a n d  e x p e l l e d  i n t o  t h e  c o l d  E p p e n d o r f  t u b e .
2 y l  a l i q u o t s  o f  t h i s  m i x t u r e  w e r e  p l a c e d  i n s i d e  t h e  l i p  o f  t h e  
E p p e n d o r f  t u b e s  c o n t a i n i n g  N* m i x e s .  The t u b e s  w e r e  b r i e f l y  
c e n t r i f u g e d  t o  m i x  t h e  d r o p s  a n d  p l a c e d  i n  a m e t a l  r a c k  a t  3 7 ° C  
f o r  15 m i n .
The dNTP c h a s e  r e a c t i o n ,  t e r m i n a t i o n  o f  r e a c t i o n  a n d  
e l e c t r o p h o r e s i s  o f  t h e  s a m p l e s  w e r e  t h e  s ame  a s  d e s c r i b e d  a b o v e  
i n  s e c t i o n s  11 ( c )  a n d  ( d ) .
(g)  D e t e r m i n a t i o n  o f  i n s e r t  o r i e n t a t i o n  i n  M13 t e m p l a t e s  by 
a n n e a l i n g  ( B a r n e s  a n d  S e v a n ,  1 9 8 3 ) .
T h i s  m e t h o d  w a s  u s e d  on o c c a s i o n s  t o  s c r e e n  t e m p l a t e s  f o r  
i n s e r t s  c l o n e d  i n  t h e  o p p o s i t e  o r i e n t a t i o n  t o  a n  a l r e a d y  
s e q u e n c e d  t e m p l a t e ,  a l l o w i n g  s e q u e n c e  t o  be  o b t a i n e d  f o r  t h e  
c o m p l e m e n t a r y  s t r a n d .  The t e m p l a t e  o f  t h e  r e c o m b i n a n t  M13 p h a g e  
t o  b e ' t e s t e d  w a s  a n n e a l e d  t o  a c h a r a c t e r i z e d  t e m p l a t e  a s  f o l l o w s :  
1.5 y l  o f  t h e  known t e m p l a t e ,  1.5 y l  o f  t h e  t e m p l a t e  t o  be 
t e s t e d ,  1 y l  10 x SSC a n d  1 y l  o f  w a t e r  w e r e  m i x e d  w e l l  a n d  
s e a l e d  i n  a c a p i l l a r y  t u b e .  The t u b e  was  h e a t e d  a t  100°C f o r  3 
mi n ,  t h e n  t r a n s f e r r e d  i m m e d i a t e l y  t o  67°C f o r  1 h.  The c a p i l l a r y  
t u b e  w a s  c u t  o p e n  a n d  t h e  a n n e a l e d  t e m p l a t e  e x p e l l e d  i n t o  1 y l  o f
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6 x b r o m o p h e n o l  b l u e  d y e  mi x  ( s o l u t i o n  n o .  1, C h a p t e r  2) .  The 
s a m p l e  wa s  a n a l y z e d  by  a g a r o s e  g e l  e l e c t r o p h o r e s i s .  T e m p l a t e s  
w i t h  i n s e r t s  w h i c h  h y b r i d i z e d  t o  t h e  known t e m p l a t e  show an  
a d d i t i o n a l  s l o w e r  m i g r a t i n g  b a n d  c o r r e s p o n d i n g  t o  a n  a n n e a l e d  
t e m p l a t e  d i m e r .
12.  E x p r e s s i o n  m e t h o d s .
( a )  DNA t r a n s f e c t i o n .
T r a n s f e c t i o n s  u s i n g  NIH 3T3 c e l l s  w e r e  c a r r i e d  o u t  i n  
c o l l a b o r a t i o n  w i t h  Dr .  C. S a n d e r s o n  o f  t h e  N a t i o n a l  I n s t i t u t e  f o r  
M e d i c a l  R e s e a r c h ,  M i l l  H i l l ,  L o n d o n .  NIH 3T3 c e l l s  w e r e  s e e d e d  
a t  5 x 1 0 5 p e r  28 mm d i a m e t e r  w e l l s  c o n t a i n i n g  5 ml  DMEM medium 
s u p p l e m e n t e d  w i t h  5% f o e t a l  c a l f  s e r u m  a n d  g r o w n  o v e r n i g h t  i n  a 
5% CO2  i n c u b a t o r  a t  37°C.  The r e s u l t i n g  c u l t u r e s  w e r e  
t r a n s f e c t e d  w i t h  DNA u s i n g  t h e  c a l c i u m  p h o s p h a t e  p r e c i p i t a t i o n  
m e t h o d  w i t h  g l y c e r o l  s h o c k  ( Gr aham a n d  Van d e r  Eb,  19 7 3 ;  P a r k e r  
a n d  S t a r k ,  1 9 79 ;  Gr a ham a n d  B a c c h e t t i ,  1 9 8 3 ) .  The med ium o f  e a c h  
c u l t u r e  w a s  r e p l a c e d  w i t h  0 . 9  ml  o f  DMEM p l u s  5% f o e t a l  c a l f  
s e r u m .  A p r e c i p i t a t e  w a s  p r e p a r e d  b y  s l o w l y  a d d i n g  1 ml  o f  DNA 
(5  yg o f  c a l f  t h y m u s  c a r r i e r  p l u s  5 yg o f  X o r  p l a s m i d  DNA) i n  
0 . 25  M C a C l 2 / t o  an  e q u a l  v o l u m e  o f  2 x H e p es  b u f f e r e d  p h o s p h a t e  
s a l i n e .  T h i s  wa s  l e f t  f o r  30 mi n  a t  room t e m p e r a t u r e .  100 y l  o f  
t h e  r e s u l t i n g  p r e c i p i t a t e  ( D N A / c a l c i u m  p h o s p h a t e  s o l u t i o n )  was  
a d d e d  t o  e a c h  c u l t u r e  t o  g i v e  a f i n a l  c o n c e n t r a t i o n  o f  0.5 yg  
e a c h  o f  c a r r i e r  a n d  X o r  p l a s m i d  DNA p e r  w e l l .  T h i s  was  a l l o w e d  
t o  s t a n d  f o r  6 h a t  r o o m  t e m p e r a t u r e .  T h e  s u p e r n a t a n t  w a s  t h e n  
r e m o v e d  a n d  0 . 2 5  ml  20% g l y c e r o l  a d d e d ,  i n c u b a t i n g  f o r  4 mi n  a t  
r oo m t e m p e r a t u r e .  The g l y c e r o l  s o l u t i o n  wa s  r e m o v e d ,  t h e  c e l l s  
w e r e  t h e n  w a s h e d  t w i c e  w i t h  5 ml o f  DMEM p l u s  5% f o e t a l  c a l f
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s e r u m  a n d  f i n a l l y  i n c u b a t e d  i n  a 5% CO2  i n c u b a t o r  a t  37°C.  
S u p e r n a t a n t s  w e r e  c o l l e c t e d  4 d a y s  p o s t  t r a n s f e c t i o n  a n d  f i l t e r e d  
t h r o u g h  A mi c o n  0 .2  urn f i l t e r s  a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y  
[ M e t h o d  12 (b)  b e l o w ] .
T r a n s f e c t i o n s  i n v o l v i n g  COS-1 monkey  c e l l s  w e r e  c a r r i e d  o u t  
i n  c o l l a b o r a t i o n  w i t h  Dr .  A. H a p e l .  COS-1 monkey  c e l l s  w e r e  
s e e d e d  a t  5 x 10^  p e r  60 mm d i a m e t e r  p e t r i  d i s h  i n  5 ml DMEM 
c o n t a i n i n g  10% f o e t a l  c a l f  s e r u m .  T h e s e  w e r e  i n c u b a t e d  o v e r n i g h t  
a t  37°C i n  a 5% CO2  i n c u b a t o r .  DNA t r a n s f e c t i o n s  w e r e  c a r r i e d  
o u t  u s i n g  t h e  a b o v e  c a l c i u m  p h o s p h a t e  t e c h n i q u e  h o w e v e r  t h e  c e l l s  
w e r e  t r e a t e d  w i t h  1.6 u g  ( p e r  c u l t u r e )  o f  s a l m o n  s p e r m  DMA a n d  
0 . 4  y g o f  p l a s m i d  o r  XDNA. T h e s e  w e r e  i n c u b a t e d  i n  a 5% CO2  
i n c u b a t o r  a t  3 7 ° C  f o r  2 h ,  a f t e r  w h i c h  t h e  e x c e s s  f l u i d  w a s  
r e p l a c e d  by 1.5 ml  o f  15% g l y c e r o l  f o r  1 m i n .  The c e l l s  w e r e  
t h e n  w a s h e d  t w i c e  i n  5 ml DMEM c o n t a i n i n g  10% f o e t a l  c a l f  s e r u m  
a n d  i n c u b a t e d  i n  a 5% CO2  i n c u b a t o r  a t  37°C.  S u p e r n a t a n t s  w e r e  
c o l l e c t e d ,  f i l t e r e d  a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y .
F o r  t r a n s f e c t i o n s  i n v o l v i n g  X, t h e  DNA w a s  f i r s t l y  h e a t e d  a t  
6 5 ° C  f o r  5 m i n  t h e n  s n a p  c h i l l e d  i n  i c e - w a t e r  t o  d e n a t u r e  t h e  
c o h e s i v e  e n d s .
( b )  A s s a y  f o r  I L - 3  a c t i v i t y .
The f a c t o r - d e p e n d e n t  c e l l  l i n e  32D c l - 2 3  ( G r e e n b e r g e r  e_t 
a 1 . ,  1983)  wa s  i n o c u l a t e d  i n t o  RPM I- 1 6 4 0  med i um c o n t a i n i n g  10% 
f o e t a l  c a l f  s e r u m  a n d  10% WEHI-3B c o n d i t i o n e d  med i um ( W a r r e n ,  
H a r g r e a v e s  a nd  H a p e l ,  1985)  a n d  g r o w n  f o r  3 d a y s  i n  a 5% CO2  
i n c u b a t o r  a t  37°C.  C e l l s  t o  be  u s e d  f o r  a s s a y  w e r e  w a s h e d  
e x t e n s i v e l y ,  by p e l l e t i n g  a n d  r e s u s p e n d i n g  3 t i m e s  i n  50 ml  o f
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fresh medium. The assays (Hapel, Warren and Hume, 1984) were 
performed by incubating two-fold serial dilutions of the sample 
to be tested with 2 x 10^ washed cells in 100 yl RPMI-1640 plus 
10% foetal calf serum in 96-well microtiter plates. These were 
incubated overnight at 37°C in a 5% CC>2 incubator. The cultures 
were then pulsed with 0.5 uCi [^Hjthymidine for 6 h at 37°C and 
then harvested onto glass fibre filters (Titerek). Incorporation 
of label was determined by scintillation counting. Background 
was taken as the average counts from wells to which no growth 
factor had been added.
Results
1. Screening the WEHI-3B X genomic library.
From the genomic Southern blot analysis in the previous 
chapter, it appeared that the leukaemia cell line WEHI-3B may 
have an alteration in the 5' region of one IL-3 allele. To 
investigate the nature of this alteration and its possible 
correlation with the constitutive expression of the IL-3 gene in 
WEHI-3B cells, a genomic X library was constructed.
High-molecular-weight DNA was isolated from WEHI-3B cells 
using Sarkosyl and proteinase K as described in Method 1 (b) in 
Chapter 2. The DMA was partially digested with the restriction 
endonuclease Mbol and the resulting fragments size-fractionated. 
The vector X EMBL 3A was digested with the enzymes EcoRI and then 
BamHI to excise the stuffer fragment, leaving the arms with Mbol 
compatible ends. The WEHI-3B DMA and vector arms were ligated 
and packaged into bacteriophage X particles. In order to have a 
99% chance of isolating a specific DMA sequence from the library 
the number of recombinant phage required to be screened was
calculated as follows (Clarke and Carbon, 1976):
l n (1 - P )
N = ______
ln(l-f)
where ? = probability (0.99)
f = fractional proportion of the genome in a single 
recombinant, which for this library means, 
f = 14 to 20 kb (size of fragments cloned)
3 x 10® kb (size of haploid mammalian genome)
Thus, N = 6.9 to 9.8 x 10®, depending on the size of the 
fragments cloned. Titration of the library, using Eh coli strain 
ED8654 as host, gave a titre of 2.0 x 10® PFU/ml.
cTwo rounds of screening were carried out using first 4 x 10J 
then 8 x 10® PFU, each distributed over 4 Pyrex 'patisserie' 
dishes. Duplicate plaque lifts were carried out using 
nitrocellulose and prewashes and hybridization were done in a 
sealed plastic box making it easier to handle the large number of 
filters. The hybridization solution (400 ml) consisted of 50% 
(v/v) deionized formamide, 6 x SSC, 5 x Denhardt's solution, 50 
mM sodium phosphate buffer, pH 6.8, lOOyg/ml denatured sonicated 
salmon sperm DMA, 1 mM sodium pyrophosphate and 0.1 mM ATP. A 
[32p]_iabelied probe was prepared by randomly primed synthesis 
using the 467 bp Hindi!I-Mcol fragment of murine IL-3 cDNA 
(discussed in Chapter 2) as template. The concentration of probe 
for this screening was 5 x 10® cpm/ml of solution (specific 
activity approximately 4.0 x 10® cpm/^g). Included as a positive 
control was a small filter used to lift plaques of AgtWES.XB 
containing the IL-3 gene (Campbell et. a_l., 1985).
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After examining the autoradiographs of the duplicate 
filters, from the two rounds of screening, 3 and 18 positive 
clones were identified, respectively. The autoradiographs of 
duplicate filters covering half of one dish are shown in Figure 
3.1. The clones were purified by further plating and screening 
[Method 6 (h)] reusing the same IL-3 cDMA probe prepared for the 
initial screening. These experiments were repeated until all 
plaques on one plate from each clone hybridized to the probe. Of 
the 21 positive clones identified initially, 13 were successfully 
purified. From these, plate lysate stocks were prepared and 
DNA isolated using the rapid small-scale preparation [Method 7 
(a)]. The final DMA concentrations were estimated by agarose gel 
electrophoresis and comparison with DMA standards of known 
concentration by ethidium bromide fluorescence under UV 
illumination. The yields of A DMA prepared from a single 
confluent plate ranged from 2 to 7 ug of DMA.
2. Characterization of the A clones.
Initial characterization involved restriction endonuclease 
mapping and Southern hybridization analysis. About 800 ng of DMA 
from each recombinant A clone was digested with EcoRI and EcoRI 
plus Sail restriction endonucleases in high salt buffer for 2 h 
at 37°C. The vector AEMBL 3A contains Sail restriction sites 
flanking the cloning site, thus digestion with this enzyme 
excises the genomic insert. Southern blot analysis was carried 
out on these samples after electrophoresis in a 1% agarose gel, 
using wild type A DMA digested with Hindlll as size standard.
The probe was prepared from the Hindi!I-Mcol IL-3 cDNA fragment 
and hybridization was carried out as for the library screening 
discussed above. The results obtained are shown in Figure 3.2.
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Figure 3.1: Autoradiographs of plaque screening of the WEHI-3B
genomic library.
A probe was prepared from the Hindlll-Ncol fragment of the IL-3 
cDNA using random primer synthesis. The autoradiographs are 
duplicate filters covering one half of a 20 x 30 cm dish 
containing 2 x 10^ plaques. The positive plaques are numbered 1 
to 5, the arrow on filter 2 indicates a false positive and (X) 













FILTER 1 FILTER 2
F i g u r e  3 . 2 : I n i t i a l  a n a l y s i s  o f  some g e n o m i c  X c l o n e s  c a r r y i n g
t h e  I L - 3  ge ne  i s o l a t e d  f r om t h e  WEHI-3B X l i b r a r y .
(a)  Each  X c l o n e  DMA was  d i g e s t e d  w i t h  E c o RI a l o n e  o r  
t o g e t h e r  w i t h  S a i l  a nd  e l e c t r o p h o r e s e d  i n  1% a g a r o s e  g e l s  a t  
25 mA o v e r n i g h t .
(b)  S o u t h e r n  b l o t s  w e r e  c a r r i e d  o u t  u s i n g  t h e  g e l s  a b o v e  and  
n i t r o c e l l u l o s e  ( Me t hod  8) .  The p r o b e  u s e d  was  p r e p a r e d  f rom 
t h e  H i nd l l l - Ncol  f r a g m e n t  o f  t h e  I L - 3  cDNA c l o n e  by r andom 
p r i m i n g .  The p o s i t i o n s  o f  X / H i n d I I I  s t a n d a r d  f r a g m e n t s  a r e  
i n d i c a t e d ,  w i t h  s i z e s  i n  kb.
The s a m p l e s  w e r e  a s  f o l l o w s :
Lane Cl on e D i g e s t
1 . 1 . 2 EcoRI
2. 1 . 2 E c o R I / S a l l
3. 3 . 2 EcoRI
4 . 3 . 2 E c o R I / S a l l
5. 3 . 3 EcoRI
6 . 3 . 3 E c o R I / S a l l
7 . 3 . 4 EcoRI
8 . 3 . 4 E c o R I / S a l l
9. 4 . 8 EcoRI
10. 4 . 8 E c o R I / S a l l
11. 4 . 9 EcoRI
12. 4 . 9 E c o R I / S a l l
a b
1 2 3 4 5 6 7 8 Kb 2 3 4 5 6 7 8
23  -
9.4  -  
6.6  -
4.4  -
2.3  -  
2 .0  -
)
9 10 11 12 9 10 11 12
-  23  -
-  9.4  -
-  6 .6  -
-  4.4  -
-  2.3  -
-  2.0  -
The  c l o n e s  a p p e a r e d  t o  b e l o n g  t o  t wo  f a m i l i e s ,  c o r r e s p o n d i n g  t o  
t h e  n o r m a l  a n d  r e a r r a n g e d  I L - 3  g e n e s  i n f e r r e d  p r e v i o u s l y  f r o m  t h e  
g e n o m i c  b l o t s  o f  WEHI-3B DNA. T h e s e  p o s s e s s e d  8.5 kb ( f o r  
e x a m p l e  c l o n e s  A3.3 a n d  A4.8)  a n d  3.8 kb ( f o r  e x a m p l e  c l o n e s  A3.2 
a n d  A4.9) E c o RI  f r a g m e n t s  r e s p e c t i v e l y ,  w h i c h  h y b r i d i z e d  w i t h  t h e  
I L - 3  cDNA p r o b e .  T h e r e  w e r e  a l s o  c l o n e s  c o n t a i n i n g  o n l y  a 
p o r t i o n  o f  t h e  I L - 3  g e n e  ( f o r  e x a m p l e  c l o n e s  A1.2 a nd  A3.4) .  As 
s e e n  f r o m  t h e  p h o t o g r a p h s  i n  F i g u r e  3 . 2 ,  many o f  t h e  A c l o n e s  
p o s s e s s e d  a n u m b e r  o f  f r a g m e n t s  i n  common.  The l a r g e  n u m b e r  o f  
o v e r l a p p i n g  c l o n e s  t o g e t h e r  w i t h  t h e  S o u t h e r n  a n a l y s i s  a l l o w e d  
t h e  p r e l i m i n a r y  m a p p i n g  o f  E c o RI  a n d  S a i l  r e s t r i c t i o n  s i t e s  i n  
t h e  I L - 3  g e n e  r e g i o n  i n  e a c h  f a m i l y  o f  c l o n e s .  Some f r a g m e n t s  
r e s u l t i n g  f r o m  p a r t i a l  d i g e s t i o n  w e r e  a l s o  p r e s e n t  w h i c h  was  an  
o c c a s i o n a l  p r o b l e m  w i t h  d i g e s t s  o f  t h e  s m a l l - s c a l e  ADNA 
p r e p a r a t i o n s .
F u r t h e r  S o u t h e r n  a n a l y s i s  o f  t h e  A c l o n e s  wa s  c a r r i e d  o u t  
u s i n g  v a r i o u s  r e s t r i c t i o n  e n z y m e s  a n d  p r o b e s  ( F i g u r e  3 . 3 ) .  The 
r e s t r i c t i o n  e n z y m e s  H i n f I  a n d  H p a l l ,  w h i c h  h a v e  4 b a s e  
r e c o g n i t i o n  s e q u e n c e s ,  w e r e  u s e d  t o  d i g e s t  A c l o n e  DNA. W i t h i n  
t h e  I L - 3  g e n e  t h e r e  a r e  a n u m b e r  o f  k n o w n  s i t e s  f o r  t h e s e  
e n z y m e s ,  a n d  t h i s  d i g e s t i o n  t h e r e f o r e  g a v e  r i s e  t o  many f r a g m e n t s  
d e t e c t a b l e  w i t h  t h e  I L - 3  cDNA p r o b e  p r e p a r e d  f r o m  t h e  H i n d l l l -  
N c o l  f r a g m e n t .  F o r  H i n f I , t h e  e x p e c t e d  h y b r i d i z a b l e  f r a g m e n t s  
a r e  1125 ,  8 44 ,  200 ,  180 a n d  165 bp  i n  l e n g t h ,  a n d  f o r  H pa l l  t h e y  
w e r e  2 0 41 ,  181 a n d  106 bp  ( F i g u r e  3 . 3 ) .  The r e s u l t i n g  s a m p l e s  
w e r e  e l e c t r o p h o r e s e d  i n  a 1.5% a g a r o s e  g e l .  As n i t r o c e l l u l o s e  i s  
n o t  e f f i c i e n t  i n  r e t a i n i n g  v e r y  s m a l l  f r a g m e n t s ,  o n l y  f r a g m e n t s  
l a r g e r  t h a n  200 bp w e r e  s e e n  on S o u t h e r n  b l o t s  ( F i g u r e  3 . 4 ) .  The  
r e s u l t s  p r e s e n t e d  a r e  f o r  t w o  r e p r e s e n t a t i v e  c l o n e s ,  A 4.8 a nd
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Figure 3.3: Restriction map of the BALB/c 8.5 kb EcoRI
fragment containing the normal IL-3 gene.
Sites for restriction endonucleases are shown: B, BamHI; E,
EcoRI; Hl, HinfI; H2, Hind i ; H3, Hindi II; H4, Hpall; N, Ncol.
The exons of the IL-3 gene are indicated by filled boxes, and the 
untranslated regions of the mRNA by open boxes. Also indicated 
are the probes used for the hybridization experiments in this 

























Figure 3.4: Southern blots of representative genomic clones
A4.8 and A4.9, carrying the normal and rearranged 
IL-3 genes, respectively.
About 800 ng of ADNA was digested with either HinfI or Hpall 
restriction endonucleases in medium salt buffer for 2 h at 37°C. 
Samples were then electrophoresed in a 1.5% agarose gel for 8 h 
at 25 mA, then transferred to nitrocellulose membrane and 
hybridized with the same IL-3 cDNA probe used for Southern blots 
shown in Figure 3.2. The sizes are indicated in bp.






X4.9 w h i c h  c o n t a i n  t h e  n o r m a l  a n d  r e a r r a n g e d  I L - 3  g ene  
r e s p e c t i v e l y .  I n  t h e  c a s e  o f  t h e  H i n f I  d i g e s t  o f  b o t h  c l o n e s ,  
t w o  s t r o n g l y  h y b r i d i z i n g  b a n d s  w e r e  d e t e c t e d  c o r r e s p o n d i n g  t o  t h e  
1125  a n d  844 b p  f r a g m e n t s .  The e x p e c t e d  200 bp b a n d  i s  a l s o  
p r e s e n t  b u t  i s  much r e d u c e d  i n  i n t e n s i t y .  The Hpa l l  d i g e s t s  o f  
e a c h  X c l o n e  DNA e x h i b i t  o n l y  one  s t r o n g l y  h y b r i d i z i n g  b a n d ,  
c o r r e s p o n d i n g  t o  t h e  e x p e c t e d  2041 bp f r a g m e n t .  Th u s  i t  a p p e a r e d  
t h a t  t h e  r e a r r a n g e d  I L - 3  g e n e  f r o m  WEHI-3B i s  n o t  a l t e r e d  i n  t h e  
r e g i o n  o f  t h e  I L - 3  g e n e  c o v e r e d  by t h e  p r o b e .  T h i s  t a k e n  
t o g e t h e r  w i t h  p r e v i o u s  S o u t h e r n  a n a l y s i s  d a t a  s u g g e s t e d  t h a t  t h e  
r e a r r a n g e m e n t  m u s t  l i e  i n  t h e  5'  u n t r a n s l a t e d  r e g i o n  o f  t h e  g e n e ,  
a n d  t h i s  w a s  c o n f i r m e d  i n  a d d i t i o n a l  e x p e r i m e n t s .
Lambda c l o n e s  w e r e  a l s o  d i g e s t e d  w i t h  e i t h e r  BamH I / E c o RI o r  
E c o R I / H i n d l l I .  The s a m p l e s  w e r e  e l e c t r o p h o r e s e d  i n  a 1.5% 
a g a r o s e  g e l  a n d  a S o u t h e r n  b l o t  p r e p a r e d  a n d  p r o b e d  w i t h  t h e  I L - 3  
cDNA f r a g m e n t .  F i g u r e  3.5 s h o w s  t h e  r e s u l t s  o b t a i n e d  f o r  t w o  o f  
t h e  c l o n e s ,  X3.2 a n d  X3.3,  c o n t a i n i n g  t h e  r e a r r a n g e d  a n d  t h e  
n o r m a l  g e n e s  r e s p e c t i v e l y .  When t h e  n o r m a l  I L - 3  EcoRI  f r a g m e n t  
i s  d i g e s t e d  w i t h  H i n d i I I ,  a 3.0 kb  h y b r i d i z i n g  f r a g m e n t  i s  
e x p e c t e d ,  w h i l e  f o r  d i g e s t i o n  w i t h  BamH I , f r a g m e n t s  o f  1.8 a n d  
2 .8  k b  a r e  e x p e c t e d  ( F i g u r e  3 . 3 ) .  W i t h  X3.3 a l l  o f  t h e  b a n d s  
e x p e c t e d  w e r e  o b t a i n e d .  The H i n d i ! I  r e s u l t s  f o r  c l o n e  X3.2  w e r e  
t h e  s ame  a s  f o r  X3 . 3 ,  h o w e v e r  t h e  BamH I / E c o RI h y b r i d i z i n g  
f r a g m e n t s  w e r e  2 .0  kb a n d  1.8 kb.  The 2.0 kb f r a g m e n t  maybe  
d e r i v e d  f r o m  t h e  e x p e c t e d  2.8 kb f r a g m e n t ,  w h i c h  i s  l o c a t e d  i n  
t h e  5'  u n t r a n s l a t e d  r e g i o n  o f  t h e  n o r m a l  I L - 3  g e n e ,  p r o v i d i n g  t h e  
l o c a l i z a t i o n  o f  t h e  a l t e r a t i o n .
To i n v e s t i g a t e  t h e  5'  r e g i o n  i n  mo r e  d e t a i l ,  a p r o b e  was
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Figure 3.5: Southern blots of representative genomic clones
A3.2 and A3.3, carrying the rearranged and normal 
IL-3 genes, respectively.
About 800 ng of ADNA was double digested with BamHI and EcoRI or 
Hindi!I and EcoRI restriction endonucleases in high salt buffer 
for 2 h at 37°C. The samples were then electrophoresed on a 1.5% 
agarose gel, transferred to nitrocellulose, and hybridized with 
probes prepared from the Hindlll-Ncol fragment of the IL-3 cDNA 
or the EcoRI-HincII fragment derived from the 5' flanking region 
of the IL-3 gene (refer to Figure 3.3). This second probe had a 
specific activity of about 7.5 x 10° cpm/yg. The positions of 
A/Hindlll standard fragments are indicated.
The samples are as follows:
Pane 1 Digest Probe
a EcoRI/BamHI IL-3 cDNA
b EcoRI/BamHI 5' flanking
c EcoRI/HindlII IL-3 cDNA














9.4 Kb -  
6 .6  Kb -
4 .4  Kb -
2.3 Kb -
2.0 Kb -
p r e p a r e d  u s i n g  a 4.8 kb E c o R I - H i n c I I  f r a g m e n t  ( k i n d l y  p r o v i d e d  by
Dr .  H. C a m p b e l l )  a s  t e m p l a t e  f o r  r a n d o m  p r i m e r  s y n t h e s i s .  T h i s  
f r a g m e n t  c o v e r s  t h e  5'  f l a n k i n g  r e g i o n  o f  t h e  I L - 3  g e n e  ( F i g u r e  
3 . 3 ) .  On r e p r o b i n g  t h e  a b o v e  S o u t h e r n  t h e  h y b r i d i z i n g  b a n d s  
e x p e c t e d  f o r  t h e  n o r m a l  g e n e  w e r e ,  5 '  t o  3 ' ,  2 . 5 ,  0 . 9  a n d  2 .1  kb  
f o r  E c o R I / H i n d l l l  a n d  2.8 a n d  3.9 kb f o r  BamH I / E c o RI .  The 
e x p e c t e d  b a n d s  w e r e  o b t a i n e d  w i t h  A3.3 .  F o r  A3.2 DNA d i g e s t e d  
w i t h  BamH I / E c o R I , t h e  3.9 kb h y b r i d i z i n g  b a n d  was  p r e s e n t  b u t  t h e  
2 . 8  kb  b a n d  w a s  r e p l a c e d  by  a 2 . 7  kb  b a n d .  W i t h  t h e  
H i n d l l l / E c o RI d i g e s t i o n  o f  A3.2 DNA, t h r e e  h y b r i d i z i n g  b a n d s  w e r e  
o b s e r v e d  a t  2 . 5 ,  1 . 6  a n d  0 . 9  k b  b u t  t h e  n o r m a l  2 . 1  kb h y b r i d i z i n g  
f r a g m e n t  wa s  a b s e n t .  I n  b o t h  c a s e s ,  t h e  f r a g m e n t s  n o t  s e e n  w i t h  
A3.2,  a r e  t h o s e  t h a t  map c l o s e s t  t o  t h e  5'  e n d  o f  t h e  n o r m a l  I L - 3  
g e n e  .
T h e s e  r e s t r i c t i o n  m a p p i n g  r e s u l t s  a l l o w e d  t h e  d e d u c t i o n  o f  a 
p r e l i m i n a r y  map o f  t h e  r e a r r a n g e d  I L - 3  g e n e  i n  WEHI-3B ( F i g u r e  
3.6) ' ,  w h i c h  i n d i c a t e d  t h a t  t h e  5'  f l a n k i n g  r e g i o n  h a s  b e e n  
d i s p l a c e d  a b o u t  5 kb  u p s t r e a m  f r o m  t h e  I L - 3  c o d i n g  r e g i o n ,  
c o n s i s t e n t  w i t h  a n  i n s e r t i o n .  R e p r o b i n g  o f  t h e  e a r l i e r  S o u t h e r n  
o f  E c o R I / S a l l  d i g e s t e d  c l o n e s  ( F i g u r e  3 .2 )  w i t h  t h e  5'  f l a n k i n g  
E c o R I - H i n c I I  f r a g m e n t  f u r t h e r  v e r i f i e d  t h i s .
3. C o n s t r u c t s  c a r r y i n g  t h e  n o r m a l  a n d  r e a r r a n g e d  I L - 3  g e n e s
f r o m  WEHI-3B c e l l s .
To f a c i l i t a t e  f u r t h e r  s t u d i e s ,  l a r g e - s c a l e  DMA p r e p a r a t i o n s  
o f  t h e  r e p r e s e n t a t i v e  c l o n e s  A3.2 a n d  A3.3 w e r e  c a r r i e d  o u t  a s  
d e s c r i b e d  i n  M e t h o d  7 (b)  u s i n g  t h e  o p t i m u m  MOI o f  0 . 0 5 .  
A p p r o x i m a t e l y  800 y g  o f  DNA wa s  o b t a i n e d  o f  e a c h  c l o n e ,  w i t h  
^ d 2 6 0 / o d 280 r a t i ° s ° f  1.3 0 a n d  1 . 86 .
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Figure 3.6: A preliminary restriction map of the normal and
rearranged IL-3 gene regions isolated from WEHI-3B 
showing various overlapping X clones.
The relevant restriction endonuclease sites shown are: B, BamHI; 
E, EcoRI; H, Hindlll; H2, Hindi? S, Sail. Also indicated are 
the site of insertion, the IL-3 gene region and the various 
fragments that were isolated and later used in sequence analysis, 
expression studies or as probes in further Southern hybridization 
experiments. Regions of Xclones where the restriction maps were 


















The 3.8 kb a n d  8.5 kb  E c o RI f r a g m e n t s  d e r i v e d  f r o m  t h e  I L - 3
g e n e s  o f  WEHI-3B c e l l s  ( F i g u r e  3 .6)  w e r e  i s o l a t e d  f r o m  4.5 yg  o f  
c l o n e s  A 3 .2 -and A3.3,  u s i n g  l o w - m e l t i n g - t e m p e r a t u r e  a g a r o s e  
( M e t h o d  2 ) ,  g i v i n g  a p p r o x i m a t e l y  44% r e c o v e r y  i n  e a c h  c a s e .  The 
v e c t o r  pAT153 wa s  l i n e a r i z e d  w i t h  E c o RI a n d  d e p h o s p h o r y l a  t e d  
u s i n g  CIAP w i t h  t w o  i n c u b a t i o n s  a t  37°C ( M e t h o d  4) .  L i g a t i o n s  
w e r e  c a r r i e d  o u t  u s i n g  a 3 : 1  m o l a r  r a t i o  o f  f r a g m e n t  t o  v e c t o r ,  
w h e r e  60 a n d  130 ng o f  t h e  3.8 a n d  8.5 kb E c o RI f r a g m e n t s ,  
r e s p e c t i v e l y ,  w e r e  l i g a t e d  w i t h  20 ng o f  p r e p a r e d  pAT153.  W i l d  
t y p e  X DMA d i g e s t e d  w i t h  E c o RI was  a l s o  l i g a t e d  w i t h  t h e  v e c t o r  
a s  a  p o s i t i v e  c o n t r o l .  10 y l  o f  t h e  l i g a t i o n  mi x  was  a d d e d  t o  
210 y l  o f  c o m p e t e n t  EL c o l i  HB101 c e l l s  p r e p a r e d  a s  i n  M e t h o d  9 
( a ) .  5 y l  a n d  45 y l  o f  t h e  r e s u l t i n g  t r a n s f o r m a t i o n s  w e r e  s p r e a d
o n t o  t e t r a c y c l i n e  L a g a r .  The n u m b e r  o f  t r a n s f o r m a n t s  o b t a i n e d  
f o r  e a c h  l i g a t i o n  w a s  r e l a t i v e l y  l ow  ( a p p r o x i m a t e l y  1.2 x 1 0 ^ / y g  
v e c t o r  DMA) b u t  a d e q u a t e  f o r  t h e  p u r p o s e  o f  s u b - c l o n i n g  a n d  w e l l  
a b o v e  t h e  n u m b e r s  o b t a i n e d  w i t h  v e c t o r  a l o n e .
12 t r a n s f o r m a n t s  o f  e a c h  t y p e  w e r e  s e l e c t e d  f o r  s m a l l - s c a l e  
p l a s m i d  DMA i s o l a t i o n  u s i n g  M e t h o d  10 ( a ) .  The r e s u l t i n g  p l a s m i d  
DMA wa s  d i g e s t e d  w i t h  H i n d l l l  t o  d e t e r m i n e  t h e  o r i e n t a t i o n  o f  
e a c h  i n s e r t .  B o t h  o r i e n t a t i o n s  o f  i n s e r t  w e r e  o b t a i n e d  f r o m  e a c h  
t y p e .  T h o s e  w i t h  t h e  I L - 3  g e n e  i n  t h e  s am e  o r i e n t a t i o n  a s  t h e  
p l a s m i d  t e t r a c y c l i n e  r e s i s t a n c e  g e n e  w e r e  u s e d  f o r  f u r t h e r  s t u d y .  
The r e c o m b i n a n t  p l a s m i d s  c o n t a i n i n g  t h e  3.8 kb a n d  8.5 kb E c o RI 
f r a g m e n t s  w e r e  d e s i g n a t e d  pILM15 a n d  p I L Ml o  r e s p e c t i v e l y .
To f a c i l i t a t e  f u r t h e r  w o r k ,  l a r g e  s c a l e  p r e p a r a t i o n s  o f  
t h e s e  p l a s m i d s  w e r e  made u s i n g  a 10 ml  t e t r a c y c l i n e  L b r o t h  
c u l t u r e  t o  i n o c u l a t e  1 1 o f  s u p p l e m e n t e d  m i n i m a l  med i um
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also containing 0.5% (w/v) casamino acids as in Method 10 (b). 
Yields of DMA were 1.61 mg (pILM15) and 1.0 mg (pILM16), with 
0D260//(^)D280 rati°s °f 1.80 and 1.82 respectively. There was no 
detectable chromosomal DMA contamination.
Also isolated was a 3.5 kb HincII-EcoRI fragment (Figure 
3.6) which contains the IL-3 gene. This fragment was isolated 
from 5 yg of appropriately digested pILMl6, using low-melting- 
temperature agarose, giving approximately 80% recovery. The 
cohesive ends were treated with T4 DMA polymerase (Method 3) to 
produce blunt ends. The vector used was pAT153 digested with 
EcoRI, treated with T4 polymerase and then dephosphorylated.
About 60 ng of fragment was ligated with 20 ng of vector (24 h at 
15°C). The ligation mixture was used to transform competent 
HB101 cells and transformants selected for by tetracycline 
resistance. Ultimately large-scale plasmid DMA preparations 
were carried out as for pILM15 and pILM16. This construct was 
designated pILMl9.
4. Characterization of the insertion in the rearranged IL-3
gene .
In order to elucidate the nature of the insert near the IL-3 
gene, fragments covering the junction region were isolated and 
sequenced. This sequencing was done in collaboration with Mr. W. 
Tucker.
A Hindlll fragment approximately 0.65 kb (Figure 3.6) in 
length was isolated from pILM15 using low-melting-temperature 
agarose. The ends of this fragment were converted to blunt ends 
with T4 DMA polymerase and then ligated with the vector M13mp8, 
which had been linearized with Smal and dephosphorylated with
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CIAP. Controls included digested and dephosphorylated vector 
alone and vector ligated with phosphorylated BamHI linker as a 
test of blunt end ligation efficiency. 3 yl of ligation mix was 
used to transfect 210 yl competent cells of E. coli strain JM101. 
A background of approximately 20% blue vector plaques were 
obtained. White recombinant plaques were picked with sterile 
toothpicks and used to prepare M13 DMA templates [Method 11 (a)].
Several M13mp8 templates containing the Hindlll fragment 
were sequenced using the universal primer and 5% acrylamide gels. 
Sequence was obtained on both strands of this fragment and 
compared with the sequence of the IL-3 gene (Campbell et. al., 
1985; Miyatake et al., 1985b). The site of the insertion was 
found to be 215 bp upstream of the putative IL-3 TATA box. 
Comparison of the insert sequence with the Genbank data base 
showed that it was highly homologous (approximately 93% identity) 
with the 5' long terminal repeat (LTR) of an intracisternal A- 
particle (IAP) genome which had previously been found to have 
inserted into the murine cellular oncogene c-mos, resulting in 
its activation (Canaani ejt al., 1983). The IAP LTR of the 
insertion near the IL-3 gene was found to have inserted in a 
"head to head" manner, that is the 5’ LTR is orientated such that 
normal transcription from within the LTR would be directed away 
from the IL-3 gene. IAP LTRs are generally flanked by the 4 base 
inverted repeat 5' TGTT/AACA 3’ (for example Canaani et. al., 
1983). The sequence obtained revealed 5’ AACA 3' at the 
insertion point plus 273 bp of the 5' LTR.
To obtain the remainder of the LTR sequence, an EcoRI-BamHI 
fragment (Figure 3.6) was isolated from pILMl5 and prepared and
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l i g a t e d  i n t o  M13mp8 a s  a b o v e .  T h i s  f r a g m e n t  wa s  s e q u e n c e d  a s  f a r  
a s  p o s s i b l e  u s i n g  t h e  u n i v e r s a l  p r i m e r  a n d  5% a c r y l a m i d e  g e l  
e l e c t r o p h o r e s i s  f o r  up t o  3 h.  To o b t a i n  c o m p l e t e  s e q u e n c e  on  
b o t h  s t r a n d s  a d d i t i o n a l  s e q u e n c i n g  p r i m e r s  ( P I ,  P2 a n d  P3) w e r e  
s y n t h e s i z e d .  The r e s u l t s  a r e  s u m m a r i z e d  i n  F i g u r e  3.7 (Ymer  e t  
a l . ,  1 9 8 5 ) ,  s h o w i n g  t h e  j u n c t i o n  r e g i o n  b e t w e e n  t h e  5'  LTR o f  t h e  
IAP g en ome  a n d  t h e  p r o m o t e r  r e g i o n  o f  t h e  I L - 3  g e n e .  The 
s e q u e n c i n g  p r i m e r s  a r e  a l s o  s h o w n .  By u s i n g  P I  a n d  t h e  2 1 - m e r  
u s e d  i n  C h a p t e r  2 a s  p r i m e r s ,  a n d  e l e c t r o p h o r e s e s  i n  5% 
a c r y l a m i d e  g e l s  f o r  3 h ,  445  bp  o f  s e q u e n c e  f r o m  t h e  j u n c t i o n  
s i t e  i n t o  t h e  I L - 3  g e n e  w a s  a l s o  o b t a i n e d .  T h i s  s e q u e n c e  was  
i d e n t i c a l  t o  t h a t  o f  t h e  n o r m a l  I L - 3  g e n e  i n  t h i s  r e g i o n  
( C a m p b e l l  et.  a l . ,  1 9 8 5 ;  M i y a t a k e  et.  a l . ,  1 9 8 5 b ) .
A l s o  s h o w n  i n  F i g u r e  3 .7  i s  a n  a l i g n m e n t  b e t w e e n  t h e  IAP LTR 
s e q u e n c e  f o u n d  (337  bp)  i n  t h e  r e a r r a n g e d  I L - 3  g e n e  ( r I L - 3 )  a n d  
t h a t  f o u n d  i n  t h e  r e a r r a n g e d  c - mos g e n e  ( r c - m o s ).  The t w o  LTRs 
show a h i g h  d e g r e e  o f  h o m o l o g y  (93%).  The i n i t i a l  s e q u e n c i n g  o f  
t h e  E c o R I - BamHI f r a g m e n t  a l s o  y i e l d e d  a 15 bp  r e g i o n  o f  t h e  b o d y  
o f  t h e  IAP g e n o m e .  T h u s ,  t h e  i n s e r t  o f  pILM15 c a r r i e s  t h e  I L - 3  
g e n e  p l u s  t h e  5'  LTR a n d  15 b p  o f  b o d y  o f  t h e  IAP g e n o m e  u p  t o  
t h e  new EcoRI  s i t e  r e s p o n s i b l e  f o r  p r o d u c i n g  t h e  3.8 kb
I
h y b r i d i z i n g  b a n d  s e e n  on  g e n o m i c  S o u t h e r n  b l o t s  o f  WEHI-3B.
As IAP e l e m e n t s  a r e  r e t r o v i r a l - l i k e ,  i t  w o u l d  be e x p e c t e d  
t h a t  t h e  3'LTR i s  l o c a t e d  i n  t h e  o t h e r  j u n c t i o n  r e g i o n  o f  t h e  
i n s e r t i o n .  H y b r i d i z a t i o n  e x p e r i m e n t s  w e r e  a l s o  c a r r i e d  o u t  u s i n g  
a p r o b e  p r e p a r e d  f r o m  t h e  E c o R I - BamHI f r a g m e n t  c o n t a i n i n g  t h e  
c o m p l e t e  5'  LTR by  r a n d o m  p r i m e r  s y n t h e s i s .  T h e s e  e x p e r i m e n t s  
r e s u l t e d  i n  t h e  m a p p i n g  o f  a s i m i l a r  s e q u e n c e  ( t h e  e x p e c t e d  3'
LTR o f  t h e  IAP g e no me )  f u r t h e r  u p s t r e a m  o f  t h e  I L - 3  g e n e .  The
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Figure 3.7: The IAP LTR present near the IL-3 gene.
(a) The junction between the 5' LTR of the IAP genome and the 
promoter region of the IL-3 gene in the rearranged IL-3 gene 
(rIL-3). The LTR is shaded. The sequencing strategy is 
summarized beneath the LTR where PI, P2 and P3 are specific 
sequencing primers and the position and direction of 
sequence obtained is indicated by the longer arrows.
(b) Nucleotide sequence covering the LTR. Included is a 15 bp 
region of the body of the IAP genome, the 5' LTR and a 
region of the IL-3 gene adjacent to the junction. The 
sequence of the 5' LTR of an IAP genome found in the 
rearranged c-mos proto-oncogene (rc-mos; Canaani £t al., 
1983) is shown for comparison. The 4 bp inverted repeat (51 
TGTT/AACA 3') characteristic of IAP LTRs is indicated.
IAP
genome
5 LTR IL-3 GENEHH
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10 20 30 40 50 60
GAATTCGGCACCAATTGTTATTCGACGCGTTCTCACGACCGGCCAGGAAGAACACCACAG
A A  A A A  A A A A A A A A A A A A A A A  A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A
rc-mos GATTTCAGCACCAATTGTTATTAGACGCGTTCTCACGACCGGCCAGGAAGAACACCACAG 
10 20 30 40 50 60
Hindlll
rIL-3
70 801 90 100
ACCAGAATCTTCTGCGGCAAAGCTTTATT-CTTACATCTTCAGGAA----------------
A A A A A A A A A A A A A A A A A A A A A A A A A A A A A  A A A A A A A A A A A A A A A
rc-mos ACC AGAATCTTCTGC GGC AAAGCTTTATTTCTTAC ATCTTC AGGAGC C AGGGTC GAGGAA 
70 80 90 100 110 120
rIL-3
110 120 130 140 150 160
--AAGAGAGCAAGAAGCAAGAGAGAGAGAAAACGAAAACCCCGTCCCTCTTAAGGAGCAT
A A A A A A A A A A A A A A A A A A A A A A  A A A A A A A A A A A A  A A A A A A A A A A A A A A A A A A A A A A
rc-mos GCAAGAGAGCAAGAAGCAAGAGAGCGAGAAAACGAAA-CCCCGTCCCTCTTAAGGAGCAT 
130 140 150 160 170
rIL-3
170 180 190 200 210 220
TCTCCTTCGCCTCGGACGTGTCACTCCCTGATTGGCTGCAGCCCATCGGCCGAGTTGACG
A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A  A A A A A A A  A A A A A A A A
rc-mos TCTCCTTCGCCTCGGACGTGTCACTCCCTGATTGGCTGCAGCC-ATCGGCC-AGTTGACG 
190 200 210 220 230
rIL-3
230 240 250 260 270 280
TCACGGGGAAGGCAGAGCACAAGTAGTCATAAGATACCCTTGGCACATGCGCAGATTATT
A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A
rc-mos TC AC GGGGAAGGCAGAGC ACAAGTAGTC ATAAGATAC C CTTGGC ACATGC GCAGATTATT 
240 250 260 270 280 290
rIL-3
290 300 310 320 330 340
TGTTTACCACTTAGAACACAGGATGTCAGCGCCATCTTGTAACGGCGAATGTGGGGGCGG
A  A  A  A  A A  A  A  A A A A A A A A  A A A A A h A A A A  A  A A A A A A A  A A A  A  A  A A  A A A  A  A  A  A  A  A A A  A  A  A A A A
rc-mos TGTTTACCACTTAGAACACAGGATGTCAGCGCCATCTTGTACCGGCGAATGTGGGCGCGG 
300 310 320 330 340 350
rIL-3
350 360 370 380 390 400
CTCCCAACACACAAC CTGTTTC C ACTCC GTCCATCTCTATGAC AAAGGAAGAAGATGGC C
A A A A A A A A A
rc-mos CTCCCAACA
360 A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A
IL-3 CACAAC CTGTTTCCACTCCGTCCATCTCTATGACAAAGGAAGAAGATGGCC
total sizs of the IAP insert was estimated to be approximately 
5.0 kb, which is very similar to that estimated for the IAP 
genome inserted into the c-mos gene.
To verify the location of the 3' LTR and to sequence its 
junction with host sequence, a 2.7 kb BamHI fragment (Figure 3.6) 
covering the upstream junction region was isolated from 
appropriately digested A3.2 in a low-melting-temperature agarose 
gel and eventually ligated with M13mp8 (as above). This fragment 
was partially sequenced using the internal primers PI and P2 
shown in Figure 3.7 (a). The first 12 templates initially 
sequenced were all of the same orientation and thus data on one 
strand only was obtained. Using one of the partially sequenced 
templates, hybridization Method 11 (g) was used to determine the 
orientation of the remaining 12 templates. After annealing, 
templates were electrophoresed in a 1% agarose gel, and when 
examined, were all found to be of the same orientation, as 
indicated by lack of hybridization. Finally the BamHI fragment 
itself was sequenced using the double-stranded Method 11 (f) and 
the internal primers PI and P2. Each termination reaction 
contained about 150 ng of the BamHI fragment. This was 
successful, providing the sequence of the upstream junction site 
and 190 bp of the IAP 3' LTR.
The sequence obtained for the 3' LTR was found to be 
completely identical to the corresponding region of the 5' LTR. 
The sequence also showed a 6 bp duplication of host sequence (5’ 
CACAAC 3') at the junctions of the IAP genome and IL-3 gene 
sequence. This is consistent with other instances of IAP genome 
insertions into cellular genes (Canaani e_t a_l., 1983; Kuff e_t
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a 1., 1983 ; Burt, Reith and Brammer, 1984).
5. Expression studies.
The transfections, involving NIH 3T3 and COS-1 monkey cells, 
were carried out in collaboration with Dr. C. Sanderson and Dr.
A. Hapel, respectively.
The DNA of the clones A3.2 and A3.3 were transfected into 
BALB/c NIH 3T3 cells using the calcium phosphate precipitation 
method and cultures were assayed periodically for IL-3 production 
using the IL-3-dependent cell line 32D cl-23 (Method 12). Cell 
transfections with clone A 3.3 DNA (which carries the normal gene) 
or with carrier DNA alone produced no detectable IL-3 activity.
In contrast, cells transfected with clone A 3.2 produced 
detectable IL-3 activity four days post-transfection, which 
continued to increase up to day 8 (Figure 3.8; Ymer et al.,
1985), reaching levels approximately 22% of those produced by 
WEH±-3B cells. Cotransfeet ion of NIH 3T3 cells with a mixture of 
A3.2 and A3.3 DNA resulted in similarly high levels, indicating 
that the A3.3 DNA did not contain inhibitors affecting the 
expression of IL-3 activity. The inability of clone A 3.3 to be 
expressed efficiently in NIH 3T3 cells is in agreement with the 
silent nature of the endogenous IL-3 gene in these cells.
Similar results to these were obtained using plasmids pILMl5 (IL— 
3 gene and 5* LTR) or pILM16 (normal IL-3 gene within the 8.5 kb 
fragment) transfected into NIH 3T3 cells. The plasmid pILM19, 
containing the normal gene and only 480 bp of sequence upstream 
from the TATA box, has also been found not to produce IL-3 
activity when transfected into NIH 3T3 cells (Ms J. Lee, 
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Figure 3.8: Production of IL-3 by BALB/c NIH 3T3 cells 8 days
after transfection with X clones from WEHI-3B.
Cultures were transfected by the calcium phosphate technique 
using 0.5 yg of X DNA and 0.5 yg of calf thymus DNA (CTD) per 
culture. Data for three individual cultures of NIH 3T3 cells are 
shown in each case. IL-3 in the supernatants diluted 1:10 was 
assayed on the dependent cell line 32D cl-23 by measuring uptake 
of [3H]thymidine after 24 h (Method 12). Maximum counts obtained 
with WEHI-3B conditioned medium diluted 1:10 = 72,000 cpm.
sufficient to result in constitutive expression of the IL-3 gene.
Verification of these results was obtained when the 
transient expression assays were repeated using monkey COS-1 
cells. Six days after transfection, cells transfected with 
clone A3.2 gave IL-3 levels 63% of those found in WEHI-3B 
conditioned medium whereas those transfected with clone A3.3 
produced no detectable IL-3.
Discussion
A WEHI-3B A genomic library was screened successfully 
isolating two families of clones containing the normal and 
rearranged IL-3 genes. The initial restriction mapping and 
Southern hybridization results indicated there was an insertion 
of approximately 5 kb located 5' to the IL-3 gene of one allele 
in WEHI-3B cells. Fragments covering the junction regions of 
insertion were isolated and sequenced. Comparison of the insert 
sequence with the Genbank database showed that it was highly 
homologous (approximately 93%; Figure 3.7) with the 5* LTR of an 
IAP genome previously found to have inserted into the murine 
cellular oncogene c-mos resulting in its activation. In WEHI-33, 
an IAP genome (IAP-IL3) had inserted 215 bp upstream from the 
putative IL-3 TATA box. The completely sequenced IAP-IL3 5' LTR 
is flanked by a perfect inverted repeat (5' TGTT/ACAA 3') 
identical to that found of the IAP element inserted in the c-mos 
gene (Canaani e_t al., 1983). Another feature of this insertion 
was the 6 bp duplication of host sequence (5' CACAAC 3') at the 
junctions of the IAP genome and IL-3 gene sequence, which is 
typical of IAP genome insertions into cellular genes (Canaani et_ 
al., 1983; Kuff et al., 1983; Burt, Reith and Brammar, 1984).
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Expression experiments were carried out involving 
transfection of X clones carrying either a normal or rearranged 
IL-3 gene into NIH 3T3 or monkey COS-1 cells. The results 
obtained (Figure 3.8) indicated that the insertion of the IAP 
genome upstream of the IL-3 gene has resulted in its activation 
and thus is responsible for the constitutive expression of IL-3 
in WEHI-3B cells. Other expression work involving the 
transfection of plasmid DMA constructs pILM15, pILM16, and pILM19 
indicated that the presence of the 5' LTR alone adjacent to the 
IL-3 gene is sufficient to result in constitutive expression of 
the gene.
The insertion of the IAP genome 215 bp upstream of the IL-3 
TATA box may have produced constitutive expression of IL-3 by one 
of several different mechanisms. The proximity of the 5' LTR to 
the IL-3 gene could provide a new promoter for the gene. However 
it seems that most transcripts in WEHI-3B are coming from the IL- 
3 promoter which is intact in the rearranged IL-3 gene (Fung e _ t  
al./ 1984; Yokota et_ a_l., 1984). Another possibility is that the
IAP genome has insertionally inactivated a cis-acting regulatory 
sequence or moved it upstream away from the IL-3 gene. Most 
likely is that the 5' LTR of the IAP genome is providing an 
enhancer sequence which promotes transcription of the IL-3 gene.
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Chapter 4
Nucleotide sequence of the IAP genome inserted 5' to the
IL-3 gene.
Introduction
Intracisternal A-particles (3ernhard, 1960; Dalton et. al., 
1966; Finnegan, 1985) or IAPs are retrovirus-like particles 
observed, by electron microscopy, in certain mouse tumour cells 
(de Harven and Friend, 1958; Dalton et al., 1961; Xakefuda, 
Roberts and Suntzeff, 1970) and in mouse oocytes and 
preimplantation embyros (Biczysko e_t al., 1973; Calarco and 
Szollosi, 1973; Chase and Piko, 1973; Kelly and Condamine, 1982) 
but are rarely seen in normal cells (Wivel and Smith, 1971). 
Characteristically, the particles form by budding from the 
endoplasmic reticulum and, when fully formed, they are localized 
exclusively within the cisternae. Unlike conventional 
retroviruses, IAPs have never been observed outside the cell and 
are therefore considered to be noninfectious. There has been 
considerable interest in IAPs because of their association with 
tumour cells.
Mouse IAP particles contain polyadenylated RNA molecules 
which range in size from 3.5 to 7.2 kb (Paterson ejt a_l., 1978; 
Ono et al., 1980) and code for the major gag-like protein of 73 
kilodaltons
, Paterson et a_l., 1978 ). IAPs also contain a
DMA polymerase activity with the properties of a magnesium-
dependent reverse transcriptase (Wilson and Kuff, 1972; Wilson e_t 
; Wong-Staal et. al. , 1975
al., 1974). DMA sequences complementary to IAP RNA have been 
A haploid
found repeated about 1,000-fold in the Mus musculus ^ genome and
DMA fragments containing IAP-related sequences have been cloned
and studied (Lueders and Kuff, 1977 and 1980; Ono et_ al., 1980).
IAP related sequences have been also observed in the DMA of other
rodents such as the rat and Syrian hamster (Lueders and Kuff,
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1 9 8 1 ) .  R e c e n t l y ,  u s i n g  low s t r i n g e n c y  h y b r i d i z a t i o n  c o n d i t i o n s ,  
IAP r e l a t e d  s e q u e n c e s  h a v e  b e e n  d e t e c t e d  a n d  c l o n e d  f r o m t h e  
human  genome  ( C a l l a h a n  et.  a l . ,  19 8 5 ;  Ono,  1 9 8 6 ) .
M u r i n e  IAP g e n o m e s  h a v e  b e e n  f o u n d  t o  be  a h i g h l y  
p o l y m o r p h i c  f a m i l y  o f  p r o v i r a l - 1 i k e  e l e m e n t s ,  r a n g i n g  i n  s i z e  
f r o m  3 t o  7.3 kb ( K u f f ,  S m i t h  a n d  L u e d e r s ,  1 9 8 1 ) .  D e s p i t e  t h e  
a p p a r e n t  h e t e r o g e n e i t y ,  t h e  IAP g e n o m e s  h a v e  b e e n  c l a s s i f i e d  i n t o  
t w o  g r o u p s  d e s i g n a t e d  t y p e  I  a n d  t y p e  I I  b a s e d  on  a n a l y s i s  by  
r e s t r i c t i o n  e n d o n u c l e a s e  m a p p i n g ,  h e t e r o d u p l e x  f o r m a t i o n  a n d  
g e n o m i c  S o u t h e r n  h y b r i d i z a t i o n  u s i n g  c l o n e d  IAP g e n e s  a s  p r o b e s  
( L u e d e r s  a n d  K u f f ,  1 9 7 7 ;  Ono e_t a l . ,  19 8 0 ;  K u f f ,  S m i t h  a n d  
L u e d e r s ,  1 9 8 1 ;  S n e n - O n g  a n d  C o l e ,  1982 ;  W u j c i k ,  Mor ga n  a n d  Huang ,  
1 9 8 4 ) .  Type  I  g e n o m e s  a r e  g e n e r a l l y  7.3 kb i n  l e n g t h ,  a l t h o u g h  
d e l e t e d  f o r m s  h a v e  b e e n  r e p o r t e d  ( S h e n - O n g  a n d  C o l e ,  1982;
W u j c i k ,  Mo rg an  a n d  Hu a ng ,  1 9 8 4 ) ,  a n d  t h e y  o u t  n u m b e r  t y p e  I I  
e l e m e n t s  by a  r a t i o  o f  a b o u t  1 0 : 1  ( S h e n - O n g  a n d  C o l e ,  1 9 8 2 ) .  The 
t y p e  I I  e l e m e n t s  a r e  4.8 kb i n  l e n g t h  a n d  a r e  g e n e r a l l y  d e l e t e d  
f o r m s  o f  t y p e  I  e l e m e n t s  h o w e v e r  t h e y  c o n t a i n  a u n i q u e  s e q u e n c e  
i n  t h e i r  5'  r e g i o n .  T h i s  s e q u e n c e  h a s  r e c e n t l y  b e e n  d e s i g n a t e d  
A l l i n s  a n d  c h a r a c t e r i z e d  by  L u e d e r s  a n d  M i e t z  ( 1 9 8 6 )  a s  a 270 bp 
i n s e r t i o n - l i k e  e l e m e n t  f l a n k e d  by a 9 bp d u p l i c a t i o n  o f  t h e  h o s t  
IAP s e q u e n c e .
IAP g e n o m e s  h a v e  b e e n  f o u n d  t o  be  f l a n k e d  by  LTRs ( K u f f ,  
S m i t h  a nd  L u e d e r s ,  1981)  w h i c h ,  u n l i k e  many o t h e r  r e t r o v i r u s e s ,  
a r e  o f t e n  n o n i d e n t i c a l .  S e q u e n c e  a n a l y s i s  o f  v a r i o u s  IAP LTRs 
( C a n a a n i  e_t aJL.,  1 9 8 3 ;  K u f f  e t  a 1 . ,  198 3 ; B u r t ,  R e i t h  a n d  
B r a m m a r ,  1 9 8 4 ;  H a w l e y ,  S h u l m a n  a n d  H o z u m i ,  1 9 8 4 ;  L u e d e r s  e_t a l . , 
1984 ;  C h r i s t y  e_t a l . ,  1985)  h a s  r e v e a l e d  s i m i l a r i t i e s  t o  t h e
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proviral structure of retroviruses, although there is little 
sequence homology. The LTRs of retroviruses are flanked by 
inverted repeats, contain several conserved sequences involved in 
the control of transcription by RNA polymerase II and have been 
subdivided into three domains, U3-R-U5 (Temin, 1981; Varmus,
1982; Chen and 3arker, 1984). The U3 region of retroviruses 
generally contains the sequences CCAAT (CAT box) and JATAAG 
(Goldberg-Hogness or TATA box). Both of these are located about 
50 to 60 bp from the 3' end of U3. The polyadenylation signal 
AqTAAA is also usually located at or near the 3* end of the U3 
region but in most mammalian type C viruses this sequence can be 
found in the 3' area of the R region. The latter region always 
starts at the capping nucleotide, G, and ends with the 
polyadenylation addition site, CA. Such sequences have been 
located in the LTRs of IAP elements and exhibit similar features 
and organization (Lueders et al., 1984; Christy et al.,
1985) to those of other retroviral LTRs (Varmus, 1982) and other 
genes transcribed by RNA polymerase II (Breathnach and Chambon, 
1981). Size differences between IAP LTRs are largely due to 
variation within the R region (Christy et_ al., 1985) which is not 
the case in other retroviruses, where the U3 region is variable 
(Chen and Barker, 1984). The U5 regions of IAP LTRs are also 
smaller than those of other retroviruses. Using SI nuclease for 
cDNA extension mapping and _in vitro transcription studies (Cole, 
Ono and Huang, 1982); Wujcik, Morgan and Huang, 1984) revealed 
that IAP RNA transcription initiates within the 5’ LTR and 
terminates in the 3' LTR, like other retroviruses. Recently, it 
has been shown that the transcription of IAP genomes can be 
influenced by the presence of nuclear oncogene products such as 
myc (Luria and Horowitz, 1986).
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Adjacent to the LTRs of IAPs and other retroviruses are 
sequences thought to be important in the initiation of proviral 
DMA synthesis by reverse transcription (Chen and Barker, 1984). 
Immediately downstream from the 5' LTR is the tRNA binding site 
involved in negative strand synthesis. For IAP genomes this site 
has been found to be complementary to the 3’ end of mammalian 
tRNApiie. A purine-rich sequence just upstream from the 3' LTR 
has been suggested as a possible initiation site for positive 
strand synthesis. Further discussion of such consensus sequences 
will be given in relation to the results of this chapter.
Insertional mutations involving IAP genomes have been 
reported for various murine genes. In the case of the rearranged 
c-mos gene, IAP insertion resulted in its activation, with
\
increased transcription probably due to a cryptic promoter 
present in the IAP LTR (Canaani et al., 1983; Horowitz et al.,
1984). In contrast, insertional inactivation has been reported 
for a K-light chain gene, where an IAP genome had inserted in an 
intron and is presumed to prevent intron splicing (Kuff e_t al., 
1983; Hawley, Shulman and Hozumi, 1984). An IAP genome (MIARN) 
has been found associated with one of the two renin genes of 
DBA/2 mice and there is circumstantial evidence for gene 
activation in this case (Burt, Reith and Brammar, 1984). In all 
these cases and also with the rearranged IL-3 gene (Chapter 3; 
Ymer e_t al., 1985), there has been a 6 bp duplication of the host 
sequence at the integration site. This suggests that the IAP 
element entered the DNA by a mechanism akin to that of other 
proviruses and transposable elements, which are also flanked by 
direct repeats of host sequence of varying lengths (Varmus, 1982;
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Finnegan, 1985).
These findings indicate that IAP genomes appear occasionally 
at new sites in the cellular DMA and can affect the expression of 
other genes. In order to determine its coding capacity and 
relationship to other retroviruses the nucleotide sequence of 
IAP-IL3 was determined. The results of this work have also been 
published (Ymer et a_l., 1986; Ymer and Young, 1986).
Materials
Reagents, solutions and vectors.
1. Ampicillin (Beecham Research Laboratories) was dissolved in 
sterile water at 25 mg/'ml and used at 50 yg/ml final 
concentration.
2. M13mpl0 (Messing, 1983), linearized with restriction 
endonuclease Smal and dephosphoryla ted with CIAP, was 
obtained from Amersham.
3. pIY2 (Young, Jaworowski and Poulis, 1979) was kindly 
supplied by Dr. H. Campbell. This consists of pGM706 (Hamer 
and Thomas, 1976) and a 7 kb HindiII chromosomal fragment 
carrying the E. coli respiratory D-lactate dehydrogenase 
gene .
4. Sonication buffer; 0.5 M NaCl, 100 mM Tris-HCl, pH 7.4, 1 mM 
EDTA, pH 8.0.
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Me t h o d s
1. DNA s e q u e n c i n g  by t h e  c h a i n  t e r m i n a t i o n  m e t h o d
( m o d i f i c a t i o n s ) .
( a )  C a l i b r a t i o n  o f  t h e  s o n i c a t o r .
The  s o n i c a t o r  wa s  f i r s t l y  c a l i b r a t e d  w i t h  4 y g  s a m p l e s  o f  
t h e  l a r g e  p l a s m i d  p I Y2  w h i c h  i s  23 kb i n  l e n g t h .  The s o l u t i o n  o f  
DNA w a s  ma d e  u p  t o  250  p i  w i t h  s o n i c a t i o n  b u f f e r  a n d  l e f t  on  i c e .
The s o n i c a t o r  p r o b e  wa s  w a s h e d  w i t h  s t e r i l e  w a t e r  a n d  t h e n  
e t h a n o l .  The t u n e  was  a d j u s t e d  t o  maxi mum a t  a me d i um p o w e r  
s e t t i n g  w i t h  t h e  s o n i c  p r o b e  i n  2 5 0  p i  s o n i c a t i o n  b u f f e r  i n  a n  
E p p e n d o r f  t u b e .  C a l i b r a t i o n  was  c a r r i e d  o u t  by s o n i c a t i n g  
s e v e r a l  s a m p l e s  o f  t h e  p I Y 2  p l a s m i d  w i t h  3 t o  8 b u r s t s  o f  5 s e c ,  
l e a v i n g  t h e  s a m p l e s  on  i c e  f o r  1 m i n  b e t w e e n  b u r s t s .  A f t e r  
c o m p l e t i o n  o f  s o n i c a t i o n  t h e s e  s a m p l e s  w e r e  p r e c i p i t a t e d  by t h e  
a d d i t i o n  o f  2 v o l u m e s  o f  c o l d  a b s o l u t e  e t h a n o l  a n d  i n c u b a t i o n  i n  
a d r y - i c e / e t h a n o l  b a t h  f o r  1 h.  The t u b e s  w e r e  t h e n  c e n t r i f u g e d  
f o r  15 m i n  a t  4° C a n d  t h e  p e l l e t s  d r a i n e d  a n d  d r i e d  u n d e r  v a c u u m  
f o r  20 mi n  a t  r oom t e m p e r a t u r e .  The  d r y  p e l l e t s  w e r e  d i s s o l v e d  
i n  20 p i  TE b u f f e r ,  pH 7. 5 a n d  2 p i  a l i q u o t s  e l e c t r o p h o r e s e d  i n  a 
1% a g a r o s e  g e l .  S i x  b u r s t s  f o r  5 s e c  was  f o u n d  t o  p r o d u c e  t h e  
g r e a t e s t  p r o p o r t i o n  o f  f r a g m e n t s  i n  t h e  d e s i r e d  s i z e  r a n g e  ( 5 0 0 -  
1 , 0 0 0  a n d  1 , 0 0 0 - 2 , 0 0 0  b p ) .
(b)  C l o n i n g  o f  s o n i c a t e d  f r a g m e n t s  i n t o  M1 3mpl 0 .
F r a g m e n t s  t o  be  s e q u e n c e d  w e r e  i s o l a t e d  f r o m a l o w - m e l t i n g -  
t e m p e r a t u r e  a g a r o s e  g e l  a n d  s e l f  l i g a t e d  f o r  24 h a t  1 5 ° C  u s i n g  
T4 DMA l i g a s e  ( Me t h o d  5,  C h a p t e r  3) .  The c o n c e n t r a t i o n  o f  
f r a g m e n t s  i n  t h e  l i g a t i o n  wa s  k e p t  h i g h  ( a p p r o x i m a t e l y  150 n g / p l )
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to promote the formation of concatemers rather than circular 
forms. Aliquots of 1 \il were electrophoresed in a 1% agarose 
gel, to confirm the presence of high-molecular-weight material. 
The ligated DMA fragment solution was made up to 250 yl with 
sonication buffer and sonicated with 6 bursts of 5 sec as above. 
The DMA was then precipitated and protruding ends converted to 
blunt ends with T4 DMA polymerase (Method 3, Chapter 3). 
Subsequently these fragments were electrophoresed in a 1% low- 
melting-temperature agarose gel and fragments in the desired size 
ranges cut out and purified as outlined in Method 2 (Chapter 3), 
then finally ligated with the Smal linearized vector M13mpl0.
The resulting ligation mix was used to transform the E. coli 
strain JM101 (Method 9, Chapter 3). Templates were prepared and 
sequenced as described in Chapter 3.
(c) Modifications to the sequencing method.
The method of sequencing was essentially the same as that 
outlined in Chapter 3, however there were some minor changes.
For convenience, microtiter plates were used in place of cap-less 
Eppendorf tubes for the reactions. The constituents of the 
reaction mix were added to the microtitre wells as separate drops 
and then the reaction initiated by brief centrifugation (Clements 
2,000 fitted with a microtiter plate rotor). The plates were 
then covered with a lid and placed in a 37°C incubator. To 
denature and concentrate the samples after adding the formamide 
dye mix, the trays (with lids removed) were placed for 15 min in 
a drying cabinet at approximately 60°C.
The standard sequencing gels used here were wedge-shaped. 
During electrophoresis on these gels, smaller fragments migrate
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more slowly as they proceed down the gel, resulting in a more 
even spacing of bands, thus allowing more DMA sequence to read be 
from a single gel. To achieve this, an extra 4 cm strips of 
'Plasticard' (0.3 mm thick) was placed on top of each spacer at 
the bottom end of the gel before the plates were taped together 
as described in Method 10, Chapter 3. Thus, the bottom 4 cm of 
the gel was 0.6 mm thick tapering quickly to the usual 0.3 mm. 
Sequencing gels eletrophoresed for periods longer than 3 h were 
not wedge-shaped.
(d) Formamide gels
To resolve compressions, formamide-acrylamide gels (Sanger 
et al., 1982) were employed. The gel mix consisted of a final 
volume of 60 ml containing 1 x TBE buffer, pH 8.3, 8 M urea, 5% 
(w/v) acrylamide and 25% (v/v) deionized formamide. The 
procedure used for pouring these gels was the same as for other 
acrylamide gels.
(e) Computer analysis of sequencing data
Assembly and analysis of DMA sequences was carried out as 
described in Chapter 3. The DIAGOM program (Staden, 1982a) was 
also used for graphical alignment and comparisons of nucleic acid 
sequences.
Results
1. Constructs used for sequencing analysis.
The overlapping fragments used to sequence the IAP-IL3 
genome are shown in Figure 4.1. The major fragments sequenced 
were the Sall-EcoRI fragment (covering the 5' area of the IAP
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g enome)  a n d  t h e  BamHI f r a g m e n t  ( c o v e r i n g  t h e  3'  a r e a ) .  I n  o r d e r
t o  o b t a i n  l a r g e  a m o u n t s  o f  t h e s e  f r a g m e n t s  t h e y  w e r e  i s o l a t e d  
f r o m  a p p r o p r i a t e  d i g e s t s  o f  c l o n e  1 3 . 2 ,  u s i n g  l o w - m e l t i n g -  
t e m p e r a t u r e  a g a r o s e ,  a n d  l i g a t e d  i n t o  p l a s m i d  v e c t o r s .  The 3.2 
kb S a l l - E c o RI f r a g m e n t  w a s  s u b c l o n e d  i n t o  pBR322,  w h i c h  h a d  b e e n  
d i g e s t e d  w i t h  S a l l - E c o RI a n d  d e p h o s p h o r y l a t e d .  The r e s u l t i n g  
p l a s m i d  wa s  d e s i g n a t e d  p ILM20.  L i k e w i s e ,  t h e  2.7 kb BamHI 
f r a g m e n t  was  s u b c l o n e d  i n t o  BamHI d i g e s t e d  pAT153,  w h i c h  was  a l s o  
d e p h o s p h o r y l a t e d .  T h i s  p l a s m i d  w a s  d e s i g n a t e d  p ILM17.  The t wo  
p l a s m i d s  w e r e  u s e d  t o  t r a n s f o r m  HB101 c e l l s  a n d  s e l e c t e d  f o r  
a m p i c i l l i n  r e s i s t a n c e .  A l a r g e - s c a l e  p r e p a r a t i o n  o f  e a c h  p l a s m i d  
wa s  made u s i n g  t h e  M e t h o d  10 (b)  o f  C h a p t e r  3, a n d  t h e  i n s e r t s  
r e s e c t e d  a n d  p u r i f i e d  on l o w - m e l t i n g - t e m p e r a t u r e  a g a r o s e  g e l s .  
E a c h  f r a g m e n t  ( a b o u t  4 yg) wa s  s e l f - l i g a t e d ,  s o n i c a t e d  a n d  t h e  
r e s u l t i n g  f r a g m e n t s  made b l u n t  e n d e d  u s i n g  T4 DMA p o l y m e r a s e .  
L o w - m e l t i n g - t e m p e r a t u r e  a g a r o s e  g e l  e l e c t r o p h o r e s i s  was  u s e d  t o  
i s o l a t e  f r a g m e n t s  i n  t h e  s i z e  r a n g e s  5 0 0 - 1 , 0 0 0  a n d  1 , 0 0 0 - 2 , 0 0 0  bp 
w h i c h  w e r e  t h e n  s u b c l o n e d  i n t o  Smal  l i n e a r i z e d  M13mpl0 .  O t h e r  
f r a g m e n t s  u s e d  i n  t h e  s e q u e n c i n g  w e r e  i s o l a t e d ,  t r e a t e d  w i t h  T4 
DNA p o l y m e r a s e  a n d  c l o n e d  d i r e c t l y  i n t o  Smal  l i n e a r i z e d  M13mpl0 .  
S e q u e n c i n g  i n v o l v e d  t h e  u n i v e r s a l  p r i m e r  o r  t h e  s p e c i f i c  p r i m e r s  
i n  F i g u r e  3 . 7 ,  C h a p t e r  3.
2. N u c l e o t i d e  s e q u e n c e  o f  I A P - I L 3 .
S e q u e n c i n g  o f  t h e  o v e r l a p p i n g  r e s t r i c t i o n  f r a g m e n t s  ( F i g u r e  
4 .1 )  y i e l d e d  s e q u e n c e  on b o t h  s t r a n d s  c o v e r i n g  100% o f  t h e  IAP 
g en o me .  F o r  a r e a s  s h o w i n g  c o m p r e s s i o n s ,  25% f o r m a m i d e  g e l s  w e r e  
u s e d .
I A P - I L 3  s e q u e n c e  r e v e a l e d  t h e  p r e s e n c e  o f  t w o  EcoRI  s i t e s
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B H H SB B EEH H B EI----■§— 1— L-l----l----- LJb-cbt---d-o-czi---1
3'LTR IAP genome 5'LTR 5’ IL-3 gene 3'
4--------
1.0 Kbi I
Figure 4.1: Restriction map of the rearranged IL-3 gene from
WEHI-3B cells carrying the inserted IAP genome 
IAP-IL3.
Sites for restriction endonucleases are shown: E, EcoRI; B, 
BamHI; H, HindiII; S, Sail. The LTRs of the IAP element are 
indicated by filled boxes and the exons of the IL-3 gene by open 
boxes. The overlapping restriction fragments used to sequence 
IAP-IL3 are also indicated.
125 bp apart in the 5' LTR region where the restriction map 
established in Chapter 3 (Figure 3.6) shows a single site. IAP- 
IL3 was found to be 50 95 bp in length with identical long 
terminal repeats (LTRs) of 337 bp. Each IAP-IL3 LTR is flanked 
by the 4 bp inverted repeat 5' TGTT/ACAA 3' often found in many 
IAP elements. The sequence of IAP-IL3 is shown in Figure 4.2 
(Ymer et al., 1986) with some sequence features of the LTRs 
indicated on the 5' LTR.
The likely U3-R-U5 structure (Christy ejt al., 1985) for IAP- 
IL3 is shown in Figure 4.2. The U3 region is 216 nucleotides 
long and contains a typical CAT box. The putative TATA box shown 
in Figure 4.2 is atypical and was located by alignment with other 
similar IAP LTRs which have more typical TATA boxes (Christy et 
al., 1985). The 64 bp R region begins with the likely capping 
nucleotide G at position 217 in the 5' LTR and ends with the 
polyadenylation acceptor site CA. Seventeen nucleotides upstream 
from the end of the R region is the po lyade ny la t ion signal 
AATAAA. The sequence TGTT, thought to be important in viral RNA 
termination (Temin, 1981) is located 19 bp downstream from the 
beginning of U5. The U5 region is 57 nucleotides long.
Viral LTRs have been found to contain enhancers, usually 
associated with Z-DNA forming sequence. An enhancer-1ike sequence 
GTGGTAAA which closely matches the SV40 core enhancer sequence 
GTGG^JJ (Khoury and Gruss, 1983; Weiher, König and Gruss, 1983) 
is present at position 60. A potential Z-DNA forming sequence of 
11 nucleotides is present at position 77. Eight nucleotides 5' 
to the enhancer, the sequence TGTTCT is present which matches a 
consensus sequence for the glucocorticoid-responsive element
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Figure 4.2: Nucleotide sequence of IAP-IL3 (Ymer e_t al., 1986).
The sequence is presented over the next three 
pages and is in the orientation 5' LTR to 3' LTR.
The terminal inverted repeats (5' TGTT/AACA 3') of the 337 bp LTRs 
are shown. In the case of the 5* LTR, the likely U3-R-U5 
structure is shown (Temin, 1981; Varmus, 1982; Christy £t al., 
1985) together with various conserved sequences thought to be 
important for transcription. GRE, glucocorticoid responsive 
element (Burt, Reith and Brammar, 1984; Scheidereit and Beato, 
1984); TBS, phenylalanine tRNA (Keith and Dirheimer, 1978) primer 
binding site for (-) strand synthesis; PU, purine-rich region 
postulated to be involved in the initiation of (+) strand 
synthesis (Chen and Barker, 1984). The amino acid sequence 
encoded by the long open reading frame present in IAP-IL3 is 
indicated, beginning at the first initiation codon.
TGTTGGGAGCCGCCCCCACATTCGCCGTTACAAGATGGCGCTGACATCCTGTGTTCTAAGTGGTAAACAAATAATCTGCGCATGTGCCA 
L” ------ 10  20  30  40  50  -------------  -----------------  70 8 0
GRE enhancer
AGGGTATCTTATGACTACTTGTGCTCTGCCTTCCCCGTGACGTCAACTCGGCCGATGGGCTGCAGCCAATCAGGGAGTGACACGTCCGAG
100 110 1 2 0  1 3 0
U 3 n
1 4 0 150 CAT box
TATA box? 200 210 2 3 0 2 4 0 2 5 0
170
GCGAAGGAGAATGCTCCTTAAGAGGGACGGGGTTTTCGTTTTCTCTCTCTCTTGCTTCTTGCTCTCTnTCCTGAAGATGTAAGAATAAA
L n 260 poly (A)  
signal
GCTTTGCCGC^GAAGATTCTGGTCTGTGGTGTTCTTCCTGGCCGGTCGTGAGAACGCGTCGAATAAC^ATTGGTGCCGAATTCTGGGACG 
U 5  2 9 0  3 0 0  3 1 0  3 2 0  3 3 0 f ß S
AGAAAAAACTCGGGACTGGCGCAAGGAAGATCCCTCATTCCAGAACCAGAACTGCGGGTCGCGGTAATAAAGGTTCCCGTAAAGCAGACT 
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0
GTTAAGAAGGATTCAACTGTATGAATTCAGAACTTTTCAGCTGGGGAACGAGAGTACCAGTGAGTACAGCTTTACGAGGTAAGTCTGATC 
4 6 0  4 7 0  4 8 0  4 9 0  5 0 0  5 1 0  5 2 0  5 3 0
TTGAACTTTCTAAGGAAATTCAAGACAGTCTATCAGAAGTAAAGTGGAAAATGTTTGGCCTTGAATTTTTTCTAGTGTTAGAAGCCCTTT 
5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0  6 1 0  6 2 0
TGTTCCTTTTCACATGTTATCAAGTGGTTAAGGCAGGGAGGATTCTAGAGGAAATTCAGGACAAGTCTATCAGAAGTAAAGCGGGGAGAG 
6 4 0  6 5 0  6 6 0  6 7 0  6 8 0  6 9 0  7 0 0  7 1 0
AGAGTAGGAGCAAGGAGAAACGGTAAGTATACAGGCCTTTCCAAGGGTCTTGAACCCGAGGAAAAGTTAAGGTTAGGTAGGAATACCTGG 
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0  7 9 0  8 0 0
AGAGAGATTAGAAGAAAAAGAGGAAAAAGGGAAAAGAAAAAAGATCGATTAGCGGAGGTCTCTAGGAGATACTCGTCACTAGATGAGCTC 
8 2 0  8 3 0  8 4 0  8 5 0  8 6 0  8 7 0  8 8 0  8 9 0
AGGAAGCCAGCTCTTAGTAGCTCTGAAGCAAGTGAAGAATCCTCCTCTGAGGAAACAGACTGGGAGGAAGAAGCAGCCCATTACCAGCCA 
9 1 0  9 2 0  9 3 0  9 4 0  9 5 0  9 6 0  9 7 0  9 8 0
GCTAATTGGTCAAGAAAAAAGCCAAAAGCGGCTGGCGAAAGTCAGCGTACTGTTCAACCTCCCGGCAGTCGGTTTCAAGGTCCGCCCTAT 
1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0  1 0 5 0  1 0 6 0  1 0 7 0
GCGGAGCCCCCGCCCTGCGTAGTGCGTCAGCAGTGCGCAGAAAGGCAGTGCGCAGACTCATTCATTCCCCGAGAGGAACAAAGGAAAATA 
1090  1100  1110  1120  1 130  1 140  1 150  1160
CAACAGGCATTTCCAGTCTTTAAAGGAGCCGAGGGTGGGCGTGTCCACGCTCCGGTAGAATATGTGCAGATTAAATATGGAATCAATGCT
1 1 8 0 1 1 9 0 1 2 0 0 1 2 1 0 1 2 2 0 1 2 3 0 1 2 4 0 1 2 5 0
M A L T  P A D W 0 M I  A K A A L P  N
AATTTTACCTTGGTGCAGTTAGACAGGCTTGCCAGCATGGCACTAACTCCTGCCGACTGGCAAATGATTGCAAAAGCCGCTCTCCCTAAT
1 2 7 0 1 2 8 0 1 2 9 0 1 3 0 0 1 3 1 0 1 3 2 0 1 3 3 0 1 3 4 0
M G K Y L E W R S L N R E A A Q A 0 A R A N A A A L T  P  E  0
ATGGGCAAATATTTGGAATGGAGATCTCTGTGGCGAGAGGCTGCACAGGCGCAGGCCCGAGCAAACGCTGCTGCTTTAACTCCAGAGCAG
1 3 6 0 1 3 7 0 1 3 8 0 1 3 9 0 1 4 0 0 1 4 1 0 1 4 2 0 1 4 3 0
R D W T F D L L T G Q R A Y S A K P D K R Y 0 W K V L P  0  G
AGAGATTGGACTTTTGACTTGTTAACGGGTCAGAGAGCTTATTCTGCTAAACCTGATAAGAGGTATCAATGGAAGGTCTTACCACAGGGG
1 4 5 0 1 4 6 0 1 4 7 0 1 4 8 0 1 4 9 0 1 5 0 0 1 5 1 0 1 5 2 0
M S N S P T M C Q L Y V Q K A L L P V R E 0 F  P S L I  L L L
ATGTCCAATAGTCCTACAATGTGCCAGCTTTATGTGCAAAAAGCTCnTTGCCAGTGAGGGAACAATTCCCCTCTTTAATTTTGCTCCTT
1 5 4 0 1 5 5 0 1 5 6 0 1 5 7 0 1 5 8 0 1 5 9 0 1 6 0 0 1 6 1 0
Y M D D I L L C H K D L T M L Q K A Y P F L L K T L S Q W G
TACATGGATGACATCCTCCTGTGCCATAAAGACCTTACCATGCTACAAAAGGCATATCCTTTTCTACTTAAAACTTTAAGTCAGTGGGGT
1630 1640 1650 1660 1670 1680 1690 1700
L 0 I A T E K V Q I S D T G Q F L G S V V S P D K I V P Q K
TTACAGATAGCCACAGAAAAGGTCCAAATTTCTGATACAGGACAATTCTTGGGCTCTGTGGTGTCCCCAGATAAGATTGTGCCCCAAAAG
1720 1730 1740 1750 1760 1770 1780 1790
V E I R R D H L H T L N D F Q K L L G D I N W L R P F L K I
GTAGAGATAAGAAGAGATCACCTCCATACCTTAAATGATTTTCAAAAGCTGTTGGGAGATATTAATTGGCTCAGACCCTTTTTAAAGATT
1810 1820 1830 1840 1850 1860 1870 1880
P S A E L R P L F S I L E G D P H I S S P R T L T L A A N Q
CCTTCTGCTGAATTAAGGCCTTTGTTTAGTATTTTAGAAGGAGATCCTCATATCTCCTCCCCTAGGACTCTTACTCTAGCTGCTAACCAG
1900 1910 1920 1930 1940 1950 1960 1970
A L 0 K V E K A L Q N A 0 L Q R I E D S Q P F S L C V F K TGCCTTACAAAAAGTGGAAAAAGCCTTACAGAATGCACAATTACAACGTATTGAGGATT’CGCAGCCTTTCAGTTTGTGTGTCTTTAAGACA
1990 2000 2010 2020 2030 2040 2050 2060
A Q L P T A V L W Q N G P L L W I H P N V S P A K I I D W Y
GCACAATTGCCAACTGCAGTTTTGTGGCAAAATGGGCCATTGTTGTGGATCCATCCAAACGTATCCCCAGCTAAAATAATAGATTGGTAT
2080 2090 2100 2110 2120 2130 2140 2150
P D A I A Q L A L K G L K A A I T H F G Q S P Y L L I V P Y
CCTGATGCAATTGCACAGCTTGCCCTTAAAGGCCTAAAAGCAGCAATCACCCACTTTGGGCAAAGTCCATATCTTTTAATTGTACCTTAT
2170 2180 2190 2200 2210 2220 2230 2240
T A A Q V 0 T L A A A S N D W A V L V T S F S G K I D N H Y
ACCGCTGCACAGGTTCAAACCTTGGCAGCCGCATCTAATGATTGGGCAGTTTTAGTTACCTCCTTTTCAGGAAAAATAGATAACCATTAT
2260 2270 2280 2290 2300 2310 2320 2330
P K H P I L Q F A Q N Q S V V F P Q I T V R N P L K N G I V
CCAAAGCATCCAATCTTACAGTTTGCCCAAAATCAATCTGTTGTGTTTCCACAAATAACAGTAAGAAACCCACTTAAAAATGGGATTGTG
2350 2360 2370 2380 2390 2400 2410 2420
V Y T D G S K T G I G A Y V A N G K V V S K Q Y N E N S P Q
GTATATACTGATGGATCAAAAACTGGCATAGGTGCCTATGTGGCTAATGGTAAAGTGGTATCCAAACAATATAATGAAAATTCACCTCAA2440 2450 2460 2470 2480 2490 2500 2510
V V E C L V V L E V L K T F L K P L N I V S D S Y Y V V N A
GTGGT AGAATGTTTAGTGGTCTTAGAAGTTTTAAAAAC CTTTTTAAAACC C CTTAATATTGTGTCAGATTC CTATTATGTGGTTAATGCA
2530 2540 2550 2560 2570 2580 2590 2600
V N L L E V A G V I K P S S R V A N I F 0 Q I Q L V L L S R
GTAAATCTTTTAGAAGTGGCTGGAGTGATTAAGCCTTCCAGTAGAGTTGCCAATATTTTTCAGCAGATACAATTAGTTTTGTTATCTAGA
2620 2630 2640 2650 2660 2670 2680 2690
R S P V Y I T H V R A H S G L P G P M A L G N D L A D K A T
AGATCTCCTGTTTATATTACTCATGTTAGAGCCCATTCAGGCCTACCTGGCCCCATGGCTCTGGGAAATGATTTGGCAGATAAGGCCACT2710 2720 2730 2740 2750 2760 2770 2780
K V V A A A L S S P V E A A R N F H N N F H V T A E T L R S
AAAGTGGTGGCTGCTGCCCTATCATCCCCGGTAGAGGCTGCAAGAAATTTTCATAACAATTTTCATGTGACGGCTGAAACATTACGCAGT2800 2810 2820 2830 2840 2850 2860 2870
R F S L T R K E A R D I V T Q C O S C C E F L P V P H V G I
CGTTTCTCCTTGACAAGAAAAGAAGCCCGTGACATTGTTACTCAATGTCAAAGCTGCTGTGAGTTCTTGCCAGTTCCTCATGTGGGAATT2890 2900 2910 2920 2930 2940 2950 2960
N P R G I R P L Q V W Q M D V T H V S S F G K L 0 Y L H V S
AACCCACGCGGTATTCGACCTCTACAGGTCTGGCAAATGGATGTTACACATGTTTCTTCCTTTGGAAAACTTCAATATCTCCATGTGTCC2980 2990 3000 3010 3020 3030 3040 3050
I D T C S G I M F A S p L T G E K A S H V I 0 H C L E A N S
ATTGACACATGTTCTGCC YrCATGTTTGCTTCTCCGTTAACTGGAGAAAAAGCCTCACATGTGATTCAACATTGTCTTGAGGCATGGAGT3070 3080 3090 3100 3110 3120 3130 3140
A W G K P R L L K T D N G P A Y T S Q K F Q Q F C R Q M D V  
GCTTGGGGG AAAC C C AGACTC CTTAAGACTGATAATGGAC C AGCTTATACGTCTC AAAAATTC C AGC AGTTCTGC _ GTC AG ATGG ACGTA 
3 1 6 0  3 170  3 180  3 1 9 0  3200  321 0  3220  3230
T H L T G L P Y N P Q G Q G I V E R A H R T L K A Y L I K Q  
ACCCACCTGACTGGACTTCCATACAACCCTCAAGGACAGGGTATTGTTGAGCGTGCGCATCGCACCCTCAAAGCCTATCTTATAAAACAG 
3 2 5 0  3 260  3 2 7 0  3 2 8 0  3290  3 300  3310  3320
K R G T F E E T V P R A P R V S V S L A L F T L N F L N I D  
AAGAGGGGAACTTTTGAGGAGACTGTACCCCGAGCACCAAGAGTGTCGGTGTCTTTGGCACTCTTTACACTCAATTTTTTAAATATTGAT 
334 0  335 0  3 360  3 3 7 0  3 380  3 390  3400  3410
A H G H T A A E R H C S E P D R P N E M V K W K N V L D N K  
GCTCATGGCCATACTGCGGCTGAACGTCATTGTTCAGAGCCAGATAGGCCCAATGAGATGGTTAAATGGAAAAATGTCCTTGATAATAAA 
3 430  3 440  345 0  3 460  347 0  3 480  3 490  3500
W Y G P D P I L I R S R G A I C V F P Q N E D N P F W V P E  
TGGTATGGCCCGGATCCTATCTTGATAAGATCCAGGGGAGCTATCTGTGTTTTCCCACAGAATGAAGACAACCCATTTTGGGTACCAGAA 
3 5 2 0  3 530  3 5 4 0  3 550  3560  357 0  3580  3590
R L T R K I Q T D Q G N T N V P R L G D V Q G V N N K E R A  
AGACTCACCCGAAAAATCCAGACTGACCAAGGGAATACTAATGTCCCTCGTCTTGGTGATGTCCAGGGCGTCAATAATAAAGAGAGAGCA 
3 610  3 6 2 0  3 630  3 640  3650  3 660  3670  3 680
A L G D N V D I S T P N D G D V x  
GCGTTGGGGGATAATGTCGACATTrCCACTCCCAATGACGGTGATGTATAATGCTCAAGTATTCTCCTGCTnTTTACCACTAACTAGGA 
370 0  3 7 1 0  3 720  373 0  3 740  3 750  3 760  3770
ACTGGGTTTGGCCTTAATTCAGACAGCCTTGGCTCTGTCTGGACAGGTCCAGACAACTGACACCATTAACACTTTGTCAGCCTCAGTGAC 
3 790  3800  381 0  3 820  383 0  3840  3850  3860
TACAGTCATAGATAAACAGGCCTCAGCTAATGTCAAGATACAGAGAGGTCTCATGCTGGTTAATCAACTCATAGATCTTGTCCAGATACA
3880 3 890 3900 3910 3920 3930 3940 3950
ACTAGATGTATTATGACAAATAACTCAGCAGGGATGTGAACAAAAGTTTCCGGGATTGTGTGTTATTTCCATTCAGTATGTTAAAGTTTA
3 970 3980 3990 4 000 4010 4 020 4030 4 0 4 0
CTAGGGCAGCTAATTTGTCAAAAAGTCTTTTTCAGTATATGTTACAGAATTGGACGGCTGAATTTGAACAGATCTTCGGGAATTGAGACT
4 0 6 0 4 070 4080 4 090 4100 411 0 4 120 413 0
TCAGGTCAACTCCACGCGCTTGGACCTGTCCCTGACCAAAGGATTACCCAATTGGATCTCCTCAGCATTTTCTTTCTTTAAAAAATTGGG
4 150 4 160 4170 4 180 4190 4 200 4210 4 2 2 0
TGGGATTAATATTATTTGGAGATACACTTTGCTGTGGATTAGTGTTGCTTCTTTGATTGGTCTGTAAGCTTAAGGCCCAAACTAGGAGAG
4 240 4 250 4 260 4270 4280 4 290 4300 4310
ACAAGGTGGTTATTGCCCAGGCGCTTGCAGGACTAGAACATGGAGCTTCCCCTGATATATCTATACTTAGGCAATAGGTCGCTGGCCACT
4 330 4 340 4 350 4360 4 370 438 0 4 390 4400
CAGCTCTTATATCTCACGAGGCTAGACTCATTGCACGAGATGGAGTGAGTGTGCTTCAGCAGCCCGAGAGAGTTGCAAGGCTAAGCACTG
4420 4 4 3 0 4 440 4 450 446 0 4 470 4 480 4 490
CAATGGAAAGGCTCTGCGGCATATATGAGCCTATTCTAGGGAGACATGTCATCTTTCATGAAGGTTCAGTGTCCTAGTTCCCTTCCCCCA
4 510 4 520 453 0 454 0 4 550 4 560 4570 4 580
GGCAAAACGACACGGGAGCAGGTCAGGGTTGCTCTGGGTAAAAGCCTGTGAGCCTAAGAGCTAATCCTGTACATGGTTCCTTTACCTACA




4 620 4630 464 0 4 650 4 660
CACTGGGGATTTGACCTCTATCTCCACTCTCATTAATATGGGTGGCCTATTTGCTCTTATTAAAAGAAAAAGGGGGAGAITGTTGGGAGCC
4 710 4 720 4 730 4 7 4 0 -
4 6 7 0
a|t g i
GCCCCCACATTCGCCGTTACAAGATGGCGCTGACATCCTGTGTTCTAAGTGGTAAACAAATAATCTGCGCATGTGCCAAGGGTATCTTAT
478 0 4 790 4800 4 810 4 820 4830 4 840 4 8 5 0
GACTACTTGTGCTCTGCCTTCCCCGTGACGTCAACTCGGCCGATGGGCTGCAGCCAATCAGGGAGTGACACGTCCGAGGCGAAGGAGAAT
4 870 4 880 4 890 4900 4 910 4 920 4 930 4 940
GCTCCTTAAGAGGGACGGGGTITTCGTTTTCTCTCTCTCTTGCTTCTTGCTCTCTTTTCCTGAAGATGTAAGAATAAAGCTTTGCCGCAG
4 960 4 970 4 980 4990 5000 5010 5020 5 0 3 0
AAGATTCTGGTCTGTGGTGTTCTTCCTGGCCGGTCGTGAGAACGCGTCGAATAACA
5 0 5 0 5060 5070 5080 5090
(GRE) f o u n d  i n  mouse  mammary  t u m o u r  v i r u s  (MMTV) a n d  MIARN LTRs 
( B u r t ,  R e i t h  a n d  B r a m m a r ,  19 8 4 ;  S c h e i d e r e i t  a n d  B e a t o ,  198 4 ) .
T h i s  s e g m e n t ,  t o g e t h e r  w i t h  t h e  e n h a n c e r  s e q u e n c e ,  may d e f i n e  a 
h o r m o n e  r e s p o n s i v e  e l e m e n t .
I m m e d i a t e l y  d o w n s t r e a m  f r o m  t h e  5'  LTR i s  t h e  tRNA b i n d i n g  
s i t e  (TBS) (Chen  a n d  B a r k e r ,  1984)  i n v o l v e d  i n  n e g a t i v e  s t r a n d  
DMA s y n t h e s i s .  I n  t h i s  r e g i o n  15 o u t  o f  18 b a s e s  a r e  
c o m p l e m e n t a r y  t o  t h e  3' e n d  o f  m a m m a l i a n  tRNA? ^e ( K e i t h  a nd  
D i r h e i m e r ,  1 9 7 8 ) .  An 18 bp p u r i n e - r i c h  s e q u e n c e  (PU) i s  p r e s e n t  
j u s t  u p s t r e a m  f r o m  t h e  3'  LTR.
A p o s s i b l e  5'  i n t r o n  s p l i c e  d o n o r  s i t e  s e q u e n c e  AG/GTAAGT 
( M o u n t ,  1982)  i s  p r e s e n t  a t  p o s i t i o n  526.  I n  o t h e r  r e t r o v i r u s e s ,  
s e q u e n c e  e x t e n d i n g  f r o m  t h e  5'  t e r m i n u s  o f  t h e  v i r a l  RNA up t o  
t h e  f i r s t  5'  i n t r o n  s p l i c e  s i t e  i s  t h o u g h t  t o  s e r v e  a s  an  
u n t r a n s l a t e d  l e a d e r  w h i c h  i s  s p l i c e d  o n t o  d o w n s t r e a m  s e q u e n c e ,  
r e s u l t i n g  i n  s u b - g e n o m i c  s i z e  mRNAs ( V ar mu s  a n d  S w a n s t r o m ,  198 4 ) .  
H o w e v e r ,  no  s u i t a b l e  a c c e p t o r  s i t e  wa s  f o u n d  i n  I A P - I L 3 .
Two p a i r s  o f  d i r e c t  r e p e a t s  w e r e  d e t e c t e d ,  o n e  18 bp  i n  
l e n g t h  s t a r t i n g  a t  p o s i t i o n s  566 a n d  693 ,  t h e  o t h e r  12 bp i n  
l e n g t h  a t  p o s i t i o n s  1109 a n d  1124 .  The 18 bp  r e p e a t s  f o r m  p a r t  
o f  a l a r g e r  p a i r  o f  i m p e r f e c t l y  r e p e a t e d  r e g i o n s  (37 a n d  39 bp 
l o n g ) ,  c o v e r i n g  n u c l e o t i d e s  5 4 7 - 5 8 3  a n d  6 7 2 - 7 1 0 .  T h r e e  p a i r s  o f  
12 bp p e r f e c t  i n v e r t e d  r e p e a t s  w e r e  a l s o  d e t e c t e d ,  a t  p o s i t i o n s  
731 a n d  2 8 8 0 ,  1898 a n d  3 7 8 9 ,  3401 a n d  4216 .  Mo o t h e r  d i r e c t  o r  
i n v e r t e d  r e p e a t s  o f  m o r e  t h a n  11 bp i n  l e n g t h  w e r e  d e t e c t e d .  
R e p e a t e d  r e g i o n s  o f  g r e a t e r  t h a n  62% h o m o l o g y  w e r e  a l s o  s e a r c h e d  
f o r  u s i n g  t h e  p r o g r a m  DIAGOM, ( S t a d e n ,  1 9 8 2 a )  b u t  n o n e  w e r e  
de t e c t e d .
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Translation of the IAP-IL3 nucleotide sequence revealed a 
single long open reading frame, with a possible methionine start 
codon at position 1296, which could code for a protein of 814 
amino acids (Figure 4.2). Analysis of this coding sequence for 
homology with IAP gag and pol genes is presented below.
3. Comparison of IAP-IL3 with other IAP Elements.
The sequence of IAP-IL3 was compared with other IAP genomes 
using the computer program DIAGON (Staden, 1982a). These other 
elements were the Syrian hamster 8.0 kb IAP-H18 (Ono et al.,
1985) and the 3.0 kb renin gene-associated mouse IAP element 
MIARN (Burt, Reith and Brammar, 1984). The results obtained are 
shown in Figure 4.3, highlighting regions of greater than 67% 
nucleotide homology.
The comparison of IAP-IL3 with IAP-H18 shows that only weak 
homology exists between the LTRs or 5' regions of these two IAP 
elements. There are three distinct regions of higher homology. 
In IAP-H18 these regions extend from nucleotides 1618-1861, 3729- 
5847 and 6639-7575, aligning with IAP-IL3 sequences at positions 
1245-1488, 1489-3612 and 3817-4758 respectively, with 
corresponding homologies of 66%, 76% and 65%. IAP-IL3 lacks two 
major regions of the IAP-H18 sequence, from 1862-3728 (1867 bp) 
and 6071-6638 (568 bp). In terms of the postulated regions of 
the gag and pol genes in IAP-H18 (Ono et al., 1985), IAP-IL3 is 
lacking about 1330 nucleotides at the 3' end of gag and about 400 
nucleotides at the 5’ end of pol.
From computer alignment studies (Wilbur and Lipman, 1983) 
the 5' regions of MIARN and IAP-IL3 were shown to have segments
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IAP-H18 MIARN
1.0 2.0 3.0 4.0 5.0 6.0 7.0 1.0 2.0 3.0
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Figure 4.3: Comparison of the nucleotide sequence of IAP-IL3
with MIARN (Burt, Reith and Brammar, 1984) and 
IAP-H18 from Syrian hamster (Ono et. al. , 1985).
The results shown were obtained using the program DIAGON (Staden, 
1982a) (span length = 21, % = 14) indicating segments of homology 
of 67% or greater. The scale for each of the sequences is in kb. 
The proposed regions corresponding to the gag and pol genes of 
IAP-H18 (Ono e_t a_l., 1985) are also shown. The boxed regions 
represent two conserved domains of pol thought to possess DNA 
polymerase and RNase H activity (region A) and endonuclease 
activity (region B) (Ono et al., 1985).
of 76%-94% homology, often interrupted by repeats in the MIARN 
sequence. Homology (94%) resumes from position 1766 in MIARN and 
position 3931 in IAP-IL3, and continues for approximately 840 bp 
before reaching the 3' LTRs of both elements. Between these 
areas MIARN lacks IAP-IL3 nucleotides 942 to 3931 (2990 bp), but 
does have 334 bp not present in IAP-IL3. The LTRs of IAP-IL3 and 
MIARN also have regions of relatively high homology (72% —86%), 
interrupted by repeats present in MIARN.
An alignment was also carried out between MIARN and IAP-H18. 
These IAP elements have a region of 72% homology at nucleotides 
1428-1744 and 1909-2226 respectively, which is not present in 
IAP-IL3. The last 819 bp preceeding the 3' LTR in MIARN shows 68% 
homology with the corresponding region of IAP-H18. Thus each of 
the three IAP elements compared in the present work has a 
conserved region of approximately 800 bp of unknown function 
adjacent to the 3' LTR.
4. Classification of IAP-IL3.
Comparisons were made with the partially sequenced type II 
IAP genomes containing the insertion-like element Allins (Lueders 
and Mietz, 1986). This element was not detected in IAP-IL3, 
although one copy of the 9 bp putative target sequence, normally 
duplicated flanking Allins in type II IAP elements, is present at 
position 2992. Another feature of type II elements (Lueders and 
Mietz, 1986) is the repetition 2 to 4 times (5' to Allins) of a 
region of 75 bp found close to the 5’ end of type I elements. 
Nucleotides 538-612 of IAP-IL3 were found to have 75% homology 
with this 75 bp repeated region. No other copies were detected. 
Within this region is a sequence which gives a 7/8 match with the
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SV40 core enhancer sequence (Khoury and Gruss, 1984; Weiher,
König and Gruss, 1983). A single copy of the 66 bp block which 
is repeated in type IIA elements (Lueders and Mietz, 1986) was 
located at nucleotides 2992-3057 in IAP-IL3. This 66 bp block 
begins with the 9 bp target sequence. Thus, in terms of the 
existing classification system, IAP-IL3 is a deleted type I 
element.
5. Analysis of the IAP-IL3 coding region.
The longest open reading frame present in IAP-IL3 lies 
between nucleotides 678 and 3738, ending with a single stop 
codon. Within this open reading frame the first potential Met 
start codon is located at position 1296 and would initiate a 
protein of 814 amino acids.
The IAP-IL3 open reading frame was compared with the 
putative gag and pol proteins of IAP-H18. Homology with the IAP- 
H18 gag gene product is largely restricted to IAP-H18 residues 
240-334 (68% homology). Homology with the IAP-H18 pol gene 
product exists from residues 136-840 (76% homology). Assuming 
that the Syrian hamster IAP pol gene is homologous with those 
from Mus musculus IAP genomes, IAP-IL3 is missing the first 135 
amino acid residues but appears to carry the rest of the pol 
coding sequence. The IAP-IL3 open reading frame terminates at 
the end of the putative pol gene. Mo other significant reading 
frames were detected.
The homology to IAP-H18 gag and pol amino acid sequence 
corresponds to areas of nucleotide homology as indicated in 
Figure 4.3. The 1867 bp region not present in IAP-IL3 covers the 
missing 3' gag and 5' pol regions. Although MIARN lacks any long
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open reading frame it does have nucleotide homology to IAP-H18 in 
the region coding for gag amino acid residues 383-483. This is 
located within the 334 bp region of MIARN not present in IAP-IL3.
6. Evolutionary relationship with other retroviruses.
In order to determine the evolutionary relationship between 
IAP-IL3 and other retroviruses, a portion of IAP-IL3 pol was 
compared with the corresponding pol regions of other 
retroviruses. Previous work has shown that the pol gene is the 
most conserved of the retroviral genes (Chiu ejt al., 1984 and
1985). The pol region coding for the putative DNA endonuclease 
domain was used as the basis of the present comparison. These 
results are shown in Table 4.1.
IAP-IL3 exhibits greatest homology with squirrel monkey 
retrovirus (type D) and mouse mammary tumour virus (type B), 
although still having significant homology with the other 
retroviral pol coding sequences.
7. Homology with the IgE-Binding factor gene.
Toh, Ono and Miyata (1985) reported the detection of 
nucleotide sequence homology between segments of a rodent IgE- 
binding factor (IgE-BF) gene (Martens et al., 1985) and IAP-H18. 
IgE-binding factors are produced by T lymphocytes and are 
believed to regulate the production of IgE by B lymphocytes 
(Hirashima, Yodoi and Ishizaka, 1980; Suemura et al., 1980; 
Ishizaka, 1984). They suggested that the IgE-BF gene is a hybrid 
which evolved very recently by integrating segments of genes of 
retroviral origin with a gene coding for an IgE-BF binding 
domain. The IgE-BF cDNA has a protein coding region of 557 amino
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Table 4.1: Amino acid homology between the pol coding region3
of IAP-IL3 and other retroviruses.
Re trovirus^ Amino Acid Homology (%) 
IAP-IL3
IAP-H13 (Type A) 86
MMTV (Type B) 49
Mo-MLV (Mammalian Type C) 40
RSV (Avian Type C) 33




aThe putative endonuclease domain located in the 3' terminal one 
third of the pol coding region (Varmus and Swanstrom, 1984) was 
used as the basis of comparison. Sequences were aligned (Wilbur 
and Lipman, 1983) and the number of identical residues 
determined. For calculating homology each gap was counted as one 
substitution, regardless of its length.
iMMTV, mouse mammary tumour virus; Mo-MLV, Moloney murine 
leukaemia virus; RSV, Rous sarcoma virus; SMRV, squirrel monkey 
retrovirus; HTLV-I, human T lymphotropic virus type I; HTLV-III, 
human T lymphotropic virus type III. HLM-2 is a recently 
described representative of a family of human endogenous 
retroviral genomes which shows homology in different regions of 
its genome with a variety of different retroviruses (Callahan e_t 
al., 1985).
acids and a non-coding region of about 1.5 kb at its 3‘ end 
(Martens e_t a_l., 1985). Comparison of the coding region with the
IAP-IL3 sequence showed high homology extending across the 
majority of the IgE-BF coding region in two major segments from 
1-1077 and 1384-1770 (Figure 4.4; Ymer and Young, 1986). Most of 
the region of IgE-BF coding sequence which is missing from the 
IAP-IL3 is found in MIARN (Figure 4.5). Thus overall, 97% of the 
IgE-BF coding sequence is present in the two endogenous mouse IAP 
elements at an average homology of 90%. The restriction map of 
the non-coding region of the IgE-BF cDNA is very similar to that 
of the terminal region of IAP-IL3 (Figure 4.6) suggesting that 
the homology extends into this region also.
The IgE-BF cDNA clone was isolated from the rat-mouse T cell 
hybridoma 23B6 prepared by fusing rat T lymphocytes with cells of 
the AKR mouse thymoma BW5147 (Huff, Uede and Ishizaka, 1982).
The .very high level of sequence homology with mouse IAP elements 
indicates that the IgE-BF cDNA was derived from a mouse IAP 
genome of the fusion partner. Hybridization analysis using mouse 
IAP gene probes has shown that mouse and rat IAP elements do not 
share the very high levels of homology observed between the IgE- 
BF gene and the mouse IAP elements (Lueders and Kuff, 1983).
IAP genomic RNAs, which are polyadenylated, start within theKuf f et a_l. , 19 81
5' LTR and terminate in the 3' LTR of the IAP provirus (Cole, OnoA
and Huang, 1982; Wujcik, Morgan and Huang, 1984). The size of 
the IgE-BF cDNA clone (approximately 3.3 kb), together with the 
restriction map of its 3' non-coding region, suggests that it was 
derived from a genomic RNA of a deleted IAP provirus intermediate 
in size between MIARN and IAP-IL3. Comparison of the coding
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, _  _ _  10 20 _____ 30 40 50 60  70 80 90 100IgE-BF....... GCTAGAGTACCAGTGAGTACAGCTTTACGAGGTAAGTCTGATCTTGAACTTTCTAAGGAAATTCAAGACAGTCTATCAGAAGTAAAGTGGAAAATGGCTTTACA
IA P-1L 3...... ACGAGAGTACCAGTGAGTACAGCTTTACGAGGTAAGTCTGATCTTGAACTCTCTAA(^AAACTCAAGACAGTCTATCAGAAGTAAAGTGGAAAATG--------
570 580 590500 510 520 530 540 550 560
H O  120 _____ 130 140 150 160 170 180 190 200 210 220
AGTTATGTTTGGC CTTGAATTTT1TCTAGTGTTAGAAGCC CTTTTGTTCCTTTTC AC ATGTTATC AAGTGGTTAAGGC AGGGCGGATTCTAGATGAAATTCAGG AC AAG - CTATC AGAAG1 i l l ! : : j : : : : : : : : : : : :  j j : s : : :  j : : :  j : : :  j : i : : : :: j j j ; j j s : : : : : : : : : :  : : : : : : : : :
-------TTTGGCCITGAATTTTTrCTAGTGTTAGAAGCCCTT'n'GTTCCTT'ITCACATGTTATCAAGTGGTTAAGGCAGGGAGGATTCTAGAGGAAATrCAGGACAAGTCTATCAGAAG
6 00  6 10  6 20  6 30  6 4 0  65 0  6 60  6 7 0  6 8 0  6 90 700
230 240 250 260 270 280 290 300 310 3 20  330 340
TAAAGCGGGGAGAGAGAGTAGGAACAAAGAGGAAATATGGTACACAAAATAAGTATACAGGCCTTTCCAAGGGTCTTGAACCCGAGGAAAAGTTAAGGTTAGGTAGGAATACCTGGAGAG
TAAAGCGGGGAGAGAGAGTAGGAGCA AGGAGAAACGGTA-------- AGT AT AC AGGC CTTTC C AAGGGTCTTG AAC C C GAGGAAAAGTTAAGGTT AGGT AGG AATAC CTGG AG AG
710 720 730 740 750 760 770 780 790 800 810
350 360 370 380 390 4 00  410 420 430 44 0  450 460
AGATTAGAAGAAAAAGAGGAAAAAGGGAAAAGAAGAAAGATCAATTAGCGGAGGTCTCTAGGAAAAGGAGCCTGTGCTCATCGCTGGATGGGCTCGGGAAGCCAGCTCTTAGTAGCTCTG
AGATTAGAAGAAAAAGAGGAAAAAGGGAAAAGAAAAAAGATCGATTAGCGGAGGTCTCTAGGAGATACTCGTCACTA- 
820 8 30  840 850 860 870 880 890
-GATGAGCTCAGGAAGCCAGCTCTTAGTAGCTCTG 
9 00  910 920
470 4 80  4 8 0 500 510 520 530 540 550 56 0  570 580
AAGCAGGTGAAGAATCCTCCTCTGAGGAAACAGACTGGGAGGAAGAAGCAGCCCATTACCAGCCAGd’AATTGGTCAAGAAAAAAGCCAAAAGCGGCTGGCGAAGGCCAGTTTGCTGATT
AAGCAAGTCÄÄGÄÄTCCTClH^ ÄGGAÄÄcÄGÄci^ ÄGGÄÄGÄÄGCÄGCCcÄTTÄccÄGCCÄGCTÄÄi^ TCÄÄGÄÄÄÄÄÄ(^ C
930 9 40  350 960 970 980 990 100 0  1010  1020  1030  1040
890 6 0 0 ____ 610 6 20  63 0  6 40  6 50  6 60  6 7 0  6 80  6 90  700
GGCCTCAGGGCAGTCGGCTTCAAGGTCCGCCCTATGCGGAGTCCCCGCCCTGCGTAGTGCGTCAGCAATGCGCAGAGAGATGCGCAGAGAGGCAGTGCGCAGAGAGGCAGTGCGCAGACT: : : :  i : : : : : : :  : s s : : i : ; : : s : : : : s s : : : : : : :  : : : : : : : : : : : : : : : s j : i : .. . . . . . . . . . . . . . . . . . . . . . . . .
AACCTCCCGGCAGTCGGTTTCAAGGTCCGCCCTATGCGGAGCCCCCGCCCTGCGTAGTGCGTCAGCA-----------------------
1050  1060  1070  1080  1090  1100  1110
-GTGCGCAGAAAGGCAGTGCGCAGACT 
1 1 2 0  1130
7 1° 720 730 740 ___ 750 7 60  770 780 790 800 810 820
CATTCATTCCCAGAGAGGAACAAAGGAAAATACAACAGGCATTTCCGGTCTTTGAAGGAGCCGAGGGTGGGCGTGTCCACGCTCCGGTAGAATACTTACAAATTAAAGAAATTGCCGAGT: : : : : : : : : : :  s : s s s : s s s s ; : 2 s ; s s j s s s s s s s : s : : : ; s s s  : :: s : : : :: s : : s : :
CA1TCATTCCCCGAGAGGAACAAAGGAAAATACAACAGGCATTTCCAGTCTTTAAAGGAGCCGAGGGTGGGCGTGTCCACGCTCCGGTAGAATATGTGCAGATTAAA------------
115 0  1160  1170  1180  1190  1200  1 210  1220  1 230  1240
830 840 850   860  87 0  8 80  8 90  900 910 9 20  930 940
CGGTTCGTAAATATGGAACCAATGCTAATTTTACCTTGGTGCAGTTAGACAGGCTCGCCGGCATGGCACTAACTCCTGCTGACTGGCAAACGGTTGTAAAAGCCGCTCTCCCTAGTATGG : : ! : ! : : = = = = : : ! i _ L L ! ! ! '■ • ■ s • ■ : : : i i s : s s : ; : s : : : : : : : : :  : : : : : : : : : :  : : : : : : : : : : :  i : : : : : : : : :  : s • • .
---------- TATGGAATCAATGCTAATTTTACCTITGGTGCAGTTAGACAGGCTTGCCAGCATGGCACTAACTCCTGCCGACTGGCAAATGATTGCAAAAGCCGCTCTCCCTAATATGG
1 250  1260  1 270  128 0  1 290  1300  1310  132 0  1 3 3 0  1340  1350
950 9 6 °  970 980 990 1 000  1010  1020  1030  1 0 4 0  1050  1060
GCAAATATATGGAATGGAGAGCGCTTTGGCACGAAGCTGCACAAGCGCAGGCCCGAGCAAACGCAGCTGCTTTGACTCCAGAGCAGAGAGATTGGACTTTTGACTTGTTAACGGGTCAGG: S 2 : ! S 2 2 2 2 s 2 : 2 : : 2 : s : : s s • s • : : : s : : s : s : : : : : : : : : :  i : : : : : : : : :  : s s s s s s s s  * t 2 : 2 : s 2 : : : 2 s s : s s 2 : : ; s : ; : : : s : 2 t : s : : : : : : : : : : : *
GCAAATATTrGGAATGGAGATCTCTGTGGCGAGAGGCTGCACAGGCGCAGGCCCGAGCAAACGCTGCTGCTTTAACTCCAGAGCAGAGAGATTGGACTi^ACTTGCT^CGGGTCAGA





1390  1 400  141 0  1 4 2 0  143 0  1440
GCTTGGGGGAAACCCAGACTCCTTAAGACTGATAATCGACCAGCTTATACGTCTCAAAAATTCI I ; i ; i ; ; ;  t ;
GCTTGGGGGAAACCCAGACTCCTTAAGACTGATAATGGACCAGCTTATACGTCTCAAAAATTC 
3 160  3170  318 0  3 1 9 0  320 0  3210
145 0  1460  1470  1480  1490  1500  1 510  152 0  1530  1 5 4 0  1550  1560
C^ <:A<^ CT^ C^ AGAT“ ACt^ CCCACCTGACTGGACITCcATACAAccCTCAAGGAcAGGGTA,rrGrrGAGCGTGCGCATCGCAcccTCAAAGCCTA,rCTrATAAAAcAGAAG 
CAGCAGTTCTGCCGTCAGATGGACGTAACCCACCTGACTGGACTTCCATACAACCCTCAAGGACAGGGTATTGTTGAGCGTGCGCATCGCACCCTCAAAGCCTATCTTATAAAACAGAAG
322 0  3 2 3 0  3240  3 2 5 0  326 0  3 2 7 0  3 280  329 0  3 3 0 0  331 0  3320  3330
157 0  1 5 8 0 1590  160 0  1610  162 0  1630  164 0  165 0  1 660  167 0  1680
AGGGGAALi-riuGAGGAGACTGTACCCCGAGCACCAAGAGTGTCGGTGTCTTTGGcACTCTTrAcACTCAATTTTTTAAATATTGATGCTCATGGCcATACTGCGGCTGAACGTCAT-GT
AGGGGAACTTTTGAGGAGACTGTACCCCGAGCACCAAGAGTGTCGGTCrrcTTTGGCACIXrrTTACACTCAATTTTTTAAATATTGATGCTCATGGCCATACTGCGGCTGAACGTCATTGT 
3340  3 350  3 360  337 0  3380  3 3 9 0  3400  341 0  3 420  3 4 3 0  344 0  3450
1690  1700  1710  1720  1730  1740  1750  176 0  1770
TCAGAGCCAGATAGGCCCAATGAGATGGTTAAATGGAAAAATGTCCTTGATAATAAATGGTATGGCCCGGATCCTATCTTGATAA
TCAGAGCCAGATAGGCCCAATGAGATGGTTAAATGGAAAAATGTCCTTGATAATAAATGGTATGGCCCGGATCCTATCTTGATAA
3460  347 0  348 0  3490  3500  3 5 1 0  3520  3530
Figure 4.4: Alignment of homologous regions of the IgE-BF 
coding sequence (upper) and IAP-IL3 (lower). Gaps 
are indicated by dashes.
IA P -IL 3
1.0 2.0 3.0 4.0 5.0
MIARN
1.0 2.0 3.0
Figure 4.5: Comparison of the nucleotide sequence of the IgE-
BF coding region (Martens et a^., 1985) with IAP-
IL3 (Ymer et. al., 1986) and MIARN (Burt, Reith and 
Brammar, 1984).
The comparisons were made using the program DIAGON (Staden,
1982a) (span length = 21, % = 16) indicating segments of homology 
of 76% or greater. The scale for each of the sequences is kb.
PstI H in d i
F i g u r e  4 . 6 : R e s t r i c t i o n  maps  o f  IgE- BF  cDNA a n d  I A P - I L 3 .
R e g i o n s  o f  h i g h  h o m o l o g y  a r e  h a t c h e d .  N o t e  t h e  
s i m i l a r i t y  o f  r e s t r i c t i o n  s i t e s  i n  t h e  3'  
n o n c o d i n g  r e g i o n .
sequence of the I‘gE-BF cDNA with IAP-IL3, MIARN and IAP-H18
indicates that it is completely derived from segments of IAP gag
and pol genes. These conclusions are also supported by the
of and
recent findings^ Moore e t a 1. 19 8 6 ^Kuff e t a 1., 1986).
Discussion
To date, MIARN (Burt, Reith and Brammar, 1984) and IAP-IL3 
(Ymer et aJL., 1986) are the only IAP genomes in Mus musculus for 
which full sequences have been published. Both of these genomes 
are partially deleted, being 3.0 and 5.1 kb in length 
respectively. Recently, cDNA clones which appear to belong to 
the IAP sequence family have been isolated and sequenced (Kuff et 
al., 1986). The sequence of IAP-IL3 is the first full sequence 
for an IAP element which has recently transposed (Ymer e_t al., 
1986 ) .
The IAP-IL3 genome is flanked by identical LTRs of 337 bp 
and conserved sequences believed to be important in RNA 
transcription and initiation of proviral DNA synthesis are also 
present. IAP-IL3 LTRs can be subdivided into three regions U3-R- 
U5 in a manner similar to other retroviruses (Temin, 1981;
Varmus, 1982). At present, putative IAP R regions fall into two 
size ranges, 66-81 and 201-222 bp (Christy et al., 1985), 
differences being due to the presence of repeated sequences. The 
IAP-IL3 LTRs have an R region of 64 bp with no significant 
repeats, and therefore belong to the first grouping.
Analysis of the coding regions of IAP-IL3 suggests that it 
has a single deletion covering the 3' end of the putative gag 
gene and a short segment of the 5' end of the putative pol gene. 
There is a single long open reading frame spanning the gag and
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p o l  r e g i o n s .  I A P - I L 3  h a s  no r e c o g n i z a b l e  e n v  c o d i n g  r e g i o n  w h i c h
n o r m a l l y  o v e r l a p s  t h e  p o l  g e n e  i n  r e t r o v i r u s e s .  G e n e r a l l y  t h e  
e n v  p r o t e i n s  a r e  s y n t h e s i z e d  f r o m  s p e c i f i c  s u b - g e n o m i c  s i z e d  mRNA 
f o r m e d  by  s p l i c i n g  t h e  5'  l e a d e r  r e g i o n  o f  t h e  v i r a l  RNA t o  t h e  
3'  e n v  c o d i n g  r e g i o n .  A 5'  s p l i c e  d o n o r  s i t e  wa s  l o c a t e d  i n  t h e  
u n t r a n s l a t e d  l e a d e r  s e q u e n c e  i n  I A P - I L 3  b u t  no a c c e p t o r  s e q u e n c e  
wa s  f o u n d .  A l s o ,  no r e a d i n g  f r a m e  w h i c h  c o u l d  c o d e  f o r  e n v  c o u l d  
be  i d e n t i f i e d .  I t  h a s  b e e n  p r o p o s e d  t h a t  t h e  l a c k  o f  an  e n v  g en e  
p r e v e n t s  t h e  f o r m a t i o n  o f  i n f e c t i o u s  e x t r a c e l l u l a r  v i r u s  ( K u f f ,  
S m i t h  a n d  L u e d e r s ,  19 8 1 ;  K u f f  a n d  F e w e l l ,  1 985 ;  Ono e t  a l . ,
1985)  .
A p a r t  f r o m  m a t c h e s  w i t h  IAP s e q u e n c e s ,  d a t a b a s e  s e a r c h e s  
u s i n g  s e g m e n t s  o f  I A P - I L 3  o n l y  d e t e c t e d  h o m o l o g y  w i t h  t h e  p o l  
r e g i o n  o f  a n u m b e r  o f  r e t r o v i r u s e s .  The p o l  g e n e  c o d i n g  f o r  
r e v e r s e  t r a n s c r i p t a s e  i s  t h e  m o s t  c o n s e r v e d  o f  t h e  r e t r o v i r a l  
g e n e s  a n d  h a s  g e n e r a l l y  b e e n  u s e d  i n  a t t e m p t s  t o  d e t e r m i n e  
e v o l u t i o n a r y  r e l a t i o n s h i p s  a mong  t h e  r e t r o v i r u s e s  ( C h i u  e t  a l . ,  
1 9 8 4  a n d  19 85 ; Ono e t  a l . ,  19 8 5 ) .  I n  t h e  p r e s e n t  c a s e  t h e  3'  
t e r m i n a l  o n e  t h i r d  o f  p o l , w h i c h  i s  t h o u g h t  t o  c o d e  f o r  t h e  DMA 
e n d o n u c l e a s e  d o m a i n ,  wa s  u s e d  a s  t h e  b a s i s  o f  c o m p a r i s o n .  I A P-  
IL3 was  f o u n d  t o  be m o s t  c l o s e l y  r e l a t e d  t o  s q u i r r e l  monkey 
r e t r o v i r u s  ( t y p e  D) a n d  mous e  mammary  t u m o u r  v i r u s  ( t y p e  3) 
a l t h o u g h  h o m o l o g y  wa s  p r e s e n t  w i t h  a l l  r e t r o v i r a l  g r o u p s .
W h i l s t  t h e  IAP s e q u e n c e  f a m i l y  i s  c a p a b l e  o f  p r o d u c i n g  
i n s e r t i o n a l  m u t a t i o n s  by t r a n s p o s i t i o n ,  u n t i l  r e c e n t l y  (Moor e  e t  
a l . , 1986)  no  o t h e r  b i o l o g i c a l  r o l e  h a s  y e t  b e e n  a t t r i b u t e d  t o
t h e m .  E v i d e n c e  t h a t  a n  I g E - b i n d i n g  f a c t o r  g e n e  i s  a l s o  a me mb er  
o f  t h e  Mus m u s c u l u s  IAP s e q u e n c e  f a m i l y  i s  o f  i n t e r e s t  i n  t h i s
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r e g a r d .  A n a l y s i s  o f  t h e  I g E - b i n d i n g  f a c t o r  c o d i n g  r e g i o n  
p r e s e n t e d  a b o v e  i n d i c a t e s  t h a t  i t  i s  e n t i r e l y  d e r i v e d  f r o m 
s e g m e n t s  o f  t h e  p u t a t i v e  IAP g a g  a n d  p o l  g e n e s  (Ymer  a nd  Young,  
1 9 8 6 ) .  Moore  e t  e l . ( 1 9 8 6 )  h a v e  a l s o  p r o v i d e d  e v i d e n c e  t h a t  t h e  
I g E - B F  g e n e  i s  d e r i v e d  f r o m  t h e  IAP g e n e  f a m i l y .  Homol ogy  was  
e s t a b l i s h e d  by S o u t h e r n  a n d  h e t e r o d u p l e x  a n a l y s i s  a n d  s e q u e n c e  
c o m p a r i s o n s .  F u r t h e r m o r e  a n t i b o d i e s  r a i s e d  a g a i n s t  s y n t h e t i c  
I g E - B F  p e p t i d e  s e q u e n c e s  r e a c t e d  w i t h  b o t h  p u r i f i e d  IAP 
s t r u c t u r a l  p r o t e i n  p73 a n d  I g E - B F ,  e s t a b l i s h i n g  t h a t  t h e s e  
p r o t e i n s  a r e  a n t i g e n i c a l l y  r e l a t e d .  X u f f  e_t a l .  ( 1986)  h a v e  
s e q u e n c e d  a n d  c h a r a c t e r i z e d  o t h e r  p r e s u m p t i v e  I g E - B F  cDNA c l o n e s  
a n d  t h e s e  w e r e  a l l  f o u n d  t o  be  s t r u c t u r a l  v a r i a n t s  o f  t h e  f u l l -  
s i z e d  ( 7 . 3  k b )  IAP e l e m e n t .  K u f f  e_t aJL. ( 1 9 8 6 )  a n d  M o o r e  e t  a 1.  
( 19 86 )  h a v e  f o u n d  no e v i d e n c e  f o r  m a j o r  b l o c k s  o f  n o n - I A P -  
r e l a t e d  DMA, i n  c o n t r a s t  t o  t h e  s u g g e s t i o n  by  Toh ,  Ono a nd  
M i y a t a ,  ( 1 9 8 5 )  t h a t  t h e  I g E -B F  g e n e  a r o s e  f r o m  r e c o m b i n a t i o n  
b e t w e e n  c e l l u l a r  a n d  IAP s e q u e n c e s .  At  p r e s e n t  t h e  s i g n i f i c a n c e  
o f  t h i s  r e l a t i o n s h i p  b e t w e e n  t h e  I g E - B F  g e n e  a n d  mouse  IAP 




I L - 3  a n d  t h e  l e u k a e m i a  c e l l  l i n e  WEHI-3B.
T h e r e  h a s  b e e n  c o n s i d e r a b l e  i n t e r e s t  i n  p o l y p e p t i d e  g r o w t h  
f a c t o r s ,  s u c h  a s  I L - 3 ,  b e c a u s e  o f  t h e i r  p o s s i b l e  r o l e s  i n  
t u m o r i g e n i c i t y .  G r o w t h  f a c t o r s  s t i m u l a t e  c e l l  p r o l i f e r a t i o n  a n d  
d i f f e r e n t i a t i o n  t h r o u g h  b i n d i n g  t o  s p e c i f i c  c e l l  s u r f a c e  
r e c e p t o r s .  A l t e r e d  e x p r e s s i o n  o f  t h e s e  f a c t o r s  a n d / o r  t h e i r  
r e c e p t o r s  may be  a s t e p  l e a d i n g  t o  u n c o n t r o l l e d  c e l l  g r o w t h ,  a 
h a l l m a r k  o f  t u m o u r s .  T h i s  t h e s i s  p r i m a r i l y  d e a l s  w i t h  t h e  m u r i n e  
m y e l o m o n o c y t i c  l e u k a e m i a  c e l l  l i n e  WEHI-3B ( M e t c a l f ,  Moor e  a n d  
W a r n e r ,  1 9 6 9 ;  W a r n e r ,  Moore  a n d  M e t c a l f ,  1969 ;  M e t c a l f  a n d  
N i c o l a ,  1 9 8 2 ) ,  w h i c h  h a s  p r o v e n  t o  be  v e r y  u s e f u l  i n  r e g a r d  t o  
t h e  m o l e c u l a r  s t u d i e s  o f  I L - 3 .
WEHI-3B c e l l s  a r e  t h e  o n l y  known m y e l o i d  s o u r c e  o f  I L - 3  a n d  
t h e y  p r o d u c e  t h i s  f a c t o r  c o n s t i t u t i v e l y  ( L e e ,  H a p e l  a n d  I h l e ,  
1 9 8 2 ) ,  w h i c h  i s  i n  c o n t r a s t  t o  t h e  r e g u l a t e d  e x p r e s s i o n  d i s p l a y e d  
by T l y m p h o c y t e s ,  t h e  n o r m a l  p h y s i o l o g i c a l  s o u r c e  o f  I L - 3 .  I n  
a d d i t i o n ,  t h e s e  c e l l s  d o  n o t  a p p e a r  t o  p r o d u c e  s i g n i f i c a n t  l e v e l s  
o f  a n y  o t h e r  l y m p h o k i n e  n o r m a l l y  s e c r e t e d  by  T l y m p h o c y t e s  a f t e r  
s t i m u l a t i o n  ( f o r  e x a m p l e  GM-CSF,  I L - 2 ,  y - i n t e r f e r o n ;  Dr .  A.
H a p e l ,  u n p u b l i s h e d  d a t a ) .
WEHI - 3B  h a s  b e e n  c o m m o n l y  u s e d  a s  a s o u r c e  o f  I L - 3  f o r  
b i o l o g i c a l  s t u d i e s  a n d  a s  t h e  s o u r c e  o f  I L - 3  mRNA f o r  cDNA 
l i b r a r y  c o n s t r u c t i o n  ( F ung  e_t a l . ,  1 9 8 4 ) .  As o u t l i n e d  i n  C h a p t e r  
2 o f  t h i s  t h e s i s ,  t h e  cDNA l i b r a r i e s  w e r e  s c r e e n e d  f i r s t l y  by  t h e  
h y b r i d - r e l e a s e - t r a n s l a t i o n  m e t h o d  ( P a r n e s  ejt £l_. ,  1984)  a n d  t h e n  
by c o l o n y  h y b r i d i z a t i o n  u s i n g  a [ ° P ] - l a b e l l e d  
o l i g o d e o x y r i b o n u c l e o t i d e  p r o b e .  A cDNA c l o n e  c o n t a i n i n g  t h e  
c o m p l e t e  c o d i n g  r e g i o n  f o r  I L - 3  wa s  s u c c e s s f u l l y  i s o l a t e d  ( F u n g
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et al., 1984) and was used in the work described in this thesis
as a probe, initially for Southern analysis of murine genomic 
DNA. It was determined that there is a single copy of the IL-3 
gene in the mouse haploid genome, with EcoRl restriction site 
polymorphism evident between various strains (Campbell e_t al., 
1985). The genes for other lymphokines and haemopoietic factors, 
such as GM-, G- and M-CSFs, IL-2, y-interferon and 
erythropoietin, also exist as single copies (Gray e_t a_l., 1982;
Devos e_t a 1., 19 83; Taniguchi e_t a 1., 1 9 8 3 ; Gough e_t a_l., 1984 ; 
Kawasaki e t a 1., 1985 ; Wong e t a 1., 19 85 ; Nagata e t a 1., 1986a).
IAP genome insertion near the IL-3 gene is responsible for 
constitutive production.
An interesting finding from this Southern analysis was 
evidence of a structural alteration in the vicinity of one of the 
IL-3 alleles of WEHI-3B cells. Further characterization of this 
alteration was presented in Chapter 3 of this thesis, where a 
genomic A library was constructed from WEHI-3B DNA and screened 
with an IL-3 cDNA probe. The genomic clones isolated belonged to 
two families, corresponding to the normal and rearranged IL-3 
genes inferred from the genomic Southern blots. Restriction 
endonuclease mapping, Southern blotting and partial sequencing 
revealed that a 5.0 kb retrovirus-like IAP genome had inserted 
215 bp upstream from the promoter in the rearranged IL-3 gene 
( Yme r e_t a 1., 19 8 5 ).
Transient expression studies provided clear evidence that 
the presence of the IAP genome, in close proximity to the 5' 
region of the IL-3 gene, was responsible for constitutive 
production of this factor by the WEHI-3B cell line. Lambda
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clones carrying the rearranged IL-3 gene produced high levels of 
IL-3 when transfected into BAL3/c NIH3T3 cells or monkey COS-1 
cells. In contrast, X clones carrying the normal IL-3 gene did 
not produce significant levels of IL-3 activity in these cells.
The inability of the X clone carrying the normal gene to be 
expressed efficiently in mouse 3T3 cells is in agreement with the 
silent nature of the endogenous IL-3 gene in these cells. These 
results are in contrast to those of Miyatake et al. (1985b) who 
transfected the mouse IL-3 gene and pSV0neo into L cells and 
after selection G418 resistance found that most of the 
transfected clones were producing low levels of IL-3. It is 
difficult to directly compare these experiments since the present 
work involves transient expression whereas the transfection 
experiments of Miyatake et al. (1985b) involved selection for 
chromosomal integration. In addition, the expression of the 
integrated IL-3 genes may have been enhanced by adjacent copies 
of pSV^neo.
In WEHI-3B cells the IAP genome may have insertionally 
inactivated a cis-acting regulatory sequence or moved it upstream 
away from the IL-3 gene. It has been found that the c-mos proto- 
oncogene is regulated by such a sequence (Wood et. al., 1984). 
These workers observed that although transcription of c-mos was 
activated when a retroviral LTR was placed in the 5* flanking 
region, it was not when the LTR was located 3' to the gene. The 
reason was the influence of a negative cis-regulatory sequence 
0.8 to 1.8 kb upstream from the c-mos initiation codon. Initial 
studies suggest that this is not true of the present case. 
Transfection of a plasmid containing the IL-3 gene and either 480
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bp ( pILM 19) o r  a b o u t  5.0 kb (p ILM16)  o f  5'  f l a n k i n g  s e q u e n c e  
u p s t r e a m  f r o m  t h e  TATA box  p r o d u c e d  no d e t e c t a b l e  I L - 3  a c t i v i t y  
i n  NIH 3T3 c e l l s .  H o w e v e r  t h e  p o s s i b i l i t y  o f  a c i s  r e g u l a t o r y  
e l e m e n t  i s  c u r r e n t l y  b e i n g  s t u d i e d  f u r t h e r  i n  t h i s  l a b o r a t o r y .
Many r e t r o v i r u s e s  c a n  a c t  a s  i n s e r t i o n a l  m u t a g e n s ,  p r o m o t i n g  
t r a n s c r i p t i o n  o f  n e a r b y  g e n e s  by p r o v i d i n g  a p r o m o t e r  o r  e n h a n c e r  
e l e m e n t  i n  t h e  LTR. I n  t h e  r e a r r r a n g e d  I L - 3  g e n e  t h e  o r i e n t a t i o n  
o f  t h e  IAP 5'  LTR i s  s u c h  t h a t  n o r m a l  t r a n s c r i p t i o n  f r o m  w i t h i n  
t h e  LTR w o u l d  b e  d i r e c t e d  a w a y  f r o m  t h e  I L - 3  g e n e  b u t  t h e r e  i s  
a l s o  t h e  p o s s i b i l i t y  o f  a c r y p t i c  p r o m o t e r  b e i n g  p r e s e n t .  T h i s  
h a s  b e e n  d e m o n s t r a t e d  i n  t h e  c a s e  o f  t h e  r e a r r a n g e d  c - m o s  ge ne  
( H o r o w i t z  e t  a l . ,  1 9 8 4 ) .  H o w e v e r ,  a l l  t h r e e  I L - 3  cDNA c l o n e s  
f r o m  WEHI-3B w h i c h  h a v e  b e e n  c h a r a c t e r i z e d  (Fung  e t  a l . ,  1984)  
h a v e  t h e  s am e  5'  e n d  a s  t h e  f u l l - l e n g t h  cDNA c l o n e s  d e r i v e d  by 
Y o k o t a  e_t al_. ( 1984)  f r o m  a T c e l l  l i n e .  Th u s  i t  s e e m s  l i k e l y  
t h a t  m o s t  t r a n s c r i p t s  i n  WEHI-3B c e l l s  a r e  c o m i n g  f r o m  t h e  n o r m a l  
I L - 3  p r o m o t e r  w h i c h  i s  i n t a c t  i n  t h e  r e a r r a n g e d  g e n e .  
T r a n s c r i p t i o n  o f  t h e  I L - 3  g e n e  may  b e  u n d e r  t h e  i n f l u e n c e  o f  t h e  
e n h a n c e r - l i k e  e l e m e n t  p r e s e n t  i n  t h e  5'  LTR ( r e s u l t s  o f  C h a p t e r  
4 ) .  T h i s  p o s s i b i l i t y  i s  s u p p o r t e d  by  t r a n s f e c t i o n  s t u d i e s ,  a 
p l a s m i d  c o n t a i n i n g  o n l y  t h e  5'  LTR a n d  t h e  I L - 3  g e n e  was  
s u f f i c i e n t  t o  p r o m o t e  c o n s t i t u t i v e  p r o d u c t i o n  o f  I L - 3  a c t i v i t y  i n  
NIH 3T3 c e l l s .
The p o s s i b l e  r o l e  o f  I L - 3  i n  t u m o r i g e n i c i t y .
A d i s c u s s i o n  o f  t h e  p o s s i b l e  r o l e s  t h a t  h a e m o p o i e t i c  g r o w t h  
f a c t o r s  may p l a y  i n  t u m o r i g e n e s i s  was  g i v e n  i n  C h a p t e r  1 o f  t h i s  
t h e s i s .  The l e u k a e m i a  c e l l  l i n e  WEHI-3B i s  m a c r o p h a g e - l i k e  a nd  
s u c h  a c e l l  t y p e  w o u l d  n o t  n o r m a l l y  be e x p e c t e d  t o  p r o d u c e  I L - 3 .
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H o w e v e r  i t  d o e s  p r o d u c e  t h i s  f a c t o r  i n  a d e r e g u l a t e d  m a n n e r  due  
t o  t h e  r e a r r a n g e m e n t  o f  t h e  I L - 3  g e n e  i n v o l v i n g  a n  IAP e l e m e n t .
A s i t u a t i o n  r e m i n i s c e n t  o f  t h i s  i s  t h e  l a t e r  r e p o r t  o f  a 
r e t r o v i r a l  i n s e r t i o n  i n  t h e  3'  f l a n k i n g  r e g i o n  o f  t h e  I L - 2  g e ne  
o f  t h e  T l y m p h o s a r c o m a  c e l l  l i n e ,  MLA-144 ( C h a p t e r  1; Chen e t  
a l . ,  1 9 8 5 ) .  I t  h a s  b e e n  s u g g e s t e d  t h a t  t h e  p r o d u c t i o n  o f  I L - 3  by 
WEHI-3B may h a v e  b e e n  an  i m p o r t a n t  s t e p  i n  t h e  e v o l u t i o n  o f  t h i s  
l e u k a e m i a  ( D e x t e r  a n d  A l l e n ,  19 8 3 ;  S c h r a d e r  a n d  C r a p p e r ,  1983;  
G a r l a n d ,  1 9 84 ;  I s c o v e  a n d  R o i t s c h ,  1 9 8 5 ) .  I t  i s  p o s s i b l e  t h a t  
WEHI-3B a r o s e  i n i t i a l l y  f r o m  an  I L - 3 - d e p e n d e n t  n e u t r o p h i l -  
m a c r o p h a g e  p r o g e n i t o r  c e l l  a n d  t h a t  t h e  a c t i v a t i o n  o f  t h e  I L - 3  
g e n e  r e s u l t e d  i n  a u t o c r i n e  g r o w t h .  F u r t h e r  e v o l u t i o n  o f  t h i s  
p r o g e n i t o r  may h a v e  r e s u l t e d  i n  b y - p a s s i n g  t h i s  i n t i a l  a u t o c r i n e  
l o o p .  T h i s  may e x p l a i n  why WEHI-3B c e l l s  p o s s e s s  o n l y  l ow l e v e l s  
o f  I L - 3  r e c e p t o r s  ( G u i l b e r t  a n d  S t a n l e y ,  1 9 8 0 ;  P a l a s z y n s k i  a n d  
I h l e ,  1 9 8 4 ) ,  a l t h o u g h  t h i s  c o u l d  be d u e  t o  down r e g u l a t i o n  ( s e e  
M e t c a l f ,  1 9 8 5 ) .  P i e r c e  e t  a l .  ( 1 9 8 5)  h a v e  s h o w n  t h a t  s p e c i f i c  
a n t i - I L - 3  a n t i s e r a ,  p r e v i o u s l y  s h own  t o  i n h i b i t  t h e  p r o l i f e r a t i o n  
a n d  s u r v i v a l  o f  I L - 3 - d e p e n d e n t  c e l l s ,  d i d  n o t  i n h i b i t  t h e  g r o w t h  
o f  WEHI-3B c e l l s .  T h i s  s u g g e s t s  t h a t  a n  a u t o c r i n e  m e c h a n i s m  i s  
n o t  o p e r a t i n g ,  h o w e v e r  i t  c a n n o t  be r u l e d  o u t  t h a t  s u c h  a 
m e c h a n i s m  wa s  i n v o l v e d  i n i t i a l l y .
To i n v e s t i g a t e  t h e  p o s s i b l e  i n v o l v m e n t  o f  I L - 3  i n  
t u m o r i g e n e s i s  by a u t o c r i n e  s t i m u l a t i o n ,  r e t r o v i r a l  e x p r e s s i o n  
wo r k  h a s  b e e n  c a r r i e d  o u t  by  t h i s  l a b o r a t o r y  i n  c o l l a b o r a t i o n  
w i t h  D r s .  T.  R o b i n s  a n d  G. Vande  Woude o f  t h e  F r e d e r i c k  C a n c e r  
R e s e a r c h  F a c i l i t y ,  F r e d e r i c k ,  USA ( H a p e l  et: a l . , 1 9 8 6 ) .  I n  t h i s
s t u d y ,  DMA c a r r y i n g  t h e  p r o m o t e r  a n d  c o d i n g  r e g i o n s  o f  t h e  I L - 3  
g e n e ,  b u t  l a c k i n g  t h e  p o l y a d e n y l a t i o n  s i t e ,  was  c l o n e d  i n t o  t h e
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Moloney murine sarcoma virus (Mo-MSV) based retroviral shuttle 
vector, fp GV-1 (Jhappan, Vande Woude and Robins, 1986). In 
order to reconstitute infectious virions, the construct fp GV-IL3 
was transfected into monkey COS-1 cells infected with the 
replicative helper virus HIX. The supernatant from this 
transfection was used to infect NIH 3T3 cells which were 
subsequently selected for G418-resistance. These cells produced 
levels of IL-3 comparable to those produced by WEHI-3B cells. 
Recombinant virus was used to infect the IL-3-dependent cell line 
FDC-P1 (Dexter et al_., 1980) and G418-resistant and IL-3
independent cells subsequently selected (FDC-P1-IL3). These were 
found to secrete IL-3 and to cause fatal myeloid leukaemias when 
injected intravenously into mice. Specific anti-IL-3 antisera 
inhibited the growth of FDC-P1-IL3 cells which suggests that the 
autonomous growth of FDC-P1-IL3 cells is dependent on secreted 
IL-3 .
This study using retroviral expression of IL-3 was therefore 
successful in showing that constitutive expression of IL-3 in 
factor-dependent cells can yield a cell line capable of producing 
a rapid myeloid leukaemia when injected into mice. Since FDC-P1 
cells are immortalized they may be considered as having already 
undegone at least one step in the transformation process.
It would be of interest to determine the oncogenic potential 
of inappropriate expression of IL-3 and other factors in primary 
bone marrow cells and whether a cooperation of other oncogenic 
factors is required for full transformation. Adkins e_t a 1.
(1984) have carried out such an investigation into oncogenic 
cooperativity where chicken macrophages, immortalized by a v-myc 
containing retrovirus, were infected with a v-src containing
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v i r u s .  T h e s e  c e l l s  a c q u i r e d  t h e  a b i l i t y  t o  p r o d u c e  t h e  n o v e l  
c h i c k e n  m y e l o m o n o c y t i c  g r o w t h  f a c t o r ,  cMGF ( L e u t z ,  Beug a n d  G r a f ,  
1 9 8 4 ) .  T h i s  a c t i v i t y  a n d  t h e  a b i l i t y  o f  t h e s e  c e l l s  t o  
p r o l i f e r a t e  w a s  i n h i b i t e d  by a n t i - c M G F  a n t i s e r a ,  i m p l i c a t i n g  
a u t o c r i n e  s t i m u l a t i o n .  An e x t e n s i o n  o f  t h e s e  s t u d i e s  i n v o l v e d  
t r a n s f o r m a t i o n  o f  c h i c k e n  m y e l o m o n o c y t i c  c e l l s  by  v a r i o u s  
d e l e t i o n  m u t a n t s  o f  t h e  r e t r o v i r u s  MH2 w h i c h  c o n t a i n s  t h e  
o n c o g e n e  v - myc a n d  v - m i l  ( G r a f  e t  a l . ,  1 9 8 6 ) .  The s e c o n d  g e n e  i s  
a d i s t a n t  r e l a t i v e  o f  t h e  t y r o s i n e  k i n a s e  e n c o d i n g  v - s r c  g e n e  b u t  
s y n t h e s i z i n g  a p r o t e i n  w i t h  a s s o c i a t e d  s e r i n e - t h r e o n i n e  k i n a s e  
a c t i v i t y .  G r a f  e_t a l . ( 1986)  s h o w e d  t h a t  b o n e  m a r r o w  c e l l s  
t r a n s f o r m e d  w i t h  t h e  t w o  o n c o g e n e s  t o g e t h e r  e s t a b l i s h  a u t o c r i n e  
g r o w t h  i n  w h i c h  v - myc s t i m u l a t e s  c e l l  p r o l i f e r a t i o n ,  w h i l e  v - m i l  
i n d u c e s  t h e  p r o d u c t i o n  o f  cMGF. T h i s  a u t o c r i n e  s y s t e m  was  
v e r i f i e d  by t h e  u s e  o f  a n t i s e r a  a g a i n s t  cMGF. T h e s e  t w o  
o n c o g e n e s  c o o p e r a t e  _in v i v o  w h e r e  MH2 e f f i c i e n t l y  i n d u c e s  
m o n o c y t i c  l e u k a e m i a s  a n d  l i v e r  t u m o u r s ,  w h i l e  d e l e t i o n  m u t a n t s  
l a c k i n g  e i t h e r  f u n c t i o n a l  v - myc o r  v - m i l  d o  n o t .  W h e t h e r  v - m i l  
c a n  i n d u c e  n o r m a l  m y e l o m o n o c y t i c  c e l l s  t o  p r o d u c e  cMGF r e m a i n s  t o  
be d e t e r m i n e d .
A n a l y s i s  o f  t h e  I A P - I L 3  s t r u c t u r e .
The IAP s e q u e n c e  f a m i l y  i n  Mus m u s c u l u s  i s  h i g h l y  
p o l y m o r p h i c  w i t h  m e m b e r s  v a r y i n g  i n  s i z e  f r o m  3 t o  7 . 3  k b .  I n  
g e n e r a l  t e r m s ,  t h e  s m a l l e r  e l e m e n t s  a p p e a r  t o  be d e l e t e d  f o r m s  o f  
t h e  f u l l  l e n g t h  g e n o m e s .  C o n s i d e r a b l e  s e q u e n c e  h e t e r o g e n e i t y  
e x i s t s  w i t h i n  t h e  IAP s e q u e n c e  f a m i l y  d ue  t o  t h e  p r e s e n c e  o f  
v a r i a b l e  n u m b e r s  o f  r e p e a t e d  s e q u e n c e s  i n  i n d i v i d u a l  IAP e l e m e n t s  
a n d  t h e  p r e s e n c e  o r  a b s e n c e  o f  an  i n s e r t i o n - l i k e  e l e m e n t  A l l i n s
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( L u e d e r s  a n d  M i e t z  , 1 9 8 6 ) .  Known c a s e s  o f  t r a n s p o s i t i o n  o f  IAP
g e n o m e s  h a v e  o f t e n  i n v o l v e d  d e l e t e d  e l e m e n t s .  At  t h e  
c o m m e n c e m e n t  o f  t h e  w o r k  i n t o  t h e  r e a r r a n g e d  I L - 3  g e n e  h o w e v e r ,  
t h e  o n l y  IAP e l e m e n t  o f  Mus m u s c u l u s  w h o s e  f u l l  s e q u e n c e  was  
p u b l i s h e d  w a s  t h a t  o f  MIARN, a d e l e t e d  3.0 kb e l e m e n t  f o u n d  
i n s e r t e d  n e a r  t h e  r e n i n  g e n e  ( B u r t ,  R e i t h  a n d  B r a m m a r ,  1 9 8 4 ) .
The s e q u e n c e  a n a l y s i s  o f  I A P - I L 3  (Ymer  £ t  a l . ,  1 9 8 6 ) ,  c a r r i e d  o u t  
i n  C h a p t e r  4 o f  t h i s  t h e s i s ,  i s  t h e r e f o r e  t h e  f i r s t  f u l l  s e q u e n c e  
o f  a n  IAP e l e m e n t  w h i c h  h a s  r e c e n t l y  t r a n s p o s e d .
S e q u e n c e  a n a l y s i s  h a s  r e v e a l e d  many f e a t u r e s  r e m i n i s c e n t  o f  
r e t r o v i r a l  p r o v i r u s e s .  I A P - I L 3  i s  5.1 kb i n  l e n g t h  a n d  f l a n k e d  
by i d e n t i c a l  LTRs w h i c h  c a n  be  s u b d i v i d e d  i n t o  U3-R-U5 r e g i o n s .  
C o n s e r v e d  s e q u e n c e s  b e l i e v e d  t o  be  i m p o r t a n t  i n  RNA t r a n s c r i p t i o n  
a n d  i n i t i a t i o n  o f  p r o v i r a l  DNA s y n t h e s i s  w e r e  a l s o  p r e s e n t .  
C o m p a r a t i v e  s t u d i e s  w i t h  o t h e r  s e q u e n c e d •IAP g e n o m e s  a n d  
r e t r o v i r u s e s  h a v e  h e l p e d  t o  e l u c i d i a t e  t h e  c o d i n g  c a p a c i t y  o f  
I A P - I L 3  (Ymer  e_t a l . ,  1 9 8 6 ) .  A l t h o u g h  I A P - I L 3  h a s  o n e  l o n g  o p e n  
r e a d i n g  f r a m e  s p a n n i n g  t h e  p u t a t i v e  g ag  a n d  p o l  g e n e s ,  e v i d e n c e  
i n d i c a t e d  t h i s  r e a d i n g  f r a m e  c a r r i e d  a d e l e t i o n  ( a p p r o x i m a t e l y  
1 .8  k b )  c o v e r i n g  t h e  3'  e n d  o f  g a g  a n d  a s h o r t  s e g m e n t  o f  t h e  5'  
e n d  o f  p o l . L i k e  o t h e r  m e m b e r s  o f  t h e  IAP genome  f a m i l y  I A P - I L 3  
h a s  no r e c o g n i z a b l e  e n v  c o d i n g  r e g i o n  w h i c h  n o r m a l l y  o v e r l a p s  t h e  
p o l  g e n e  i n  o t h e r  r e t r o v i r u s e s .
IAP p a r t i c l e s  a r e  f o u n d  b u d d i n g  f r o m  t h e  e n d o p l a s m i c  
r e t i c u l u m  i n  s o m e  c e l l s  b u t  t h e  l a c k  o f  e n v , w h i c h  c o d e s  f o r  
e n v e l o p e  g l y c o p r o t e i n s ,  i s  t h o u g h t  t o  p r e v e n t  t h e  f i n a l  f o r m a t i o n  
o f  i n f e c t i o u s  e x t r a c e l l u l a r  v i r u s  ( K u f f ,  S m i t h  a nd  L u e d e r s ,  1 981 ;  
K u f f  a n d  F e w e l l ,  1 9 8 5 ;  Ono e_t a l . , 1 9 8 5 ) .  F o r m a t i o n  o f  p a r t i c l e s
f r o m d e l e t e d  IAP e l e m e n t s  s u c h  a s  I A P - I L 3  c o u l d  be e x p e c t e d  t o
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require complementation by elements coding for complete IAP 
proteins. There is evidence for the packaging of short RNAs 
derived from deleted IAP genomes supporting this possibility (Ono 
et. al., 1980 ). The particles have been found to contain a 
structural gag-like protein (p73) and a polymerase with reverse 
transcriptase activity (Kuff et al., 1972; Wilson et al., 1974).
In Chapter 4 of this thesis comparisons of IAP-IL3 with 
other retroviruses were made using the most conserved terminal 
one third of the pol gene, thought to code for the DMA 
endonuclease domain. IAP-IL3 was found to be most closely related 
to squirrel monkey retrovirus (type D) and mouse mammary tumour 
virus (type B), although homology was present with all retroviral 
groups. These results are in agreement with other studies 
carried out on the evolutionary relationships of retroviruses 
(Chiu e_t aJL., 1984 and 1985 ; Ono e_t al., 19 8 5).
Homology of IAP-IL3 with an IgE-BF cDNA.
Evidence is presented in Chapter 4, and has been reported 
elsewhere (Toh, Ono and Miyata, 1985; Moore et al., 1986; Ymer ejt 
al., 1986; Ymer and Young, 1986) for the close relationship of 
IAP elements and IgE-binding factor (IgE-BF) cDNA (Martens et 
al., 1986). IgE-BF factors are produced by T lymphocytes and are 
believed to regulate the production of IgE by B lymphocytes 
(Hirashima, Yodoi and Ishizaka, 1980; Suemura et. al_., 1980; 
Ishizaka, 1984). Analysis of the IgE-BF coding region indicates 
that it is entirely derived from segments of the putative IAP gag 
and pol (Ymer and Young, 1986). Further evidence for this has 
come from the work of Moore £t_ al. ( 1986) who showed that apart 
from the nucleotide homology, IgE-BF and the mouse IAP structural
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p r o t e i n  ( p 73)  s ee m t o  s h a r e  a n t i g e n i c  d e t e r m i n a n t s .  F u r t h e r  
p r e s u m p t i v e  I g E - B F  cDNA c l o n e s  h a v e  b e e n  s e q u e n c e d  a n d  
c h a r a c t e r i z e d  by K u f f  e t  aJL. ( 1986)  a n d  a l l  w e r e  f o u n d  t o  be 
s t r u c t u r a l  v a r i a n t s  o f  t h e  f u l l - s i z e d  (7 . 3  kb) IAP e l e m e n t .
T h e s e  w o r k e r s  s p e c u l a t e  t h a t  t h e  I g E - b i n d i n g  c a p a c i t y  i s  c o d e d  by 
t h e  g a g - r e  l a t e d  p o r t i o n s  o f  t h e  cDNA c l o n e s .
T h i s  r a i s e s  t h e  i n t e r e s t i n g  p o s s i b i l i t y  t h a t  some  m e m b e r s  o f  
t h e  IAP g e n e  f a m i l y  may h a v e  e v o l v e d  t o  e n c o d e  p r o t e i n s  w i t h  
b i o l o g i c a l  f u n c t i o n s  u n r e l a t e d  t o  r e t r o v i r a l  r e p l i c a t i o n .
H o w e v e r  t h e r e  a r e  some  p u z z l i n g  o b s e r v a t i o n s .  The I g E - B F  cDNA 
c l o n e  was  i s o l a t e d  f r o m  t h e  r a t - m o u s e  T c e l l  h y b r i d o m a  23B6,  
p r o d u c e d  by  f u s i n g  r a t  T l y m p h o c y t e s  w i t h  c e l l s  o f  t h e  AKR mouse  
t hy mo ma  BW5147 ( H u f f ,  Uede a n d  I s h i z a k a ,  1 9 8 2 ) .  As BW5147 was  
s h o w n  n o t  t o  p r o d u c e  I g E - B F ,  o ne  w o u l d  h a v e  e x p e c t e d  t o  i s o l a t e  
r a t  a n d  n o t  mouse  cDNA c l o n e s .  Moore  e_t a_l. ( 1986)  s u g g e s t  t h a t  
t h e , f u s i o n  may h a v e  a c t i v a t e d  t h e  p r o d u c t i o n  o f  I g E - B F  f r o m  t h e  
mouse  f u s i o n  p a r t n e r ,  a p h e n o m e n o n  t h a t  h a s  b e e n  o b s e r v e d  i n  B 
c e l l  h y b r i d s  ( R a s c h k e ,  M a t h e r  a n d  K o s h l a n d ,  1 9 7 9 ) .  I n  N o r t h e r n  
b l o t  a n a l y s i s  o f  mRNA i s o l a t e d  f r o m  s t i m u l a t e d  o r  u n s t i m u l a t e d  
23B6 c e l l s ,  p r o b i n g  w i t h  I g E - B F  cDNA, no d i f f e r e n c e  i n  t h e  
h y b r i d i z a t o n  p a t t e r n s  was  o b s e r v e d .  P e r h a p s  i n  s t i m u l a t e d  23B6 
c e l l s  I g E - B F  e x p r e s s i o n  i s  s t i l l  t o o  l o w  t o  be  d e t e c t e d  a b o v e  t h e  
h i g h  d e g r e e  o f  h y b r i d i z a t i o n  d ue  t o  o t h e r  IAP t r a n s c r i p t s .  
F i n a l l y ,  t h e  IAP p73  i s  a s t r u c t u r a l  p r o t e i n  i n v o l v e d  i n  t h e  
f o r m a t i o n  o f  p a r t i c l e s  w h i c h  a c c u m u l a t e  i n  t h e  e n d o p l a s m i c  
r e t i c u l u m .  T h i s  c o n t r a s t s  w i t h  t h e  s e c r e t o r y  n a t u r e  o f  I g E- BF .
T h i s  i s  t h e  f i r s t  b i o l o g i c a l  r o l e  a t t r i b u t e d  t o  IAP e l e m e n t s  
a p a r t  f r o m  t h e  p r o d u c t i o n  o f  i n s e r t i o n a l  m u t a t i o n s  t h r o u g h
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transposition and further work is obviously required to answer 
the questions raised.
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